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SUMMARY 
The intestinal spirochaetes Brachyspira aalborgi and Brachyspira pilosicoli 
colonise the large intestine of humans, whilst B. pilosicoli also colonises a number of animal 
species. Both organisms have been detected in human intestinal spirochaetosis (HIS), a 
syndrome where the spirochaetes attach end-on to the colorectal epithelium, forming a 
characteristic “false brush border”. Colonisation by B. pilosicoli occurs at >30% in 
Australian Aborigines (Lee & Hampson, 1992), homosexual males (Trivett-Moore et al., 
1998), human immunodeficiency virus (HIV)-positive individuals and individuals from 
developing countries (Barrett, 1990; Trott et al., 1997a). Studies on B. aalborgi have 
focussed mainly on its detection from Caucasians.  
Clinically, colonisation with Brachyspira spp. has been linked to gastrointestinal 
disorders, including chronic diarrhoea, abdominal pain and rectal bleeding. More seriously, 
invasive colitis and hepatitis associated with intestinal spirochaetes have been recorded, and 
B. pilosicoli has been isolated from the blood of nine patients. However, the pathogenic 
significance of Brachyspira spp. remains uncertain, due to an inconsistent clinical picture, 
carriage by healthy individuals and the absence of accurate spirochaete identification in 
many studies.  
Identification of the organisms by culture and microscopy has been difficult, due to 
morphological similarities and biochemical heterogeneity of the Brachyspira  spp.. In 
addition, B. pilosicoli is the easier spirochaete to culture, and so has predominated in studies 
assessing faecal carriage. The recent development of molecular methods has allowed 
unequivocal speciation of the Brachyspira spp.. Thus the main aim of this thesis was to 
examine the prevalence and epidemiology of B. pilosicoli and B. aalborgi in Australia, using 
this new methodology.  
Intestinal carriage of both species was examined in faecal specimens using 
culture, microscopy and two species-specific 16S rRNA PCRs. Carriage of 
Brachyspira spp. was determined in individuals from rural areas of Western 
Australia (WA) with gastrointestinal symptoms, (including 151 Aboriginal and 
142 non-Aboriginal Australians), 227 migrants to Australia, and 90 healthy 
control individuals from Perth, Western Australia. When samples were 
assessed by culture, B. pilosicoli was isolated from the faeces of 10.6% of 
migrant and 9.9% of Aboriginal Australian individuals. B. pilosicoli carriage 
was significantly higher in Aboriginal children aged 2 - 4 years (P = 0.0027) 
and migrants of African, Middle Eastern or Asian origin (P = 0.0034). 
Carriage in each population was associated with the detection of a number of 
intestinal parasites. It was not clear whether an association existed between 
B. pilosicoli isolation and disease, as similar proportions were found in sick 
Aboriginal patients and presumably healthy migrant individuals. B. pilosicoli 
may have caused disease in Aboriginal children where other pathogens were 
not present, or may have contributed to disease with known or suspected 
pathogens. In particular, colonisation was significantly more frequent in Table of Contents 
  
individuals with chronic diarrhoea or failure to thrive (FTT) (P = 0.016), and 
was also increased in elderly patients. The association of B. pilosicoli with 
parasites may have been due to behavioural factors, or an as yet unknown 
relationship between the organisms. 
B. aalborgi was not isolated from the specimens of rural individuals or 
migrants, as culture media and conditions for this organism were not optimal, 
but was thought to have been the spirochaetes seen by microscopy in 
culture negative samples. As a result, a more appropriate isolation medium 
for B. aalborgi was developed, containing brain heart infusion agar with 10% 
bovine blood, spectinomycin and polymyxin B. One isolate of B. aalborgi was 
obtained on this medium, from a control individual with self-reported chronic 
diarrhoea. The colonial, phase contrast and electron microscopic 
morphologies of two cell types present in the sample were described, and 
partial 16S rRNA sequences obtained. However, even with the modified 
media, other samples in this population contained spirochaetes that could 
not be cultured.  
PCR conducted on DNA extracted by the Qiagen QIAmp column method was more 
suitable for determining the prevalence of Brachyspira spp. in these specimens. B. pilosicoli 
was detected in higher proportions by PCR, in 15.0% of migrants and 14.5% of Aboriginals, 
but again not in symptomatic or healthy non-Aboriginal Australians. Detection of B. 
pilosicoli by PCR changed the identification of risk factors only a little; detection of 
protozoa in migrants, and protozoa, G. intestinalis, H. nana in Aboriginals were no longer 
associated with B. pilosicoli detection. B. aalborgi DNA was detected in 7.9% of migrants, 
6.9% of Aboriginals, 5.6% of non-Aboriginal patients, and 5.6% of controls. Approximately 
equal proportions were obtained from migrant individuals from African, Middle Eastern and 
Eastern European countries. Both spirochaete species were detected in migrants (5.6%) and 
Aboriginal Australians (4.1%), and carriage of one spirochaete was significantly associated 
with carriage of the other spirochaete in both populations (P <0.001). These data suggest 
that the two Brachyspira spp. have a different epidemiology, and that B. aalborgi may be 
distributed at a similar prevalence in many human populations.  
Carriage of B. aalborgi  was  associated  with  larger  family  size  in  migrants              
(P <0.001), and if a family member was positive, it was significantly more likely that other 
family members would be colonised (P = 0.008). Two colonised control individuals also 
came from the same family, all suggesting that transmission of B. aalborgi can occur 
between family members. Carriage of B. aalborgi was significantly higher in Aboriginal 
patients aged 2 - 18 y, and in non-Aboriginal patients aged >18 y and between 60 - 69 y. 
Detection was associated with various parasites in Aboriginals, but only protozoans in 
migrants (P = 0.014). Detection of B. aalborgi was associated with diarrhoea in non-
Aboriginals (P = 0.048), with an absence of diarrhoea (P = 0.016) amongst Aboriginals, and 
with eosinophilia, weight loss, being underweight and suspected worms in this group also (P 
<0.001). Whether B. aalborgi was a cause of these symptoms, or was excreted as a result of 
the symptoms caused by some other source, was unknown. The pathogenic significance of Table of Contents 
  
B. aalborgi also could not be resolved in this investigation, as similar proportions were 
detected in ill and healthy individuals, and detection was associated with different reasons 
for investigation in the two ill population groups. B. aalborgi could be a commensal in the 
human gastrointestinal tract, or may have the capacity to cause disease under certain 
circumstances, such as in individuals with poor immune status, or in a conducive gut 
microenvironment. 
PCR products were sequenced to attempt to differentiate between B. 
aalborgi strains. All except five strains were identical to the type strain, three 
had nucleotide changes that placed them in cluster 3 described by 
Pettersson et al. (2000), another strain shared similarity with cluster 2 or 3 
strains and the final strain remained in cluster 1. More complete sequencing 
of this gene, or the use of another sequence based typing method, such as 
multi-locus sequence typing, would be useful to further investigate the 
molecular epidemiology of B. aalborgi carriage in human populations. 
A comparison between techniques for intestinal spirochaete detection was made. 
PCR was the most successful method for detecting spirochaetes in faeces, with a lower limit 
of detection of B. pilosicoli in seeded faeces at 1 x 10
6 organism/g and 1 x 10
5 organism/g 
for B. aalborgi. Microscopy was inadequate for identifying the spirochaetes, and lacked 
sensitivity, with only 1 x 10
7 - 1 x 10
5 organisms/g of seeded faeces visible in this way. 
Culture was adequate for B. pilosicoli, with isolation possible from seeded faeces containing 
1 x 10
2 – 2 x 10
3 cfu/g. Culture was inadequate for B. aalborgi detection, despite isolation 
from seeded faeces at 2 x 10
4 cfu/g, and advances made to isolation media for this 
spirochaete in the course of this investigation.  
There were concerns that B. pilosicoli spirochaetaemia might be occurring in 
Western Australian populations with a high rate of intestinal carriage, but going 
undiagnosed. An evaluation of the blood culture systems commonly used in Australia 
indicated that the automated BACTEC system using the BACTEC plus Anaerobic/F bottle 
was best for the detection of B. pilosicoli in seeded blood. A protocol longer than the 5 d 
normally utilised by clinical laboratories was required to detect the organism when seeded at 
low concentrations. Both manual Hémoline and Septi-Chek media were as reliable as the 
BACTEC for B. pilosicoli growth, however detection in these systems required frequent 
subculture, and was thus time-consuming and laborious. The automated BacT/Alert system 
performed poorly both for detection and recovery of B. pilosicoli, and medium and 
algorithmic components were probable contributing factors. 
BACTEC Plus Anaerobic/F bottles inoculated with blood from 801 patients 
thought to be at risk for blood infection with B. pilosicoli were cultured for 14 
d, or 21 d after transport from rural centres. No isolate was obtained from 
these individuals, but there were some problems inherent in the 
investigation. However, while bacteraemia with B. pilosicoli is clearly a rare 
medical event, it should be considered as a differential diagnosis in Table of Contents 
  
immunocompromised individuals with gastrointestinal symptoms, and 
possibly in groups with high rates of intestinal carriage of B. pilosicoli. 
Pulsed-field gel electrophoresis, utilising MluI and SmaI restriction enzymes, 
was used to examine the relationships between B. pilosicoli isolates 
collected from Aboriginal and migrant individuals, and some pre-existing 
strains. In migrants, isolates were distributed throughout the dendrogram 
created after analysis with MluI; however, the migrants had originated from 
10 countries around the world. Two B. pilosicoli isolates from two individuals 
from the same family were closely related, indicating that exposure from a 
common source or transmission from one individual to another might have 
occurred. As no other isolate from migrants were related, even among 
members of other families, transmission between family members did not 
appear to be common. 
Strains from Australian Aboriginals were also distributed throughout the MluI 
dendrogram, but the majority (89.7%) were clustered in one of six clonal 
groups. Isolates were obtained from different locations and years of 
sampling, supporting previous observations that B. pilosicoli colonising 
Aboriginal people have an epidemic population structure (Trott et al., 1998). 
An explanation for the presence of clonal groups was not clear. Increased 
virulence of isolates may have contributed to the spread of B. pilosicoli 
clones in WA Aboriginals. All isolates from hospitalised individuals, and those 
obtained from samples where no other pathogen was detected were 
members of clonal groups, however, no isolate from healthy Aboriginals was 
included in the investigation. Resistance to one or more antimicrobial also 
may have favoured selection for and spread of clonal isolates in the 
Aboriginal population.  
The antimicrobial susceptibility of 139 B. pilosicoli isolates was obtained by a 
procedure modified from the NCCLS agar dilution method (NCCLS, 1990). 
Strains were generally sensitive to agents tested, but variably resistant to 
clindamycin and amoxicillin, depending on the source of strains. Over 50% of 
strains contained a β-lactamase that was inhibited by clavulanic acid. 
Significantly higher proportions of isolates from Aboriginal Australians (P 
<0.001) contained a β-lactamase than other isolates, while no isolate from 
PNG natives did (P <0.001), nor was any isolate from this population 
resistant to any other antimicrobial. Isolates from pigs and homosexuals 
demonstrated raised MICs for tetracycline and resistance to amoxicillin and 
clindamycin. All Aboriginal isolates in clonal groups contained a β-lactamase, 
as did other isolates not classified within clonal groups. Further analysis of 
the virulence characteristics and antibiotic susceptibility of the isolates is 
required. 
Based on susceptibility results and success in previous studies, 
metronidazole was a potential choice for treatment of HIS, and to remove 
intestinal carriage of B. pilosicoli. For therapy in spirochaetaemia, 
intravenous ceftriaxone or Timentin would be preferred over penicillin 
antibiotics in view of the frequent occurrence of resistance. Carriage of 
spirochaetes is currently going unrecognised in Australian laboratories, as 
current protocols do not specifically target their detection, and current 
medical opinion remains ambivalent about their significance. Detection by 
any of culture, microscopy, PCR is not difficult, and could be implemented to 
examine faecal specimens during investigations of individuals with chronic 
diarrhoea of unknown aetiology, or in children who are failing to thrive. Table of Contents 
  
In conclusion, the work presented in this thesis examined a range of issues 
relating to the epidemiology of intestinal spirochaetes in humans. The 
prevalence of B. aalborgi and B. pilosicoli was determined in faeces by 
microscopy, culture and PCR. The spirochaetes were present in both healthy 
and ill individuals, at around 15% for B. pilosicoli and 6% for B. aalborgi. 
Each organism was associated with specific risk factors in the populations 
assessed. The prevalence of bacteraemia with B. pilosicoli was examined, 
but no episode was identified in the study. The molecular epidemiology of B. 
pilosicoli was analysed using PFGE. MIC data were determined for B. 
pilosicoli and based on these, therapies for infections with this organism 
were suggested. Similar studies on B. aalborgi are now required to provide a 
more complete understanding of the epidemiology of this organism in 
humans.  Table of Contents 
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SUMMARY 
The intestinal spirochaetes Brachyspira aalborgi and Brachyspira pilosicoli 
colonise the large intestine of humans, whilst B. pilosicoli also colonises a number of animal 
species. Both organisms have been detected in human intestinal spirochaetosis (HIS), a 
syndrome where the spirochaetes attach end-on to the colorectal epithelium, forming a 
characteristic “false brush border”. Colonisation by B. pilosicoli occurs at >30% in 
Australian Aborigines (Lee & Hampson, 1992), homosexual males (Trivett-Moore et al., 
1998), human immunodeficiency virus (HIV)-positive individuals and individuals from 
developing countries (Barrett, 1990; Trott et al., 1997a). Studies on B. aalborgi have 
focussed mainly on its detection from Caucasians.  
Clinically, colonisation with Brachyspira spp. has been linked to gastrointestinal 
disorders, including chronic diarrhoea, abdominal pain and rectal bleeding. More seriously, 
invasive colitis and hepatitis associated with intestinal spirochaetes have been recorded, and 
B. pilosicoli has been isolated from the blood of nine patients. However, the pathogenic 
significance of Brachyspira spp. remains uncertain, due to an inconsistent clinical picture, 
carriage by healthy individuals and the absence of accurate spirochaete identification in 
many studies.  
Identification of the organisms by culture and microscopy has been difficult, due to 
morphological similarities and biochemical heterogeneity of the Brachyspira  spp.. In 
addition, B. pilosicoli is the easier spirochaete to culture, and so has predominated in studies 
assessing faecal carriage. The recent development of molecular methods has allowed 
unequivocal speciation of the Brachyspira spp.. Thus the main aim of this thesis was to 
examine the prevalence and epidemiology of B. pilosicoli and B. aalborgi in Australia, using 
this new methodology.  
Intestinal carriage of both species was examined in faecal specimens using culture, 
microscopy and two species-specific 16S rRNA PCRs. Carriage of Brachyspira spp. was 
determined in individuals from rural areas of Western Australia (WA) with gastrointestinal 
symptoms, (including 151 Aboriginal and 142 non-Aboriginal Australians), 227 migrants to 
Australia, and 90 healthy control individuals from Perth, Western Australia. When samples 
were assessed by culture, B. pilosicoli was isolated from the faeces of 10.6% of migrant and 
9.9% of Aboriginal Australian individuals. B. pilosicoli carriage was significantly higher in 
Aboriginal children aged 2 - 4 years (P = 0.0027) and migrants of African, Middle Eastern 
or Asian origin (P = 0.0034). Carriage in each population was associated with the detection 
of a number of intestinal parasites. It was not clear whether an association existed between 
B. pilosicoli isolation and disease, as similar proportions were found in sick Aboriginal 
patients and presumably healthy migrant individuals. B. pilosicoli may have caused disease ii 
   
in Aboriginal children where other pathogens were not present, or may have contributed to 
disease with known or suspected pathogens. In particular, colonisation was significantly 
more frequent in individuals with chronic diarrhoea or failure to thrive (FTT) (P = 0.016), 
and was also increased in elderly patients. The association of B. pilosicoli with parasites may 
have been due to behavioural factors, or an as yet unknown relationship between the 
organisms. 
B. aalborgi was not isolated from the specimens of rural individuals or migrants, as 
culture media and conditions for this organism were not optimal, but was thought to have 
been the spirochaetes seen by microscopy in culture negative samples. As a result, a more 
appropriate isolation medium for B. aalborgi was developed, containing brain heart infusion 
agar with 10% bovine blood, spectinomycin and polymyxin B. One isolate of B. aalborgi 
was obtained on this medium, from a control individual with self-reported chronic diarrhoea. 
The colonial, phase contrast and electron microscopic morphologies of two cell types 
present in the sample were described, and partial 16S rRNA sequences obtained. However, 
even with the modified media, other samples in this population contained spirochaetes that 
could not be cultured.  
PCR conducted on DNA extracted by the Qiagen QIAmp column method was more 
suitable for determining the prevalence of Brachyspira spp. in these specimens. B. pilosicoli 
was detected in higher proportions by PCR, in 15.0% of migrants and 14.5% of Aboriginals, 
but again not in symptomatic or healthy non-Aboriginal Australians. Detection of B. 
pilosicoli by PCR changed the identification of risk factors only a little; detection of 
protozoa in migrants, and protozoa, G. intestinalis, H. nana in Aboriginals were no longer 
associated with B. pilosicoli detection. B. aalborgi DNA was detected in 7.9% of migrants, 
6.9% of Aboriginals, 5.6% of non-Aboriginal patients, and 5.6% of controls. Approximately 
equal proportions were obtained from migrant individuals from African, Middle Eastern and 
Eastern European countries. Both spirochaete species were detected in migrants (5.6%) and 
Aboriginal Australians (4.1%), and carriage of one spirochaete was significantly associated 
with carriage of the other spirochaete in both populations (P <0.001). These data suggest 
that the two Brachyspira spp. have a different epidemiology, and that B. aalborgi may be 
distributed at a similar prevalence in many human populations.  
Carriage of B. aalborgi  was  associated  with  larger  family  size  in  migrants              
(P <0.001), and if a family member was positive, it was significantly more likely that other 
family members would be colonised (P = 0.008). Two colonised control individuals also 
came from the same family, all suggesting that transmission of B. aalborgi can occur 
between family members. Carriage of B. aalborgi was significantly higher in Aboriginal 
patients aged 2 - 18 y, and in non-Aboriginal patients aged >18 y and between 60 - 69 y. 
Detection was associated with various parasites in Aboriginals, but only protozoans in iii 
   
migrants (P = 0.014). Detection of B. aalborgi was associated with diarrhoea in non-
Aboriginals (P = 0.048), with an absence of diarrhoea (P = 0.016) amongst Aboriginals, and 
with eosinophilia, weight loss, being underweight and suspected worms in this group also (P 
<0.001). Whether B. aalborgi was a cause of these symptoms, or was excreted as a result of 
the symptoms caused by some other source, was unknown. The pathogenic significance of 
B. aalborgi also could not be resolved in this investigation, as similar proportions were 
detected in ill and healthy individuals, and detection was associated with different reasons 
for investigation in the two ill population groups. B. aalborgi could be a commensal in the 
human gastrointestinal tract, or may have the capacity to cause disease under certain 
circumstances, such as in individuals with poor immune status, or in a conducive gut 
microenvironment. 
PCR products were sequenced to attempt to differentiate between B. aalborgi 
strains. All except five strains were identical to the type strain, three had nucleotide changes 
that placed them in cluster 3 described by Pettersson et al. (2000), another strain shared 
similarity with cluster 2 or 3 strains and the final strain remained in cluster 1. More complete 
sequencing of this gene, or the use of another sequence based typing method, such as multi-
locus sequence typing, would be useful to further investigate the molecular epidemiology of 
B. aalborgi carriage in human populations. 
A comparison between techniques for intestinal spirochaete detection was made. 
PCR was the most successful method for detecting spirochaetes in faeces, with a lower limit 
of detection of B. pilosicoli in seeded faeces at 1 x 10
6 organism/g and 1 x 10
5 organism/g 
for B. aalborgi. Microscopy was inadequate for identifying the spirochaetes, and lacked 
sensitivity, with only 1 x 10
7 - 1 x 10
5 organisms/g of seeded faeces visible in this way. 
Culture was adequate for B. pilosicoli, with isolation possible from seeded faeces containing 
1 x 10
2 – 2 x 10
3 cfu/g. Culture was inadequate for B. aalborgi detection, despite isolation 
from seeded faeces at 2 x 10
4 cfu/g, and advances made to isolation media for this 
spirochaete in the course of this investigation.  
There were concerns that B. pilosicoli spirochaetaemia might be occurring in 
Western Australian populations with a high rate of intestinal carriage, but going 
undiagnosed. An evaluation of the blood culture systems commonly used in Australia 
indicated that the automated BACTEC system using the BACTEC plus Anaerobic/F bottle 
was best for the detection of B. pilosicoli in seeded blood. A protocol longer than the 5 d 
normally utilised by clinical laboratories was required to detect the organism when seeded at 
low concentrations. Both manual Hémoline and Septi-Chek media were as reliable as the 
BACTEC for B. pilosicoli growth, however detection in these systems required frequent 
subculture, and was thus time-consuming and laborious. The automated BacT/Alert system iv 
   
performed poorly both for detection and recovery of B. pilosicoli, and medium and 
algorithmic components were probable contributing factors. 
BACTEC Plus Anaerobic/F bottles inoculated with blood from 801 patients thought 
to be at risk for blood infection with B. pilosicoli were cultured for 14 d, or 21 d after 
transport from rural centres. No isolate was obtained from these individuals, but there were 
some problems inherent in the investigation. However, while bacteraemia with B. pilosicoli 
is clearly a rare medical event, it should be considered as a differential diagnosis in 
immunocompromised individuals with gastrointestinal symptoms, and possibly in groups 
with high rates of intestinal carriage of B. pilosicoli. 
Pulsed-field gel electrophoresis, utilising MluI and SmaI restriction enzymes, was 
used to examine the relationships between B. pilosicoli isolates collected from Aboriginal 
and migrant individuals, and some pre-existing strains. In migrants, isolates were distributed 
throughout the dendrogram created after analysis with MluI; however, the migrants had 
originated from 10 countries around the world. Two B. pilosicoli isolates from two 
individuals from the same family were closely related, indicating that exposure from a 
common source or transmission from one individual to another might have occurred. As no 
other isolate from migrants were related, even among members of other families, 
transmission between family members did not appear to be common. 
Strains from Australian Aboriginals were also distributed throughout the MluI 
dendrogram, but the majority (89.7%) were clustered in one of six clonal groups. Isolates 
were obtained from different locations and years of sampling, supporting previous 
observations that B. pilosicoli colonising Aboriginal people have an epidemic population 
structure (Trott et al., 1998). An explanation for the presence of clonal groups was not clear. 
Increased virulence of isolates may have contributed to the spread of B. pilosicoli clones in 
WA Aboriginals. All isolates from hospitalised individuals, and those obtained from samples 
where no other pathogen was detected were members of clonal groups, however, no isolate 
from healthy Aboriginals was included in the investigation. Resistance to one or more 
antimicrobial also may have favoured selection for and spread of clonal isolates in the 
Aboriginal population.  
The antimicrobial susceptibility of 139 B. pilosicoli isolates was obtained by a 
procedure modified from the NCCLS agar dilution method (NCCLS, 1990). Strains were 
generally sensitive to agents tested, but variably resistant to clindamycin and amoxicillin, 
depending on the source of strains. Over 50% of strains contained a β-lactamase that was 
inhibited by clavulanic acid. Significantly higher proportions of isolates from Aboriginal 
Australians (P <0.001) contained a β-lactamase than other isolates, while no isolate from 
PNG natives did (P <0.001), nor was any isolate from this population resistant to any other v 
   
antimicrobial. Isolates from pigs and homosexuals demonstrated raised MICs for 
tetracycline and resistance to amoxicillin and clindamycin. All Aboriginal isolates in clonal 
groups contained a β-lactamase, as did other isolates not classified within clonal groups. 
Further analysis of the virulence characteristics and antibiotic susceptibility of the isolates is 
required. 
Based on susceptibility results and success in previous studies, metronidazole was a 
potential choice for treatment of HIS, and to remove intestinal carriage of B. pilosicoli. For 
therapy in spirochaetaemia, intravenous ceftriaxone or Timentin would be preferred over 
penicillin antibiotics in view of the frequent occurrence of resistance. Carriage of 
spirochaetes is currently going unrecognised in Australian laboratories, as current protocols 
do not specifically target their detection, and current medical opinion remains ambivalent 
about their significance. Detection by any of culture, microscopy, PCR is not difficult, and 
could be implemented to examine faecal specimens during investigations of individuals with 
chronic diarrhoea of unknown aetiology, or in children who are failing to thrive. 
In conclusion, the work presented in this thesis examined a range of issues relating 
to the epidemiology of intestinal spirochaetes in humans. The prevalence of B. aalborgi and 
B. pilosicoli was determined in faeces by microscopy, culture and PCR. The spirochaetes 
were present in both healthy and ill individuals, at around 15% for B. pilosicoli and 6% for 
B. aalborgi. Each organism was associated with specific risk factors in the populations 
assessed. The prevalence of bacteraemia with B. pilosicoli was examined, but no episode 
was identified in the study. The molecular epidemiology of B. pilosicoli was analysed using 
PFGE. MIC data were determined for B. pilosicoli and based on these, therapies for 
infections with this organism were suggested. Similar studies on B. aalborgi are now 
required to provide a more complete understanding of the epidemiology of this organism in 
humans.  vi 
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1.1 INTRODUCTION 
The work described in this thesis is a study into the detection, distribution and 
epidemiology of the intestinal spirochaetes Brachyspira pilosicoli and Brachyspira aalborgi 
in humans in Australia, particularly Western Australia. This literature review is structured to 
facilitate an understanding of intestinal spirochaetes in general, and intestinal spirochaetes in 
humans in particular. Firstly, general morphological and biological characteristics of all 
spirochaetes will be described, placing the genus Brachyspira  in the context of other 
spirochaete genera. A brief history, and changes to the taxonomy of the current genus 
Brachyspira will be followed by definitions and nomenclature used throughout this thesis.  
Background information will then be presented, regarding members of the genus 
Brachyspira which do not infect humans, including the five described species; B. 
hyodysenteriae, B. innocens, B. intermedia, B. murdochii, B. alvinipulli, and two proposed 
species “B. pulli” and “B. canis”. A brief description will be made of the history, 
morphology and biochemistry of each species, plus details of transmission, colonisation and 
the diseases that each cause in animals. These attributes then will be described in greater 
detail for B. pilosicoli and B. aalborgi, the organisms under study. This information will 
serve to highlight the broad host and geographic distribution of Brachyspira spp., and 
emphasise similarities in morphology, distribution and disease-causing capacity throughout 
animals. In addition, this section will provide a context for studies on these organisms in the 
diagnosis and typing sections.  
The next section will describe studies of intestinal spirochaetes in humans, with an 
emphasis on symptoms, association with disease, and how improved diagnostic technology 
has shaped an understanding of this complex situation. The section will begin with the early 
history of spiral organisms in faeces. Human intestinal spirochaetosis (HIS) will then be 
defined, and symptoms, prevalence, pathogenic significance of the syndrome and 
identification of Brachyspira spp. will be described. A description of concurrent studies 
using cultural techniques of human intestinal spirochaetes will follow, again describing 
prevalence, symptoms, significance and representative Brachyspira  spp. Lastly, a 
description will be made of the isolation of B. pilosicoli from the blood of human patients.  
The last three sections will detail the numerous techniques which have been utilised 
for the diagnosis, typing and antimicrobial susceptibility testing of the intestinal 
spirochaetes, in order to contextualise those which will be described in later chapters. 
Traditional techniques will be followed by molecular methods of diagnosis and typing, and Chapter 1 - Literature Review  
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in each section, emphasis will be placed upon research on B. pilosicoli and on the human 
intestinal spirochaetes. A general summary and aims of the work will conclude the chapter.  
 
1.2 INTESTINAL  SPIROCHAETES 
1.2.1  An introduction to spirochaetes 
Spirochaetes are helically shaped, motile bacteria characterised by a unique cellular 
anatomy and morphology (Hampson & Trott, 1995; Paster & Dewhirst, 2000). They are 
exceptional in their possession of periplasmic flagella, also known as periplasmic fibrils, 
axial fibrils or filaments, or endoflagella (Paster & Dewhirst, 1997). Periplasmic flagella are 
internal organelles of motility, located between the outer membrane and the protoplasmic 
cylinder that encloses the cytoplasmic and nuclear regions (Holt et al., 1994). One end of a 
flagellum is inserted subterminally to the end of the cell, the flagellum wraps permanently 
around the protoplasmic cylinder and the other end remains free (Holt et al., 1994; Paster & 
Dewhirst, 1997). The flagella are paired and overlap to a certain extent in the centre of the 
cell, thus a cell with two flagella will have one inserted at each end of the cell. Periplasmic 
flagella can number two to hundreds per cell, depending on spirochaete species (Paster et al., 
1991).  
The flagella are integral to the translational, rotational and flexing motilities of 
spirochaetes. The endocellular location allow for a swimming movement in environments of 
high viscosity, and creeping on solid surfaces such as agar (Holt et al., 1994). Possession of 
periplasmic flagella allow spirochaetes motility in niches where the high viscosity of fluids 
inhibit the movement of organisms with external flagella (Holt et al., 1994). The 
biodiversity of spirochaetes extends from the intestinal tract of mammals, insects and 
bivalves, to aquatic and marine environments (Paster & Dewhirst, 2000).  
Spirochaetes possess a limited affinity for Gram and other stains, probably due to 
their unique cellular structure (Baranton & Old, 1995), and appear weakly Gram negative 
(Holt et al., 1994). However, they can be easily identified by the characteristic helical 
morphology, and flexing and rotational motilities using phase contrast or dark phase 
microscopy (Holt et al., 1994; Baranton & Old, 1995). Spirochaetes can be free living or 
host associated, and both pathogenic and saprophytic species are represented. They can be 
aerobic, microaerophilic, facultative anaerobes or strict anaerobes, and division is by binary 
fission (Holt et al., 1994). Spirochaetes are fastidious organisms and many species are 
uncultivable (Baranton & Old, 1995). Fortunately, molecular taxonomic techniques have 
allowed for classification of these bacteria (Olsen et al., 2000).  
Spirochaetes are one of the few major bacterial groups where gross phenotypic 
characteristics reflect phylogenetic relationships (Paster et al., 1991). Comparisons of 16S Chapter 1 - Literature Review  
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rRNA or 16S rDNA sequences indicate that spirochaetes constitute a coherent phylogenetic 
phylum (Paster & Dewhirst, 2000). Despite deep branching within the phylum, unique base 
signatures in the 16S rRNA support the inclusion of spirochaetes in a single monophyletic 
phylum descending from a common ancestor (Paster et al., 1991), rather than as the result of 
convergent evolution as was previously thought (Greenberg & Canale-Parola, 1977). Class 
Spirochaetes,  Order  Spirochaetales  contains three families, the Brachyspiraceae, 
Spirochaetaceae  and  Leptospiraceae (Paster & Dewhirst, 2000), and the current 
phylogenetic relationships between representatives of these families are demonstrated in 
Figure 1.1. 
 
1.2.2  An introduction to Brachyspira  
1.2.2.1  History, taxonomy and nomenclature  
The first identified member of the current Genus Brachyspira was isolated from a 
pig with swine dysentery (Taylor & Alexander, 1971), and was named Treponema 
hyodysenteriae (Harris et al., 1972a), based on morphology, habitat, and a requirement for 
anaerobic growth (Hampson & Trott, 1995). Subsequently, T. innocens, a morphologically 
identical, biochemically related, non-pathogenic spirochaete of swine was isolated (Kinyon 
& Harris, 1979). However, it was found that the G+C contents of T. hyodysenteriae and T. 
innocens were 25.8 mol%, compared with the 53 mol% G+C content of T. pallidum (Miao 
& Fieldsteel, 1978). Moreover, only <5% sequence homology was shared between T. 
pallidum  and the type strains of T. hyodysenteriae and  T. innocens. Unique 16S rRNA 
regions were found in T. hyodysenteriae (Paster et al., 1984), and levels of 16S rRNA 
sequence similarity were over 99% between T. hyodysenteriae and T. innocens, yet only 
76.5% with other spirochaetes (Figure 1.1). The T. hyodysenteriae branch was thus 
concluded to be distantly related (Stanton et al., 1991). For these reasons the genus was 
renamed  Serpula  (L. little serpent) (Stanton et al., 1991), and subsequently changed to 
Serpulina (L little serpent of), as Serpula was already used to designate a fungal species 
(Stanton, 1992). Multilocus enzyme electrophoresis (MLEE) studies of spirochaetes from 
pigs, chickens, dogs and humans revealed other Serpulina  species distinct from S. 
hyodysenteriae and S. innocens (Lee et al., 1993b; Lee et al., 1993c; McLaren et al., 1997; 
Duhamel et al., 1998c). Among these was Serpulina pilosicoli (Trott et al., 1996c). 
In the meantime, a spirochaete had been isolated from rectal biopsies of humans 
(Hovind-Hougen et al., 1982). Morphological and biochemical differences were observed 
with T. hyodysenteriae and T. innocens, as they were still called. The new organism did not 
possess cytoplasmic tubules, a criterion for classification as a Treponeme (Hovind-Hougen Chapter 1 - Literature Review  
   4
et al., 1982). Thus a new genus and species, Brachyspira (Gr. short helix) aalborgi, were 
proposed for this organism (Hovind-Hougen et al., 1982).  
Further phenotypic and genotypic differences between Serpulina and Brachyspira 
spirochaetes were described, with B. aalborgi branching earlier in phylogenetic trees 
(Pettersson et al., 1996) and separated from other Serpulina  species by MLEE (Lee & 
Hampson, 1994). However, a ≥96.0% 16S rDNA sequence homology between B. aalborgi 
and S. pilosicoli, S. hyodysenteriae and S. innocens prompted reclassification of the species 
Serpulina as Brachyspira (Ochiai et al., 1997), as this was the first-named genus. While use 
of  Brachyspira  has now been generally accepted, there are still those who debate the 
inclusion of all the species within a single genus (Pettersson et al., 2000).  
The genus Brachyspira currently contains at least seven, and perhaps as many as ten 
or eleven species. The taxonomy of the genus continues to expand as new classification 
techniques emerge. All members of the genus will be referred to as Brachyspira,  even 
though not all have been officially named thus (Anonymous, 1998). The term Brachyspira 
will be used, even if investigations were carried out on species before this name was applied, 
except when historical accuracy is required. The epithet “intestinal spirochaete” refers to a 
biological habitat, rather than a specific genetic grouping, and in the context of this thesis 
will be used to refer to any member of the genus Brachyspira. Treponema succinifaciens, an 
anaerobic, non-pathogenic spirochaete which inhabits the swine intestine (Cwyk & Canale-
Parola, 1979), will not be mentioned further. “Human intestinal spirochaete” will be used to 
refer to a member of the Brachyspira genus inhabiting the human intestine, particularly 
where the organism has not been identified, and while it is most likely that the spirochaete is 
one of B. aalborgi or B. pilosicoli, recent evidence to be discussed indicates that this may 
not always be the case. “Weakly β-haemolytic intestinal spirochaete” (WBHIS) will be used 
to refer to any member(s) of the species Brachyspira which form a characteristic weak β-
haemolysis on blood agar.  
 
1.2.3 The  genus  Brachyspira  
To provide a biological, host range, pathogenic and a historical context for the 
human intestinal spirochaetes, other members of the genus Brachyspira are introduced in 
this section. General morphological and biochemical properties, together with associated 
diseases in animals will be described. Important background information, which is currently 
unknown for B. pilosicoli and B. aalborgi, also will be provided about these species. 
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1.2.3.1  Brachyspira hyodysenteriae  
Brachyspira  hyodysenteriae (L. gen. n. of swine dysentery) is the best studied 
species in the genus (Hampson et al., 1999). Cells are 7 - 12 µm in length and 320 - 380 nm 
diameter, and have 7 - 14 periplasmic flagella inserted in each cell end. The key biochemical 
properties of the organism are given in Table 1.1. Strong β-haemolysis, a positive indole 
reaction, fructose production and the lack of α-galactosidase activity have been to used to 
distinguish the species from other Brachyspira. However, other Brachyspira strains are 
occasionally strongly haemolytic (Neef et al., 1994), and indole negative B. hyodysenteriae 
from Belgium and Germany (Hommez et al., 1998a; Fellström et al., 1999) have been 
described.  
B. hyodysenteriae is the primary aetiological agent of swine dysentery (Sd). This is a 
severe mucohaemorrhagic diarrhoea of pigs in the growing to finishing period (Harris et al., 
1999). The disease was first described in 1921 (Whiting et al., 1921), but the causative 
organism was not determined until the early 1970’s when Taylor and Alexander (Taylor & 
Alexander, 1971), and Harris and colleagues (1972a) simultaneously described Treponema 
hyodysenteriae. Harris et al. (1972a) were responsible for naming the organism, and both 
groups inoculated the organism into pigs to reproduce symptoms and lesions of Sd (Taylor 
& Alexander, 1971; Glock & Harris, 1972; Harris et al., 1972a).  
Sd is widespread throughout the world in swine farming areas and is an 
economically important disease due to mortality, decreased growth rate, poor feed 
conversion and costs of chemotherapy. Pigs are the main host for B. hyodysenteriae 
(Hampson & Trott, 1995). The organism can also cause necrotising typhlocolitis in rheas, 
without contact with swine (Sagartz et al., 1992; Jensen et al., 1996; Stanton et al., 1996). 
Rats and mice can harbour B. hyodysenteriae (Joens & Kinyon, 1982; Hampson et al., 
1991), and the organism has been isolated from a dog which had eaten pig faeces (Songer et 
al., 1978). Experimental infection has been successful in mice, starlings, young chicks, 
guinea pigs and dogs, with the mice, chicks and guinea pigs demonstrating clinical signs 
(Glock et al., 1978; Joens et al., 1978; Joens & Glock, 1979; Adachi et al., 1985).  
Transmission of B. hyodysenteriae to swine and other animals occurs by ingestion of 
faecal material from either clinically affected or asymptomatic pigs carrying the organism in 
the gut (Harris et al., 1999). Sows can infect suckling young in this manner (Harris et al., 
1999). Transmission can also occur via vectors such as swine caretakers, lagoon water 
containing effluent, pits under pig houses, and animal vectors including dogs, field mice, rats 
and flies (Glock et al., 1975; Songer et al., 1978; Joens & Kinyon, 1982; Hampson et al., 
1991; Olson, 1995; Harris et al., 1999). The spirochaete can survive in faeces for 7 d at 
25°C, for 61 d at 5°C (Chia & Taylor, 1978) and in soil (Boye et al., 2001), thus Chapter 1 - Literature Review  
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demonstrating a potential to survive a wide range of environmental conditions, despite the 
anaerobic nature of the organism (Harris et al., 1999). The asymptomatic carrier pig is 
believed to be the most important mode of transmission between farms.  
Treatment of Sd involves the use of antibiotics including streptomycin, bacitracin, 
neomycin, tylosin, gentamicin, chlortetracycline, virginiamycin and lincomycin. Resistances 
to carbadox and tiamulin have been reported uncommonly (Harris et al., 1999), and 
complete resistance to lincomycin, ronidazole and metronidazole has been shown only in 
Poland (Binek et al., 1994). A variety of vaccines have been developed to attempt the 
control of Sd, including bacterins and recombinant proteins (Fernie et al., 1983; Gabe et al., 
1995). Of these, only bacterins have been successful in experimental studies, and even here 
the results have been variable (Fernie et al., 1983; Hampson et al., 1993). Elimination of the 
spirochaete is possible by treatment of infected pigs, particularly asymptomatic carriers, with 
antibiotics, housing in conditions with minimum exposure to faeces, cleaning and 
disinfection of facilities and control of rodent populations (Harris et al., 1999).  
 
1.2.3.2  Brachyspira innocens  
B. innocens is a weakly β-haemolytic non-pathogenic spirochaete commensal of the 
swine colon (Kinyon & Harris, 1979). Early investigators of Sd soon realised that some 
spirochaetes isolated from swine were not B. hyodysenteriae, despite sharing morphology 
and serological cross reactivity with this species (Hudson et al., 1976). These isolates were 
not enteropathogenic for swine, could be isolated from pigs without Sd, and had only 28% 
DNA-DNA homology with B. hyodysenteriae (Miao & Fieldsteel, 1978), indicating that 
they were a genetically distinct species. The species could be differentiated from B. 
hyodysenteriae on the basis of enteropathogenicity, weak β-haemolysis, and the ability to 
ferment fructose but not produce indole (Table 1.1). Consequently the group was described 
as a new species, B. innocens (L. doing no harm) (Kinyon & Harris, 1979).  
The species is commonly isolated from pigs (Lee et al., 1993b) and such isolates 
have failed to colonise experimentally infected chickens (Trott et al., 1995). The organism is 
non-pathogenic in conventional pigs (Kinyon & Harris, 1979), and two isolates from 
Australian chickens were regarded as having no significance (McLaren et al., 1997). 
 
1.2.3.3  Brachyspira intermedia  
B. intermedia (L. in the middle) was described after the MLEE analysis of a large 
collection of intestinal spirochaetes from swine revealed new groups that did not correspond 
to previously described species (Lee et al., 1993b). DNA-DNA reassociation studies 
confirmed this new assignment (Stanton et al., 1997). B. intermedia PWS/AT has a G+C Chapter 1 - Literature Review  
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content of 25 mol%, cells have 12 - 14 flagella at each end and average dimensions are 7.5 – 
10  µm by 0.35 - 0.45 µm. It is not possible to distinguish B. hyodysenteriae and  B. 
intermedia by cell dimension, morphology or number of flagella (Stanton et al., 1997). B. 
intermedia is biochemically similar to B. hyodysenteriae, but can be differentiated on the 
basis of haemolysis (Table 1.1). In fact, the name B. intermedia refers to the biochemically 
intermediate position it occupies between B. hyodysenteriae and B. innocens (Stanton et al., 
1997), as it is a WBHIS but produces indole and resembles B. hyodysenteriae. 
B. intermedia has been found in swine and poultry, and in swine the pathogenic 
potential of this species is unknown. The organism has been isolated from pigs with 
diarrhoea (Fellström & Gunnarsson, 1995; Hampson & Trott, 1995), although experimental 
infection of pigs with the type strain did not produce disease (Hudson et al., 1976). In 
poultry however, the pathogenic potential of B. intermedia has been confirmed. The 
organism has been isolated from commercial layer and broiler breeder poultry flocks with 
diarrhoea, poor egg production and stunted growth (Griffiths et al., 1987; McLaren et al., 
1996; McLaren et al., 1997). Experimental infection of broilers and layers resulted in 
increased faecal water content, faecal egg staining, reduced egg production and poor growth 
and body condition (Dwars et al., 1989; Dwars et al., 1990; Dwars et al., 1992a; Dwars et 
al., 1992b; Hampson & McLaren, 1999). It is considered that the widespread distribution of 
B. intermedia is likely to be a cause of economic loss in Australian and European poultry 
industries (Hampson & McLaren, 1999).  
 
1.2.3.4  Brachyspira murdochii  
Initial investigations into B. murdochii (for Murdoch University) occurred 
concomitantly with B. intermedia. B. murdochii 56-150T has a G+C content of 27 mol%, 
cells of 5 – 8 µm by 0.35 - 0.4 µm, with 11 - 13 periplasmic flagella at each end (Stanton et 
al., 1997). The species differs biochemically from B. innocens by lacking α-galactosidase 
activity (Lee, 1994; Stanton et al., 1997).  
B. murdochii is commonly isolated from the intestinal contents of healthy swine and 
wild and laboratory rats (Trott et al., 1996a). The spirochaete failed to colonise 
experimentally challenged day old chicks (Trott & Hampson, 1998), although experimental 
infection of pigs has not been attempted (Hampson et al., 1999). B. murdochii was originally 
considered to be non-pathogenic (Stanton et al., 1997). However, the isolation of the 
organism from the hip joint of a lame pig demonstrated the capacity of the organism to 
access extra-intestinal body sites (Hampson et al., 1999). Thus B. murdochii may have 
pathogenic potential, which requires further clarification. 
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1.2.3.5  Brachyspira alvinipulli  
MLEE analysis of a collection of intestinal spirochaetes from chickens again 
revealed previously undescribed groups (McLaren et al., 1997). One such group contained 
two strains, isolated from a chickens with diarrhoea and typhlitis in the USA (Swayne et al., 
1992; Swayne et al., 1995). The organisms were subsequently designated Brachyspira 
alvinipulli (L. chicken suffering from diarrhoea) (Stanton et al., 1998). This weakly 
haemolytic spirochaete had a 24.6% G+C content, a mean cell length 8 – 11 µm by 0.22 - 
0.34 µm and 11 - 15 flagella per cell end. It was positive for hippurate hydrolysis and β-
galactosidase production and negative for indole and α-glucosidase production (Swayne et 
al., 1995; Stanton et al., 1998). When inoculated into chickens, the type strain, C1T, caused 
mild intestinal disease, consisting of pale droppings and mild typhlitis (Swayne et al., 1995). 
 
1.2.3.6 “Brachyspira pulli” 
The second new group of intestinal spirochaetes identified by McLaren and 
colleagues (1997) after MLEE analysis, has been undescribed to date and is of uncertain 
pathogenicity. Provisionally designated “Brachyspira pulli”, this group consisted of 
spirochaetes isolated from chickens in Western Australia (WA), Queensland and the 
Netherlands, mostly from flocks with production problems (McLaren et al., 1997). One 
isolate was mildly pathogenic when inoculated into experimental broiler chickens (Hampson 
& McLaren, 1997). The group are weakly haemolytic, but lack consistent phenotypic and 
genetic characteristics (McLaren et al., 1997), and thus await further investigation.  
 
1.2.3.7 “Brachyspira canis” 
“B. canis” was proposed as a new member of the genus after a group of indole 
negative WHBIS isolates from dogs was found to be distinct from B. pilosicoli (Duhamel et 
al., 1998c). The study found the isolates did not amplify with a B. pilosicoli specific 16S 
rRNA gene PCR, and a new cluster separate from other Brachyspira spp. was identified 
using MLEE. The absence of attachment of one isolate to chick caecal cells (Duhamel et al., 
1998c), and the subsequent isolation of “B. canis” from healthy puppies (Oxberry & 
Hampson, 2003a) led researchers to believe that the group were non-pathogenic commensals 
of the dog colon. Further molecular studies such as DNA-DNA reassociation are required 
and the characterisation and firm designation of “B. canis” as a member of Brachyspira 
awaits further investigation. 
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1.2.4  Brachyspira pilosicoli  
In this and the following section, the two main Brachyspira species which infect 
humans, B. pilosicoli and B. aalborgi, will be described in detail. This will include their 
history, morphology, biochemistry, distribution and the diseases they cause in animals other 
than humans. This will provide a background to subsequent sections on the current 
understanding of the roles these organisms have in human infection, as well as prevalence, 
transmission and treatment of intestinal spirochaetes in humans.  
 
1.2.4.1  History and taxonomy 
After the description of B. innocens, and the subsequent isolation of further strains 
of WBHIS from swine, investigators realised that these isolates were in fact a 
morphologically, biochemically, antigenically and pathogenically diverse group of 
organisms (Lemcke & Burrows, 1981; Lymbery et al., 1990; Ramanathan et al., 1993; 
Duhamel et al., 1995a). Again MLEE proved a most valuable tool for characterisation of B. 
pilosicoli. Lee and colleagues (1993b) examined 90 porcine WBHIS by MLEE, and 
determined that 56 isolates were morphologically, biochemically and genetically distinct 
from B. hyodysenteriae and B. innocens, and proposed a new genus and species, Anguillina 
coli. DNA-DNA reassociation studies (Lee et al., 1993c) and 16S rDNA sequence analysis 
(Stanton et al., 1996) confirmed A. coli as a distinct genetic group. However, the high degree 
of 16S rDNA sequence homology shared between Serpulina and Anguillina suggested they 
belonged to a single genus, therefore A. coli became Serpulina pilosicoli (L. little serpent of 
the hairy colon) (Trott et al., 1996c), which were later renamed Brachyspira pilosicoli when 
the genus was transferred to Brachyspira (1.2.2.1).  
 
1.2.4.2  Morphology and growth characteristics  
B. pilosicoli possesses the typical spirochaete ultrastructure shared by Brachyspira 
spp., in that the cells are serpentine and form loose coils with a variable amplitude and 
regular wavelength (Trott et al., 1996c; Sellwood & Bland, 1997) (Figure 1.2). Cells stain 
weakly Gram negative, and under phase contrast or dark field microscopy, motility is of a 
serpentine swimming or rotational type (Jones et al., 1986). However, the cells are thinner 
and shorter than the majority of members of the genus, being 4 – 12 µm in length and 0.25 - 
0.3 µm in width (Trott et al., 1996c; Trott et al., 1996d). The cell ends are pointed, rather 
than the rounded morphology observed for B. hyodysenteriae, B. innocens, B. intermedia 
and B. murdochii (Lee, 1994). B. pilosicoli has fewer periplasmic flagella, with only 4 - 7 
flagella being subterminally attached per cell end. The flagella are arranged in a single row Chapter 1 - Literature Review  
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(Lee et al., 1993b; Lee et al., 1993c), contrast to the previously discussed species, which 
have 7 - 14 flagella per cell end, arranged in two rows (Lee et al., 1993b). 
On solid media containing blood, colonies are described as weakly beta-haemolytic, 
in that a slight complete clearing is observed around growth, contrasting to the strong β-
haemolysis of B. hyodysenteriae. Two colonial morphologies have been described for 
primary isolates, one type is 1 - 1.5 mm in diameter, crenated, mucoid, grey and translucent, 
and the other is <1 mm in diameter, convex, grey and translucent (Trivett-Moore et al., 
1998). Alternatively a flat, spreading film of growth occurs, or occurs with successive 
subcultures (Barrett, 1990). Cultures may take 1 - 2 weeks or as little as 5 - 7 d to appear on 
initial isolation, and can be visible after 2 - 5 d after laboratory adaptation has occurred 
(Jones et al., 1986; Lee & Hampson, 1992). 
Growth of B. pilosicoli in brain hear infusion broth (BHIB) with 10% heated treated 
foetal calf serum (FCS) in an atmosphere of 99% N2 and 1% O2 is maximal at 37°C or 42°C, 
with a doubling time of 1 - 2 h. No growth occurs at 32°C or 45°C. B. pilosicoli will tolerate 
up to 7% O2 in the headspace of a broth culture, will multiply in a pH range of 5.6 to 8.0, 
and produces a final pH of 5.6 (Trott et al., 1996c). A comparison of growth substrates 
which are utilised by B. pilosicoli and other Brachyspira spp. are presented in Table 1.2.  
 
1.2.4.3 Biochemistry 
The biochemical characteristics of B. pilosicoli are presented in Table 1.3. Those 
which differentiate B. pilosicoli from other Brachyspira spp. are the presence of hippurate 
hydrolysis and α-galactosidase activity, and the lack of α-glucosidase and β-glucosidase 
activities (Fellström & Gunnarsson, 1995) (Table 1.1). Indole production is generally 
negative, although reports exist of some indole positive B. pilosicoli isolates from humans 
(Sanna et al., 1984; Tompkins et al., 1986; Lee & Hampson, 1992).  
 
1.2.4.4  Distribution and disease in animals 
Brachyspira pilosicoli has the widest host range of the intestinal spirochaetes. As 
well as colonising humans (Trott et al., 1996c; Trivett-Moore et al., 1998) (discussed in 
Section 1.3.3), the organism has been isolated from or detected in a large number of farmed 
and wild animals and birds. Infection with B. pilosicoli causes a condition known as 
intestinal spirochaetosis (IS) in humans and in the animal species affected, although B. 
aalborgi and currently unclassified Brachyspira species are capable of causing the same 
histological condition in some hosts.  
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Porcine Intestinal Spirochaetosis 
The best studied host is the pig, where B. pilosicoli is the aetiological agent of 
porcine intestinal spirochaetosis (PIS) (Trott et al., 1996c), also known as porcine colonic 
spirochaetosis (Girard et al., 1995; Duhamel et al., 1995a), or spirochaetal diarrhoea (Taylor 
et al., 1980). This is a disease of swine aged between 4 - 20 weeks, most commonly 
occurring in animals 1 - 2 weeks post weaning (Taylor, 1992; Girard et al., 1995). The 
disease is characterised by mild, persistent, mucoid diarrhoea with occasional flecks of 
blood, a tucked-up appearance, a rectal temperature of 40 - 41°C, growth retardation and 
anorexia (Duhamel et al., 1995a). The infection results in poor feed conversion, loss of 
condition and lowered growth rates (Taylor et al., 1980; Spearman et al., 1988; Jacques et 
al., 1989; Girard et al., 1995). Recovery occurs within 7 to 10 d of onset, although some 
animals develop chronic diarrhoea which persists beyond the grower stage. Mortality is not a 
feature of uncomplicated PIS, instead concurrent infections contribute to the severity and 
mortality. Reports have noted respiratory distress, coughing and pneumonia in some 
animals, and mortality due to pneumonia or other infections rather than PIS (Girard et al., 
1995; Duhamel et al., 1995a).  
PIS has now been recognised in most major pig producing countries in the world 
including the UK (Taylor et al., 1980; Taylor, 1992), continental Europe (Taylor, 1992; 
Fellström & Gunnarsson, 1995), Canada (Spearman et al., 1988; Jacques et al., 1989; Girard 
et al., 1995), the USA (Andrews & Hoffman, 1982; Duhamel et al., 1993), and Australia 
(Hampson, 1991).  
A striking feature of PIS, and in other animals infected with B. pilosicoli, is the 
histological appearance of infection. Intestinal spirochaetoses and thus PIS are characterised 
by the adherence of large numbers of B. pilosicoli cells by one cell end, to the apical surface 
of the mature colonic epithelium, causing a brush border effect (Taylor et al., 1980; 
Spearman et al., 1988; Jacques et al., 1989; Duhamel et al., 1993; Girard et al., 1995) 
(Figures 1.3 and 1.4). This attachment can result in effacement of the microvilli (Duhamel et 
al., 1995a). In PIS, the colonisation varies from multifocal to extensive, may not be apparent 
in all cases, and is not present on immature, cuboidal or squamous epithelial cells (Taylor et 
al., 1980; Girard et al., 1995).  
Gross lesions on colonic or caecal tissue may be quite subtle (Hampson & Trott, 
1995), and the mucosa may appear macroscopically normal in early cases. In progressive 
cases, mucosal inflammation, local haemorrhage, increased mucus production and small 
areas of necrosis may become obvious (Taylor et al., 1980; Girard et al., 1989; Taylor & 
Trott, 1997). Microscopic changes in swine intestinal mucosa associated with PIS have 
included mucosal oedema and thickening, inflammation of the lamina propria, and 
accumulation of lymphoid cells (Taylor et al., 1980; Taylor & Trott, 1997). Patches of Chapter 1 - Literature Review  
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epithelial necrosis can develop, and cellular debris containing large numbers of spirochaetes 
adheres to damaged epithelium (Hampson & Trott, 1995).  
Taylor and colleagues (1980) were the first to isolate the spirochaete which later was 
named B. pilosicoli, describe the aetiological agent, and reproduce symptoms and lesions in 
orally challenged pigs (Girard et al., 1995). Experimental infection has been studied in pigs, 
day-old chicks and mice (Trott et al., 1995; Trott et al., 1996b; Sacco et al., 1997). In swine, 
lesions and symptoms were similar to natural PIS infections, but the attachment of B. 
pilosicoli to the epithelium was limited to the first 3 weeks post-inoculation (Taylor et al., 
1980; Trott et al., 1996b; Duhamel, 1998). In chicks, attachment was consistent for 21 d, and 
macroscopic lesions were lacking, but production of diarrhoea and epithelial damage and 
inflammation at a microscopic level were variable, dependent on isolate origin (Trott et al., 
1995; Muniappa et al., 1997; Trott & Hampson, 1998). One study has examined infection of 
C3H mice, where colonisation for 30 d was observed, but there were no clinical signs or 
symptoms (Sacco et al., 1997).  
Little is known about the pathogenicity of PIS, nor the mechanisms by which B. 
pilosicoli causes disease in pigs (Hampson & Trott, 1995). It is assumed that diarrhoea is a 
consequence of reduced or failed passive fluid absorption in the colon, due to the physical 
blocking affect of adhering B. pilosicoli on the colonic absorptive surface (Hampson & 
Trott, 1995; Duhamel et al., 1995a). The presence of gap-like lesions between enterocytes in 
experimentally infected day-old chicks could suggest the involvement of a secretory 
mechanism (Hampson & Trott, 1995). B. pilosicoli, unlike B. hyodysenteriae is not 
chemotactic to porcine mucin (Milner & Sellwood, 1994). Investigations on the eradication 
of B. pilosicoli after dietary changes in affected animals indicate that bacterial fermentation 
may support colonisation by B. pilosicoli (Wilkinson & Wood, 1987; Hampson et al., 2000). 
Synergism may play a role in PIS, as Bacteroides vulgatus enhanced the production of 
watery diarrhoea in gnotobiotic pigs (Neef et al., 1994), and Balantidium coli is commonly 
found in cases of PIS (Taylor et al., 1980; Andrews & Hoffman, 1982; Spearman et al., 
1988; Hampson et al., 2000). Additionally, an increased viscosity of the gut contents may 
influence colonisation, since feeding carboxymethylcellulose to Escherichia coli-infected 
experimental animals led to more and earlier faecal shedding of B. pilosicoli (Hopwood et 
al., 2002). It thus appears that many factors affect the colonisation and production of 
symptomatic disease by B. pilosicoli in pigs.  
 
Intestinal spirochaetosis and disease in other animals 
The role of B. pilosicoli as a cause of disease in other animals remains uncertain. 
This is due in part to the occurrence of more than one spirochaete species in other hosts 
(Duhamel et al., 1998c), and the lack of identification of these organisms in earlier reports. Chapter 1 - Literature Review  
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The situation is complicated further by the appearance of spirochaetes in animals without 
disease in other instances. B. pilosicoli infection has been reported in birds, including farmed 
chickens (McLaren et al., 1997; Stephens & Hampson, 1999), mallards and partridges 
(Jansson et al., 2001), pheasants (Webb et al., 1997; Jansson et al., 2001), a rhea and a 
chiloe widgeon (Anas sibilatrix) (Trott et al., 1996a), and wild water bird species (Oxberry 
et al., 1998). B. pilosicoli was among spirochaetes responsible for diarrhoea and reduced egg 
production in chickens in the USA (Swayne et al., 1995; McLaren et al., 1997; Trampel et 
al., 1999). Isolates from chickens and the chiloe widgeon caused diarrhoea and reduced 
growth rate in experimental infection of day-old chicks (Swayne et al., 1993; Hampson & 
McLaren, 1997). Attachment of organisms to the caecal mucosa in a manner similar to that 
in PIS also was observed. The onset of egg laying was delayed, and egg production and 
eggshell quality reduced in breeder females inoculated with B. pilosicoli (Stephens & 
Hampson, 1999; Stephens & Hampson, 2001; Stephens & Hampson, 2002a). 
B. pilosicoli can infect dogs, and has been found both in young dogs with and 
without diarrhoea (Duhamel et al., 1996; Duhamel et al., 1998c; Fellström et al., 2001; 
Oxberry & Hampson, 2003a), and adult animals with normal stools (Duhamel et al., 1998c). 
In most instances, attachment to the epithelium was again observed. Isolates from dogs have 
been shown to adhere and cause damage to the caecal epithelium of experimentally infected 
chicks (Turek & Meyer, 1977; Muniappa et al., 1996). It is thought that infection in adult 
dogs is subclinical, and that some unknown contributing factors are required for 
development of diarrhoea (Duhamel et al., 1998c). 
B. pilosicoli has been identified in IS in non-human primates, although in the 
majority of cases, the observed spirochaetes were not identified (Duhamel, 2001). In the 
more recent studies where identification was carried out, B. aalborgi was the principle 
organism involved (Duhamel, 2001; Munshi et al., 2003b). However, B. pilosicoli has been 
associated with IS in rhesus monkeys (Duhamel, 1997), although the clinical significance of 
this attachment was not stated. Additionally, B. pilosicoli was detected in three macaques 
with severe colitis, without B. aalborgi or signs of typical attachment (Duhamel et al., 
1997). In two animals, Shigella flexneri and Yersinia pseudotuberculosis were also found 
and thus the significance of B. pilosicoli detection was again uncertain.  
Unclassified spirochaetes which could have been Brachyspira  spp.  have been 
observed in opossums (Turek & Meyer, 1979; Duhamel et al., 1998a) and guinea pigs 
(McLeod et al., 1977; Zwicker et al., 1978; Vanrobaeys et al., 1998). In the opossums, 
which were healthy, the size and number of flagella were consistent with the organisms 
being B. pilosicoli. The spirochaetes were attached to the caecal mucosa in the characteristic 
manner that has been described above for pigs, chickens and dogs (Turek & Meyer, 1979; 
Duhamel et al., 1998a). However, based on growth characteristics, it has been suggested that Chapter 1 - Literature Review  
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these spirochaetes were more closely related to B. aalborgi than to B. pilosicoli (Duhamel, 
1997), although PCR methods demonstrated characteristics shared with both B. pilosicoli 
and B. aalborgi (Duhamel, 2001).  
In the earlier reports regarding guinea pigs, animals had Tyzzer's disease, caused by 
Bacillus piliformis (McLeod et al., 1977; Zwicker et al., 1978), and concurrent 
Cryptosporidia infections were seen in some (McLeod et al., 1977). The spirochaetes 
formed a false brush border on the colonic epithelium, but also invaded the crypts and had 
15 - 40 (McLeod et al., 1977) or a variable number of axial filaments (Zwicker et al., 1978). 
In a more recent report, haemorrhagic inflammation of the colon was associated with slimy 
yellow faeces and sudden death in guinea pigs (Vanrobaeys et al., 1998). Again the 
spirochaetes attached perpendicularly to the mucosa, and were more likely to be B. 
pilosicoli, or possibly B. aalborgi, as 4 - 7 periplasmic flagella were observed. However 
experimental infection was not successful and spirochaetes isolates were not obtained. No 
other known pathogens were identified, although flagellar parasites were observed and 
weight loss and vitamin C deficiency were noted. Definitive identification of B. pilosicoli by 
PCR was obtained in a pet guinea pig with a rectal prolapse, in which the exposed mucosa 
was ulcerated, necrotic and haemorrhagic (Hélie et al., 2000). A protozoal species similar to 
Eimera caviae was noted also. 
 
1.2.4.5  Transmission in animals 
Transmission of B. pilosicoli between pigs is by the faecal-oral route, with faeces, or 
contaminated food and water being the mostly likely methods of spread of PIS (Taylor & 
Trott, 1997). PIS is maintained in pig herds by asymptomatic carrier pigs, and transmission 
of PIS between farms is thought to be due mainly to the movement of infected pigs. B. 
pilosicoli can be isolated from pigs at any stage of growth, but PIS is most common and 
severe in weaner and grower pigs. The evidence for vertical transmission in swine does not 
yet exist, even though pregnant sows can be infected, and can transmit the organisms to their 
offspring soon after birth (Hampson & Trott, 1995; Taylor & Trott, 1997).  
B. pilosicoli can be cultivated from experimentally infected soil after 119 d at 10°C, 
and from soil with 10% faeces added, and unadulterated faeces for over 210 d (Boye et al., 
2001). The organism has been isolated from the water of a lake inhabited by water birds in a 
zoo, and survived experimentally in this lake water for 66 d at 4°C and 4 d at 25°C (Oxberry 
et al., 1998). It may be possible that these sources remain infective for similar long periods 
outside the laboratory situation, and pose an infectious threat to animals and humans with 
which they came into contact. Wild water birds may act as another reservoir of infection 
(Oxberry et al., 1998) and may spread infection to farmed birds in areas where contact 
occurs, by contaminating soil and water (Jansson et al., 2001). It is possible that infected Chapter 1 - Literature Review  
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birds or other animals may introduce infection to pigs (Oxberry & Hampson, 2003b). B. 
pilosicoli apparently does not naturally infect rodents.  
The potential for cross-species transmission has been identified, as B. pilosicoli can 
infect a wide range of animal species, with typical lesions demonstrated in all hosts. 
Experimental infection using isolates from humans and pigs has been successful in chicks, 
with development of IS and symptoms (Trott et al., 1995). Pigs with PIS are not considered 
to pose a significant health risk to pig industry workers, as the same strains have not been 
identified from pigs and humans after MLEE analysis (Lee & Hampson, 1994). However, 
only one study has specifically examined pig industry workers, in which two pig workers 
were both negative for carriage of B. pilosicoli (Oxberry & Hampson, 2003b). Further 
discussion of the potential for infection in humans to be of zoonotic origin will be discussed 
in Section 1.3.3.2. 
 
1.2.4.6  Treatment and control 
The treatment and control of PIS and IS in chickens have been essentially based on 
procedures developed for treatment and control of Sd (Hampson & Trott, 1995; Swayne & 
McLaren, 1997; Fossi et al., 2001). Antibiotic therapy is necessary to eliminate B. pilosicoli 
infection in pigs and chickens, and susceptibility testing studies of B. pilosicoli have 
ascertained that required drug levels are generally lower than for treatment of Sd (Hampson 
& Trott, 1995). Further details on susceptibility testing of Brachyspira spp. is provided in 
Section 1.6. In PIS, appropriate therapies are tiamulin, lincomycin, dimetridazole, tylosin 
and carbadox, which is no longer used in Australia (Hampson & Trott, 1995). In chickens, 
lincomycin and tiamulin have both demonstrated effectiveness for treatment of B. pilosicoli 
infection in poultry (Stephens & Hampson, 2001; Stephens & Hampson, 2002b). 
In swine, control methods recommended for Sd (Hampson et al., 1997) are regarded 
by some authors to be effective also for PIS, particularly in hygiene measures to prevent the 
ingestion of infective faeces (Hampson & Trott, 1995). The strict hygiene and quarantine 
measures recommended for Sd are not generally warranted, as PIS is a less severe disease 
(Taylor, 1992). However, a programme to eradicate B. pilosicoli from one small farrowing 
herd was instigated because of long-term problems with post-weaning diarrhoea (Fossi et 
al., 2001). The eradication was achieved with a combination of in-feed tiamulin medication, 
and cleaning and disinfection of the facilities. Reports do exist regarding the reappearance of 
clinical signs after cessation of treatment (Spearman et al., 1988). Reinfection is believed to 
be common, and may be due to the persistence of predisposing factors such as dietary 
composition and host immune response (Hampson & Trott, 1995). Feeding a rice diet low in 
fermentable carbohydrates  has been shown to reduce colonisation of B. pilosicoli and 
alleviate PIS (Hampson et al., 2000). Chapter 1 - Literature Review  
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Generally, more stringent control methods are recommended for chickens to prevent 
reinfection between batches of birds. Such measures include preventing the introduction of 
contaminated fomites and potential animal vectors, and advocating good hygiene and stress 
reduction measures (Stephens & Hampson, 2001). 
There is currently only one study which has examined the utility of a vaccine to 
control PIS (Hampson et al., 2000). Here a bacterin vaccine induced a primary and 
secondary antibody response in experimentally infected pigs, but the duration of intestinal 
colonisation, diarrhoea or colonic changes were not reduced. Instead, a dietary change to 
cooked rice delayed the establishment of infection and shedding of B. pilosicoli. The 
apparent lack of a systemic immune response that was seen could create future difficulties 
with vaccination against B. pilosicoli.  
 
1.2.5  Brachyspira aalborgi  
1.2.5.1  History and taxonomy 
Brachyspira aalborgi is one of the least characterised species of the Brachyspira 
genus, despite having been first identified in 1982 (Hovind-Hougen et al., 1982). A 
combination of the difficulties involved with isolating and culturing this spirochaete (Section 
1.3.1), and assumptions about its lack of pathogenicity (Section 1.3.2.5), have contributed to 
this dearth of information. The species was named for the Danish town Aalborg, where the 
first isolates originated (Hovind-Hougen et al., 1982). The history of the genus Brachyspira 
and inclusion of the other Brachyspira spp. in this genus has been previously described 
(Section 1.2.2.1). 
 
1.2.5.2  Morphology and growth characteristics 
Despite the current inclusion of other former members of the genus Serpulina in the 
genus Brachyspira, cells of B. aalborgi are much shorter, thinner and more flexible than 
those of the other intestinal spirochaetes. Cells are comma shaped or helical with 1 - 1.5 
wavelengths/cell and are only 1.7 – 6 µm long and 0.2 µm wide. The ends are tapered and 
have an abrupt rounded point, and only 4 flagella are inserted into each cell end (Hovind-
Hougen et al., 1982).  
B. aalborgi will grow in an atmosphere of 5% CO2 - 95% H2 or 20% CO2 - 80%H2 
at 37°C or 38.5°C, but not in 50% CO2 - 50%H2, 100% H2, or at 30°C or 42.5°C. Growth is 
maximal at 38.5°C, in an atmosphere of 5% CO2 - 95% H2. Initial colonial morphology on 
agar containing blood is a thin haze after 2 - 3 weeks incubation (Hovind-Hougen et al., 
1982). Like B. pilosicoli, two colony types have been observed, either immediately or after 3 
- 4 subcultures. These can be a clear flat rough-edged colony with weak β-haemolysis, or a Chapter 1 - Literature Review  
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pinpoint smooth-edged convex colony lacking haemolytic activity (Hovind-Hougen et al., 
1982). After successive subcultures, pinpoint colonies can be observed after 5 - 7 d (Kraaz et 
al., 2000). Broth culture of isolates has been reported in BHIB with 5% calf blood and 
Barbour-Stoenner-Kelly medium (Sigma, St Louis, MO, USA), a medium for culture of 
Borrelia spp. (Kraaz et al., 2000), and very recently in TSB with 10% FCS (Calderaro et al., 
2003), however other growth substrates have not been systematically ascertained for this 
species to date. 
 
1.2.5.3 Biochemistry 
Although their biochemical reactions have not been characterised completely, B. 
aalborgi are catalase and oxidase negative, and possess β-galactosidase activity and traces of 
esterase lipase (C8), acid phosphatase and phosphoamidase activities (Hovind-Hougen et al., 
1982) (Table 1.3). More recently isolated organisms were negative for esterase lipase (C8) 
activity (Munshi et al., 2003b). 
 
1.2.5.4  Distribution in animal species 
B. aalborgi has a more narrow host range than B. pilosicoli, as it has been identified 
only in humans (Hovind-Hougen et al., 1982) (Section 1.3.1), non-human primates 
(Duhamel et al., 1997; Munshi et al., 2003b) and possibly opossums (Duhamel et al., 
1998a). IS caused by B. aalborgi in these species is microscopically indistinguishable from 
IS caused by B. pilosicoli, and observing IS without identifying the involved intestinal 
spirochaetes has complicated the study of B. aalborgi distribution.  
B. aalborgi is the primary cause of IS in Old World (Catarrhine) monkeys. IS has 
been observed in captive-bred rhesus monkeys (Takeuchi & Zeller, 1972; Takeuchi et al., 
1974), and wild-caught baboons (Pearson et al., 1985) and vervet monkeys (Cowley & Hill, 
1986), but the organisms involved were not identified in these studies. However, Duhamel et 
al. (1997) did identify B. aalborgi in colony-bred rhesus and crab-eating macaques, as well 
as B. pilosicoli by using PCR (discussed in Section 1.1.4.3). These researchers observed the 
characteristic attachment of the organisms to the intestinal mucosa, as well as concurrent 
infection with flagellated bacteria. Some earlier researchers also observed these flagellates 
(Takeuchi & Zeller, 1972; Takeuchi et al., 1974; Cowley & Hill, 1986), but only recently 
have they been identified as a new species of Helicobacter  (Duhamel et al., 2002). B. 
aalborgi has also been detected in the faeces of vervet monkeys, Japanese and Tonkean 
macaques and Hamadrys baboons, although histology was not performed (Munshi et al., 
2003b). In this study, B. aalborgi was not detected in birds, reptiles, mammals including 
marsupials, prosimians or New World (Platyrrhine) monkeys held in a zoological collection.  Chapter 1 - Literature Review  
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Regardless of whether the intestinal spirochaetes observed in the non-human 
primates were identified, the majority of colonised monkeys were without intestinal 
symptoms or gross lesions, and mucosal inflammation was generally absent (Takeuchi et al., 
1974; Pearson et al., 1985). Spontaneously-resolving diarrhoea, which lasted for 1 d, was 
observed in some baboons, however, no differences at a cellular level could be observed 
between intestinal samples from these and other animals (Pearson et al., 1985). Some 
animals were reported to have inflammatory cell infiltrates in the lamina propria, and a 
chronic ulceration which was likened to ulcerative colitis observed in humans (Duhamel et 
al., 1997; Duhamel, 2001). However, researchers have generally agreed that infection in 
these animals is without pathogenic significance. 
B. aalborgi was apparently detected by PCR in North American opossums, however 
it was not clear whether this test was specific for detection of this spirochaete alone 
(Duhamel et al., 1998a). Thus further work is required to identify intestinal spirochaetes in 
opossums.  
 
1.3  INTESTINAL SPIROCHAETES IN HUMANS 
Spirochaetes have been recognised and studied in the human lower intestine for 
nearly 120 years, and yet many questions regarding their identity and clinical significance 
remain. In this section of the review, the early history of intestinal spirochaete research will 
be presented, followed by the investigations into histologically determined intestinal 
spirochaetosis in humans, which, for the purposes of this review, will be termed human 
intestinal spirochaetosis (HIS), to distinguish it from PIS and IS in other animal species. 
Studies regarding the carriage of intestinal spirochaetes in human populations, mainly 
involving the culture and detection of B. pilosicoli will then be presented.  
 
1.3.1  Early research on spirochaetes in the human lower intestine 
The earliest recorded observation of spirochaetes from the human intestinal tract 
was made by Van Leeuwenhoek of “organisms with a spirochaete-like motility” in human 
stools (Ruane et al., 1989). The first detailed report of human intestinal spirochaetes was 
made by Escherich in 1884 (cited in (Fantham & Cantab, 1916a; Ruane et al., 1989)), who 
found large numbers of spirochaete-like organisms in the stools of patients with cholera and 
in normal human faeces. Many other researchers found spirochaetes when investigating 
cases of cholera (Abel, 1894; Aufrecht, 1894; Kowalski, 1894; cited in (Fantham & Cantab, 
1916a; Ruane et al., 1989)). Spirochaetal organisms were observed also in the faeces of 
individuals with gastrointestinal conditions such as infantile diarrhoea, appendicitis, 
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dysentery including pure spirochaetal dysentery, fusospirochaetal dysentery and protozoal 
dysentery (Escherich, 1886; Le Dantec, 1903; Werner, 1909; Thiroloix & Durand, 1911; 
Luger & Neuberger, 1921; Dumont, 1922; cited in (Fantham & Cantab, 1916a; Parr, 1923)). 
Special mention was made of spirochaetal infestation with, or secondary to, protozoal 
infections, particularly chronic amoebic dysentery (Fantham & Cantab, 1916b; Hogue, 1922; 
Parr, 1923) Luger, 1917; Haughwort & Horrilleno, 1920; cited in (Parr, 1923).  
However, even in these early reports, scepticism existed regarding the pathogenic 
significance of intestinal spirochaetes in the human host. As well as being present with 
gastrointestinal symptoms, spirochaetes were noted in combination with non-gastrointestinal 
diseases such as anaemia and rheumatoid arthritis (Thomson et al., 1914), and were also 
distributed in healthy people; in one report “almost constantly” (Kuisl, 1885; Wolbach, 1918 
cited in (Parr, 1923)). A number of large prevalence studies were performed in populations 
between 1914 and 1923, and are summarised in Table 1.4. In these studies, spirochaetes 
were observed at similar high proportions (30 - 100%) in healthy individuals, and those ill 
with gastrointestinal and non-gastrointestinal symptoms. The prevalence was highest (100%) 
in African and non-Africans in the Gold Coast (MacFie, 1917), and in ill adults and children 
in the Philippines (76% and 61%) (Crowell & Haughwort, 1918 and Haughwort & 
Horrilleno, 1920, cited in (Parr, 1923; Ruane et al., 1989)), but prevalence was still high (30 
- 60%) in individuals outside tropical countries (MacFie, 1917; Parr, 1923). It was generally 
concluded that the organisms were commensals, but that the presence of large numbers may 
contribute to illness in patients (MacFie, 1917). 
Some researchers attempted culture of the organisms. Wolbach (1918; cited in (Parr, 
1923)) reported being able to filter spirochaetes and cultivating the filtered spirochaetes. 
Hogue (Hogue, 1922) also reported growing spirochaetes, although not in pure culture, using 
an aerobic serum saline method. However, all other attempts failed (Parr, 1923), and it was 
not until the 1980s that anaerobic bacteriology techniques were advanced enough to allow 
routine cultivation of human intestinal spirochaetes. 
Thus the classification of spirochaetes in these early studies was based only on 
microscopic morphology. Attempts were made to characterise the observed intestinal 
spirochaetes by measuring cell length and width; size, number and tightness of cell coiling; 
the shape of cell ends and characteristics of motility (Fantham & Cantab, 1916b; Hogue, 
1922). Various nomenclature arose from these descriptions. Werner (1909, cited in 
(Fantham & Cantab, 1916b; Ruane et al., 1989)) described Spirochaeta eurygyrata, a “wide 
wound form” of 4.6 µm - 7.3 µm in length, and Spirochaeta stenogyrata, a “narrow wound 
form” of 3.5 µm - 6.1 µm length. By contrast, Fantham (Fantham & Cantab, 1916b) 
considered that coiling was based on a rate of movement and cell thickness, and that Chapter 1 - Literature Review  
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variations in length could be explained by growth and cell division processes. He suggested 
“Spirochaeta eurygyrata emend. Fantham” was a single species of length 3 – 15 µm and 
width 0.25 µm, and this name was adopted by later researchers (MacFie, 1917; Hogue, 
1922). 
There was such an early interest in these spirochaetes that by 1923, Parr (Parr, 1923) 
was able to publish a review of the literature containing over 50 articles pertaining to human 
intestinal spirochaetes. However, between 1923 and 1967, interest in human intestinal 
spirochaetes declined. Researchers were possibly convinced that these organisms were non-
pathogens, and thus unworthy of further description, or were unable to further describe the 
spirochaetes without cultivation of the organisms. A few reports were published on specific 
infections with intestinal spirochaetes, such as necrosis and perforation of the ileum leading 
to death in a patient (Broughton-Alcock, 1926-27). Here streptococci and spirochaetes were 
observed, the latter described as large numbers closely packed within exudate and extending 
deep into the ileum wall with comparatively little cellular reaction, and is possibly an early 
observation of HIS. Other reports described spirochaetes with ulcerative colitis (Hurst & 
Vollum, 1943) or “strawberry lesions” of the colon (Thomas, 1956; Shera, 1962). However, 
only one report (Broughton-Alcock, 1926-27) mentioned Spirochaeta eurygyrata, and all 
considered that the causative spirochaetes were Vincent’s organisms (Borrelia vincentii); 
spirochaetes newly described in the oral cavity at that time (Broughton-Alcock, 1926-27). 
Both Shera (Shera, 1962) and Thomas (Thomas, 1956) described “strawberry lesions” linked 
to vitamin C deficiency and the presence of fusiform bacilli and spirochaetes, which look 
remarkably similar to Brachyspira spp. in the published microscopic views (Shera, 1962). 
“Strawberry lesions” have not been reported since, although their description is similar to 
recent cases of HIS in AIDS patients (Guccion et al., 1995; Kostman et al., 1995). 
 
1.3.2  Human intestinal spirochaetosis 
1.3.2.1  Characteristics and diagnosis  
The description of HIS by Harland and Lee (Harland & Lee, 1967) in 1967, led to a 
reawakened interest in human intestinal spirochaetes. The term HIS described the 
characteristic adhesion of spirochaetes aligning perpendicularly to the apical surface of 
intestinal epithelial cells, forming a “false brush border” (Harland & Lee, 1967) (Figure 1.4). 
Using electron microscopy (EM), a forest of spirochaetes was observed on the surface of 
epithelial cells from a rectal biopsy of a man with persistent diarrhoea of 3 years duration. 
Reappraisal of presumed normal histological sections from this patient, stained with 
haematoxylin and eosin, revealed a 3µm basophilic zone overlying the epithelial cells. Based 
on the staining properties, the organism was tentatively classified as Borrelia eurygyrata. Chapter 1 - Literature Review  
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Interestingly, only a few researchers have compared HIS to IS in other animals species 
(Sanna et al., 1984; Tompkins et al., 1986), and the findings relating to intestinal 
spirochaetes in the veterinary world were largely ignored.  
Diagnosis of HIS has been made on histological sections by light microscopy with 
regular staining (Lee et al., 1971), as the basophilic fringe is so distinctive (Willén et al., 
1977). Rarely, a basophilic fringe has not contained spirochaetes (Roberts et al., 1989), and 
silver stains are recommended, which allow better visualisation of spirochaetes (Crucioli & 
Busuttil, 1981; Surawicz et al., 1987; Guccion et al., 1995). This fringe can be overlooked if 
the infestation is focal (Lindboe et al., 1993), or disregarded when the underlying mucosa 
looks normal by light microscopy (Burns & Hayes, 1985).  
Studies utilising transmission electron microscopy (TEM) have allowed more 
detailed examination of HIS. By TEM, the perpendicular alignment of the organism to the 
host cell is obvious, and relates to the way in which the spirochaetes interdigitate between 
the microvilli (Lee et al., 1971; Nielsen et al., 1983). In transverse section, a star shaped or 
rosette arrangement of spirochaetes is visible around the microvilli (Lee et al., 1971; 
Delladetsima et al., 1987). Microvilli are often shortened or absent in areas of spirochaete 
infestation (Gear & Dobbins, 1968; Takeuchi et al., 1974; Cooper et al., 1986), reportedly in 
proportion to organism density (Cooper et al., 1986; Gebbers et al., 1987). A small 
invagination or pit in the terminal web of the epithelial cell occurs at the point of attachment 
(Crucioli & Busuttil, 1981; Antonakopoulos et al., 1982; Calderaro et al., 2003), and an 
electron dense area is visible just below the attachment site. The crypts and goblet cells are 
generally free of spirochaetes (Gad et al., 1977), but even they can be involved when 
infestation is heavy (Willén et al., 1977; Antonakopoulos et al., 1982).  
Colonisation by spirochaetes in HIS has been reported in all parts of the large bowel 
(Lindboe et al., 1993), extending from the rectum and throughout the colon to the terminal 
ileum. HIS of the appendix can occur, and possesses similar cellular aspects to IS of the 
colon and rectum (Harland & Lee, 1967; Gad et al., 1977; Mooney et al., 1988). 
Colonisation can be extensive, with spirochaetes observed in biopsies from many sites 
(Willén et al., 1977; Prior et al., 1987; Lindboe et al., 1993; Lo et al., 1994; Guccion et al., 
1995; Kostman et al., 1995; Mikosza et al., 2001), or can be patchy and not detected in all 
biopsies (Prior et al., 1987; Lo et al., 1994). Thus absence of IS in a rectal biopsy does not 
exclude IS in other parts of the large intestine (Lo et al., 1994; Mikosza et al., 2001). 
Colonisation can be heavy (40 spirochaetes/epithelial cell) and extend into the crypts, or 
sparse (3 spirochaetes/cell) (Gad et al., 1977; Cooper et al., 1986; Jensen et al., 2001). 
Spirochaetes have only been seen on neoplastic or abnormal tissue in rare instances (Lee et 
al., 1971; Willén et al., 1977; Delladetsima et al., 1987; Lindboe et al., 1993). As these Chapter 1 - Literature Review  
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tissues often lack microvilli, it is possible that intact microvilli are required for spirochaete 
attachment to epithelial cells (Coyne et al., 1995). 
Using sigmoidoscopy, the appearance of the intestinal mucosa in HIS is generally 
normal. Oedema and loss of vascularity are occasional abnormalities (Gad et al., 1977; 
Crucioli & Busuttil, 1981; Antonakopoulos et al., 1982; Cotton et al., 1984; Burns & Hayes, 
1985; Rodgers et al., 1986; Lo et al., 1994).  
By histological examination, colonic and rectal epithelial cells infested with 
spirochaetes are usually normal, aside from microvillus loss or shortening, and are generally 
without inflammatory or necrotic changes. The most minor changes to cell structure have 
been the presence of R bodies, vacuoles and irregular mitochondria (Crucioli & Busuttil, 
1981; Gebbers et al., 1987). Some investigators have observed increased lysosomes in the 
cells (Harland & Lee, 1967; Crucioli & Busuttil, 1981; Antonakopoulos et al., 1982; 
Gebbers et al., 1987). On occasion, the presence of macrophages, inflammatory cells, 
plasma cells and mast cells have been observed in the infested epithelial cells and the 
underlying lamina propria (Minio et al., 1973; McMillan & Lee, 1981; Antonakopoulos et 
al., 1982; Gebbers et al., 1987; Cunha Ferreira et al., 1993; Guccion et al., 1995; Kostman et 
al., 1995; Peghini et al., 2000; Mikosza et al., 2001).  
Intracellular spirochaetes also have been seen, but have not necessarily been 
associated with inflammation. They have been observed free in the cell cytoplasm, in 
vacuoles, in activated lysosomes and within phagolysosomes of macrophages in the 
epithelial cells and in the lamina propria (Minio et al., 1973; Takeuchi et al., 1974; 
Antonakopoulos et al., 1982; Rodgers et al., 1986; Gebbers et al., 1987; Gebbers & Marder, 
1989; White et al., 1994; Guccion et al., 1995; Kostman et al., 1995; Padmanabhan et al., 
1996; Peghini et al., 2000). The involvement of other cells has been noted very rarely. 
Invasion of goblet cells has been reported in situations of heavy infestation (Willén et al., 
1977; Padmanabhan et al., 1996; Peghini et al., 2000), and on two occasions spirochaetes 
have been observed in Schwann cells in the lamina propria (Antonakopoulos et al., 1982; 
Padmanabhan et al., 1996). 
 
1.3.2.2 Prevalence   
By examining routine intestinal biopsies, the prevalence of HIS has been reported as 
between 1.1 - 10% in large studies of populations in developed countries, with Delladetsima 
and colleagues (1987) finding 16.5% in Greece. These studies are summarised in Table 1.5. 
Few investigations have been carried out in developing countries, as these countries have 
less resources to perform routine intestinal biopsies as a part of a disease investigation. 
However, an infestation of 1.4% was reported from Brazil (De Brito et al., 1996a), and 9/14 
(64%) cases of HIS were found in healthy individuals in India (Mathan & Mathan, 1985). It Chapter 1 - Literature Review  
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is possible that a geographic or racial variation exists in the prevalence of IS (Delladetsima 
et al., 1987).  
Other reports on HIS have been small case series, again on individuals in developed 
countries, and these studies are summarised in Table 1.6. HIS appears to have a world-wide 
distribution, as it has been documented from the UK, the USA, Australia, Norway, 
Denmark, Sweden, Switzerland, Germany, Ireland, Japan, Greece, Brazil, South Africa, 
India, Russia, and recently in Italy also (Teglbjærg, 1990; Calderaro et al., 2003).  
Most cases of HIS have been reported in adults, but infection in children appears to 
exhibit similar characteristics (Cunha Ferreira et al., 1993; White et al., 1994; De Brito et 
al., 1996b; Heine et al., 2001; Marthinsen et al., 2002). HIS does not demonstrate a seasonal 
variation (Henrik-Nielsen et al., 1983; Lindboe et al., 1993). In a number of studies, no 
significant gender bias has been reported for heterosexual individuals, and only one group 
has noted a predominance of male cases (Lindboe et al., 1993; Lindboe, 2001). However, it 
would appear that after totalling the number of males and females affected with HIS in case 
studies, and in those prevalence studies which stated gender, the ratio of males to females is 
1.7:1 (see Tables 1.5 and 1.6). The reason for this slight predominance of men is currently 
unknown, but may be due to an under-reporting of homosexuality. Prevalence of HIS is 
higher among homosexual males at 30 - 39%, and is believed to relate to sexual behaviours 
which increase faecal-oral contact and a mechanical disruption to rectal mucosa (McMillan 
& Lee, 1981; Surawicz et al., 1987; Law et al., 1994). HIS is also more prevalent in people 
infected with HIV, recorded at around 44% in two reports (Käsbohrer et al., 1990; Law et 
al., 1994), although most recorded cases have been homosexual males also. Infection in 
these cases may be due to reduced immune status of these individuals.  
 
1.3.2.3  Symptoms and significance of HIS 
Much controversy still exists regarding the pathogenic significance of HIS, although 
the condition was first described over 35 years ago (Harland & Lee, 1967). Several aspects 
of HIS have made it difficult for researchers to confirm absolutely the importance of 
observing the basophilic fringe of intestinal spirochaetes on colonic and rectal epithelium.  
Firstly, there is no specific symptom complex associated with the condition. 
Symptoms which have been reported in each case series and prevalence study can be found, 
with references, in Table 1.5 and Table 1.6. The most frequently noted symptoms with the 
infestation are diarrhoea, which can be bloody, mucoid or watery, and abdominal pain. Other 
symptoms have included rectal bleeding, weight loss, constipation and constipation 
alternating with diarrhoea. Many of these symptoms have been long term, lasting months or 
even years, or recurrent, where multiple episodes have occurred over these long periods. Chapter 1 - Literature Review  
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However, HIS also has been observed in asymptomatic individuals (Minio et al., 1973; 
Neutra, 1980; Mathan & Mathan, 1985).  
Secondly, HIS has been observed on epithelial cells without inflammation or 
invasion, and, in some cases, on totally normal epithelial cells. Clearly, the absence of tissue 
damage or discomfort has led researchers to question the significance of HIS. Thirdly, HIS 
has been found in the presence of other organisms, and concurrently with a variety of more 
recognised intestinal diseases. These have included carcinoma of the colon, adenomatous 
and metaplastic polyps, diverticulitis, haemorrhoids, idiopathic chronic ulcerative colitis, 
Crohn's disease, irritable bowel disease and proctitis. HIS has been found with other diseases 
outside the GI tract such as chronic lymphoblastic leukaemia (Cotton et al., 1984), systemic 
lupus erythema (Gear & Dobbins, 1968), gonorrhoea, syphilis (McMillan & Lee, 1981; 
Surawicz et al., 1987; Law et al., 1994) and diabetes (Nakamura et al., 1998). Rather than 
HIS, the other organisms or more recognised diseases may have been responsible for the 
symptoms of patients in these instances.  
HIS of the appendix has been described (Harland & Lee, 1967; Lee et al., 1971; 
Takeuchi et al., 1974; Gad et al., 1977; Henrik-Nielsen et al., 1985; White et al., 1994). A 
large study by Henrik-Nielsen et al. (1985) found IS in significantly more cases of pseudo-
appendicitis than in acute appendicitis. Pseudoappendicitis is the term for a condition in 
which the symptoms of acute appendicitis occur, but histological evidence of true 
appendicitis, such as inflammation, is lacking. However, the researchers were unable 
establish any clinical evidence for differentiating patients with HIS of the appendix, or 
differentiating patients with pseudoappendicitis, and thus the significance of HIS in 
appendices also remains undecided. However, the seriousness of the symptoms of 
appendicitis require that treatment takes place, even if the final finding is pseudoappendicitis 
due to spirochaetes.  
However, in several reports, intestinal spirochaetosis has been the only abnormal 
finding associated with diarrhoea, abdominal pain and rectal bleeding. In many of these 
cases, invasion and/or inflammation have been present (Crucioli & Busuttil, 1981; 
Kovalchuk et al., 1981 (cited in Guccion et al., 1995); Rodgers et al., 1986; Gebbers et al., 
1987; Gebbers & Marder, 1989; White et al., 1994; Padmanabhan et al., 1996; Peghini et 
al., 2000; Mikosza et al., 2001), and symptoms have resolved after treatment of the 
spirochaetal infection (Crucioli & Busuttil, 1981; Douglas & Crucioli, 1981; Cotton et al., 
1984; Rodgers et al., 1986; Gebbers et al., 1987; Lo et al., 1994; Guccion et al., 1995; 
Peghini et al., 2000). 
Rarely, more serious infestation and cellular changes have been reported. Kostman 
and colleagues (1995) reported on two HIV positive patients in whom necrosis, 
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and bloody mucus in the stools. The liver of a third HIV positive patient was involved, with 
inflammation, necrosis and invasion of the bile canaliculi by the spirochaetes. In each case, 
therapy removed spirochaetes and resolved symptoms, supporting a pathogenic role of the 
intestinal spirochaetes on these occasions. Another recent article described the progression 
towards death by septicaemia of a 14 year old girl in Peru, who had experienced bloody 
diarrhoea for 15 months before hospitalisation (Zerpa et al., 1996). Massive numbers of 
spirochaetes were observed on colonic cells by Vago staining, and were the probable cause 
of the intestinal symptoms. However, it is not clear what role the spirochaetes had in her 
eventual death by septic shock, as many other infections were present by the end of her 
hospitalisation.  
In these situations, it is possible that the intestinal spirochaetes involved may be 
pathogenic, and a cause of the symptoms observed. However, the mechanisms by which 
inflammation, invasion and symptoms might be caused in some, but not all instances, are yet 
to be determined. 
 
1.3.2.4  Possible mechanisms of disease 
Considering the many reports of HIS on otherwise histologically normal cells, it is 
possible that HIS may be a cause of symptoms without causing inflammation or necrosis. 
Various mechanisms for the production of diarrhoea in HIS have been postulated. A popular 
theory is that the layer of spirochaetes adherent to the colonic or rectal mucosa forms a 
barrier to the resorption of water in the large intestine, thus creating the watery diarrhoea 
(Gad et al., 1977). Stunting or ablation of microvilli would also block passive absorption 
without causing an inflammatory response (Cooper et al., 1986; Padmanabhan et al., 1996). 
Additionally, the irritation of goblet cells could cause over-production of mucus, resulting in 
the mucoid texture of the diarrhoea which is observed (Gad et al., 1977; Kraaz et al., 2000). 
Comments are yet to be made as to why rectal bleeding or bloody stools is a common 
observation.  
Gad  et al. (1977) have suggested the pathogenicity of HIS is dependent on the 
degree and extent of infestation, with more spirochaetes resulting in a more serious 
diarrhoea. However, not all agree with this view, as a case with extensive colonisation of the 
intestine which resolved without treatment demonstrated milder symptoms than a persistent 
case where HIS was seen in fewer biopsies (Lo et al., 1994). As has been postulated for PIS, 
overgrowth of spirochaetes in humans may be due to factors that change the intestinal 
microenvironment. A change upsetting the microflora balances might result in proliferation, 
or invasion, or symptoms might be triggered in certain microenvironments. Relapse or 
recurrence could be expected if these factors persist or recur (Takeuchi et al., 1974; Gad et 
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An alternative or additional possibility is that spirochaetes in HIS could interfere 
with neural transmission, causing altered colonic motility (Padmanabhan et al., 1996). On 
occasions, intestinal spirochaetes have been observed in intestinal Schwann cells 
(Antonakopoulos et al., 1982; Padmanabhan et al., 1996), and it is possible that neural 
signalling is affected by spirochaetal infection. Along similar lines, Delladetsima and 
colleagues (1987) suggested that chronic intestinal stasis favoured development of HIS. By 
extrapolation, gastrointestinal conditions which disrupt normal intestinal peristalsis, such as 
cancer, possibly favour the proliferation of the organisms. A comparison of HIS prevalence 
in healthy and diseased individuals may confirm this idea. Mechanisms behind HIS of the 
appendix have not yet been suggested. 
The high prevalence of HIS in homosexual men has allowed researchers to examine 
causes of HIS in these individuals (Surawicz et al., 1987; Law et al., 1994). The increased 
presence of HIS in homosexual males may be due to an altered rectal environment. A 
number of causes might include mechanical irritation and local trauma due to rectal 
intercourse, chemical effects from semen, lubricants or enemas, and intestinal changes due 
to an increased prevalence of intestinal infections and the frequent use of antibiotics to treat 
them. Additionally, the effects of systemic infections or immunosuppression may predispose 
these individuals to HIS (Surawicz et al., 1987; Law et al., 1994).  
Little has been said about the transmission of spirochaetes in HIS, as many 
researchers believe the organism to be commensals. In homosexual males, it has been 
suggested that intestinal spirochaetes are sexually transmitted (McMillan & Lee, 1981). 
However, it seems more likely that transmission occurs by faecal-oral transmission as for 
other intestinal spirochaetes, with certain sexual behaviours increasing faecal oral contact in 
homosexual men. The finding of spirochaetes associated with 3 - 5 non-pathogenic protozoa 
is believed to be an indication of faecal exposure in these individuals (Law et al., 1994).  
 
1.3.2.5  The identity of spirochaetes in HIS 
The remaining difficulty associated with determining the pathogenic significance of 
HIS exists in relation to the identity of the spirochaetes involved. In all except the most 
recent reports, identification of the spirochaetes in HIS has generally not been performed. In 
the earliest descriptions of HIS, investigators considered that the organisms were Borrelia 
eurygyrata, based on staining and microscopic characteristics, and the name given in pre-
HIS reports of intestinal spirochaetes in human faeces (Harland & Lee, 1967; Lee et al., 
1971; Takeuchi et al., 1974; Gad et al., 1977). In 1982, B. aalborgi was isolated from the 
rectal biopsies of six individuals with HIS (Hovind-Hougen et al., 1982), named, and 
morphologically and biochemically characterised (Section 1.2.5). In the patients from whom 
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(Henrik-Nielsen et al., 1983). The ultrastructure of B. aalborgi seemed similar to the 
spirochaetes observed in earlier reports (Lee et al., 1971; Takeuchi et al., 1974; Crucioli & 
Busuttil, 1981).  
Following the initial description of B. aalborgi, there was a tendency to assume that 
organisms seen by light microscopy and TEM in HIS were B. aalborgi, although few 
investigators attempted culture or characterisation (Table 1.7). Most reports focussed on the 
characterisation of HIS, and descriptions of the organisms were either absent, or limited to 
measurements of the size of the fringe of spirochaetes adhering to the mucosa (Delladetsima 
et al., 1987; Padmanabhan et al., 1996). Authors who described the cell size and flagella of 
the spirochaetes they saw, concluded that the features were consistent with those described 
for B. aalborgi (Henrik-Nielsen et al., 1985; Gebbers & Marder, 1989; Lindboe et al., 1993; 
Nakamura et al., 1998). The majority of reports described cells which were 2 - 6 µm by 0.2 - 
0.4 µm with 4 flagella, although longer organisms also were observed (Gebbers & Marder, 
1989; Kostman et al., 1995; Nakamura et al., 1998). Attempts to repeat the isolation of B. 
aalborgi were unsuccessful until 2000 (Kraaz et al., 2000; Jensen et al., 2001), although 
isolation of B. aalborgi may have been achieved in an earlier report. Tompkins et al. (1982) 
isolated a spirochaete which was different from spirochaetes they isolated from homosexual 
males (probably B. pilosicoli (Tompkins et al., 1981), see Section 1.3.3). Culture was 
difficult and subculture was not possible, and for these reasons, the organism was probably 
B. aalborgi. 
Isolation of intestinal spirochaetes from HIS that were different from B. aalborgi in 
terms of growth characteristics rather than morphology was achieved on rare occasions 
(Cooper et al., 1986; Käsbohrer et al., 1990). In the meantime, spirochaetes which were 
eventually classified as B. pilosicoli were being isolated from human faeces (Sanna et al., 
1984; Jones et al., 1986; Tompkins et al., 1986; Barrett, 1990; Lee & Hampson, 1992) (see 
Section 1.4). Thus it was becoming obvious that more than one species of intestinal 
spirochaete existed in humans. A comparison of the morphology of B. pilosicoli (6 – 11 µm 
long, 0.25 - 0.3 µm wide, pointed ends, 4 - 7 flagella at each cell end (Trott et al., 1996c)) 
and B. aalborgi (1.7 – 6 µm long, 0.2 µm wide, pointed ends, 4 flagella at each cell end 
(Hovind-Hougen et al., 1982)) demonstrates either spirochaete could have been those seen 
in HIS.  
A study in homosexual males where B. pilosicoli was isolated from over 50% of 
biopsies with HIS led the authors to conclude that B. pilosicoli was the main species 
involved in HIS (Trivett-Moore et al., 1998). B. aalborgi was not isolated in the study. As a 
consequence, they thought that the presence of B. aalborgi had been previously exaggerated, Chapter 1 - Literature Review  
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that where symptoms were seen in HIS, the cause was B. pilosicoli, and that B. aalborgi was 
a commensal. 
However, this idea was discarded after the most recent studies examined HIS using 
PCR, sequencing and fluorescent in-situ hybridisation (FISH) directly on biopsy tissue 
(Table 1.5). These techniques bypassed the difficulties encountered in cultivating B. 
aalborgi, and allowed assessment of the prevalence of Brachyspira spp. in HIS. In studies of 
Norwegian, Swedish, Danish and Australian individuals (Mikosza et al., 1999; Kraaz et al., 
2000; Jensen et al., 2001; Mikosza et al., 2001), B. aalborgi has been identified in 58 – 86% 
of HIS cases, B. pilosicoli at 0 – 14%, and currently uncharacterised Brachyspira  spp. 
(tentatively named Brachyspira christiani in one study (Jensen et al., 2001)) at 17.4% and 
44%. B. aalborgi also has been identified in HIS in four Australian children (Heine et al., 
2001), and retrospectively in the two cases described by Guccion et al. (1995; Mikosza et 
al., 1999). In these studies, B. aalborgi was associated with the range of symptoms described 
in Section 1.3.2.4, with inflammation and invasion, and on normal cells.  
It seems probable that B. aalborgi were the organisms seen in the majority of cases 
of HIS prior to 1999, particularly when culture was unsuccessful. A further species of 
Brachyspira,  B. ibaraki has been recently proposed to describe intestinal spirochaetes 
isolated in Japan, based on 16S rDNA sequencing analysis (Tachibana et al., 2003). 
However, analysis by other researchers has retained this species within B. aalborgi (Mikosza 
et al., 2003). Thus the significance of B. aalborgi, B. pilosicoli and other Brachyspira spp. in 
HIS remains far from clear, particularly as the majority of these studies have been performed 
on individuals in developed countries who had symptoms requiring examination of a biopsy 
specimen.  
 
1.3.2.6 Treatment 
Regardless of the identity of intestinal spirochaetes involved in HIS, treatment with 
antibiotics has been successful at removing HIS and symptoms in the majority of cases. 
Other treatment of HIS has included therapy for other concomitant infections, or non-
specific methods. The particular treatment prescribed and outcome in each case report are 
summarised in Table 1.6. Prevalence studies have tended not to describe treatment except in 
rare instances (Henrik-Nielsen et al., 1983; Käsbohrer et al., 1990).  
The most frequently employed antimicrobial has been metronidazole, which has 
been made use of in almost all HIS case reports since 1981. On many occasions, 
metronidazole has resolved the symptoms, and the absence of the spirochaetes has been 
confirmed. However, a post-treatment biopsy has not always been obtained and in these 
instances there was no way of knowing if the spirochaetes were removed with the symptoms 
(Crucioli & Busuttil, 1981; Peghini et al., 2000; Heine et al., 2001). Metronidazole treatment Chapter 1 - Literature Review  
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has been associated with occasional relapses (Douglas & Crucioli, 1981; Rodgers et al., 
1986; Kostman et al., 1995; Heine et al., 2001), and situations where symptoms were not 
resolved by the first course of therapy, although a second course was successful (Cotton et 
al., 1984). 
Other antimicrobial treatment has included neomycin, which was mostly used in 
early accounts (Gad et al., 1977; Henrik-Nielsen et al., 1983; White et al., 1994). Neomycin 
successfully removed HIS and symptoms in one report (Gad et al., 1977), but neomycin plus 
bacitracin, and neomycin plus metronidazole removed HIS, but left symptoms unaltered in 
two reports (Henrik-Nielsen et al., 1983; White et al., 1994). This led one group of 
investigators to conclude spirochaetosis was without clinical significance, on the basis of 
therapy failure. However, neomycin is the only antimicrobial where symptoms have not 
resolved as a result of anti-spirochaetal therapy. Although the spirochaetes were B. aalborgi 
in at least one of these studies, it is interesting to note that other Brachyspira  spp. are 
resistant to neomycin and bacitracin, with minimum inhibitory concentrations (MICs) of 100 
- 200µg/ml and 12.5 - 50 µg/ml (Kitai et al., 1979; Trott et al., 1996d; Trampel et al., 1999).  
Treatment with the antimicrobials of the penicillin family has met with varied 
success; there has either been no change to spirochaete infestation (Gad et al., 1977), limited 
improvement (Kostman et al., 1995), or the resolution of symptoms (Cotton et al., 1984). 
Removal of spirochaetes was reported when ampicillin was combined with metronidazole 
(Antonakopoulos et al., 1982). Doxycycline and trimethoprim sulfamethoxazole have not 
been useful in the treatment of HIS (Gad et al., 1977; Guccion et al., 1995). Removal of 
symptoms has also been achieved with anti-parasitic agents, such as mebendazole and 
piperazine (Burns & Hayes, 1985; Cunha Ferreira et al., 1993), and by non-specific methods 
such as hydrocortisone foam or increased dietary fibre (Cotton et al., 1984; Padmanabhan et 
al., 1996). Symptoms also have resolved after polyp removal (Willén et al., 1977; Coyne et 
al., 1995; Guccion et al., 1995), and spontaneous resolution of symptoms has occurred 
(Crucioli & Busuttil, 1981; Gebbers et al., 1987; Lo et al., 1994; White et al., 1994). 
 
1.3.3  Studies on faecal carriage and culture of intestinal spirochaetes 
Numerous investigations have examined the faecal carriage of intestinal 
spirochaetes, without determining if HIS is present, although these are fewer than studies on 
HIS. Most have relied on culture of the intestinal spirochaetes from faecal specimens, and 
used biochemical, MLEE or PCR techniques to identify the organisms. A summary of these 
studies is presented in Table 1.8, together with case reports of the isolation of intestinal 
spirochaetes from blood.  
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1.3.3.1  Prevalence of intestinal spirochaetes in humans determined by 
carriage 
Brachyspira pilosicoli is the predominant spirochaete which has been isolated from 
faecal specimens. This organism has been isolated or detected by PCR in similar high 
proportions from a number of diverse population groups. These have included Aboriginal 
Australians (32.6%) (Lee & Hampson, 1992), and natives of Oman (26.7%, 11.4%) (Barrett, 
1990), India (25.6%) (Munshi et al., 2003c), Papua New Guinea (PNG) (22.8%) (Trott et 
al., 1997a) and Rwanda (22.6%, 14%) (Goossens et al., 1983), and natives of the island of 
Bali in Indonesia, at a somewhat lower prevalence (11.8%) (Margawani et al., 2003). A 
unifying feature of these individuals is their residence in a developing country, and while the 
Aboriginal Australians live in a developed country, the standard of living for some rural 
Aboriginal Australians is sometimes lower than that for other Australians.  
By contrast, the prevalence of B. pilosicoli carriage in heterosexual individuals in 
developed countries has been very low. Only 1.2 % of 1679 Belgian patients with diarrhoea 
carried a spirochaete the authors called T. hyodysenteriae (Goossens et al., 1983), which was 
almost certainly B. pilosicoli. Likewise, spirochaetes later identified as B. pilosicoli (Lee & 
Hampson, 1994) were present at under 0.9% in non-Aboriginal Australians, including 656 
children and adults with gastrointestinal disturbances, and 39 healthy children (Lee & 
Hampson, 1992). In a large study carried out in Britain, the overall prevalence of 
spirochaetes with the growth and biochemical characteristics of B. pilosicoli was 1.5%, 
however, all positive individuals were either of Indian descent and had recently visited the 
Indian sub-continent, or were homosexual males (Tompkins et al., 1986). The specific 
prevalence of carriage in each population was 4.8% and 20.6%, respectively. Another study 
isolated spirochaetes from 13.4% of homosexual males in Australia (Trivett et al., 1992), in 
a precursor to work examining B. pilosicoli carriage in homosexual males with evidence of 
HIS (Trivett-Moore et al., 1998).  
The reason for the increased prevalence of B. pilosicoli in individuals in developing 
countries is currently unknown, but could relate to poorer hygiene, environmental factors, 
host factors such as lowered immune status, nutritional deficiencies or differences in diet 
between developing and developed populations (Lee & Hampson, 1994; Trott et al., 1997a). 
Increased prevalence in homosexual males probably relates to sexual practices, as discussed 
for HIS in this population (section 1.3.2.5).  
The remaining studies on faecal carriage of intestinal spirochaetes have been case 
reports detailing spirochaete isolation from either homosexual males (Tompkins et al., 1981; 
Jones et al., 1986; Ruane et al., 1989), or a group of Italians sampled over a seven year 
period (Sanna et al., 1984; Coene et al., 1989), all with a variety of symptoms.  Chapter 1 - Literature Review  
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The reports in Table 1.8 give the impression that B. pilosicoli is the main 
spirochaete to be found in human faeces. However, B. pilosicoli is much easier of the two 
spirochaetes to cultivate, and in humans B. aalborgi has been isolated only from intestinal 
biopsies, except in one very recent instance where B. aalborgi was successfully cultivated 
from biopsies and faeces (Råsbäck et al., 2003). Thus none of the studies examining faecal 
carriage of intestinal spirochaetes by culture have determined prevalence of this organism. 
However, direct PCR of faeces in two recent studies has ascertained B. aalborgi carriage 
rates of 22.2% in Bali and 6% in Assam, India, (compared to a B. pilosicoli carriage of 
11.8% and 25.6%, respectively). Both species were detected in and almost 6% of Balinese, 
and 3.2% of Indians (Munshi et al., 2003a; Munshi et al., 2003c). 
B. pilosicoli was more prevalent in children in the Aboriginal Australian, Rwandan 
and Omani populations that have been studied. Aboriginal children aged 2 - 18 were 
significantly more likely to be colonised than children less than 2 years of age, or adults (Lee 
& Hampson, 1992). In hospitalised Omanis, colonised patients were more likely to be over 2 
years of age (Barrett, 1990). In PNG, while villagers aged 2 years and under had the lowest 
rate of colonisation, this was not significantly different to other groups (Trott et al., 1997a). 
Additionally, the only British Indian with symptoms in the study of Tompkins et al. (1986) 
was aged 2 years. However, in contrast to these studies, gastrointestinal disorders were 
suggested to be associated with carriage in Rwandan children aged 0 - 11 months (Goossens 
et al., 1983). In both India and Bali, carriage of B. pilosicoli or B. aalborgi were not 
associated with the age of participants (Margawani et al., 2003; Munshi et al., 2003a; 
Munshi et al., 2003c). 
The gender of individuals has not been determined in most studies of B. pilosicoli 
carriage in heterosexual individuals. In the PNG individuals, no difference in carriage 
according to gender was noted, but the remaining studies did not state prevalence by gender.  
Treatment has been infrequently described in these studies, and trends are similar to 
those found following treatment of HIS. Tinidazole (a nitroimidazole similar to 
metronidazole) achieved cure of spirochaetes in 16/18 PNG villagers (Trott et al., 1997a), as 
did mebendazole, metronidazole and erythromycin in homosexual males (Ruane et al., 
1989). Ampicillin, penicillin and oxytetracycline were not useful at removing spirochaetes 
or symptoms (Tompkins et al., 1981; Ruane et al., 1989), and spontaneous recovery was 
noted in some colonised individuals (Tompkins et al., 1986; Ruane et al., 1989). 
 
1.3.3.2  Transmission of intestinal spirochaetes in humans  
The transmission of human intestinal spirochaetes is currently poorly understood. 
The faecal carriage studies have allowed an examination of environmental factors which 
may be important in the transmission, and thus prevalence of B. pilosicoli in humans. It has Chapter 1 - Literature Review  
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been presumed that infection with this organism occurs in humans via the faecal oral route, 
as it does for animals (Trott et al., 1997a). In PNG, carriage of the organism was associated 
with living in a village, rather than in an urban area. Hygiene was poorer in the villages, and 
sanitation and running water were inadequate, with villagers obtaining their water from a 
nearby river (Trott et al., 1997a). In Bali, the highest rate of B. pilosicoli colonisation 
occurred in a peri-urban area, instead of in villages. This area was crowded and people relied 
on wells rather than tap water (Margawani et al., 2003). In India, carriage of B. pilosicoli 
was significantly higher if drinking water was again sourced from a well, or if the water was 
treated prior to consumption. Apparently, it was the poorer quality water which required 
treatment (Munshi et al., 2003c). As previously discussed, B. pilosicoli can survive for long 
periods in water, and these studies indicate that B. pilosicoli carriage in these populations 
may relate to contaminated water sources. However, the presence of B. pilosicoli in each 
water source was not tested.  
The role of B. pilosicoli as a zoonosis has been examined in some studies. B. 
pilosicoli has a wide host range, as discussed in section 1.2.4.3, and in environments where 
animals and humans live in close proximity, the potential for zoonotic transmission of B. 
pilosicoli might exist. Infection studies in which human and pig isolates of B. pilosicoli 
colonised chick and pig epithelium and caused diarrhoea, showed that cross-species 
infection was possible (Trott et al., 1995; Trott et al., 1996b). Restriction enzyme analysis 
(REA) examination of B. pilosicoli strains demonstrated relationships between isolates from 
dogs and humans (Koopman et al., 1993). A canine B. pilosicoli isolate and isolates from 
Australian Aboriginal children living in the same community were similar (Lee & Hampson, 
1994), suggesting dogs may be a reservoir for human B. pilosicoli infection. In PNG, B. 
pilosicoli was identified only in four dogs and a duck, and none of the native pigs (Trott et 
al., 1997a). PFGE confirmed a dog isolate was identical to an isolate from a human from 
another village, but no evidence of direct transmission was shown. In India, only one canine 
isolate of B. pilosicoli was obtained (Munshi et al., 2003c), even though the dogs were 
heavily colonised with numerous other gastrointestinal parasites of human and canine origin 
(Traub et al., 2002). The ownership of dogs or any other animal was not a risk factor for 
human carriage. The lower prevalence of B. pilosicoli in dogs compared to humans in all 
three studies indicated that dogs are unlikely to be a major reservoir of human infection. In 
fact, humans may be a source of infection for dogs after coprophagy of human faeces. 
Infection in humans seems more common from contaminated water sources in these 
environments.  
Similar factors may operate in the transmission of B. aalborgi, although so far, 
studies on faecal carriage of the organism have been few. In both India and Bali, carriage of 
B. aalborgi was significantly associated with carriage of B. pilosicoli (Munshi et al., 2003a; Chapter 1 - Literature Review  
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Munshi et al., 2003c). In common with B. pilosicoli, the consumption of treated drinking 
water was a significant factor for carriage of B. aalborgi in India. Proportions of B. aalborgi 
were higher if another family members was colonised, or if an individual was a resident of 
one particular village. In Bali, as for B. pilosicoli, living in a crowded peri-urban area was 
significantly associated with B. aalborgi carriage. Further studies on the prevalence of B. 
aalborgi are required to fully investigate the epidemiology of this organism in humans.  
 
1.3.3.3  Symptoms and significance of intestinal spirochaete carriage 
As in HIS, the carriage of B. pilosicoli in the faeces has been detected when 
intestinal symptoms including diarrhoea, abdominal pain, constipation, and/or weight loss 
have been present. In most of the prevalence studies, B. pilosicoli was isolated from 
individuals both with and without gastrointestinal symptoms. In Oman, carriage was higher 
in a healthy population (26.7%) than in hospital patients (11.4%). These latter patients had 
gastrointestinal symptoms such as diarrhoea, abdominal pain and vomiting, however, similar 
symptoms were recorded for hospitalised control patients without spirochaete carriage 
(Barrett, 1990). Likewise, carriage of B. pilosicoli was lower in Rwandan individuals with 
diarrhoea (14.0%) than asymptomatic controls (22.6%) (Goossens et al., 1983). In PNG, 
India and Bali, B. pilosicoli also was isolated from individuals with and without 
gastrointestinal symptoms, including abdominal pain and diarrhoea, and carriage was not 
significantly associated with the presence of these symptoms (Trott et al., 1997a; Margawani 
et al., 2003; Munshi et al., 2003c). Carriage of B. aalborgi in these latter two populations 
also was not associated with symptoms. 
Symptoms were not stated in the study involving the Aboriginal population, but B. 
pilosicoli was more likely to be isolated from watery or abnormal samples than normal 
faecal samples (Lee & Hampson, 1992). B. pilosicoli isolation was again significantly 
associated with the consistency of samples in PNG and Bali, with watery samples being 
significantly more likely to contain the spirochaete than normal samples (Trott et al., 1997a; 
Margawani et al., 2003). 
As a result of these prevalence studies, authors have felt that there was no evidence 
for B. pilosicoli being a cause of intestinal disease, and that the spirochaetes were normal 
bowel flora associated with ethnic or environmental rather than pathological factors (Barrett, 
1990). However, experimental infection of a healthy volunteer with a B. pilosicoli isolate 
obtained from a Aboriginal child produced mild nausea, headaches and abdominal 
discomfort (Oxberry et al., 1998). After treatment, which removed B. pilosicoli carriage, 
symptoms also ceased. Thus, other investigators remain undecided as to whether B. 
pilosicoli is a commensal, opportunistic or frankly pathogenic organism in humans (Trott et 
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1.3.3.4  Isolations of intestinal spirochaetes from blood 
On a few rare occasions, B. pilosicoli has been isolated from the blood of patients 
(Table 1.8), and these constitute the most serious infections with intestinal spirochaetes in 
humans. All of the nine cases occurred in patients who were critically ill. Eight cases 
occurred in males, one man was heterosexual, but the sexual orientation of the remaining 
patients was unknown. The ethnicity of all patients was likewise unknown. 
Seven of the patients in whom the isolation of B. pilosicoli from blood has been 
described were French (Lambert & Goursot, 1982; Fournié-Amazouz et al., 1995). In the 
first, a man suffering non-obstructive cardiomyopathy due to alcoholism had bloody 
diarrhoea and hepatitis, suffered an aneurism, and died due to renal, hepatic and cardiac 
failure despite penicillin therapy (Lambert & Goursot, 1982). Similarly, two of the patients 
described in a case series of six French patients were alcoholics, four had a fever, one had 
circulatory problems (cardiac arteriopathy) and four subsequently died (Fournié-Amazouz et 
al., 1995). Other diagnoses of the patients included stroke and hemiplegia with 
bronchopulmonary congestion (n=2), myeloma (n=1), and acute peritonitis and necrosis of 
the caecum (n=1). Interestingly, only two of these six patients had diarrhoea (Trott et al., 
1997b).  
Another European case was described from Greece (Kanavaki et al., 2002). This 
man was a heavy smoker and drinker (alcoholism was not noted) with high grade non-
Hodgkin’s lymphoma. He developed fever, bloody diarrhoea and abdominal pain, and also 
had cervical lymphadenopathy, jaundice and ascites. Penicillin resolved his fever and 
removed  B. pilosicoli from his blood cultures, however this patient died from hepatic 
encephalopathy as a result of multiorgan failure with intravascular coagulation. The final 
reported case was of a Californian AIDS patient who was receiving chemotherapy for 
Kaposi’s sarcoma, and presented with thrombophlebitis (Trott et al., 1997b). Nothing further 
is known about this patient. It is possible that B. pilosicoli was involved in the case of 
haemorrhagic rectocolitis which led to the death of a 14 year old girl by septicaemia (Zerpa 
et al., 1996), described in section 1.3.2.4. However, the spirochaetes in this report were not 
cultured or identified.  
It is unknown what role B. pilosicoli had in the morbidity and mortality of these 
individuals. All were seriously ill, gastrointestinal symptoms were not always present, and in 
two cases, death occurred after treatment of spirochaetes with penicillin. A trend towards 
liver involvement and immunosuppression by alcohol use, cancer or AIDS can be seen in the 
patients. It is interesting to note that a more serious report of HIS, which may have been 
caused by B. pilosicoli, also involved the liver (Kostman et al., 1995). It is possible that 
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which also permit organism survival in the blood (Trott et al., 1997b). Seeding of the blood 
stream might occur from the liver, via the portal and hepatic veins, and in the case where 
caecal necrosis occurred, the appendix may have been involved. However, faecal carriage of 
spirochaetes was determined in only one case (Lambert & Goursot, 1982), and the presence 
of HIS in spirochaetaemia with B. pilosicoli has not been examined. Clearly, further 
examination of blood infection with B. pilosicoli is required.  
 
1.4  DIAGNOSTIC METHODS FOR EXAMINING INTESTINAL 
SPIROCHAETES 
Numerous techniques have been employed for the detection, identification and strain 
typing of intestinal spirochaetes, some of which will be utilised throughout the work 
described in later chapters of this thesis. This and the next section will serve to introduce 
methods of laboratory diagnosis and typing for Brachyspira spp., with particular emphasis 
on the human intestinal spirochaetes. The testing of antimicrobial activity of the Brachyspira 
spp. will be presented in the final section. 
 
1.4.1 Microscopy 
Diagnosis and identification of intestinal spirochaetes by microscopic methods has 
been discussed in Sections 1.3.1 and 1.3.2.1. Light, phase contrast and dark field microscopy 
were the only methods which were used to examine intestinal spirochaetes until the 1970s 
(Jensen, 1997). Identification of intestinal spirochaetes by staining properties, size, shape 
and types of motility were attempted. Visualisation of the organisms with Gram’s and Vago 
stains, and a variety of normal and silver stains for histological examination of HIS have 
been tried. However, by these methods, the Brachyspira are too morphologically similar to 
allow accurate classification. Determining the presence of spirochaetes in fresh wet smears 
of faeces by phase contrast microscopy may provide additional evidence for spirochaetal 
infection, however, this method alone is not reliable to differentiate between various 
spirochaetes (Taylor & Trott, 1997). 
With the advent of electron microscopy came the ability to better characterise 
Brachyspira spp.. Transmission and scanning EM have been used to characterise IS and 
HIS, and to examine more closely the spirochaetes involved. The high magnification of 
TEM allows differentiation between some species by enumeration of periplasmic flagella 
(Table 1.1). However, even with the enhanced view afforded by this technique, some 
spirochaete species present in the same host cannot be differentiated by this method, such as 
B. hyodysenteriae and B. innocens in the pig, and B. pilosicoli and B. aalborgi in humans.  
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1.4.2 Bacterial  culture 
Culture and phenotypic characterisation has been regarded as the gold standard 
method to characterise bacterial species. As previously mentioned, human intestinal 
spirochaetes were observed long before anaerobic culture techniques were developed, and a 
similar situation occurred for the Brachyspira  spp. in animals (Jensen, 1997). Cultural 
techniques utilised for B. pilosicoli in a veterinary setting have been based on techniques 
developed for B. hyodysenteriae culture, while cultivation of human intestinal spirochaetes 
have often been on media described for the first isolation of B. aalborgi.  
 
1.4.2.1 Solid  media 
Early techniques for the cultivation of B. hyodysenteriae on solid media comprised 
serial dilution or filtration through membranes of decreasing pore size to 0.45 µm, to isolate 
spirochaetes from colonic material or rectal swabs (Harris et al., 1972b; Kinyon & Harris, 
1979). Samples were grown on bovine or ovine blood agar plates at 37 - 42°C in anaerobic 
atmospheres, and examined after 3 d. This allowed observations about the type of 
haemolysis that isolates produced. However, the filtration method in particular was 
cumbersome, and the addition of antibiotics to blood agar media significantly improved the 
diagnosis of Sd (Hampson & Trott, 1995).  
The first selective medium contained trypticase soy agar (TSA), bovine blood and 
400µg/ml spectinomycin, based on the resistance of five B. hyodysenteriae isolates at 
1000µg/ml (Songer et al., 1976). However, overgrowth of other intestinal organisms on this 
agar led the development of media containing other antibiotics (Jenkinson & Wingar, 1981). 
These included CVSBA media containing spectinomycin (400 µg/ml), colistin and 
vancomycin (25 µg/ml each) (Jenkinson & Wingar, 1981), Serpulina agar with 
spectinomycin (800 µg/ml), colistin and vancomycin (25 µg/ml each) and 1% sodium 
ribonucleate (Fellström & Gunnarsson, 1995), and BJ medium with spectinomycin (200 
µg/ml), spiramycin (25 µg/ml), rifampin (12.5 µg/ml), vancomycin, colistin (6.25µg/ml 
each) and pig faeces extract (Kunkle & Kinyon, 1988). Each have been used widely in 
veterinary research, and the latter is the best available for isolating B. hyodysenteriae from 
pig faeces (Achacha & Messier, 1992). Incubation at 42°C is reported to be useful for 
inhibiting other flora (Hampson & Trott, 1995).  
Many of the same techniques have permitted the isolation of B. pilosicoli from 
animal sources. Isolation of B. pilosicoli is possible on the media described for B. 
hyodysenteriae, although the appearance of growth is somewhat slower, taking up to 6 d 
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media containing rifampicin and spiramycin, as some strains of B. pilosicoli are moderately 
sensitive to these antibiotics (Trott et al., 1996c; Calderaro et al., 1997).  
By contrast, the media and conditions for isolation of human intestinal spirochaetes 
are less well developed, due to a less unified approach to research in this field than in study 
of infection with Brachyspira spp. in animals. Media and growth conditions utilised for the 
isolation or attempted isolation of human intestinal spirochaetes are summarised in Table 
1.9. Isolation of the first B. aalborgi strain was achieved on a pre-reduced TSA with 10% 
calf blood, containing spectinomycin (400 µg/ml), and polymyxin B (5 µg/ml) (Hovind-
Hougen et al., 1982). Other studies have used similar media and conditions to a certain 
extent. Blood-containing TSA media incubated at 37°C have been utilised in the majority of 
instances, but blood has been sourced from cows, horses, sheep and humans. Blood 
concentrations also have varied from 5 - 10%, and antibiotics have been spectinomycin 
alone, or with polymyxin B or other antimicrobials. CVSBA medium has been utilised in all 
reports by one group (Lee & Hampson, 1992; Trott et al., 1997a; Margawani et al., 2003), 
and amphotericin B and nalidixic acid have rarely been used (Goossens et al., 1983; 
Käsbohrer et al., 1990; Trott et al., 1997a). Incubation temperatures have included 36, 37, 
38.5, 39 and 42°C, and a variety of anaerobic atmospheres have been used, with 5 - 10% 
CO2, with N2 and or H2.  
 
1.4.2.2 Liquid  media 
Liquid media used for B. pilosicoli again have been those developed for propagation 
of B. hyodysenteriae. A trypticase soy broth (TSB) containing FCS, sodium bicarbonate, 
cysteine hydrochloride, cholesterol, glucose and yeast extract has frequently been used, 
prepared under a flow of 10% CO2 – 90% N2 and then autoclaved (Kunkle et al., 1986). This 
was better for growth than modified Lemke medium containing TSB, glucose and rabbit 
serum (Lemcke et al., 1979) or modified Kinyon medium containing TSB and 10% FCS 
(Kinyon & Harris, 1974; Kunkle et al., 1986). Other broths routinely used to cultivate B. 
pilosicoli include BHIB, and heart infusion broth for growth substrate studies (Stanton & 
Lebo, 1988; Trott et al., 1996c), both supplemented with 10% heat treated FCS, and 0.2% 
w/v glucose. 
Growth studies of probable B. pilosicoli isolates from homosexual males were 
carried out in liquid media by Jones et al. (1986). Thioglycollate and brucella broths alone 
did not support growth of the organisms. but when TSB, PPLO medium (BBL, Becton 
Dickinson, Cockeysville, MD, USA) and thioglycollate were tested in concert with human, 
horse, rabbit and foetal calf sera, the thioglycollate - FCS combination was superior for 
growth. Broth culture of B. aalborgi has been reported in BHIB with 5% calf blood and 
modified Barbour-Stoenner-Kelly medium (Sigma) (Kraaz et al., 2000), the latter being a Chapter 1 - Literature Review  
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highly complex medium containing bovine serum albumin for culture of Borrelia 
burgdorferi (Pollack et al., 1993). Very recently, selective enrichment of B. aalborgi from 
rectal biopsies and faeces has been described in BHIB and TSB with 10% FCS, 
spectinomycin and rifampicin (Calderaro et al., 2003). 
 
1.4.2.3 Blood  culture 
The spirochaete isolates from the nine cases of bacteraemia, discussed in Section 
1.3.3.4, were isolated using a variety of specialised blood culture media, with difficulty in 
some cases. Primary isolation of five of the six French B. pilosicoli isolates was achieved in 
Hémoline blood culture bottles (bioMérieux, Marcy l’Etoile, France), and the sixth in 
Bioarges Sanofi diagnostic anaerobic medium (Diagnostic Pasteur, Paris, France) (Fournié-
Amazouz et al., 1995). Subculture was achieved using TGY anaerobic media (Diagnostic 
Pasteur) plus 10% foetal calf serum. The first French spirochaete isolate was obtained in the 
Vital Aer medium (bioMérieux) enriched with blood (Lambert & Goursot, 1982). Isolation 
of the organism was difficult using classic BHI, TGY and Legroux’s gelatine broths, 
enriched with horse serum, and with and without supplementary vitamins. The isolate from 
the USA grew in the ESP automated blood culture system (Difco, Detroit MI, USA), but 
failed to produce a signal (Trott et al., 1997b). Changes in the medium were noticed by an 
observant operator, the organism was observed microscopically and then subcultured from 
the bottle. By contrast, the isolate from the Greek patient was detected by automated signal 
in the BacT/Alert system (Organon Teknika, Greece), after only 75 h incubation. The B. 
pilosicoli isolate was obtained by subculture after anaerobic culture on 5% human blood 
agar.  
 
1.4.3 Phenotypic  characterisation 
The colonial morphologies of the Brachyspira spp. on blood agar are identical. The 
production of a strong β-haemolysis by B. hyodysenteriae allows identification of this 
organism, although confirmation of identity is required by another means. However, the 
WBHIS cannot be differentiated by colonial morphology, thus once isolated, further 
characterisation is necessary.  
The traditional approach to organism characterisation is a phenotypic one. The 
biochemical attributes of the Brachyspira spp. have been stated previously (Section 1.2, 
Table 1.1), with the key reactions for differentiation being indole production, hippurate 
cleavage,  α-galactosidase,  α-glucosidase and β-glucosidase activities, as well as type of 
haemolysis on blood agar. Indole production can be measured by a spot test on filter paper 
soaked with indole reagent (Sutter & Carter, 1972; Fellström & Gunnarsson, 1995), or the Chapter 1 - Literature Review  
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addition of xylose and Kovac’s reagent to a broth culture (Lee et al., 1993b). Hippurate 
hydrolysis can be determined in broth with 1% sodium hippurate (Kinyon & Harris, 1979) or 
by a ninhydrin method (Fellström & Gunnarsson, 1995). The other enzymatic reactions are 
ascertained by the API ZYM system (bioMérieux), which involves the rapid reaction of 19 
enzymes in a test strip (Hunter & Wood, 1979). A standardised organism suspension is 
inoculated into the cupules of the strip, which is then incubated for 4 h at 37°C. After the 
addition of colour developing reagents, the reactions are scored by a numerical coding 
system, and a distinctive five digit code is produced.  
Fellström and Gunnarsson (1995) suggested these phenotypical reactions, rather 
than just haemolysis, were necessary for adequate differentiation of all the intestinal 
spirochaetes. Spirochaetes from pigs were divided into six groups; Group I consisted of 
organisms with the features of B. hyodysenteriae, Group II were identical to Group I but 
were weakly β-haemolytic, Group III contained three sub groups which included the B. 
innocens type strain, while Group IV were WBHIS associated with diarrhoea in pigs. MEE 
and 16S rRNA sequence analysis demonstrated that these groupings had a phylogenetic 
basis (Lee et al., 1993b; Fellström et al., 1995), and that Group II strains were B. intermedia, 
Group IIIa was B. murdochii, groups IIIb and IIIc were B. innocens, and Group IV was B. 
pilosicoli (Lee et al., 1993b).  
Biochemical characterisation also has been performed on intestinal spirochaetes 
from humans, to identify and compare isolates with porcine intestinal spirochaetes. Most of 
the organisms analysed were B. pilosicoli, based on growth characteristics and inclusion in 
Group IV by biochemical characteristics. Few isolates of B. aalborgi have been tested, due 
to the difficulties involved in isolating the organism, as previously described. In general, 
variability in characteristics were noted in spirochaetes later shown to be B. pilosicoli. Indole 
positive B. pilosicoli isolates were obtained from Italians, Omanis, Aboriginal Australians 
and homosexual males (Sanna et al., 1984; Tompkins et al., 1986; Lee et al., 1993c; De 
Smet et al., 1998), while most isolates are indole negative. Other isolates have been 
hippurate negative where most isolates are positive, α-glucosidase positive where most 
isolates are negative, and variable for acid phosphatase, and α-galactosidase, with examples 
of weak activity (Jones et al., 1986; Tompkins et al., 1986; Lee et al., 1993c; De Smet et al., 
1998). 
 
1.4.4  Molecular methods of detection and characterisation 
Cultivation of Brachyspira spp. followed by phenotypic characterisation is time 
consuming and laborious. Biochemical characterisation of the WBHIS in particular are Chapter 1 - Literature Review  
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prone to variation and thus ambiguity. Recently, diagnostic methods based on genotype have 
provided rapid and more specific alternatives to diagnosis of Brachyspira spp.. 
 
1.4.4.1  Nucleic acid probes and fluorescent in situ hybridisation 
Nucleic acid probes are sections of DNA or RNA which have been labelled with an 
enzyme, radioisotope, or antigenic or chemiluminescent substrate (Tenover & Unger, 1993). 
Following hybridisation of the labelled probe with the target sequence, specific detection of 
the probe allows diagnosis of the target species. A number of probes for use in solid phase 
hybridisation (Northern blots) were developed for B. hyodysenteriae in the early 1990s. 
These included a whole chromosomal DNA probe (Combs & Hampson, 1991), a 16S rRNA 
gene probe (Jensen et al., 1990), a probe to the B. hyodysenteriae haemolysin gene, to 
flagellar proteins and various random chromosomal probes (Sotiropoulos et al., 1993; Harel 
& Forget, 1995). However these were limited in their usefulness, as species specificity was 
either not ideal or not well evaluated, and the techniques lacked sensitivity and simplicity 
required for routine diagnosis (Hampson & Trott, 1995). Many of these problems have been 
overcome with the use of PCR techniques.  
Fluorescent  in situ hybridisation (FISH) is an application of nucleic acid probe 
technology which may be useful for studies on the pathogenicity of intestinal spirochaetes. 
This technique involves the principles of solid phase hybridisation, but probing and 
detection of the infectious agent occurs within the tissue (Podzorski & Persing, 1995). 
Advantages of FISH include the ability to identify and differentiate organisms within their 
natural environment, without the need for culture (Boye et al., 1998). The technique is 
sensitive and rapid, but requires skilled microscopy and pathology to locate organisms 
within specimens (Boye et al., 1998). Although FISH is too complex for use as a routine 
diagnostic tool (Podzorski & Persing, 1995), the procedure has been utilised successfully for 
detection and identification of intestinal spirochaetes.  
FISH probes have been developed specifically to detect B. aalborgi, B. pilosicoli 
and B. hyodysenteriae, as well as a general probe to detect all members of the Brachyspira 
genus (Boye et al., 1998; Jensen et al., 2000; Jensen et al., 2001). The probes targeted 16S 
and 23S rRNA, which are present in high numbers in active cells, so sensitivity was greater 
than if cellular DNA was targeted. The procedure has been used on intestinal tissue from 
experimentally infected pigs, and pigs and humans with naturally acquired spirochaete 
infection (Boye et al., 1998; Jensen et al., 2000; Jensen et al., 2001). Visualisation plus 
identification of the organisms within colonic biopsy tissues allowed differentiation between 
pathogenic and non-pathogenic organisms in swine, and the in situ examination of the 
morphology and distribution of organisms (Jensen et al., 2000).  Chapter 1 - Literature Review  
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FISH has been utilised in a report of HIS (Jensen et al., 2001). Here, the technique 
allowed visualisation and identification of B. aalborgi in samples, and identification of 
human intestinal spirochaetes which did not fluoresce with B. aalborgi or B. pilosicoli 
specific probes, but did react to the general Brachyspira probe. The authors suggested these 
organisms may represent a new species, “B. christiani”. This technique unequivocally 
demonstrated that B. aalborgi is a cause of HIS, and that the organisms responsible for HIS 
may be even more numerous than previously realised.  
 
1.4.4.2  Polymerase Chain Reaction 
The polymerase chain reaction was first described in 1985 (Saiki et al., 1985) and 
has since revolutionised many aspects of the biological sciences. The technique is based on 
repeated cycles of primer-directed synthesis of target nucleic acid sequences (Persing, 1991). 
The primary objective is to improve the sensitivity of detection of a target nucleic acid 
sequence by the amplification of that sequence (Podzorski & Persing, 1995). In terms of 
microbiological diagnosis, PCR is a simple and flexible procedure which has allowed the 
rapid diagnosis of infections due to slowly growing, fastidious or non-cultivable agents 
(Louie et al., 2000). For this reason, it has been an ideal technique for the identification of 
intestinal spirochaetes, and in particular, has application for study of B. aalborgi.  
The first developed primers for intestinal spirochaetes were directed towards 
amplification of B. hyodysenteriae, but the technique has been very valuable for the 
detection of the WBHIS. Early B. hyodysenteriae primers were based on the B. 
hyodysenteriae nuclear probes described in the previous section, and thus targeted unknown 
gene sequences (Elder et al., 1994; Harel & Forget, 1995). In later reactions, the 16S and 
23S rRNA genes were among those which were targeted for amplification (Leser et al., 
1997; Atyeo et al., 1999b). 
A variety of B. pilosicoli specific PCR primers have been created in the 16S rRNA 
gene, based on a unique ‘signature sequence’ (Stanton et al., 1996) first identified by Park et 
al. (1995). Most reactions have utilised the forward primer ‘A coli 1’ based on this sequence 
(Park et al., 1995), with an assortment of different reverse primers. In the reaction developed 
by Park and colleagues (1995), the reverse primer was a universal eubacterial primer and the 
reaction generated a product of 1330bp. The PCR showed complete specificity for B. 
pilosicoli after testing against 82 Brachyspira isolates.  
Another reaction utilising A coli 1 was developed (Muniappa et al., 1997), 
apparently because negative results were obtained for some human isolates with the first 
reaction. However, only 11 Brachyspira  were tested and clinical samples were not 
examined. Fellström and colleagues (1997) developed a reaction with a 930bp product that 
was tested against 36 Brachyspira isolates and eight other enteric bacterial species, and Chapter 1 - Literature Review  
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again demonstrated species specificity for B. pilosicoli. A further two B. pilosicoli specific 
16S rRNA gene PCRs using A coli 1 with products of 196bp and 439bp were developed to 
examine DNA from paraffin embedded tissues (PET) (Mikosza et al., 1999; Mikosza et al., 
2001). These reactions were chosen for the small size of the expected product in case DNA 
was degraded in this tissue and the primers again demonstrated good species specificity. The 
latter of these reactions has been utilised in other studies (Heine et al., 2001; Margawani et 
al., 2003; Munshi et al., 2003c).  
Various PCR tests also have been developed to amplify areas of the 16S rRNA gene 
of B. aalborgi. Reactions were designed to generate products of 314 bp (Duhamel et al., 
1997), 472 bp (Mikosza et al., 1999), 207 bp (Kraaz et al., 2000) and 520 bp (Jensen et al., 
2001), and were designed for amplification of DNA from biopsy tissue.  
Few other sites on the B. pilosicoli genome have been the object of PCR primer 
design, as the signature sequence has been such a successful target. However, the 23S rRNA 
gene has also been utilised as a target for PCR primers for B. pilosicoli, as well as B. 
hyodysenteriae (Leser et al., 1997) and B. intermedia (Suriyaarachchi et al., 2000). The 23S 
rRNA gene consists of larger regions of hypervariability, which is of particular importance 
for the species without a clear 16S rDNA signature sequence (Leser et al., 1997). However, 
this 23S rRNA reaction appeared to be species non-specific for B. intermedia in one report 
(Suriyaarachchi et al., 2000).  
Another gene which has been a major target for PCR amplification of Brachyspira 
spp. has been the NADH oxidase (nox) gene. This well characterised enzyme chemically 
reduces oxygen to water, and may allow the spirochaete to associate with oxygen rich 
epithelial cells (Harris et al., 1999). The nox gene is present throughout the genus (Stanton et 
al., 1995), and is conserved among Brachyspira spp. (Atyeo et al., 1999b). Nox reactions 
have been developed for B. pilosicoli and B. aalborgi (Mikosza et al., 1999), for 
amplification of DNA from PET, as well as reactions for detection of B. hyodysenteriae, B. 
intermedia and a single reaction for both B. innocens and B. murdochii (Atyeo et al., 1999b). 
Sequence identities of the nox genes indicated a minimum sequence identity of 86.3% 
among species, which suggest that it may be better suited for species differentiation than 16S 
or 23S rRNA genes, which have only 2 – 3 % difference (Atyeo et al., 1999b). 
The more recent descriptions of HIS and intestinal spirochaete carriage in humans 
have relied on PCR rather than phenotypic methods for diagnosis, due to the rapidity and 
specificity of PCR for spirochaete identification. The identity of B. pilosicoli isolates from 
the blood, faeces and biopsy specimens (Trott et al., 1997a; Trott et al., 1997b; Trivett-
Moore et al., 1998) have been confirmed using the 16S rDNA PCRs of Park et al. (1995) or 
Mikosza et al. (2001). Furthermore, detection of B. pilosicoli directly from faeces has been 
performed (Munshi et al., 2003c).  Chapter 1 - Literature Review  
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The presence of B. aalborgi has been confirmed on PET, fresh biopsies and in 
faeces by PCRs for the nox gene and the 16S rRNA gene (Mikosza et al., 1999; Kraaz et al., 
2000; Heine et al., 2001; Jensen et al., 2001; Mikosza et al., 2001; Munshi et al., 2003c). 
The presence and identity of B. aalborgi has been confirmed in these tissues with extreme 
ease when compared with the difficulties of cultivating this species. Thus PCR is a 
promising technique for use in studies designed to assess the prevalence of B. aalborgi.  
 
1.4.4.3  DNA-DNA homology studies 
Other molecular techniques which have been used to characterise intestinal 
spirochaetes have included DNA-DNA homology studies (Jensen, 1997). This method is the 
recommended technique for description of a new bacterial species (Stackebrandt et al., 
2002). DNA-DNA homology studies have been used extensively to confirm the taxonomic 
position of the various species within the genus Brachyspira, and to characterise new species 
(Miao & Fieldsteel, 1978; Stanton et al., 1991; Trott et al., 1996c; Stanton et al., 1997; 
Stanton et al., 1998). However, the technique is complex and laborious, so few isolates have 
been analysed by this technique (Jensen, 1997), and will not be discussed further.  
 
1.4.5  Other detection methods 
Other approaches to diagnosis of intestinal spirochaetes have included serological 
and antigenic detection methods. Diagnosis of Sd has been attempted by serology, as a 
strong immunological response is elicited in pigs colonised with B. hyodysenteriae (Galvin 
et al., 1997), and such methods bypass the need for identification via culture and 
biochemistry. In theory, the detection of carrier animals is possible, which are important in 
the maintenance and spread of intestinal spirochaete infections through animal populations. 
A variety of approaches have been attempted, including use of the microtitre agglutination 
test, enzyme linked immunosorbent assay, and indirect fluorescent antibody test (IFAT). 
However, no assay developed so far is sensitive or completely specific for routine diagnosis 
of Sd (La & Hampson, 2001), and none have been developed for B. pilosicoli.  
Antigen detection methods have used both polyclonal sera and monoclonal 
antibodies. Polyclonal rabbit antiserum raised against B. hyodysenteriae and used in an 
IFAT directly on pig faeces showed cross reactivity for other Brachyspira spp. (Hampson & 
Trott, 1995). Likewise, rabbit antiserum raised against human intestinal spirochaetes, later 
identified as B. pilosicoli, cross-reacted with B. hyodysenteriae and B. innocens in a Western 
blot analysis (Dettori et al., 1988b). Preabsorption of antiserum with proteins from related 
spirochaetes removed cross-reacting antibodies in pigs (Hudson et al., 1976), but sensitivity 
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The use of a monoclonal antibody (mAb) to a single, highly immunogenic 
membrane-associated protein would solve specificity problems, however finding a suitable 
protein has been problematic. Flagellar proteins are highly conserved among spirochaetes 
and cross-reactions are still a potential problem (Hudson et al., 1976; Jensen, 1997). Other 
B. hyodysenteriae candidates have been a 39 kDa variable cell surface protein encoded by 
vspA – vspD (Gabe et al., 1998), a periplasmic ATP-binding cassette iron import system 
(Dugourd et al., 1999), recently described 17 and 22 kDa proteins (Ochiai et al., 2000), and 
a 30 kDa outer membrane lipoprotein which did not cross react with 20 other spirochaete 
spp. (Lee & Hampson, 1996).  
So far, none of these techniques have been used for routine diagnosis of B. 
pilosicoli. Difficulties experienced with antigenic detection of B. hyodysenteriae, combined 
with the knowledge that B. pilosicoli swine infection produces a far poorer immune response 
(Hampson et al., 2000) have probably hampered progress. A mAb specific for a 29 kDa 
lipoprotein of B. pilosicoli has been created and shown to be capable of detecting B. 
pilosicoli in faecal smears when used in IFAT (Lee & Hampson, 1995). A 80 kDa mAb was 
created and found to identify B. pilosicoli strains from a range of animals as well as humans 
(Tenaya et al., 1998), but is yet to be used diagnostically. The 29 kDa mAb for B. pilosicoli 
and the 30 kDa mAb for B. hyodysenteriae have been used successfully on one occasion to 
differentiate between these species (Rayment et al., 1997).  
Examination of human intestinal spirochaetes has been made with an immunological 
technique on few occasions only (Dettori et al., 1988a; Dettori et al., 1988b; Kraaz et al., 
2000, Råsbäck et al., 2003). A monoclonal antibody was made to a human spirochaete strain 
(B. pilosicoli) and used in a MAT to serotype 11 isolates (Dettori et al., 1988a), however, 
this monoclonal does not appear to have been used as a diagnostic tool in wide ranging 
serological surveys. More recently, polyclonal rabbit serum produced to an 
“uncharacterised” intestinal spirochaete was used to aid visualisation of B. aalborgi in HIS 
(Kraaz et al., 2000). Spirochaetes on the mucosal surface were stained by an indirect IFAT 
method. However, B. hyodysenteriae,  B. pilosicoli,  B. innocens and  B. murdochii also 
reacted with the antiserum, and identification was made by PCR and sequence analysis.  
 
1.5  METHODS OF TYPING INTESTINAL SPIROCHAETES  
A variety of methods have been utilised to carry out subspecific differentiation of 
intestinal spirochaetes. Again, the majority of the work has been carried out on B. 
hyodysenteriae, but some techniques have been applied to B. pilosicoli, and recently, 
sequence characterisation of B. aalborgi has been performed. 
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1.5.1 Serotyping 
Serotyping is a traditional method for sub-typing bacterial isolates, and generally 
has been replaced by molecular methods. For this reason, serotyping has only been used as a 
typing technique for isolates of B. hyodysenteriae. Analysis of lipopolysaccharide-like 
material extracted by a hot water-phenol method originally allowed the identification of four 
serotypes (Baum & Joens, 1979). Further serotypes were designated over the next 10 years, 
then a system with serovars contained within serogroups (currently 11; (Hampson et al., 
1997)) was proposed (Hampson et al., 1989; Hampson et al., 1990). Isolates from the USA 
have been of serotype 1 and 2, while those from Europe and Australia are serologically 
diverse. Virulence did not appear to correspond to serotype (Harris et al., 1999).  
Eight isolates of B. pilosicoli from pigs and humans have been serotyped in the same 
manner as B. hyodysenteriae, and all had a distinct profile, suggesting that B. pilosicoli is 
antigenically diverse as a species (Lee & Hampson, 1999). 
 
1.5.2  Multilocus Enzyme Electrophoresis 
MLEE is the technique that has been used most frequently to type intestinal 
spirochaetes. In particular, the method was used to identify all the currently recognised 
species of the genus Brachyspira (Lee et al., 1993b; Lee et al., 1993c; Stanton et al., 1996). 
It has also been used to examine the subspecific relationships between strains of the 
representative species, and to examine the population genetics of B. hyodysenteriae (Trott et 
al., 1997c) and B. pilosicoli (Trott et al., 1998). MLEE as a technique determines differences 
in the electrophoretic mobility of a set of constitutive enzymes on starch gels (Selander et 
al., 1986). Variation in enzyme mobility is interpreted to represent the products of different 
alleles at the enzyme locus. A dendrogram is created, which depicts the genetic relatedness 
between isolates, and each unique enzyme mobility pattern is known as an electrophoretic 
type (ET) (Paster & Dewhirst, 1997). While MLEE is recognised as a powerful tool for 
studying bacterial populations, it is only moderately discriminatory, and is thus favoured less 
for analysing the epidemiology of clinical isolates (Arbeit, 1995). 
For Brachyspira spp., typing was initially based on the mobility of five enzymes 
(Lymbery et al., 1990), then the selection was expanded to include 15 constitutive enzymes 
(Lee et al., 1993a). As has been previously described (Section 1.2.2 and 1.2.3), MLEE was a 
crucial technique to assign the WBHIS into genetic groups. Isolates from pigs with diarrhoea 
from swine were found to be separate from B. innocens and B. hyodysenteriae (Lee et al., 
1993b). Isolates from humans clustered within this group, and were distinct from B. 
hyodysenteriae (Lee et al., 1993c), contrary to other studies at the time which suggested 
human intestinal spirochaetes were B. hyodysenteriae (Coene et al., 1989; De Wergifosse & Chapter 1 - Literature Review  
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Coene, 1989). Additionally, the newer species of Brachyspira including B. intermedia, B. 
murdochii and B. alvinipulli (Stanton et al., 1997; Stanton et al., 1998), as well as the 
proposed species “B. canis” and “B. pulli” (McLaren et al., 1997; Duhamel et al., 1998c) 
have been taxonomically defined with this technique. 
MLEE has been used to analyse over 200 B. pilosicoli isolates from humans, dogs, 
pigs, birds and water samples (Lee et al., 1993b; Lee & Hampson, 1994; Trott et al., 1996a; 
McLaren et al., 1997; Oxberry et al., 1998; Oxberry, 2002). In particular, human WBHIS 
including B. aalborgi and “S. jonesii” (Jones et al., 1986) from various geographic locations 
were compared with porcine B. pilosicoli (Lee & Hampson, 1994). Most porcine isolates 
were distinct from human isolates, with twenty-nine isolates from Aboriginals located in 
eight ETs and isolates from siblings sampled in consecutive years located in one of these 
groups (Lee et al., 1993c). B. aalborgi was separate from B. pilosicoli, but “S. jonesii” 
grouped with other B. pilosicoli (Lee & Hampson, 1994). Another study used MLEE to 
ensure that B. pilosicoli recovered from faeces after experimental human infection was the 
same as the inoculated strain (Oxberry et al., 1998).  
The relationships between B. pilosicoli isolates obtained in the PNG Highlands were 
examined with MLEE, and due to the geographic isolation of the population, the technique 
also was used to examine B. pilosicoli population genetics (Trott et al., 1998). The majority 
(69%) of human isolates were located in only four of 33 ETs, although considerable strain 
diversity was found overall. The population was determined to be highly recombinant, 
which contrasted to B. pilosicoli from Australian Aboriginals, and to B. hyodysenteriae, 
where epidemic clones were present (Trott et al., 1997c; Trott et al., 1998). More detail 
regarding the population structure of Brachyspira  spp., will be discussed in the work 
presented in Chapter 6.  
 
1.5.3  Pulsed-Field Gel Electrophoresis 
Pulsed-field gel electrophoresis (PFGE) is a genotypic typing method which is a 
variation on conventional agarose gel electrophoresis (Maslow & Mulligan, 1996). The 
bacterial cells are embedded in agarose plugs, to minimise shearing of genomic DNA, and 
the DNA is then digested by restriction enzymes with few recognition sites (Maslow et al., 
1993), generating fragments of around 10 - 800 kb (Arbeit, 1995). The DNA fragments, 
which are too large to separate by conventional electrophoresis, are separated on an agarose 
gel under an electric field, the orientation and duration of which are periodically changed. 
The results are simple, highly discriminating, highly reproducible restriction profiles (Arbeit, 
1995; Tenover et al., 1997).  Chapter 1 - Literature Review  
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PFGE is considered to be the gold standard typing method, as it is superior to other 
phenotypic and molecular typing methods in terms of sensitivity and reproducibility. Thus it 
has been applied to a broad range of bacterial species since its development in 1984 
(Schwartz & Cantor, 1984; Olive & Bean, 1999). The technique has been highly effective 
for the subspecific typing of intestinal spirochaetes of human and animal origin (Atyeo et 
al., 1996; Rayment et al., 1997; Trott et al., 1998). PFGE was first used to compare isolates 
of B. pilosicoli from pigs, dogs, birds and humans, using the enzyme MluI (Atyeo et al., 
1996). The genetic heterogeneity of isolates was obvious, with 40 different pulsed-field 
types for only 52 isolates. Greater diversity was observed for avian and human isolates than 
pig isolates. Isolates shared the same pattern only if they were from the same pig herd, or 
from Aboriginal children within the same community.  
This and a study on B. hyodysenteriae (Atyeo et al., 1999a) compared typing by 
PFGE and MLEE, and in each, PFGE was the more discriminatory. For B. hyodysenteriae, 
PFGE was also more discriminating than serotyping, and although REA and PFGE were of a 
similar level of discrimination, results were easier to analyse with PFGE (Atyeo et al., 
1999a). Again multiple isolates from the same farms were identical or had similar patterns, 
although similarities also were detected between isolates on unrelated piggeries in different 
states.  
Both B. intermedia and B. innocens have been examined by PFGE also. Twenty 
eight isolates of B. intermedia were digested with MluI, and heterogeneity was observed. 
The only close similarities between isolates were from chicken isolates obtained on same 
farm (Suriyaarachchi et al., 2000). B. innocens isolates have been analysed with MluI and 
SmaI enzymes, and were found to be heterogeneous (Fossi et al., 2001). 
Because of the high discrimination afforded by PFGE, the technique has been used 
for small scale epidemiological comparisons of Brachyspira isolates. In the eradication of B. 
pilosicoli infection from a farrowing swine herd, PFGE was used to ascertain that a single 
strain of B. pilosicoli was present in pigs at three different sampling points (Fossi et al., 
2001). A group of 14 indole negative B. hyodysenteriae from Belgium and Germany were 
indistinguishable using Mlu1 and SalI, unlike indole positive isolates from Belgium, Sweden 
and the USA, which had a variety of patterns with each enzyme (Fellström et al., 1999). 
PFGE was used to confirm MLEE results discriminating between intestinal spirochetes from 
rats, rheas and pigs (Trott et al., 1996a). B. hyodysenteriae isolated from a rat and a pig on 
the same farm were indistinguishable after MluI digestion, suggesting transmission between 
these species.  
After the original report in which B. pilosicoli from Aboriginal Australians were 
typed using PFGE (Atyeo et al., 1996), only two other studies have examined the 
relationships between intestinal spirochaetes from humans with this technique. In the first, B. Chapter 1 - Literature Review  
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pilosicoli isolates from the faecal carriage studies in Oman (Barrett, 1990), Italy (Sanna et 
al., 1984), and Australian Aborigines (Lee & Hampson, 1992) were compared with isolates 
from homosexual males, AIDS patients, dogs and pigs (Rayment et al., 1997). Blood 
isolates from the series of French patients (Fournié-Amazouz et al., 1995) also were 
included, as were 10 B. hyodysenteriae isolates. After digestion with SmaI and SacI, only 
two B. pilosicoli isolates from the same homosexual male were identical, and the remaining 
isolates were heterogeneous. Isolates from the blood did not group together, and neither 
disease manifestation nor geographical origin affected typing relationships. The B. aalborgi 
type strain was included in the study, but too few bands were observed after digestion with 
these enzymes, so the species could not be typed. 
Isolates from PNG were also typed by PFGE using MluI and SalI, as well as by 
MLEE (Trott et al., 1998). Once again, greater subspecific differentiation was possible using 
PFGE, and once more a large number of types was observed for the isolates. Six PFGE types 
contained indistinguishable isolates obtained from more than one village, while the majority 
of remaining types contained 1 - 3 isolates obtained from only one village. Dog and human 
isolates shared pattern identity, and identical patterns were observed in a repeat sampling of 
13 of 19 individuals. The use of PFGE in this study supported the potential for cross-species 
transmission between dogs and humans, and indicated the presence of persistent infection in 
PNG natives (Trott et al., 1998). 
 
1.5.4  16S rRNA gene sequencing 
Sequencing of the 16S rRNA gene of the various Brachyspira species has been 
carried out for phylogenetic analysis, as was described in Section 1.2.2.1. Using this 
technique, B. hyodysenteriae and B. innocens were taxonomically placed in relation to other 
spirochaetes, and showed around 99% similarity to each other (Paster et al., 1991; Stanton et 
al., 1991). Two studies carried out almost simultaneously in 1996 examined the placement 
of other intestinal spirochaetes identified at that time, comparing the technique with MLEE 
(Stanton et al., 1996) or biochemical analyses (Pettersson et al., 1996). Stanton et al., (1996) 
confirmed their earlier work, with other Brachyspira showing 98-99.9% similarity to B. 
hyodysenteriae and B. innocens, and even B. aalborgi being 96.4% similar at this gene. They 
concluded that the technique only had limited usefulness for typing of the Brachyspira, as 
the 16S rRNA sequences were highly conserved. Similar results were obtained in the other 
study from analysis of swine spirochaetes plus B. aalborgi, however, here a more thorough 
examination of signature nucleotide positions was made for each species (Pettersson et al., 
1996). Chapter 1 - Literature Review  
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Commensurate investigations of human intestinal spirochaetes have been made 
using 16S rDNA sequencing. Hookey and co-workers (1994) compared the sequence of B. 
aalborgi  with  B. hyodysenteriae,  B. innocens and a human isolate from Oman, N26. 
Surprisingly, the latter strain branched outside all other spirochaetes tested, but was 
subsequently proven to be a B. pilosicoli isolate by MLEE (Prof. David Hampson, Murdoch 
University, pers comm.). More recent analyses of human intestinal spirochaetes has focussed 
particularly on B. aalborgi. Analysis of a library of PCR clones generated from biopsies 
from two individuals without symptoms of HIS identified three lineages of B. aalborgi, with 
all three lineages present in one individual (Pettersson et al., 2000). The lineages had 98.3 - 
99.1% similarity to each other while being 99.4 - 99.9% similar within each cluster. Other 
previously identified signature nucleotide features were confirmed (Pettersson et al., 1996; 
Pettersson et al., 2000). An examination of sequences from a wider range of individuals and 
geographical locations did not reveal further lineages, and indicated that B. aalborgi from 
non-human primates clustered together, separate from the human clones (Mikosza & 
Hampson, 2003).  
Sequence analysis of small fragments (<500 bp) of 16S rDNA has been performed 
to aid diagnosis of HIS after PCR detection (Mikosza et al., 1999; Kraaz et al., 2000; 
Calderaro et al., 2003), and to gain further knowledge about the sequence variation within B. 
aalborgi and other human Brachyspira spp. (Kraaz et al., 2001).  
 
1.5.5  Other typing methods 
Other typing methods used to differentiate between intestinal spirochaetes species 
and characterise them at a subspecies level have included REA of chromosomal DNA, 
restriction fragment length polymorphism (RFLP) analysis, RFLP-PCR and amplified 
fragment length polymorphism (AFLP) analysis. REA uses frequently cutting restriction 
enzymes to digest the entire bacterial genome, with 0.5 – 50kb products separated by 
agarose gel electrophoresis (Tenover et al., 1997). Complex profiles consisting of hundreds 
of bands are produced, which are difficult to interpret. This was the experience of 
investigators who analysed B. hyodysenteriae (Combs et al., 1989; Combs et al., 1992). 
However, the analysis was useful to indicate that B. hyodysenteriae and B. innocens strains 
were genetically heterogeneous (Combs et al., 1989; Stanton et al., 1991; Combs et al., 
1992; ter Huurne et al., 1992), and that single strains of B. hyodysenteriae were spread 
during two outbreaks of Sd (Hampson, 1991). 
In the RFLP method, digestion of chromosomal DNA and electrophoresis is carried 
out as for REA, the DNA is transferred to a membrane by Southern blotting, and a labelled 
probe is hybridised to the DNA (Tenover et al., 1997). A more recent alternative is RFLP-Chapter 1 - Literature Review  
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PCR, where amplification by PCR of the specific locus of interest is followed by restriction 
digestion of the PCR product to detect the polymorphisms (Olive & Bean, 1999). The small 
number of bands can be separated and visualised by agarose gel electrophoresis without the 
need for membrane transfer or probing.  
Each technique has been applied more often to identification of Brachyspira at the 
specific rather than a subspecific level. Probes have included those for the 16S and 23S 
rRNA genes (Jensen et al., 1992; Stanton et al., 1997; Barcellos et al., 2000), the nox genes 
(Rohde et al., 2002), haemolysin and flagella genes (ter Huurne et al., 1992; Koopman et al., 
1993; Fisher et al., 1997) and probes containing random DNA fragments (Jensen & Stanton, 
1993; Sotiropoulos et al., 1994). 
While good results have been obtained with a 16S (Stanton et al., 1997) and a 23S 
rRNA gene RFLP-PCR (Barcellos et al., 2000), two species in each test had identical 
patterns, due to the conserved nature of these genes across the genus, as previously 
described (Sections 1.4.5.2 and 1.4.5.3). A novel nox gene RFLP-PCR was successful at 
differentiating all five porcine Brachyspira  spp. (B. hyodysenteriae,  B. pilosicoli,  B. 
intermedia, B. innocens and B. murdochii) (Rohde et al., 2002). The results compared well 
with biochemical characterisations, and although rapid and easy to use, B. aalborgi and B. 
alvinipulli were not tested. REA, RFLP and RFLP-PCR have been used infrequently in 
studies of human intestinal spirochaetes, and have not been useful in clarifying taxonomic 
positions of human isolates (Dettori et al., 1992; Koopman et al., 1993). However, very 
recently, a PFGE-PCR method utilising the 16S rRNA primers of Stanton and colleagues 
(1997) using MboII and TaqI was used to rapidly B. aalborgi in HIS and exclude B. 
pilosicoli  (Calderaro et al., 2003). RFLP-PCR may prove to be a useful technique for 
identification of spirochaetes in HIS in the future. Nevertheless, both MLEE and PFGE were 
far more powerful techniques to perform subspecific typing of the intestinal spirochaetes.  
PFGE of B. pilosicoli also has been compared with AFLP analysis (Møller et al., 
1999). In this technique, genomic DNA is digested and ligated to oligonucleotide adapters, 
which then serve as target sites for annealing of PCR primers. Selective amplification of 
restriction
  fragments and gel analysis follows (Vos et al., 1995). AFLP was as 
discriminatory as PFGE and less time consuming, and was thus suggested as a method of 
choice for typing B. pilosicoli, although to date no other studies utilising this technique have 
been reported.  
 
1.6 ANTIMICROBIAL  SUSCEPTIBILITY TESTING 
Antimicrobial susceptibility testing is performed to provide an in vitro assessment of 
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antimicrobial agent (Jorgensen & Sahm, 1995). The generation of an MIC or a category 
result (sensitive, intermediate, resistant) for isolates allows the selection of appropriate 
therapy. The majority of antimicrobial susceptibility testing of intestinal spirochaetes has 
been carried out in a veterinary setting to aid therapeutic decisions for B. hyodysenteriae, 
and to a lesser extent, B. pilosicoli. A few isolates of B. innocens, B intermedia, B. 
murdochii and B. alvinipulli also have been tested (Messier et al., 1990; Smith et al., 1991; 
Hommez et al., 1998b; Trampel et al., 1999; Karlsson et al., 2003).  
Most studies have utilised the agar dilution method, in which dilutions of an 
antimicrobial are incorporated into a solid medium. Kitai and colleagues (1979) used this 
method to investigate the susceptibility of 23 B. hyodysenteriae isolates against 39 agents 
over 10 dilutions. The MIC was defined as the lowest concentration of antimicrobial to 
completely prevent haemolysis of the organisms on a TSA medium containing 5% ovine 
blood. Many agents showed a high degree of activity, with carbadox being the most 
effective. Limited activities were observed for lincomycin, peptides including colistin, 
aminoglycosides (neomycin, kanamycin and streptomycin), and other agents such as 
novobiocin, vancomycin, rifampicin and nalidixic acid. Subsequently, agents for Sd therapy 
and for use in selective media have been chosen as a result of this work (Jenkinson & 
Wingar, 1981).  
Many other investigations have based agar dilution methodology upon this report 
(Smith et al., 1991; Trott et al., 1996c). Variations have been made to the medium, inoculum 
size and conditions of incubation, which are know to effect results (Summanen et al., 1993). 
The definition of MIC has generally remained a constant, although some investigators have 
used the more traditional definition of the lowest concentration of antimicrobial to inhibit 
growth of the organisms (Trampel et al., 1999).  
The antimicrobial susceptibility of B. pilosicoli also has been examined using the 
agar dilution method. The agents tested again have been those relevant to veterinary 
medicine, particularly carbadox, lincomycin, metronidazole, tiamulin, and tylosin. Other 
agents have been tested less often (Oxberry & Hampson, 1998; Duhamel et al., 1998b; 
Hommez et al., 1998b; Trampel et al., 1999). Generally, results indicated that B. pilosicoli 
strains were either as, or more susceptible to agents than B. hyodysenteriae. B. pilosicoli was 
susceptible to carbadox, tiamulin, metronidazole, dimetridazole, tetracycline, 
oxytetracycline, chloramphenicol, olaquindox and salinomycin, and had high MICs to 
chlortetracycline, erythromycin, neomycin, nalidixic acid and tylosin in the studies in which 
they were assessed (Fellström et al., 1996; Trott et al., 1996d; Oxberry & Hampson, 1998; 
Duhamel et al., 1998b; Hommez et al., 1998b; Trampel et al., 1999). MIC values of 10 - 50 
µg/ml were obtained for kanamycin, novobiocin and bacitracin when they were each tested 
in only one study (Trott et al., 1996d; Trampel et al., 1999). Variability has been observed Chapter 1 - Literature Review  
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within studies for ampicillin, penicillin, streptomycin and gentamicin, and between studies 
for lincomycin. These results have influenced therapy for PIS and IS in other animals such 
as chickens (see Section 1.2.4.6). A few isolates have been investigated for resistance to 
agents for use in selective media, including colistin, polymyxin B, rifampicin, 
spectinomycin, spiramycin and vancomycin (Trott et al., 1996c; Trott et al., 1996d). 
Resistance to colistin, polymyxin B, spectinomycin and vancomycin at 500 µg/ml were 
noted for six isolates, while MICs of rifampicin and spiramycin were 10 - 20 µg/ml and 10 - 
50 µg/ml, respectively (Trott et al., 1996d).  
Susceptibility testing by alternative methods have been performed with B. 
hyodysenteriae. The agar disc diffusion technique was used together with agar dilution to 
assess the sensitivity of 332 isolates from Hungary (Molnár, 1986). While the disc method 
does not allow for determination of precise MICs, the authors found the method of some use 
for examining trends in the large number of strains over the 15 year test period. A broth 
macrodilution method using the medium of Kunkle et al. (1986) was performed for 30 
isolates, and results were comparable to those obtained using agar techniques (Buller & 
Hampson, 1994). However, this method has not been used subsequently. More recently, a 
broth dilution method in which the agent was dried onto tissue culture trays has been used 
for B. hyodysenteriae susceptibility testing (Karlsson et al., 1999). The method has very 
recently been applied to susceptibility testing of B. intermedia, B. innocens and B. murdochii 
(Karlsson et al., 2003), but has not yet been applied to B. pilosicoli. Although special 
preparation of the trays was required, the method was convenient, easy to use and allowed 
the acquisition of clear end points (Karlsson et al., 2001).  
The susceptibility of human intestinal spirochaetes has been ascertained on few 
occasions. The antibiotic sensitivities of spirochaetes isolated by Tompkins et al. (1986), 
which were almost certainly B. pilosicoli, were ascertained by disc diffusion to penicillin, 
cephradine, tetracycline, chloramphenicol, metronidazole, fusidic acid, vancomycin, and 
colistin. The 23 isolates from Asians and homosexual males were resistant to vancomycin 
and colistin, variably resistant to penicillin and cephradine depending on incubation and 
inoculum, and sensitive to the remaining agents. This prompted further study of the isolates 
by disc diffusion and agar dilution, and the inclusion of additional β-lactam agents 
(Tompkins et al., 1987). Four isolates were penicillin and ampicillin resistant, with 
membrane bound, non-inducible β-lactamases which were susceptible to clavulanic acid at 
sub-inhibitory levels. Resistance to ampicillin has been observed also in B. pilosicoli strains 
from a pig, an Italian and an Aboriginal Australian (Trott et al., 1996d), and also in 2 
isolates from chickens (Trampel et al., 1999). However, the description of β-lactamases has 
not yet been reported in a veterinary setting. The two human isolates had no other Chapter 1 - Literature Review  
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differences with another human and other swine strains (Trott et al., 1996d). The 
antimicrobial susceptibilities of B. aalborgi have not been investigated. 
Antimicrobial susceptibility patterns also have been used as a typing method, but the 
technique has poor discriminatory power (Tenover et al., 1997). Antimicrobial agents can 
place tremendous selective pressure upon organisms, and thus epidemiologically related 
organisms may have different antibiotic profiles as a result of these selective pressures. 
Conversely, unrelated isolates may have indistinguishable profiles, as a result of acquisition 
of the same mobile genetic element containing antimicrobial resistance genes. To date, 
typing by antimicrobial susceptibility patterns has not been attempted for Brachyspira spp., 
and as MLEE, PFGE and sequencing represent far more successful methods, this technique 
is unlikely to be utilised for this purpose. 
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1.7  AIMS OF THE INVESTIGATION 
While the presence of intestinal spirochaetes in humans has been known for a long 
time, until recently, unequivocal speciation of the spirochaetes has not been possible. 
Diagnostic difficulties experienced using microscopy, cultivation and biochemical 
identification have been overcome using molecular methods such as PCR plus sequencing of 
the product, or by FISH, applied directly to intestinal tissue or faeces. It is now apparent that 
Brachyspira aalborgi and Brachyspira pilosicoli are both present in the human intestine, 
although our understanding of the prevalence of each organism is incomplete, and the role 
each organism plays in human disease remains undefined.  
With these points in mind, the main aim of this thesis was to examine the prevalence 
and epidemiology of both B. pilosicoli and B. aalborgi in Australia, using cultural and 
molecular methodologies. Individuals with gastrointestinal disease and healthy individuals 
were chosen so that the significance of intestinal spirochaete carriage and possible 
associations with gastrointestinal illness could be examined further. The prevalence and 
significance of B. pilosicoli in blood infections in Australia is currently unknown, thus it was 
intended that the prevalence of bacteraemia with this organism be assessed. Regardless of 
the significance of intestinal spirochaetes in patients with symptoms, therapy has been 
empiric rather than based on MIC data. Thus it was proposed to examine the antimicrobial 
susceptibilities of B. pilosicoli. Consequently, the specific objectives of this study were to:  
1.  Develop appropriate methods for the detection of the two spirochaete species B. 
aalborgi and B. pilosicoli in human faeces, including improved isolation media, and 
DNA extraction and PCR techniques directly on faeces. 
2.  Use these methods to investigate the epidemiology and disease associations of B. 
pilosicoli and B. aalborgi carriage in Western Australians.  
3.  Develop methods to detect B. pilosicoli from the human blood, and determine the 
prevalence of B. pilosicoli spirochaetaemia. 
4.  Examine the genotypic relationships between isolates obtained and pre-existing strains 
using pulsed-field gel electrophoresis. 
5.  Examine the antimicrobial susceptibilities of B. pilosicoli isolates obtained and compare 
these with those of existing B. pilosicoli strains. Chapter 2 - Materials and Methods 
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C CH HA AP PT TE ER R   2 2: :   M MA AT TE ER RI IA AL LS S   A AN ND D   G GE EN NE ER RA AL L   M ME ET TH HO OD DS S   
The following chapter details materials and general methods used throughout the 
course of this study. Methods that are specific to one particular chapter will be provided as a 
part of that chapter.  
 
2.1 MATERIALS 
2.1.1 Chemicals,  reagents and media 
Chemicals (reagent or analytical grade), reagents and desiccated media used in this 
study are presented with details of suppliers in Appendix A1.1. 
 
2.1.2 Water 
Water used to prepare buffers, solutions and media was deionised water (DIW), 
sterile deionised water (SDW), high pure water (HPW) (>18MΩ-cm resistivity water) and 
ultrafiltered high pure water (UHPW) (>18 MΩ-cm resistivity water with 0.2 µm filtration). 
HPW and UHPW were prepared with a Milli-Q water purification system (Millipore 
Corporation, Bedford, MA, USA). 
 
2.1.3  Buffers and solutions 
Solutions used throughout the study are listed in Appendix A1.2. Buffers and 
solutions were made in DIW except for PFGE solutions and some solutions used in PCRs, 
which were made in sterile HPW and UHPW. Solutions were made up to 1 L and stored at 
room temperature (RT) unless otherwise stated. Adjustments to pH were made with 
concentrated HCl or NaOH. Where appropriate, solutions were sterilised by autoclaving at 
121°C for 15 min. 
 
2.1.4 Other  consumables 
Various plasticware was used throughout the study. This included 1.5 ml and 2 ml 
microfuge tubes, 1.8 ml cryotubes, 5 ml and 50 ml sample containers, 1, 3, 5, 10 and 50 ml 
syringes, 90 mm petri dishes, transfer pipettes, and 200 µl and 1 ml pipette tips, including 
aerosol resistant tips. They were supplied by Interpath Ltd. (West Heidelberg, Vic, 
Australia), Quality Scientific Plastics (Petaluma, CA, USA), Intermed (Roskilde, Denmark), 
Sarstedt Australia Pty. Ltd. (Mawson Lakes, SA, Australia), Techno-plas (St Marys, SA, 
Australia), Terumo Medical Corporation (Elkton, MD, USA), Selby Biolab (Welshpool, 
WA, Australia), Samco Scientific Corporation (San Fernando, CA USA), Elkay Eireann Chapter 2 - Materials and Methods 
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(Costelloe Co Galway, Ireland), Greiner Bio-one (Longwood, FL, USA) and Molecular 
Bioproducts Inc. (San Diego CA USA), respectively. Kits and non-plastic consumables are 
listed in Appendix A1.3. 
 
2.1.5  Bacterial culture media 
Blood agar (BA), Brain Heart Infusion broth (BHIB) (2%) with glycerol (20%) and 
horse serum (HS) were supplied by Excel Laboratory Products, Belmont, Western Australia. 
Mueller Hinton (MH) agar and Wilkins-Chalgren agar (WCA) were prepared from 
dry powders according to the manufacturer’s instructions.  
The remaining solid and liquid media utilised throughout this investigation are listed 
in Appendix A1.4. They were prepared by suspending or dissolving the dry components 
(details and suppliers in Appendix A1.1) in DIW and autoclaving at 121°C for 15 min to 
sterilise. Solid media were cooled to 56°C, blood or serum supplements and antibiotics were 
added if necessary, the agar mixed immediately and plates of 15 ml were poured. Solid and 
liquid media were stored at 4°C until required, unless otherwise stated.  
 
2.1.5.1  Selective media  
Anaerobe basal agar (ABA), Brain Heart Infusion agar (BHIA), Columbia base agar 
(CBA), Trypticase Soy agar (TSA) and WCA were prepared according to manufacturer's 
instructions for development of selective media for Brachyspira. Kunkle's agar base and 
Brucella blood agar base were prepared as per Appendix A1.4. The details of selective 
compounds and supplements, which were added to these bases at 56°C after autoclaving, are 
presented in Chapter 3, Sections 3.2.2 and 3.2.3.  
 
2.1.6 Antibiotics 
Antibiotics used in this study are listed together with their suppliers in Appendix 
A1.1. 
Antibiotics for use in selective media, including colistin, polymyxin B and 
spectinomycin were reconstituted in SDW and stored at -20°C at the appropriate 
concentration for addition to media. Rifampicin and vancomycin were first dissolved in the 
recommended solvents listed in Appendix A1.5, before dilution in SDW. 
Antibiotics for susceptibility testing, including ceftriaxone, ciprofloxacin, 
clindamycin, gentamicin, meropenem, moxifloxacin, spectinomycin and tetracycline were 
dissolved in SDW and stored at -80°C at concentrations of 2560 µg/ml or 5120 µg/ml. The 
appropriate solvents and diluents for the remaining antibiotics are presented in Appendix 
A1.5. 
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2.2 BACTERIAL  STRAINS 
2.2.1  Brachyspira strains 
All  B.  pilosicoli strains were obtained from the culture collection held at the 
Reference Centre for Intestinal Spirochaetes at Murdoch University, or were isolated as a 
part of this study. Strains of other Brachyspira spp., including B. aalborgi,  B. 
hyodysenteriae,  B. innocens and  B. intermedia,  also were obtained from the Reference 
Centre for Intestinal Spirochaetes culture collection. Details of strain and isolate source are 
provided in Appendix A2.1. 
 
2.2.2 Other  organisms 
Other organisms used in this study included Staphylococcus aureus ATCC 29213, S. 
aureus ATCC 25923, Enterococcus faecalis ATCC 29212, Clostridium perfringens ATCC 
13124, Bacteroides fragilis ATCC 25285 and Bacteroides thetaiotaomicron ATCC 29741. 
These were obtained from the Division of Microbiology and Infectious Diseases, Western 
Australian Centre for Pathology and Medical Research (PathCentre), except the B. 
thetaiotaomicron, which was obtained from Judy Holdsworth, Fremantle Hospital 
Microbiology Section.  
Leigh Mulgrave from the Division of Microbiology and Infectious Diseases, 
PathCentre, provided five E. coli strains containing resistance plasmids. These were 
originally obtained from Prof. L Gutmann, Hopital St Joseph, Paris, France (two E. coli 
BM694 strains with plasmids encoding SHV-2 and SHV-5) and the Glaxo Culture 
Collection (Glaxo Collection Nos 1993E R-TEM/ TEM-1 (Datta & Kontomichalou, 1965), 
1725E RP1/ TEM-2 (Sykes & Matthews, 1976) and 2008E p453/ SHV-1 (Matthew et al., 
1979)). 
 
2.2.3  Growth and storage conditions 
Spirochaetes were cultured on BA incubated at 37°C, unless otherwise stated. B. 
pilosicoli cultures were routinely incubated for 5 d in an anaerobic chamber (Don Whitley 
Scientific Ltd, Shipley, Yorkshire, UK) with an atmosphere of 80% N2, 10% H2 and 10% 
CO2. B. aalborgi cultures were incubated for 10 d in an anaerobic jar using a GasPak Plus 
envelope (Becton Dickinson) to produce an atmosphere of 94% H2 and 6% CO2. Broth 
cultures of Brachyspira species except B. aalborgi were grown in Kunkle's medium, shaken 
in stoppered Hungate tubes at 37°C for 5 - 10 d.  
Other organisms were cultured on BA at 37°C: the anaerobes B. fragilis and B. 
thetaiotaomicron for 48 h in the anaerobic chamber, and the facultative anaerobes for 18 h in 
air. Chapter 2 - Materials and Methods 
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All organisms were stored as heavy suspensions in 40% BHIB - 10% glycerol - 50% 
HS at -80°C. 
 
2.3  GENERAL CULTURAL AND EXPERIMENTAL METHODS 
2.3.1 Preparation  of cell suspensions 
Spirochaete suspensions were made by resuspending growth from BA in Brucella 
broth (BrB), diethylpyrocarbonate treated water (DepC), phosphate buffered saline (PBS) or 
Tris EDTA buffer (TE), using a sterile cotton tipped swab. When viable organisms were 
required, the suspensions were replaced in anaerobic conditions until inoculation, generally 
for less than 30 min. The purity of suspensions was ascertained by phase contrast 
microscopy and subculture to BA.  
 
2.3.2 Centrifugation 
Centrifugation was carried out in microfuge tubes in a Hettich Mikroliter microfuge 
(Hettich Zentrifugen, Germany) at 13860 x g unless indicated otherwise. 
 
2.3.3 Microscopy 
2.3.3.1  Phase contrast microscopy 
Spirochaetes were routinely observed by phase contrast microscopy, using an 
Olympus BH-2 BHT or BX40F4 microscope (Olympus Optical Co. Ltd, Japan). Wet mount 
suspensions of spirochaete growth were prepared from solid media, suspended in one drop 
of PBS, or from spirochaetes in Kunkle's broth. Slides were viewed with a green glass filter 
(Gelbgrün, Germany) at x 40 magnification.  
Microscopy of stool samples was performed by resuspending 50 – 100 mg of stool 
in 1 ml PBS, vortexing briefly and centrifuging at 985 x g for 5 min. Ten µl of supernatant 
was examined for spirochaetes for 1 min per sample as above.  
 
2.3.3.2 Electron  microscopy 
For electron microscopy, spirochaete suspensions were prepared in PBS and 10 µl 
was added to a formvar-coated reinforced copper grid for 3 min. Grids were blotted on filter 
paper and stained with phosphotungstic acid for 3 min. Blotted, air dried grids were 
examined in a Philips CM100 Biotwin transmission electron microscope (Phillips, Industrial 
and Electro-acoustic Systems, Holland).  
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2.3.4  Estimations of cell number 
For microscopic assessment of cell number, an aliquot of a spirochaete suspension 
was diluted, approximately 10 µl applied to a Helber counting chamber and viewed by phase 
contrast microscopy. An average was taken of the number of spirochaete cells in 3 squares, 
and the concentration of spirochaetes/ml calculated after correcting for dilution factors and 
counting chamber dimensions.  
Numbers of viable organisms were estimated by the spread plate method. Briefly, an 
aliquot of a suspension was diluted 10-fold, and 100 µl of three consecutive dilutions were 
added in duplicate to the surface of well-dried BA plates and spread with a sterile glass 
spreader. After incubation (Section 2.2.3), colony numbers were counted on the plate with 
30 - 300 colonies. The concentration in colony forming units (cfu)/ml of viable organisms in 
suspensions was calculated after correction for dilution factors. 
 
2.3.5 Identification  of  Brachyspira isolates 
Presumptive  Brachyspira isolates were identified by colonial and phase-contrast 
microscopic morphologies. B. pilosicoli grew as a thin spreading haze with weak incomplete 
haemolysis on BA, while B. aalborgi was either a thin haze or formed more discrete 
colonies of 0.1 - 1 mm. Under phase contrast microscopy, both were motile, spiral-shaped 
organisms. Spirochaete identity was confirmed by adding cells by the direct method (Section 
2.4.2) to tubes for B. pilosicoli and B. aalborgi 16S rRNA PCR amplification (Section 
2.4.3). Each isolate was tested in duplicate. In some cases, products were sequenced and 
compared with known 16S rRNA sequences of B. pilosicoli and B. aalborgi (Section 2.5).  
 
2.3.6  Ethical approval  
Approval for aspects of this study involving human subjects was obtained from the 
Sir Charles Gairdner Hospital and the Murdoch University Human Ethics Committees.  
 
2.3.7 Statistical  analysis 
Univariate statistical analysis to compare proportions was carried out using a Yates 
corrected Chi-square or a Fisher’s exact test with 1-tailed P value, depending on the 
expected population size. Continuous data were analysed using one-way analysis of variance 
(ANOVA). Multiple logistic regression was used to quantify the association between 
spirochaete prevalence and each variable, after adjusting for other variables. Variables were 
considered eligible for inclusion in the logistic model if significant at P ≤ 0.25 by univariate 
analysis. Backward elimination was used to drop factors from the model, and the likelihood 
ratio Chi-square statistic was calculated to determine significance at each step of the model Chapter 2 - Materials and Methods 
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building. The level of significance for a factor to remain in the final model was set at 10%. 
Age group variables were only included if two, rather then three or four outcomes were 
possible.  
The sensitivity and specificity of diagnostic procedures were calculated using the 2 x 
2 contingency table method (Dawson-Saunders & Trapp, 1994). Statistical analyses were 
performed using Statistix for Windows (Analytical Software, Tallahassee, FL, USA), Excel 
97 (Microsoft, Redmond, WA, USA) and Epi Info 6 (CDC Atlanta GA, USA). ANOVA and 
multivariate analyses were carried out by Dr Ian Robertson of the School of Veterinary and 
Biomedical Sciences, Murdoch University. 
 
2.4  MOLECULAR METHODS  
2.4.1  Agarose gel electrophoresis 
Electrophoresis of PCR products was performed in a Bio-rad DNA subcell 
electrophoresis tank with 1x TAE buffer. Two µl of loading buffer was mixed with 25 µl 
PCR product and 10 µl loaded into the wells of an agarose gel. A DNA size standard (ladder 
VIII or 123 bp ladder) was used for band size comparison. At the conclusion of 
electrophoresis, gels were stained in ethidium bromide for 20 - 25 min and destained in DIW 
for 7 - 10 min. Bands were visualised under UV light. Gels were either photographed with a 
Polaroid CU-5 Land Camera using Polaroid Polapan 667 film, or an image was recorded on 
a UVSave display (UVItec Ltd, Cambridge, UK) and printed on a video copy processor 
(Mitsubishi Electric Co., Kyoto, Japan).  
 
2.4.2 Preparation  of  whole  cells for PCR amplification 
Direct Method 
Spirochaete growth was swabbed from BA with a sterile cotton tipped swab and 
resuspended in 1 ml DepC or TE. Suspensions were stored at 4°C until required.  
 
Cell Pick from Agar 
A single colony from an agar plate was added to a PCR reaction by touching a 
sterile tip or toothpick to the colony. This was then immersed in a reaction tube, and 2.5 µl 
DepC added to make the volume up to 25 µl.  
 
Frozen Cell Pick Method 
Control organisms were added to PCR reactions as frozen cells. Spirochaetes were 
grown to late log phase in Kunkle’s broth. Organisms were pelleted from 350 ml of broth by 
centrifugation at 15000 x g for 20 min at 4°C. Pellets were washed twice in PBS, Chapter 2 - Materials and Methods 
   61
resuspended in 2 ml DDIW, lysed by three 30 s cycles of sonication and cooled on ice. After 
further centrifugation at 2000 x g for 20 min at 4°C, supernatants were dispensed in 150 µl 
volumes and stored at -20°C until required. Alternatively, growth was swabbed from BA, 
resuspended in 1 ml TE, centrifuged for 5 min and the supernatant removed. Storage was 
again at -20°C.  
To add cells to a PCR reaction, a sterile toothpick or pipette tip was touched on the 
frozen cells then immersed in the reaction tube and 2.5 µl DepC added to make the volume 
up to 25 µl.  
 
Boiling Method 
Colonies were removed from an agar plate and resuspended in 500 µl DepC. The 
suspension was boiled for 10 min, centrifuged for 2 min and the DNA containing 
supernatant was transferred to a new tube. These were stored at 4°C until required.  
 
2.4.3  Polymerase chain reaction 
2.4.3.1 Oligonucleotide  primers 
Primers used in this study are described in Table 2.1. Primers were from GibcoBRL 
(Life Technologies, Mulgrave, Vic, Australia), except for β-lactamase primers for TEM β-
lactamase and SHV β-lactamase reactions, which were manufactured by Geneworks Pty Ltd, 
(Thebarton, SA, Australia). Primers were diluted to 100 ρmol/µl in TE and a 1:10 working 
solution of these stocks was prepared in sterile UHPW. Both concentrations were stored at -
20°C. 
 
2.4.3.2  16S rRNA PCRs  
Reaction mixture and cycling conditions used to amplify fragments of the 16S 
rRNA gene are given below. Reaction mixtures were routinely made in bulk and stored at -
20° C prior to the addition of template DNA.  
  10x  Tth  Plus  buffer    2.5  µl 
  d N T P s       2 . 5   µl 
  M g C l 2  (25  mM)     1.5  µl 
  Tth  Plus  (5.5  U/µl)    0.1  µl 
 Primer  forward  (10  ρmol/µl)   2.5  µl 
 reverse  (10  ρmol/µl)   2.5 µl 
  T e m p l a t e   D N A      2 . 5   µl 
  S t e r i l e   U H P W      1 0 . 9   µl 
       2 5 . 0   µl Chapter 2 - Materials and Methods 
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Template DNA was obtained by extraction, using one of the above methods. Primer 
pairs used were Acoli 1 - Serp 16S R583 for the B. pilosicoli 16S rRNA reaction and 
(Mikosza et al., 2001) and Brach F161 - Brach R596c for the B. aalborgi 16S rRNA reaction 
(Mikosza et al., 1999). The expected size of products were 439 bp and 472 bp, respectively. 
The amplification protocol for the B. pilosicoli 16S rDNA PCR was; 
Initial denaturation     94°C    4 min 30 s 
Denaturation    94°C   30  s 
  Annealing    50°C   30  s 
  Extension    72°C   30  s 
        3 3   c y c l e s  
The amplification protocol for the B. aalborgi 16S rRNA gene PCR was as above, 
however annealing was carried out at 48°C. Fragments were resolved by electrophoresis on 
a 1.5% agarose gel. B. pilosicoli P43/6/78
T and B. aalborgi 513A
T were used as positive 
controls in the appropriate reaction and the negative controls was DepC.  
 
2.5 DNA  SEQUENCING 
PCR products were sequenced in both directions using a commercially-available 
cycle sequencing kit (ABI PRISM BigDye
TM dye terminator cycle sequencing ready reaction 
kit, Version 1.0; Applied Biosystems), according to the manufacturer’s instructions. Primers 
were the appropriate forward and reverse primers of the 16S rRNA gene PCRs. All other 
reagents were supplied as part of the sequencing kit. Sequencing was performed by Brian 
Brestovac and staff of the PCR laboratory at the Division of Microbiology and Infectious 
Diseases, PathCentre. Sequences were analysed on the ABI PRISM 310 Genetic Analyser 
(Applied Biosystems). The sequence data obtained were aligned and compared with 16S 
rRNA sequences of the B. aalborgi and B. pilosicoli type strains by BLAST search. Multiple 
sequence alignments were performed by the Clustal method using BioManager with the 
ANGIS Server (Sydney, NSW, Australia). 
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C CH HA AP PT TE ER R   3 3: :   S ST TU UD DI IE ES S   I IN NV VE ES ST TI IG GA AT TI IN NG G   T TH HE E   O OC CC CU UR RR RE EN NC CE E   O OF F   
B B. .   P PI IL LO OS SI IC CO OL LI I   A AN ND D   B B. .   A AA AL LB BO OR RG GI I   I IN N   H HU UM MA AN N   F FA AE EC CA AL L   S SA AM MP PL LE ES S   
B BY Y   C CU UL LT TU UR RE E   
3.1 INTRODUCTION 
Colonisation of the human large intestine by intestinal spirochaetes has been 
reported to result in a variety of intestinal disturbances, including chronic diarrhoea, 
abdominal pain and rectal bleeding (Gad et al., 1977; Crucioli & Busuttil, 1981; Douglas & 
Crucioli, 1981; Padmanabhan et al., 1996; Peghini et al., 2000). Recently, studies, which 
have identified these spirochaetes, have revealed that both B. aalborgi and B. pilosicoli are 
capable of colonisation (Guccion et al., 1995; Trivett-Moore et al., 1998; Heine et al., 2001; 
Mikosza et al., 2001). The prevalence of intestinal carriage of B. pilosicoli in human 
populations has been studied, as it is the easier of the two spirochaetes to culture from 
faeces, although the clinical significance of colonisation still remains uncertain. B. aalborgi 
is more fastidious and requires at least 2 - 3 weeks for isolation. At the time of undertaking 
this study, B. aalborgi isolation in humans was reported only from colonic biopsy specimens 
from Scandinavian patients (Hovind-Hougen et al., 1982; Kraaz et al., 2000; Jensen et al., 
2001) and had not been isolated from human faeces. Consequently, there is a dearth of 
information regarding carriage of this organism by human populations. Also, the lack of 
isolates has hampered comprehensive characterisation, pathogenicity and epidemiological 
studies of this organism. Thus the aims of this chapter were to: 
1.  Ascertain whether methods currently used to culture intestinal spirochaetes are 
appropriate for isolation of B. pilosicoli and B. aalborgi from human faeces. 
2.  Obtain isolates of B. pilosicoli and  B. aalborgi from faeces of humans in Western 
Australia, for use in characterisation studies. 
3.  Describe the epidemiology of B. pilosicoli and  B. aalborgi carriage in humans in 
Western Australia. 
4.  Determine if there were any associations between carriage of either spirochaete and 
symptoms.  Chapter 3 - Faecal Culture  
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3.2  MATERIALS AND METHODS 
3.2.1  Evaluation of solid media for the isolation of B. pilosicoli and B. 
aalborgi  
3.2.1.1  Preparation of inocula 
Media development studies were carried out using B. pilosicoli strains P43/6/78
T, 
WesB, RA87, H1, H171, 382/91 and WPH11, and B. aalborgi strains 513A
T and W1 
(sources in Appendix A2.1). Suspension were made in sterile PBS or Brucella broth (BrB) 
and returned to anaerobic conditions until inoculation. The organisms were counted in a 
Helber counting chamber, adjusted to 1x 10
8 organisms/ml, and their viability assessed. For 
some tests, serial 10-fold dilutions were performed in the same diluent. Volumes of 50 µl 
were added to plates and the suspensions were streaked for single colonies in a standard 
manner.  
 
3.2.1.2  Preparation of seeded faeces 
Seeded faeces samples were prepared by adding 1 ml of bacterial suspension at 1 x 
10
8 cfu/ml to 1 g of faeces from a healthy donor. This donor was confirmed free of B. 
aalborgi  and  B. pilosicoli by culture and PCR (Section 2.4.3). The suspensions were 
thoroughly vortexed to mix. Seeded faeces were used to evaluate formulations of selective 
media, and to determine the limits of detection for culture, microscopy and molecular 
methods. 
 
3.2.1.3  Determinations of the limit of detection by culture and microscopy 
The lower limit of detection of spirochaetes in faeces by culture was assessed on 
selective media by seeding faeces as above with a series of 10-fold dilutions of 1 x 10
8 to 1 x 
10
3 spirochaetes/ml, in a blinded fashion. The mixtures were inoculated on agar with 10 µl 
inoculation loops, and streaked for single colonies as above. Microscopy was performed on 
these suspensions, as per Section 2.3.3, in a blinded manner. 
 
3.2.1.4  Assessment of growth 
Growth on the various isolation media was examined after 2, 5, 7, 10 and 14 d 
incubation for B. pilosicoli, and after 10, 14, 18 and 21 d for B. aalborgi. Growth was 
assessed by scoring the extent of growth along streaks on the test plates, and colony size was 
recorded for B. aalborgi. For this organism, a grading method was developed also, where the 
best medium was scored '1' at a given time point, the next best medium '2' and so on, and an Chapter 3 - Faecal Culture  
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average was determined for each medium after 21 d. Each medium was included in duplicate 
and all procedures were repeated at least once. 
 
3.2.1.5  Media development studies on B. pilosicoli  
Antimicrobial susceptibility testing 
The susceptibility of 21 B. pilosicoli strains was tested to spectinomycin, 
vancomycin and polymyxin B, in order to confirm resistance to these antimicrobials, so that 
they could be used in isolation media. Susceptibility testing was determined by the agar 
dilution method, described in Chapter 7, Section 7.2.4. These strains were from Aboriginal 
Australians (WesB, Rosie 2299, H21), homosexual males (Gap 34, Gap 51-2, Gap417, FT6), 
Italians (HRM 5C, HRM 8B, HRM 14A), migrants (WHP17, WHP18, WHP19), Omanis 
(Oman 11A, Oman 13A), PNG villagers (V1 H7, V1 H39, V1 H82) and pigs (1648, 3295 
95/1000). Further details can be found in Appendix A2.1. 
 
Isolation media 
All combinations of spectinomycin (S) (400 µg/ml), vancomycin (V) (25 µg/ml) and 
colistin (C) (25 µg/ml), as well as spectinomycin plus polymyxin B (P) (5 µg/ml) were 
incorporated directly into TSA containing 5% ovine blood (OB). Growth at 37°C and 42°C 
in anaerobic jars was assessed. The selective capacity of TSA 5% OB with all combinations 
of S, V and C, and SP was tested by streaking seeded faeces on each medium with all strains 
except WHP11. The limit of detection of TSA 5% OB S (S medium) was determined at 
42°C in an anaerobic jar, and for TSA 5% OB SP (SP medium) at 37°C in an anaerobic 
chamber, using strains WHP11 and WesB. BA was used as a control medium in all tests.  
 
3.2.1.6  Media development studies on B. aalborgi 
Antimicrobial susceptibility testing 
The susceptibility of B. aalborgi strains 513A
T and W1 to a range of antimicrobials 
for potential use as selective agents was performed by placing Micro-rings AC and AN on 
BA swabbed with suspensions of these organisms. The selective compounds and their disc 
strengths are listed in Table 3.1 (after p. 68). Susceptibility to bile was assessed with bile 
discs on BA swabbed with the suspensions. Growth of B. aalborgi strains on media for agar 
dilution susceptibility testing was carried out as described in Section 7.2.4.  
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Isolation media 
Initial tests examined B. aalborgi strain 513A
T on BHIA and TSA with 5% OB and 
5% human blood (HB) at 37°C and 42°C, and TSA 5% OB with SP and all combinations of 
S, V and C at the same concentrations as above.  
In later studies, agar bases were first tested with a range of primary blood 
supplements, secondary supplements and with altered incubation parameters. The selective 
capacity of media was then determined. Each medium was included in duplicate and all 
procedures were repeated at least once. BA was used as a control medium in all tests. 
Strains 513A
T and W1 were tested on ABA, BrBAB with and without vitamin K and 
haemin, BHIA, CBA, Kunkle’s agar base, TSA and WCA. All bases were tested with 10% 
bovine blood (BB) as a primary supplement, but only TSA, BHIA and BrBAS without 
vitamin K were tested with 5% and 10% OB and 10% defibrinated BB. CBA and Kunkle's 
agar base were tested with the secondary supplements 2% foetal calf serum and 5% pig 
faeces extract, and the latter extract also was tested with BHIA and TSA. Additional 
parameters assessed included 30 min pre-reduction prior to inoculation, and incubation 
either in an anaerobic jar or an anaerobic chamber. Growth was compared at 37°C, 38.5°C 
and 42°C. The influence of pH was assessed by adding 4 ml 10 mM KCl to 2 ml of set TSA 
10% BB (Carson et al., 2000), and the pH was measured after 30 min incubation at RT. 
The selective capacity of TSA 10% BB with all combinations of S, V and C at 
previous concentrations was assessed by streaking seeded faeces on each medium. 
Additionally, S plus all combinations of C, P and rifampicin (R) (12.5 µg/ml) were tested. 
The lower limit of detection of B. aalborgi from seeded faeces on the selective medium 
BHIA 10% BB SP was determined at 37°C in an anaerobic jar.  
 
3.2.2  Isolation of intestinal spirochaetes from faeces 
3.2.2.1 Stool  specimens 
Stool samples (n=550) were selected from those sent to the Enteric Laboratory at the 
Western Australian Centre for Pathology and Medical Research for routine testing between 
September 1998 and July 1999. Samples included 323 specimens from 293 rural patients 
who were being investigated for gastrointestinal complaints and 227 samples from 227 
migrants from developing countries who were screened for faecal pathogens on entering 
Australia. Control specimens (n=60) were collected from healthy individuals living in Perth, 
Western Australia. The control specimens were collected so that the proportions of samples 
from each age group and gender were the same as the age and gender of all other samples.  
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3.2.2.2 Microbiology 
Except for samples from the control group, specimens underwent routine 
examination for bacterial pathogens and intestinal parasites in the Enteric Laboratory, 
according to current protocols (Balows et al., 1991). This included culture for Clostridium 
difficile, Salmonella, Shigella, Campylobacter, Aeromonas, Vibrio, and Yersinia spp., and 
microscopic examination of stools for intestinal parasites such as Giardia, hookworm, 
Strongyloides and Hymenolepis nana. The presence of potentially pathogenic (Blastocystis 
hominis) and non-pathogenic parasites was noted also.  
For isolation of spirochaetes, all faecal samples were streaked onto S and SP media. 
S medium was incubated at 42°C in an anaerobic jar for 14 d and SP medium at 37°C in an 
anaerobic chamber for 28 d. Plates were examined for spirochaete growth every two days 
until 14 d, and thereafter at weekly intervals for SP medium only. Control group specimens 
were additionally cultured on BHIA 10% BB SP incubated in an anaerobic jar for 21 d 
before being exposed to oxygen. Phase contrast microscopy of clinical and control 
specimens was carried out as described in Chapter 2, Section 2.3.3.1. Presumptive 
spirochaetes were identified by colonial and phase-contrast microscopic morphologies, and 
identity confirmed by adding cells to 16S rRNA PCRs, as described in Sections 2.3.5 and 
2.4.3.2.  
 
3.2.2.3  Patient and sample characteristics  
Details of patient demographics and reasons for investigation were available from 
request forms accompanying clinical samples. Staff from the Enteric Laboratory recorded 
faecal consistency (formed, semi-formed, loose or watery) and the results of routine 
investigations for bacteria and parasites. Additional information, including time between 
sample collection and culture for spirochaetes, and the presence of spirochaetes by 
microscopy was also collected. Demographic details of control group volunteers, including 
age, gender, country of birth and household pets were ascertained from a questionnaire 
accompanying the consent form. This questionnaire is presented in Appendix A3.1. 
Statistical analysis by univariate analysis and then logistic regression (Section 2.3.7) was 
carried out separately for each population, and the reasons for investigation were analysed 
separately from risk factors and the presence of bacteria and parasites.  
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3.3 RESULTS 
3.3.1 Optimisation  of cultural methods 
3.3.1.1   B. pilosicoli  
Antimicrobial susceptibility 
The MIC range, MIC50 and MIC90 of polymyxin B, spectinomycin and vancomycin 
for 21 strains of B. pilosicoli are presented in Table 3.2. The MICs for these antimicrobials 
were high, regardless of the original source of strains.  
 
Isolation media 
Growth of all B. pilosicoli strains examined was faster at 42°C than at 37°C, 
whether the medium was BA, TSA 5% OB or contained antibiotics. In initial tests, growth 
of strains was ample at 5 d and appeared equal on TSA 5% OB with S, SP or SCV. Later 
studies were carried out using strains WesB and WHP11 only. Here, the growth of strains 
was best on TSA 5% OB with SC, SP, CV, V and SCV in various replicates. Selection from 
seeded faeces was best on TSA 5% OB with SP, S and SCV. The lower limit of detection for 
WesB and WHP11 was 1 - 20 cfu/10 µl (equivalent to 1 x 10
2 – 2 x 10
3 cfu/g) of seeded 
faeces on both TSA 5% OB S and SP. 
 
3.3.1.2  B. aalborgi  
Antimicrobial susceptibility 
Both reference strains of B. aalborgi were susceptible to bile, metronidazole, 
penicillin G, kanamycin and vancomycin, and resistant to spectinomycin, polymyxin B, 
colistin, erythromycin, and rifampicin using the Micro-rings AC and AN. Equivocal results 
were obtained for sodium polyanetholsulfonate (SPS) and novobiocin for strain W1, while 
strain 513A
T was susceptible to these compounds. B. aalborgi 513A
T grew on WC+HS and 
BrBAS+H after 14 d incubation in an anaerobic jar, however, growth of W1 was present 
only on WC+HS after 18 d incubation.  
 
Isolation media 
In initial tests, B. aalborgi did not grow on media incubated at 42°C; BHIA was a 
better base for growth than TSA; and growth on media with OB was marginally better than 
media with HB. Growth did not occur on TSA 5% OB with V, CV, SV or SCV, and growth 
on TSA 5% OB with SP was marginally better than with S. 
In later studies, the most effective agar base for B. aalborgi growth was BHIA with 
10% BB. After 21 d, colonies on this medium were 1.2 mm in diameter, light grey and 
weakly β-haemolytic. A diameter of 1 mm was attained after 14 d incubation. The next best Chapter 3 - Faecal Culture  
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growth was on TSA with 10% BB, on which colonies reached 0.8 mm diameter and had a 
transparent appearance. All the other bases supported growth, but colonies were small and 
slow to appear. As a supplement, 10% BB was superior to 10% OB, which in turn allowed 
larger colonies and faster growth than 5% OB, where a maximum size of only 0.5 mm was 
achieved after 21 d. Additional supplements of 2% FCS and 5% pig faecal extract offered no 
growth advantage. Defibrination of BB or pre-reduction of the media did not improve 
growth of B. aalborgi strain 513A
T or W1, and again growth of B. aalborgi did not occur at 
42°C. Colonies on BHIA incubated at 38.5°C were at best only 0.2 mm larger at some time 
points than colonies on BHIA incubated at 37°C. The best pH for B. aalborgi growth on 
TSA 10% BB was pH 7. Growth to pH 8 was satisfactory, but agar below pH 6.5 would not 
withstand prolonged incubation. The pH of BHIA 10% BB was 7.6. For all media, 
incubation in an anaerobic jar resulted in larger colonies, by 0.2 - 0.5 mm, compared to 
incubation in the anaerobic chamber.  
On media with antimicrobials incorporated, growth of B. aalborgi occurred on all 
plates except those containing vancomycin, although colonies were frequently 0.2 mm 
smaller than on the corresponding medium without antimicrobials. Selection of B. aalborgi 
from seeded faeces was achieved on media containing S, SP, SC, SR, SRC, SPR, SRC and 
SRPC, and no single medium produced consistently superior growth. The lower limit of 
selection of B. aalborgi from seeded faeces on SP was around 200 cfu/10 µl of seeded 
faeces, or 2 x 10
4 cfu/g.  
 
3.3.2 Isolation  of  B. pilosicoli from clinical specimens 
Forty spirochaete isolates were obtained. These grew as a thin haze with weak β-
haemolysis after 5 - 10 days of culture, and all were confirmed as B. pilosicoli by PCR. B. 
aalborgi was not isolated. The B. pilosicoli isolates came from 24 (10.6%) of the 227 
migrants and from 16 samples from 15 (5.1%) of the rural patients, all of whom were 
Aboriginal. Prevalence amongst the 151 Aboriginals therefore was 9.9%. B. pilosicoli was 
not isolated from any of 142 rural non-Aboriginal patients, nor any of the 60 healthy control 
individuals. Thus the overall prevalence of B. pilosicoli colonisation for all individuals was 
6.7% (39/580).  
Two isolates, WHP06 and WHP12, were obtained from the same Aboriginal child at 
an interval of two months. Epidemiological analysis was carried out only on details 
pertaining to the first sample. Descriptive statistics and results of univariate analysis are 
presented for the population groups, followed by the results of the logistic regression 
models. 
 Chapter 3 - Faecal Culture  
   70
3.3.2.1  Descriptive statistics and univariate analysis 
Patient characteristics 
Risk factors associated with carriage of B. pilosicoli in Aboriginal Australians that 
had a P value ≤0.25 after univariate analysis, and were thus considered for inclusion in 
logistic regression analysis, are presented in Table 3.3. Factors associated with carriage in 
migrants are presented in Table 3.4. Any factor with a P value of >0.25 by Chi square 
analysis is presented in Appendix A4.1 for Aboriginals and Appendix A4.2 for migrants.  
No significant gender related difference was found in B. pilosicoli carriage in 
Aboriginals or migrants. The mean age of colonised Aboriginals (18.7 y, SD 30.3 y) was not 
significantly different from non-colonised patients (P = 0.48), neither was the mean age of 
colonised migrants (19.5 y SD 13.6) different from non-colonised migrants (P = 0.11). The 
age distributions of carriage were different for the migrants and Aboriginals, which reflected 
different age distributions for each population. The age distribution for migrants 
approximated a normal distribution and the ages of positive migrant individuals were not 
significantly different from this distribution (Figure 3.1). Conversely, nearly half (47%) of 
the Aboriginal samples came from children under two years of age (Figure 3.2). 
Nevertheless, significantly more isolates (P = 0.0027) came from patients between 2 - 4 
years of age than from <2 year old or >5 year old individuals. Only one of 36 (2.8%) 
patients of between 20 and 59 years of age was colonised, whilst three of the nine (33.3%) 
patients over 60 were colonised. A significantly greater proportion of isolates came from 
Aboriginals >60 years than from those ≤60 years. 
 
Aboriginal Australians 
Aboriginal patients came from various regions throughout WA, however 80% 
(12/15) of colonised individuals were from the Kimberley region (Figure 3.3). Analysis 
based on rainfall distribution showed that 53.3% of isolates came from patients from areas of 
northern WA that received a rainfall of over 800 mm during the study period. Neither 
distribution differed significantly from the geographical distribution of the other members of 
the population.  
Three Aboriginal patients between 2 - 5 years were in-patients of children’s wards in 
regional hospitals when samples were obtained. Additionally, a child from whom two 
isolates were obtained was hospitalised at the time the second sample was taken. However, 
there was no significant difference in prevalence according to hospitalisation status for B. 
pilosicoli positive patients and the remaining patients. 
Samples were collected from Aboriginals with a variety of symptoms and other 
reasons for investigation (Table 3.5 univariate analysis P value ≤0.25, Appendix A4.3 P Chapter 3 - Faecal Culture  
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value >0.25). Of the 15 patients from whom spirochaetes were isolated, seven (46.6%) had 
diarrhoea, including three with chronic/recurrent diarrhoea and two with diarrhoea and 
vomiting. The submitting clinicians had suspected Giardia or “worms” in three samples, 
whilst failure to thrive (FTT) or being underweight was noted in three young patients. The 
Aboriginal patients who were positive for B. pilosicoli were significantly more likely to have 
chronic diarrhoea, FTT or be underweight than those who were not positive for B. pilosicoli 
(P = 0.016). This also was the case for Giardia intestinalis (P = 0.016). No spirochaetes 
were recovered from patients with symptoms of gastroenteritis, bloody stools or rectal 
bleeding, anaemia, abdominal pain or green stools, although patients with these symptoms 
comprised totalled only 22.5% (34/151) of the entire population sampled.  
 
Migrants 
Amongst migrants, B. pilosicoli isolates were obtained from 25% (2/8) of Asian, 
3.2% (3/94) of Eastern European, 13.8% (9/65) of Middle Eastern and 20.0% (10/50) of 
African individuals. Positive individuals originated from Afghanistan, Burma, Croatia, 
Eritrea, Ethiopia, Iran, Iraq, Serbia, Somalia or were Kurds. Significantly fewer cases came 
from Eastern Europe than from the other areas (P = 0.0048).  
Some migrant individuals were grouped into families, and a total of 49 family 
groups were tested. A family was defined as two or more people with a common surname 
who presented to the Migrant Health Unit, Murray St, Perth, on the same day. The total 
number of individuals within a family ranged from 2 – 10 individuals (mean = 4.0, SD 1.8 
people), and by chance, the faecal samples of only a proportion of these were tested, 
between 2 – 7 individuals (mean = 3.2, SD 1.4 people). Of the 49 families tested, seven 
families had one positive individual, while three families contained multiple positive 
individuals. Two isolates were obtained from a family where three members were tested, 
two from a family where five members were tested, and three isolates came from a family 
where six people were tested. If one family member was colonised, it was not significantly 
more likely that another family member would be colonised (P = 0.53). The mean family 
size for positive individuals (4.6 people) was not significantly different from the mean 
family size for negative individuals (3.9 people; P = 0.28). Neither the number of individuals 
who were tested within a family, nor the proportion of family members who were tested, 
affected the number of family members from whom B. pilosicoli was isolated.  
 
Samples 
The average time between sample collection and processing was 1.1 days for 
migrants and 3.6 days for Aboriginal patients. B. pilosicoli isolates were obtained with the 
same frequency in all months tested for both population groups. The consistency of samples Chapter 3 - Faecal Culture  
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from which B. pilosicoli was isolated was not significantly different from that of negative 
samples. For Aboriginal Australians, 40% of isolates were obtained from normal faeces 
(formed or semi-formed), 46.6% from loose and 13.3% from watery stools. For migrants, 
75% of isolates came from normal faeces and 25% from loose stools.  
 
Other enteric organisms 
Some samples contained bacterial pathogens and/or intestinal parasites which were 
pathogenic, potentially pathogenic (Blastocystis hominis) or of uncertain pathogenicity. An 
enteric pathogen was found in 33.1% of Aboriginal patients and 11.0% of migrants, while no 
organism was detected in 61.5%, and 62.5% of samples, respectively. Two or more 
pathogens, not including B. pilosicoli, were found in 13.2% of Aboriginal patients but in 
only one sample from the migrant individuals. Organisms associated with colonisation of B. 
pilosicoli with a P value of ≤0.25 are presented in Table 3.3 for Aboriginals and Table 3.4 
for migrants. Any factor with a P value of >0.25 after univariate analysis is presented in 
Appendix A4.1 for Aboriginals and Appendix A4.2 for migrants.  
In both Aboriginal and migrant cohorts, the isolation of B. pilosicoli was associated 
with the presence of parasites generally (Aboriginal (P = 0.0013); migrant (P = 0.041)), or 
protozoa (Aboriginal (P  = 0.0022); migrant (P = 0.023)), regardless of their pathogenic 
status. Within the Aboriginal group, carriage of B. pilosicoli was significantly associated 
with detection of any other organism (P  = 0.0036), specifically, detection of Giardia 
intestinalis ( P  = 0.025), Hymenolepis nana ( P  = 0.014) or B. hominis ( P  = 0.022). In 
migrants, B. pilosicoli carriage was significantly associated with Entamoeba coli (P = 0.036) 
and Iodamoeba bütschlii (P = 0.005). Only 2/24 (8.3%) B. pilosicoli isolates from migrants 
were obtained from samples containing another pathogen, and on both occasions this was G. 
intestinalis.  
 
3.3.2.2  Logistic regression analysis 
In the final logistic regression model generated for risk factors in Aboriginal 
Australians (Table 3.6), the odds of colonisation with B. pilosicoli was 6.2 times greater in 
patients >60 years than ≤60 years (95% CI 1.2 - 32.3). The detection of parasites, regardless 
of pathogenicity, increased the odds of B. pilosicoli colonisation to 6.3 times that of patients 
in whom parasites were not detected (95% CI 2.0 – 20.4). 
No age related risk factor remained in the logistic regression model for migrants 
(Table 3.7), although colonisation was 6.4 times greater if an individual was not of European 
origin (95% CI 1.7 – 23.9). Two organisms were significantly associated with B. pilosicoli 
carriage in migrants, I. bütschlii (P = 0.018; OR 6.0, 95% CI 1.4 – 26.3) and B. aalborgi Chapter 3 - Faecal Culture  
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when detected by PCR (P = 0.0036; OR 6.0, 95% CI 1.8 – 20.3). The latter organism will 
not be discussed further until Chapter 4.  
In a separate logistic regression model created to analyse the association between 
colonisation and reasons for investigation in Aboriginals (Table 3.8), the presence of 
diarrhoea was negatively associated with colonisation with B. pilosicoli (OR 0.3, 95% CI 0.1 
– 0.91), while patients with long term or recurrent diarrhoea were 7.8 times more likely to be 
colonised (95% CI 1.7 – 35.8).  
 
3.3.3 Isolation  of  B. aalborgi from control specimens 
3.3.3.1 Isolate  characteristics 
Spirochaetes were isolated from one of the 60 faecal samples from control 
individuals. After 21 d incubation, two types of weakly β-haemolytic colonies were seen on 
BHIA 10% BB inoculated with faeces from this individual. These were grey spreading 
colonies of 1.2 mm diameter with a raised pinpoint centre inside an irregular flat edge (type 
A), and smooth pinpoint colonies (<0.1 mm diameter) (type B). On subculture, a mixture of 
both colony types persisted, however, the type A colonies predominated.  
PCR of both colony types from the primary isolation plate confirmed their identity 
as B. aalborgi. B. pilosicoli was not isolated from this population. Sequences of the 16S 
rRNA gene from both colony types were identical to each other, and to the sequence from 
the PCR product generated from DNA extracted from the faecal sample, as described in 
Chapter 4 (Figure 3.4). Sequences showed 99% alignment with the sequences for B. 
aalborgi 513A
T, W1, and nine of the uncultured Brachyspira strains sequenced by 
Pettersson  et al. (2000). For each colony type, polymorphisms occurred at the base 
equivalent to position 416 in Escherichia coli (Brosius et al., 1978), where a guanidine 
residue was replaced by a thymine residue, and at the base equivalent to position 436, where 
thymine was replaced by cytosine. 
Under the phase contrast microscope, the spirochaetes appeared as short helical cells 
with a pronounced flexuous motility. Cells from both colony types had a similar appearance. 
Electron microscopy revealed two cell types. One cell type was plump, varying from 2.0 -
6.0 µm long and being about 250 nm wide. Cells were typically “S” or comma shaped with a 
2  µm wavelength. The other cell type was similar in length and shape but was only 
approximately 120 - 130 nm in width and the amplitude was slightly less (Figure 3.5). Both 
cell types had four periplasmic flagella inserted in one row at each cell end (Figures 3.6 and 
3.7). A mixture of cell types was observed in the large grey spreading colonies, whilst only 
the thin cell type was observed in the pinpoint colonies.  
 Chapter 3 - Faecal Culture  
   74
3.3.3.2  Patient and sample characteristics  
The individual from whom the B. aalborgi isolate was obtained (individual C07) 
was self-diagnosed as having “chronic diarrhoea” with cramps and urgency, for which he 
had not sought medical attention. Obtaining further faecal samples was not possible because 
he moved to the UK shortly after the first sample was submitted, so no further 
microbiological investigations were attempted. However, while in the UK he took a course 
of metronidazole, which reportedly cured the diarrhoea and cramping. A faecal sample from 
his (female) partner was culture negative for B. aalborgi. 
 
3.3.4  Detection of spirochaetes in specimens by microscopy 
Phase contrast microscopy was performed on samples from 555 patients, including 
the 60 control specimens. Spirochaetes were observed by wet mount microscopy in 68.4% 
(26/38) of samples from which a B. pilosicoli isolate was obtained. Sample WHP12, the 
second samples from the Aboriginal child, was not included in the analysis, although 
spirochaetes were observed in this sample. In both the Aboriginal and migrant groups, the 
observation of spirochaetes was significantly associated with the isolation of B. pilosicoli (P 
<0.001 for both groups). Microscopy of faecal samples from control individuals revealed 
spirochaetes in four samples, but not the sample from which the B. aalborgi was isolated. In 
total, samples from 15 patients (2.7%) were observed to contain spirochaetes that were not 
recovered by culture, including seven migrants, three Aboriginals, one non-Aboriginal rural 
patient and the four specimens from the control group. Thus, the sensitivity of microscopy 
compared to culture of B. pilosicoli was 68.4% and the specificity was 97.1%.  
Detection of B. pilosicoli and B. aalborgi from seeded faeces by microscopy was 
inconsistent, but generally 1 x 10
4 to 1 x 10
2 organisms per slide, or the equivalent of 1 x 10
7 
to 1 x 10
5 organisms/g of faeces were visible by this method. 
 
3.4 DISCUSSION 
In this study, the carriage of intestinal spirochaetes in Western Australian 
populations was examined by culturing faecal specimens. Although intestinal biopsies are 
useful for investigating individual cases of IS, since they can be used to link the presence of 
spirochaetes to specific pathological changes, taking biopsies is an invasive process which is 
only undertaken routinely in developed countries. Biopsies are performed only when 
gastrointestinal or other symptoms require this process, and consequently may not detect 
spirochaetes when colonisation is scanty, or when individuals are asymptomatic (and hence 
not biopsied). Collection and examination of faeces for studies on the presence and disease 
associations of B. pilosicoli and B. aalborgi is easier, less expensive and more acceptable to Chapter 3 - Faecal Culture  
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patients. Carriage studies also allow an assessment of the role each spirochaete may play in 
human gastrointestinal disease, as healthy individuals can be studied easily, and potential 
transmission can be examined. The ability to culture these organisms permits future 
characterisation of isolates, and facilitates studies on molecular epidemiology and 
pathogenicity. Consequently, investigations into the carriage of intestinal spirochaetes by 
cultural methods were carried out as described in this chapter. In the discussion that follows, 
a description of studies into cultural methodology is first made, followed by discussion of 
the study examining the faecal carriage of intestinal spirochaetes. Elements of the design and 
analysis of this study are first presented, followed by the epidemiological results.  
 
3.4.1 Optimisation  of cultural methods 
Initial tests on culture media were performed to determine if media used by the 
Reference Centre for Intestinal Spirochaetes at Murdoch University were appropriate for the 
growth of B. pilosicoli and B. aalborgi. B. pilosicoli grew well on TSA 5% OB SVC, a 
medium known as CVSBA in the intestinal spirochaete literature (Jenkinson & Wingar, 
1981). The medium has been routinely used to isolate B. hyodysenteriae and B. pilosicoli 
from pigs and other animals (Lee & Hampson, 1994), and is thus well standardised. B. 
pilosicoli grew equally well if SVC was replaced by S or SP, combinations favoured by 
investigators into human intestinal spirochaetes (Tompkins et al., 1981; Hovind-Hougen et 
al., 1982; Jones et al., 1986). B. pilosicoli strains grew faster at 42°C and, while this finding 
does not appear to have been specifically reported, this incubation temperature is commonly 
used by researchers (Fellström & Gunnarsson, 1995; Duhamel et al., 1995b; Hommez et al., 
1998a) to culture the faster growing Brachyspira spp..  
B. aalborgi 513A
T was not able to grow at 42°C, as previously observed (Hovind-
Hougen et al., 1982), and media with vancomycin appeared to inhibit the growth of the 
organism. The potential clinical importance of B. aalborgi was not as well realised when 
these early tests were performed, and decisions were made with B. pilosicoli isolation being 
of primary importance. Although BHIA allowed better growth of B. aalborgi, growth on 
TSA appeared ample, and this base was retained for testing of clinical faecal samples. Media 
containing vancomycin was rejected in favour of spectinomycin and polymyxin B, an 
antibiotic combination previously verified for B. aalborgi isolation (Hovind-Hougen et al., 
1982) and isolation from clinical samples was attempted on SP medium (TSA 5% OB SP) at 
37°C.  
Isolation of B. pilosicoli from clinical samples was attempted on S medium (TSA 
5% OB S) at 42°C, the raised temperature replacing other antibiotics as a selective method, 
although growth of B. pilosicoli also was possible on SP medium. These choices were highly Chapter 3 - Faecal Culture  
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suitable for B. pilosicoli isolation from faecal specimens, as later studies indicated that 
selection from seeded faeces was a very low 1 - 20 cfu/10 µl faeces, and growth and 
isolation of B. pilosicoli was good on S medium, SP medium and TSA 10% OB with SCV. 
Additionally, MICs obtained for spectinomycin, vancomycin and polymyxin B for 21 strains 
were well over the concentration in the media, demonstrating that susceptibility to 
antimicrobials incorporated in the agar was unlikely.  
When determining the lower limit of detection of B. aalborgi by culture on SP 
medium under the conditions chosen for the isolation from clinical samples, that is, at 37°C 
in an anaerobic chamber, this organism grew poorly. Thus extensive tests were performed 
examining the growth and means for selection of this organism. The strategy which was 
followed was to test B. aalborgi 513A
T and W1 for growth on a range of agar bases, initially 
supplemented with 10% BB as for the original isolation medium of Houvind-Hougen et al. 
(1982). The bases that supported better growth were tested with different primary 
supplements (blood), secondary supplements and under different environmental conditions. 
To make a medium selective for B. aalborgi, a range of potentially inhibitory substances 
was evaluated using human faeces seeded with the B. aalborgi strains. Finally, the optimised 
isolation medium was tested on the faeces of the control individuals and one isolate was 
cultured from this population. 
In these later, more extensive tests, the best base medium for growth of B. aalborgi 
was BHIA, supplemented with 10% BB, whilst selection of B. aalborgi from seeded faeces 
was achieved with media containing S, SC, SP, SR, SRC, SPR, SPC or SRPC. Each of these 
antimicrobials, aside from polymyxin B, has been used previously in solid media for 
Brachyspira spp. isolation in a veterinary setting (Jenkinson & Wingar, 1981; Kunkle & 
Kinyon, 1988), although not in all combinations examined. In addition, some of these agents 
have been tested for use in media to isolate B. pilosicoli from humans (Calderaro et al., 
1997). The medium used in previous isolations of B. aalborgi was TSA 10% BB SP 
(Hovind-Hougen et al., 1982; Kraaz et al., 2000; Jensen et al., 2001). As the performance of 
these combinations appeared equal, SP was chosen due to the history of successful isolation 
in previous studies. In this investigation, BHIA 10% BB supported better growth than TSA 
10% BB, and it is possible that the additional nutrients provided by the BHIA allowed the B. 
aalborgi strain to be isolated in this study. Subsequent to the studies described in this 
chapter being performed, isolates of B. aalborgi were obtained using BHIB and TSB plus 
10% FCS, which were subcultured to BA and TSA with SP or SR, with SR being the more 
effective (Calderaro et al., 2003). 
TSA 5% OB SVC has been used to isolate B. pilosicoli from human faeces (Lee & 
Hampson, 1992; Trott et al., 1997a; Margawani et al., 2003). Results from the extended 
study supported the initial findings discussed earlier and indicated that this medium did not Chapter 3 - Faecal Culture  
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support the growth of B. aalborgi, presumably as a result of the susceptibility to 
vancomycin. Poor growth of B. aalborgi W1 on a similar medium has been reported 
previously (Kraaz et al., 2000). Therefore studies in which TSA 5% OB SVC is used to 
isolate human intestinal spirochaetes are likely to fail to isolate B. aalborgi. Likewise, 
growth on a solid version of Kunkle's broth (Kunkle et al., 1986) was poor and, although the 
broth medium has been used commonly to culture other spirochaetes (Elder et al., 1994; 
Hampson & McLaren, 1999; Hampson et al., 2000), it is unlikely to be suitable for B. 
aalborgi.  
Pre-reduction of media did not influence B. aalborgi growth, however tests were 
carried out on laboratory-adapted strains. This technique was utilised for isolation of the 
other B. aalborgi strains to date (Hovind-Hougen et al., 1982; Kraaz et al., 2000; Jensen et 
al., 2001), and it is possible that pre-reduction of media may have allowed the isolation of 
other strains in the samples tested. Likewise, growth of these strains was barely improved at 
38.5°C, despite a previous report of optimal growth at this higher temperature (Hovind-
Hougen et al., 1982). This may again be due to the laboratory adaptation of strains, or 
possibly the difference observed by Hovind-Hougen et al. (1982) was more marked when 
using TSA as the base medium.  
The superior growth achieved in the anaerobic jars compared to an anaerobic 
chamber was unexpected. This result was obtained despite the anaerobic chamber quality 
control test organisms growing as expected. It may be that the poorer growth of B. aalborgi 
in the anaerobic chamber accounted for the poor results in the lower limit of detection tests 
described earlier. Initial tests on media were carried out in anaerobic jars, but clinical 
samples on SP media were incubated in the anaerobic chamber, due to the large number of 
samples and long duration of incubation limiting jar space. Humidity levels tended to be 
higher in jars, and the gas composition differed between the two atmospheres. It is possible 
that either of these factors may have impacted upon B. aalborgi growth, however successful 
isolation of two B. aalborgi strains was achieved in the same atmosphere as the anaerobic 
chamber (Jensen et al., 2001). It is also likely that these organisms are quite sensitive to 
changes in the incubation environment, as it was noted that B. aalborgi growth was inhibited 
in the presence of large numbers of contaminating organisms on other plates.  
The addition of pig faecal extract to media previously enhanced growth of B. 
hyodysenteriae (Kunkle & Kinyon, 1988). While filtered extract appeared to improve 
growth somewhat, contaminants were present. Autoclaving media with extract added 
entirely inhibited growth of the organism, and likely destroyed a vital nutrient or liberated a 
metabolite harmful to B. aalborgi growth. Foetal calf serum did not enhance growth, 
however there are many other potential supplementary compounds that were not tested as a 
part of this study, which may improve B. aalborgi growth further.  Chapter 3 - Faecal Culture  
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In vitro antimicrobial susceptibility testing by agar dilution was not performed for B. 
aalborgi, as sufficient growth of strain W1 was observed on WC+HS only after 18 d and not 
on any other media tested. Additionally, growth of 513A
T on WC+HS and BrBA+H was 
visible only after 14 d incubation, and it was uncertain if antimicrobials would retain activity 
after this prolonged incubation.  
The disc susceptibility tests did not provide any further compounds useful for 
addition to selective media, as B. aalborgi was susceptible to most compounds tested. 
Surprisingly, the bile discs inhibited growth of B. aalborgi. This compound was considered 
as a potential selective agent since B. hyodysenteriae and B. innocens grew in the presence 
of bile (Kinyon & Harris, 1979). Resistance to colistin and rifampicin was already suspected 
as media with these compounds are used to isolate other Brachyspira species (Achacha & 
Messier, 1992). Colistin and rifampicin were thus utilised in this study, while erythromycin 
was not considered suitable for use in anaerobic atmospheres containing CO2 (Goldstein et 
al., 1981). Demonstration of metronidazole susceptibility at 5 µg corresponded to reports of 
the successful use of this agent for treatment of cases of HIS caused by B. aalborgi (Guccion 
et al., 1995; Mikosza et al., 1999; Heine et al., 2001). 
 
3.4.2 Study  design 
The aim of the study described in Chapter 3, and subsequently in Chapter 4, was to 
examine the epidemiology of B. pilosicoli and B. aalborgi carriage in at - risk Western 
Australian populations, in order to determine the prevalence, and detect any disease 
associations. Previous carriage studies have included those performed on healthy individuals 
in Oman, Australia, PNG, India and Bali (Barrett, 1990; Lee & Hampson, 1992; Trott et al., 
1997a; Margawani et al., 2003; Munshi et al., 2003c), on Australian Aboriginals with 
diarrhoeal symptoms but who were not seeking medical attention (Lee & Hampson, 1992), 
and in ill natives of Oman in a hospital setting (Barrett, 1990). In addition, studies into HIS 
have identified spirochaetes in gastrointestinal biopsies from mainly heterosexual adults in 
developed countries, who have required the procedure as part of an investigation of 
symptoms. HIS also has been reported in children, healthy individuals and, at a higher 
prevalence, in homosexual males and HIV positive individuals.  
The populations chosen for analysis in this study included a group of individuals 
living in rural areas of Western Australia, comprising both Aboriginal and non-Aboriginal 
Australians. These patients had gastrointestinal symptoms serious enough to require medical 
investigation. Reasons for investigation were ascertained only from the request forms, 
however a complete medical history was not obtained for each individual. Nevertheless, the 
patients represented groups that have previously not been well investigated for faecal Chapter 3 - Faecal Culture  
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spirochaete carriage. Data were available on the detection of other organisms in these 
patients and few studies have examined the relationship of other pathogens with intestinal 
spirochaete carriage.  
A crucial requirement for the success of this study was the ability to determine the 
ethnicity of these patients. This was considered to be a simpler exercise with a rural 
population, as rural Aboriginal individuals often lived in Aboriginal communities, or were 
known to medical personnel. It was considered that the identification of Aboriginal 
individuals in an urban setting such as Perth would have been more difficult. As the risk 
factors and living conditions of these two ethnic groups were likely to be different, statistical 
analysis was carried out separately for each.  
As a contrast, a group of presumably healthy migrants who were seeking entry into 
Australia was tested. Individuals originated from countries throughout Asia, Africa the 
Middle East and Eastern Europe. While the prevalence of intestinal spirochaete carriage had 
not been determined from these countries previously, B. pilosicoli was suspected to be high 
in individuals from the Middle Eastern and African countries, as B. pilosicoli was described 
from Oman (Barrett, 1990) and Rwanda (Goossens et al., 1983). Moreover, high spirochaete 
prevalence in the West African Gold Coast (MacFie, 1917) and the Philippines (Cromwell & 
Haughwort, 1918, cited in (Parr, 1923; Ruane et al., 1989)) was reported in early 
investigations. While it may have been interesting to examine the epidemiology of human 
intestinal spirochaete carriage in HIV positive patients, there was likely to be too few 
individuals in Perth with HIV to allow a meaningful epidemiological analysis (Dr Chris 
Heath, Royal Perth Hospital, pers. comm.). A group of healthy individuals of mainly 
Caucasian derivation from Perth also was included for comparative purposes.  
The design of the current study was a cross-sectional survey. As such, the methods 
available for statistical analysis were few, and the conclusions that could be made were 
relatively simple in epidemiological terms. Univariate analysis using the Yates corrected 
Chi-square test was performed, except when an expected value was less than 5, and in these 
cases it was more correct to perform Fisher’s exact Chi-square test. The univariate analysis 
was used to determine which risk factors and reasons for investigation, and the presence of 
which non-spirochaetal organisms, were significantly associated with the carriage of 
intestinal spirochaetes in each population. Logistic regression analysis was then performed 
on variables which had a P value of ≤0.25. This technique is used to describe the relative 
contribution each variable makes to a single outcome, in this case, the carriage of each 
spirochaete, while controlling for the influence of other variables (Bagley et al., 2001). In 
performing this analysis, the assumption was made that colonisation with the two 
spirochaetes was independent, although this is currently unknown.  Chapter 3 - Faecal Culture  
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A perceived limitation of the study was the choice of risk factors, which were the 
demographic details available from request forms, except in the case of control individuals 
who completed a short questionnaire. Other risk factors for spirochaete colonisation such as 
diet or a measure of immune status or living conditions may have been useful. A larger study 
would be required to confirm trends, and this study could be used to determine suitable 
factors to examine in future studies.  
 
3.4.3 Isolation  of  B. pilosicoli  
Carriage of B. pilosicoli from the WA population was assessed using the cultural 
methods described in Section 3.4.1. Isolates were obtained from 9.9% of 151 Australian 
Aborigines with gastrointestinal symptoms. This is consistent with the previous study in WA 
(Lee & Hampson, 1992), where intestinal spirochaetes, later identified as B. pilosicoli, were 
found in the faeces of 32.6% of predominantly children in a rural community of Aboriginal 
Australians in the Kimberley region (Lee & Hampson, 1992). In the current study, colonised 
patients were again mostly Aboriginal children from the Kimberley region.  
The lower overall prevalence recorded here, compared to the study of Lee and 
Hampson  (1992), may reflect the greater proportion of individuals over 18 years in the 
current study (30.5% compared to 9.4%). Information about antibiotic usage in patients was 
unknown, however, prior antimicrobial therapy in Aboriginal patients may account for lower 
rates among the Aboriginals in this investigation. Barrett (Barrett, 1990) suggested this to 
explain the lower prevalence in hospitalised Omani patients than in healthy individuals. 
Alternatively, the lower prevalence may be a result of the differences in the disease states of 
the Aboriginal population in this and the previous study. 
B. pilosicoli was not obtained by culture from any of 142 non-Aboriginal 
Australians from rural areas who had symptoms similar to those exhibited by the Aboriginal 
patients, nor from any members of the control population. Similar low rates of B. pilosicoli 
carriage in Caucasian individuals have been reported previously (Tompkins et al., 1986; Lee 
& Hampson, 1992; Trott et al., 1997a). It appears from these data that living in rural areas in 
WA is not itself a risk factor for infection with B. pilosicoli. Rather, colonisation in rural 
areas seems linked to factors associated with Aboriginality.  
Rural patients from the two ethnic backgrounds probably did not originate from 
equivalent environments. The generally low socio-economic status and poorer living 
conditions of rural Aborigines (Meloni et al., 1993) may have predisposed this population to 
infection. Factors such as poor drinking water quality and poor nutrition, increased contact 
with animals, crowded living conditions and lack of hygienic facilities can favour infections 
transmitted by the faecal-oral route. In a survey of B. pilosicoli carriage in Papua New Chapter 3 - Faecal Culture  
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Guinea (Trott et al., 1997a), some of these factors were cited to account for colonisation 
rates of 22.6 - 30.1% in four of five rural villages, compared with rates of 9.3% amongst 
indigenous people living in an urban environment in the region. In the current study, 
information about these risk factors was not available, however, exposure to faecal material 
can be indirectly indicated by the high rate of intestinal bacterial and parasitic infection in 
the Aboriginal patients.  
It was difficult to assess whether B. pilosicoli had a pathological role in the 
colonised individuals in this study, due to the frequent presence of multiple enteric 
pathogens and the lack of a healthy control group amongst the Aboriginal Australians. The 
predominantly loose consistency of samples, the presence of gastrointestinal symptoms and 
a variety of pathogens confirmed that samples were from a diseased population. In the seven 
children and one elderly patient (53.3%) from whom B. pilosicoli and other known 
pathogens were identified, the significance of B. pilosicoli was unclear. The spirochaete may 
have contributed to the symptoms recorded, or may have been flushed out because of the 
diarrhoea caused by other organisms. In those patients where no other pathogens were 
found, a stronger argument can be made for the role of B. pilosicoli as a cause of disease. 
These patients included four hospitalised children, and four over 20 years of age, three of 
whom were elderly.  
The age distribution of the entire Aboriginal cohort reflects the high incidence of 
infectious diarrhoea in Aboriginal children from birth to three years (Gracey, 1973; 
Gunzburg et al., 1992). Over and above this, a significant proportion of the B. pilosicoli 
isolates was from patients aged 2 - 4 years or 2 - 18 years. This observation is in agreement 
with others who found B. pilosicoli mainly colonised children over two years of age 
(Tompkins et al., 1986; Barrett, 1990; Lee & Hampson, 1992; Trott et al., 1997a). In 
particular, Lee and Hampson (Lee & Hampson, 1992) reported that Aboriginal children aged 
2 to 18 years were more likely to be colonised with B. pilosicoli than adults or babies less 
than two years. Although only a few samples were obtained from elderly patients, B. 
pilosicoli carriage was also significantly associated with individuals aged >60 years, and 
surprisingly, this was the only age group to remain within the logistic regression model for 
Aboriginal patients. The high prevalence in this group may be the result of waning immunity 
leading to an increased susceptibility to the organism. Possibly, the association of B. 
pilosicoli carriage with other age groups was dependent on some other characteristic. 
Intestinal parasites also are more common in Aboriginal children aged ≤5 years than 
in older groups (Meloni et al., 1993), however, little data have been published specifically 
examining older age groups. The acquisition of G. intestinalis and H. nana in particular are 
believed to relate to the age of weaning, the commencement of infants mouthing objects and 
their increased mobility (Gill & Jones, 1985). It is possible that isolation of both parasites Chapter 3 - Faecal Culture  
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and B. pilosicoli at this age, and the significant association between these organisms in this 
study related to a similar nature of acquisition of the organisms or with the concomitant loss 
of maternal antibody protection at weaning. An age related predisposition to infection by B. 
pilosicoli has been demonstrated in pigs, which occurs following mixing and weaning 
(Hampson & Trott, 1999).  
Protozoa and B. pilosicoli may have a more intimate relationship than just similar 
modes of acquisition. Previously, both Giardia (Duhamel et al., 1996) and Balantidium coli 
(Trott et al., 1996b) have been suggested as having a synergistic relationship with intestinal 
spirochaetes. In the earliest studies of human intestinal spirochaetes, protozoal and 
spirochaetal dysenteries were often observed together (Fantham & Cantab, 1916b; Hogue, 
1922; Parr, 1923). In a study of homosexual men (Law et al., 1994), spirochaete carriage 
was associated with detection of three to five unspecified “non-pathogenic protozoa”. In the 
present study, there was a significant association between B. pilosicoli and protozoa, or 
parasites generally, in both cohorts after univariate analysis. For the Aboriginal patients 
these parasites tended to be recognised pathogens, however, for migrants the parasites were 
species of uncertain pathogenicity, which may reflect the differing health status of the 
cohorts. This association with parasites and Aboriginals remained in the logistic regression 
analysis, while for migrants, only I. bütschlii remained, despite the small numbers of 
individuals in the study in whom this organism was detected. 
How intestinal spirochaetes and parasites may interact is not known. Infection with 
one organism could have caused flushing out of the other, one or other organism may have 
initiated a predisposition to infection, or a dual role in colonisation or disease could be 
occurring. Some researchers have suggested that IS occurs due to changes in the 
microenvironment of the gut (Surawicz et al., 1987). Potentially, parasites may be 
responsible for such changes and may result in the relationships observed here. However, 
further investigation into the interactions between parasites and B. pilosicoli, and the 
possible polymicrobial nature of the infections, is clearly required. 
The roles of B. pilosicoli in disease and in interactions with protozoa are further 
complicated by an examination of therapy. Resolution of symptoms and removal of 
spirochaetes has been achieved with metronidazole (Crucioli & Busuttil, 1981; Rodgers et 
al., 1986; Käsbohrer et al., 1990), while Giardia, and B. hominis if necessary, also are 
treated with this drug (Stenzel & Boreham, 1996; Zaat et al., 1997). Giardia  has been 
considered responsible for FTT, as treatment of Aboriginal children with metronidazole and 
tinidazole is “often followed by rapid weight gain and an improvement in health” (Meloni et 
al., 1988). FTT is a term used to describe infants and children with unexplained weight loss 
or who fail to maintain the proper weight for their age. The syndrome is recognised to be 
multifactorial in most cases, with gastrointestinal abnormalities being one of many possible Chapter 3 - Faecal Culture  
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responsible elements (Garcia Careaga & Kerner, 2000; Marino et al., 2001). In this study, 
both Giardia and B. pilosicoli were significantly associated with symptoms of FTT, chronic 
diarrhoea and reduced weight. Whether or not B. pilosicoli contributes to FTT in Aboriginal 
children requires further investigation. In addition, the role of these spirochaetes in older 
Aboriginal individuals also requires further examination.  
B. pilosicoli was isolated at a prevalence of 10.6% from the migrant group, which 
was composed of individuals of unknown health status. This group was presumed to be 
healthy, despite the possible stressful conditions of their situation. The predominantly 
normal consistency of samples and the relative absence of other pathogens for the entire 
group led to this assumption. The lack of significance of these characteristics in the B. 
pilosicoli positive samples indicates that these individuals were probably healthy also. This 
finding has been reported previously; B. pilosicoli carriage was described in healthy 
villagers in PNG and in Oman (Barrett, 1990; Trott et al., 1997a). 
The ages of migrant individuals were more evenly distributed than those of the 
Aboriginal patients, and no age group contained significantly more B. pilosicoli isolates than 
another. The lack of association in the 2 - 4 year age group may have been due to the small 
number of individuals under 5 years and those over 60 years, or due to other differences 
between the two populations, such as disease status or ethnic differences. 
The individuals from whom B. pilosicoli was isolated originated from a variety of 
countries, further extending our understanding of the widespread distribution of the 
organism. Even early reports noted the geographical variation in spirochaete incidence 
(Fantham & Cantab, 1916b; MacFie, 1917). The significantly greater isolation rate from 
Africa and the Middle East compared to Eastern Europe is likely to reflect differences in 
opportunities for exposure to the organism in the different countries. A high prevalence of 
intestinal spirochaetes has been documented previously in Africans (MacFie, 1917) and in 
Arabs from the Middle East (Barrett, 1990). Unfortunately, whether some migrants had 
spent time in transit camps, where they may have been infected, rather than in their country 
of origin, was not known. 
The finding of B. pilosicoli colonisation in multiple members of some migrant 
families is of considerable interest. Tompkins et al. (1986) also assessed the prevalence of 
intestinal spirochaetes in immigrant samples from a screening clinic, and cultured organisms 
from more than one member of three separate Asian families. In addition, Gad and 
colleagues (1977), reported on HIS in a mother and daughter, although the identity of the 
spirochaetes was unknown. These results could indicate that transmission between family 
members may have occurred, that they were all exposed to some other point source, such as 
contaminated water, or be merely a reflection of the high prevalence of the organisms in 
these populations. While family size was not significantly higher in individuals carrying B. Chapter 3 - Faecal Culture  
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pilosicoli in this investigation, transmission may have occurred between these individuals. 
Further investigation of these possibilities using a method to type B. pilosicoli isolates is 
required.  
 
3.4.4 Isolation  of  B. aalborgi  
A selective medium was developed and used to isolate B. aalborgi from one of the 
faecal samples collected from the control population. At the time of study, this was the first 
isolation of B. aalborgi from human faeces, with all previously obtained isolates having 
been grown directly from biopsy samples. Subsequently, a group from Italy have also 
reported isolating B. aalborgi from human faeces using a broth enrichment technique 
(Calderaro et al., 2003). They were unable to isolate the strain directly from biopsy or faeces 
onto solid media, which highlights the rarity of the event described here. In common with 
previous descriptions (Hovind-Hougen et al., 1982; Kraaz et al., 2000), two colony types 
grew from the positive faecal sample. The colony types were similar to those previously 
described, and the size and electron microscopic morphology of one cell type was consistent 
with previous descriptions of B. aalborgi (Hovind-Hougen et al., 1982; Kraaz et al., 2000; 
Jensen et al., 2001).  
Sequencing of PCR product confirmed that the isolate was B. aalborgi. Both colony 
types gave identical 16S DNA sequences, suggesting that the two types were at least 
identical in this region. A discussion of how this sequence relates to previously published 
sequences and lineages occurs in Chapter 4. An unusual feature, however, was the 
identification of some cells that were much thinner by electron microscopy than the 
“typical” cells. The smaller colony types appeared to be made up of these thinner types, 
although they were also present in the larger colonies. The differences in cell size may have 
been an artefact, the result of the presence of two distinct types of organism, or reflect a 
genuine difference in the phenotype of a given strain. These possibilities require further 
investigation. 
B. aalborgi was isolated from only one of 60 faecal samples from this population, 
therefore statistical analysis was not appropriate. Although metronidazole therapy appeared 
to alleviate symptoms in this individual, obtaining microbiological evidence of cure was not 
possible, and it is difficult to speculate on the potential pathogenicity of this isolate.  
There were 15 samples (2.5%) where spirochaetes were observed by microscopy but 
were not recovered by culture, including four from the control population. Although B. 
aalborgi was not isolated from any clinical sample from Aboriginals, non-Aboriginals or 
migrants, the inappropriateness of the media originally chosen to isolate the organism in this 
part of the study has been discussed in Section 3.4.1. Thus the uncultured spirochaetes in Chapter 3 - Faecal Culture  
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these populations could represent either B. aalborgi or some other spirochaete which was 
not isolated on the SP medium, or non-viable B. pilosicoli. They were unlikely to represent 
viable B. pilosicoli, as the limit of detection of B. pilosicoli by microscopy at 1 x 10
5 - 1 x 
10
7 organisms/g of faeces was well above the limit of detection for culture of B. pilosicoli at 
1 x 10
2 – 2 x 10
3 cfu/g.  
The four control samples that were observed to contain spirochaetes also may have 
contained non-viable B. aalborgi, or another as yet uncultivable spirochaete. It was unlikely 
that these organisms were B. pilosicoli, as this organism is rarely isolated from Caucasian 
populations (Goossens et al., 1983; Tompkins et al., 1986; Lee & Hampson, 1992). 
Additionally, PCR amplification of biopsies from mainly Caucasian patients in WA has 
demonstrated that B. aalborgi is the principal species involved in IS (Mikosza et al., 1999; 
Mikosza et al., 2001). Conceivably, the best medium for B. aalborgi isolation described in 
this chapter may still not be optimal for isolation of B. aalborgi from faecal specimens, and 
the recently described broth enrichment technique (Calderaro et al., 2003) may be more 
successful. The lower limit of detection of B. aalborgi from seeded faeces on the best 
isolation medium was quite poor at 2 x 10
4 cfu/g of faeces. Prior to attempting further 
modifications to media, it would be necessary to determine the identity of the observed 
spirochaetes. If B. aalborgi were present, it would then be important to ascertain their 
viability in faecal samples by performing studies such as vital staining with microscopy, 
before isolation was attempted again.  
Using PCR to assess the prevalence of B. pilosicoli and B. aalborgi would be one 
way to determine the identity of the spirochaetes in the additional samples. Since 
microscopy was less sensitive detection than culture, it is also possible that other samples 
may have contained B. aalborgi or non-viable B. pilosicoli that were not identified. To 
obtain a more complete understanding of the intestinal spirochaete prevalence in these 
populations, PCR detection of spirochaete DNA in these samples was undertaken in the 
work described in Chapter 4.  Chapter 4 - Faecal PCR 
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4.1 INTRODUCTION 
The intestinal spirochaetes Brachyspira aalborgi and B. pilosicoli have both been 
associated with histologically defined intestinal spirochaetosis in Caucasian patients, with B. 
aalborgi being the more commonly detected organism (Mikosza et al., 1999; Mikosza et al., 
2001). However, prior to the study described in Chapter 3, B. aalborgi has not been detected 
when cultural studies examining intestinal spirochaete carriage in faeces were performed 
(Lee & Hampson, 1992; Trott et al., 1997a), as B. aalborgi is not easy to cultivate. 
Currently, the majority of studies examining B. aalborgi have focussed on its detection from 
intestinal biopsies, with only two other very recent studies examining the carriage of B. 
aalborgi  in faecal specimens (Munshi et al., 2003a; Munshi et al., 2003c). Thus our 
understanding of the distribution and pathogenic status of B. aalborgi is limited. 
Despite the advances made in developing a medium for the isolation of B. aalborgi, 
in work described in the previous chapter, results suggested it may have been sub-optimal 
for B. aalborgi isolation from faecal specimens, as microscopy revealed samples containing 
spirochaetes that were not recovered by culture. To circumvent the problems with the 
spirochaete’s fastidious cultural requirements, a more suitable technique to assess B. 
aalborgi prevalence in human faeces would be the use of PCR. PCR is widely used as a tool 
for detecting bacteria that are difficult to culture, and has been successfully applied to the 
amplification of Brachyspira DNA from paraffin embedded biopsy tissue (Mikosza et al., 
1999; Kraaz et al., 2001), faeces (Munshi et al., 2003a; Munshi et al., 2003c) and 
spirochaete cells. Thus the aims of the work described in this chapter were to:  
1.  Determine a suitable method to extract Brachyspira DNA from faecal specimens. 
2.  Optimise PCR methods to detect B. pilosicoli and B. aalborgi in faeces, and determine 
the detection limits of these methods.  
3.  Describe the epidemiology of B. pilosicoli and  B. aalborgi carriage in Western 
Australians, and determine if carriage of either of these spirochaetes was clinically 
significant.  
4.  Compare culture, PCR and microscopy as methods of detecting Brachyspira in human 
faecal specimens. Chapter 4 - Faecal PCR 
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4.2  MATERIALS AND METHODS 
4.2.1  16S rRNA PCRs  
The 16S rRNA PCRs for amplification of B. aalborgi and B. pilosicoli DNA were 
carried out described in Chapter 2, section 2.4.3.2. PCR products were resolved by agarose 
gel electrophoresis (Section 2.4.1). Target DNA was either whole cells, prepared for 
amplification by the direct, frozen cell pick, boiling or cell pick from agar methods of DNA 
delivery (Section 2.4.2), or was added after extraction of a faecal specimen by one of three 
DNA spin column extraction methods.  
 
4.2.2  DNA spin column extraction methods 
All three kit methods were carried out according to the manufacturers’ instructions, 
using solutions provided, as described below. Resultant DNA solutions were stored at 4°C. 
 
4.2.2.1  JETQuick tissue DNA spin kit extraction method 
Faeces samples of 50mg were diluted 1:10 w/v with 500 µl TE, vortexed briefly to 
mix and centrifuged at low speed for 5 s. If the sample was frozen seeded faeces, tubes were 
thawed and the initial dilution step was eliminated. The supernatant (SN) was removed, 
centrifuged for 5 min and the pellet resuspended in 100 µl TE. This was boiled for 5 min and 
100 µl T2 buffer was added. The sample was incubated at 70°C for 10 min, cooled to RT for 
1 min and 100 µl 100% ethanol was added and immediately mixed to avoid DNA 
precipitation. The sample was then applied to the membrane of a JETQuick spin column. 
The column was centrifuged at 11900 x g in an Eppendorf 5417C centrifuge (Eppendorf, 
Hamburg, Germany) for 1 min and the filtrate tube discarded. Subsequent centrifugations for 
the JetQuick method were under these conditions unless otherwise stated. A 500 µl volume 
of T3 Buffer was added and the centrifugation repeated. Residual T3 was removed by a 2 
min centrifugation. The column was placed in a sterile 1.5 ml tube and 75 µl elution water at 
70°C was added to the column. After centrifugation at 20800 x g, the elution was repeated 
and the eluate stored.  
 
4.2.2.2  Roche High Pure Viral RNA extraction kit 
The Roche RNA extraction method (suitable for DNA extraction) was carried out as 
follows. Approximately 100 mg of faeces was mixed in 5 ml DepC and then centrifuged at 
1780 x g. A 200 µl volume of the SN was added to a 1.5 ml tube containing 400 µl of lysis 
buffer. This was vortexed to mix and incubated at RT for 10 min. The sample was applied to 
a Roche filter column and centrifuged at 20800 x g in the Eppendorf centrifuge for 3 min. Chapter 4 - Faecal PCR 
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The filtrate was discarded, 450 µl of wash buffer was added to the column and the 
centrifugation repeated. The wash procedure was repeated, however the final centrifugation 
was for 5 min. The column was then placed in a sterile 1.5 ml tube, 100 µl of DepC was 
applied to the membrane and the column incubated for 5 min at 80°C. The samples was then 
centrifuged for 1 min and the DNA containing filtrate stored until required.  
 
4.2.2.3  QIAmp DNA Stool Mini Kit DNA extraction method 
Between 180 - 220 mg of frozen stool sample was weighed into a 2 ml centrifuge 
tube and placed on ice. A volume of 1.4 ml of buffer ASL was added and the sample 
vortexed for 1 min until homogenised. The suspension was heated for 5 min at 70°C, 
vortexed for 15 s and centrifuged at full speed for 1 min to pellet stool particles. An 
Inhibitex tablet was added to 1.2 ml SN in a 5ml tube and vortexed immediately until the 
tablet was completely suspended. The samples were incubated for 1 min at RT and then 
centrifuged in a Econospin Sorvall Instrument centrifuge (Dupont Corporation, Wilmington, 
DE, USA) for 10 min at 1600 x g to pellet bound inhibitors. The entire SN was transferred to 
a new 1.5 ml tube, centrifuged for 3 min at full speed and 200 µl of the new SN was added 
to a 1.5 ml tube containing 15 µl proteinase K. Two hundred µl of buffer AL was added, the 
sample vortexed, and incubated at 70°C for 10 min. A 200 µl volume of 100% ethanol was 
added and vortexed. The entire lysate was applied to a QIAmp DNA stool column. The 
following centrifugation steps were carried out in the Eppendorf 5417C centrifuge at 20800 
x g for 1 min unless otherwise stated. The sample was centrifuged and the filtrate tube 
discarded. Buffer AW1 (500 µl) was added, the column centrifuged, and the filtrate 
discarded. Buffer AW2 (500 µl) was added, centrifuged for 3 min and the filtrate discarded. 
Centrifugation for a further 1 min removed residual buffer, the column was transferred to 
new 1.5 ml tube and 200 µl buffer AE added onto the membrane. After 1 min incubation at 
RT, the column was centrifuged to elute the DNA. Half the sample was stored at -20°C for 
sequencing.  
 
4.2.3  Optimisation of molecular methods  
4.2.3.1 Reaction  parameters 
Parameters which were assessed for optimisation of 16S rRNA PCRs included 
MgCl2 and Tth plus enzyme concentration, the addition of 3% DMSO, and annealing 
temperature for B. aalborgi only. Variations were made to the standard 16S rRNA PCR 
protocol by reducing or increasing the volume of sterile UHPW in the reaction mixtures. 
Reaction mixtures stored at –20°C for one month were compared with freshly made 
mixtures. The use of a two - phase reaction was tested, in which the enzyme, template DNA Chapter 4 - Faecal PCR 
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and half the volume of UHPW in the upper phase was separated by 20 µl of Chillout wax 
from the remaining reaction components in the bottom phase. All optimisation procedures 
were carried out in at least duplicate PCRs. 
 
4.2.3.2  Methods of DNA delivery, DNA extraction and limits of PCR detection 
The four methods of whole cell delivery were compared by adding to PCR tubes  
2.5 µl of 1 x 10
8 cells in TE directly, 2.5 µl of 1 x 10
8 cells prepared by the boiling method, 
or cells picked from agar or frozen stocks, as described for the cell pick methods (Chapter 2, 
Section 2.4.2). The three kit methods of DNA extraction were compared by testing the limits 
of detection of each extraction method either with faeces seeded with B. pilosicoli strains 
P43/6/78
T or WesB, or B. aalborgi strain 513A
T. Seeded faeces samples were prepared in a 
similar way to faeces seeded for other tests examining limits of detection, as described in 
Chapter 3, sections 3.2.1.2 and 3.2.1.3. Slight departures included preparing cell suspensions 
at 10
8 – 10
1 spirochaetes/ml in DepC or TE, and adding 200 µl suspension to 200 mg faeces, 
or 1ml suspension to 100 mg faeces. These seeded samples were used fresh or stored at -
80 C until extraction was performed. The effect of storage on DNA in seeded samples was 
tested by comparing the limits of detection of freshly prepared samples with samples stored 
at -80°C for over 3 months. Limits of detection of PCRs also were assessed on their own, 
using freshly prepared whole cell suspensions at 10
8 – 10
1 spirochaetes/ml in TE, of which 
2.5 µl was added directly to reactions. Procedures were performed in duplicate. 
 
4.2.4  Design and optimisation of nested primers 
4.2.4.1 Primer  design 
A search of Genbank was made for the DNA sequences of the 16S rRNA and nox 
genes of B. pilosicoli and B. aalborgi, by comparing these to published primer sequences for 
these genes (Mikosza et al., 1999; Mikosza et al., 2001). The program Oligo 5.0 was used to 
create high stringency primer pairs located inside each existing 16S rRNA gene and nox 
gene primer pair for the sequences of B. pilosicoli WesB and B. aalborgi 513A
T. Potential 
primer pairs were subjected to a BLAST search with the National Centre for Biotechnology 
information server at the National Library of Medicine (Bethesda, MD, USA) to eliminate 
primers which were homologous with 16S rRNA and nox gene sequences of Brachyspira 
spp. which were not the target of the particular primer pair. A clustal alignment was obtained 
for each primer against published sequences using the Clustal-X program. The number of 
potential primers was reduced further by eliminating those pairs which were dissimilar to 
published B. aalborgi and B. pilosicoli sequences at the 3' end. Five pairs of nested and Chapter 4 - Faecal PCR 
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semi-nested primers were chosen for further study. These were diluted and stored as 
described in Chapter 2, Section 2.4.3.1. 
 
4.2.4.2  Optimisation of nested primer pairs 
To optimise primer pairs, reaction tubes with and without DMSO and glycerol, and 
containing 2.0 µM MgCl2, were prepared using the reaction mixture and cycling conditions 
listed below. Cycling was carried out as a first round reaction. Initially, the annealing 
temperature was the optimum temperature recommended by the Oligo 5.0 program. After 
the temperature was optimised, and requirement for DMSO/glycerol ascertained, MgCl2 
concentration was varied between 0.5 - 3 µM and the concentration with best amplification 
chosen. Template DNA was cells of B. pilosicoli WesB or B. aalborgi 513A
T (depending on 
the primer pair) in TE at concentrations of 1 x 10
8 - 1 x 10
5 spirochaetes/ml. DepC was the 
negative control for each reaction mix.  
  10x  Tth  Plus  buffer    2.5  µl 
  d N T P s       2 . 5   µl 
  M g C l 2 (25 mM)       0.5 - 3 µl 
  Tth  Plus  (5.5  U/µl)    0.1  µl 
 Primer  forward  (10  ρmol/µl)   0.5 µl 
 reverse  (10  ρmol/µl)   0.5 µl 
  DMSO  &  glycerol    0  µl or 1.25 µl 
Template  DNA     2.5  µl 
  S t e r i l e   U H P W        t o   2 5 . 0   µl 
 
Initial denaturation     94°C    4 min 30 s 
Denaturation    94°C   30  s 
  Annealing   primer  dependent  30  s 
  Extension    72°C   30  s 
        3 0   c y c l e s  
The sequence of and final conditions chosen for each potential primer pair is 
presented in Table 4.1. Using these conditions, all primers were tested with frozen cell 
preparations of B. pilosicoli strains P43/6/78
T, WesB, Oman 26, HRM 2B and “S. jonesii”, 
B. aalborgi strains 513A
T and W1, and the type strains of B. hyodysenteriae B78
T,  B. 
innocens B256
T and B. intermedia PWS/A2
T. Primer pairs were then tested as the second 
round in the nested or semi-nested reactions. The first round reaction of the 16S rRNA gene 
PCRs is described in Chapter 2, Section 2.4.3.1 and the first round reaction of the B. 
aalborgi and B. pilosicoli Nox gene PCRs was carried out as per Mikosza et al. (1999). Chapter 4 - Faecal PCR 
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Briefly, the reaction mixes were as for the 16S rRNA gene PCRs, with the primers F Ba nox 
and R Ba nox for B. aalborgi, and F Sp nox and R Sp nox for B. pilosicoli. The cycling 
conditions were as follows. 
Initial denaturation     94°C    4 min 30 s 
Denaturation    94°C   30  s 
  Annealing   46°C  B. aalborgi or   30 s 
     4 5 ° C   B. pilosicoli  
  Extension    72°C   30  s 
        3 0   c y c l e s  
 
4.2.5  PCR detection of intestinal spirochaetes in faeces 
4.2.5.1 Stool  specimens 
Clinical stool samples (n=550) and control specimens (n=60) were those previously 
selected for isolation of intestinal spirochaetes in the work described in the previous chapter 
(Section 3.2.2). An additional 30 samples from healthy individuals living in Perth, Western 
Australia were available for PCR detection of Brachyspira spp.. Culture was not performed, 
as they had been stored at -20°C prior to testing. These samples were collected and 
previously examined by a colleague (Munshi, 2001). 
 
4.2.5.2  DNA extraction and PCR 
The DNA from 80 clinical samples was extracted using the JETQuick DNA 
extraction method. Following inconsistent results, the QIAmp DNA extraction method was 
performed on 542 clinical and 90 control specimens. Seventy-three clinical samples were 
extracted using both methods and these results were compared directly. Extracted template 
DNA was added to B. pilosicoli 16S rRNA and B. aalborgi 16S rRNA gene PCRs in 
duplicate for each sample. Where different results were obtained between duplicates, these 
were repeated, and if negative, were repeated again.  
 
4.2.5.3 Statistical  analysis 
Statistical analysis by univariate was performed separately for each population and 
Brachyspira  spp., and where applicable, for the detection of both organisms together. 
Logistic regression analysis (Section 2.3.7) was then performed, again separately for each 
population group and positive Brachyspira spp.. Reasons for investigation in Aboriginal and 
non-Aboriginal groups were modelled independently of risk factors and the presence of 
other organisms.  
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4.2.6 Sequencing 
Sequencing of the B. pilosicoli and B. aalborgi 16S rRNA gene PCR products was 
performed according to the methods described in Chapter 2, Section 2.5. Sequences of 24 B. 
pilosicoli and 12 B. aalborgi 16S rRNA gene PCR products were generated with forward 
and reverse primers. Samples for sequencing were selected from all positive population 
groups. Sequences were compared with the sequences of the 16S rRNA genes of B. 
pilosicoli strains P43/6/78
T (Accession number U23032), WesB (U23034) and B. aalborgi 
strains 513A
T (Accession Z22781) and W1 (AF200693), using BioManager with the ANGIS 
Server (Sydney, NSW, Australia). 
 
4.3 RESULTS 
4.3.1  Optimisation of molecular methods 
4.3.1.1  Optimisation of 16S rRNA gene PCRs 
The 16S rRNA gene PCRs for B. aalborgi and B. pilosicoli were optimised. The 
production of bands of 472 bp and 439 bp, respectively, was reproducible and occurred at 
the lowest template concentration with 1.5 mM MgCl2. Annealing temperature was assessed 
for the B. aalborgi 16S rRNA PCR only, where a product was obtained more consistently at 
48°C than at 46°C. The inclusion of 3% DMSO in a reaction mixture and the use of a two-
phase reaction only minimally improved reproducibility and sensitivity, and only when 
primers were of poorer quality. A single phase reaction without DMSO was utilised to test 
clinical samples.  
The reproducibility and sensitivity of band production was not affected by the 
storage of reaction mixtures at –20°C for over one month, prior to the addition of template 
DNA. No amplification of B. aalborgi strains 513A
T or W1 in the B. pilosicoli 16S rRNA 
gene PCR nor amplification of B. pilosicoli strains P43/6/78
T or WesB in the B. aalborgi 
16S rRNA gene PCR was observed. 
Methods of DNA delivery to the reactions were compared. The direct, frozen cell 
pick and boiling methods allowed reproducible amplification of target DNA and were 
comparable and satisfactory methods of delivery. The cell pick from agar method was less 
reproducible for delivery of DNA to reactions. The frozen cell pick and direct methods were 
utilised throughout this study; the cell pick from agar method was used occasionally, if the 
other methods were impractical.  
 
4.3.1.2  Methods of DNA extraction from faeces 
The JETQuick and Roche kit methods of DNA extraction from faeces were 
compared directly. At best, the JETQuick method allowed detection after extraction of 1 ml Chapter 4 - Faecal PCR 
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of 1 x 10
5 B. pilosicoli P43/6/78
T and WesB per 100 mg of faeces, and the Roche method 
allowed detection of 1 ml of 1 x 10
6 of these organisms per 100 mg of faeces (Figure 4.1). 
These corresponded to DNA from 3.3 x 10
3 B. pilosicoli per reaction tube and DNA from 1 
x 10
3 B. pilosicoli per reaction tube, respectively, if it was assumed there was no loss of 
DNA during extraction. The JETQuick method was chosen for extraction of clinical faecal 
samples, however a number of false negative results (see 4.3.1.3) led to attempts to develop 
nested primers (4.2.4) and, ultimately, the use of the QIAmp kit DNA extraction method.  
Using the QIAmp method, 200 µl of 1 x 10
6 B. pilosicoli P43/6/78
T per 200 mg of 
faeces (Figure 4.2) and 200 µl of 1 x 10
5 B. aalborgi 513A
T per 200 mg of faeces were 
detected after amplification by the appropriate 16S rRNA gene PCRs. This corresponded to 
DNA from 4.2 x 10
2 and 4.2 x 10
1 organisms per reaction tube, respectively, if no DNA loss 
during extraction was assumed. Storage of duplicate seeded faecal preparations at –80°C for 
over 3 months followed by DNA extraction did not reduce this level of detection in either 
reaction. The lowest concentration of whole cells in TE which allowed PCR amplification 
was 2.5 – 25 cells per reaction tube for B. pilosicoli (Figure 4.2) and 25 cells per reaction for 
B. aalborgi.  
 
4.3.1.3  JETQuick and QIAmp extraction of DNA from clinical samples 
The DNA from 73 clinical stool samples was extracted using both the JETQuick and 
the QIAmp methods. The results for 65 (89.0%) samples were in agreement by both 
methods using B. aalborgi and B. pilosicoli 16S rRNA gene PCRs. Of the remaining eight 
samples, three (4.1%) were PCR negative after JETQuick extraction but PCR positive by the 
QIAmp method and by culture. One sample (1.4%) was positive by PCR after JETQuick 
extraction, but negative after extraction by the QIAmp method, and the remaining four 
samples (5.5%) were positive in one of two tubes on one occasion only. Three of these 
samples were extracted and added to the PCR adjacent to a tube which was positive in both 
duplicates. As all subsequent tests were negative, these results were regarded as false 
positives.  
Analysis of the 632 samples subjected to QIAmp extraction revealed 16 (2.5%) 
samples which were positive in only one of two tubes on one occasion. Six (0.9%) of these 
were extracted and added to the PCR adjacent to a subsequently positive tube, and in two 
samples, amplification occurred in the B. aalborgi PCR in samples which were subsequently 
positive for B. pilosicoli only. The remaining eight samples shared neither of these 
characteristics. The numbers of false positive results obtained after JetQuick and QIAmp 
methods were not significantly different (P = 0.13). Chapter 4 - Faecal PCR 
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The DNA extracted by the QIAmp method from 110 samples was added to the B. 
pilosicoli and B. aalborgi 16S rRNA gene PCRs on two occasions, regardless of the result of 
the first PCR. The results for 106 samples were unchanged after the repeat PCR, with 99 
negative samples and seven samples positive for either Brachyspira spp. in both instances. 
The results of four samples (3.6%) were changed after the second assessment, thus multiple 
further repeats were required to confirm one sample positive and three (false positive) 
samples negative for B. pilosicoli.  
 
4.3.1.4  Design and optimisation of nested primers 
Five pairs of PCR primers for use in nested reactions were designed, the annealing 
temperatures and MgCl2 concentrations optimised and the requirement for DMSO and 
glycerol determined for each (Table 4.1). A forward primer with potential for use in the B. 
pilosicoli 16S rRNA gene PCR was not identified, so a single reverse primer was paired 
with primer A coli 1 (Park et al., 1995) in a semi-nested reaction for this gene. One primer 
pair each was designed for use in the B. aalborgi 16S rRNA and B. pilosicoli nox gene 
reactions, and two forward primers were paired with the same reverse primer for the B. 
aalborgi nox gene reaction (‘A’ and ‘B’ reactions). Other potential primer pairs designed 
using Oligo 5.0 were excluded prior to manufacture as the Clustal alignment demonstrated 
that they were not specific for the target B. aalborgi or  B. pilosicoli and would have 
amplified other Brachyspira spp.  
The production of bands of the correct size for the B. pilosicoli nox gene primers 
and the B. aalborgi nox gene A primers was sporadic, despite reaction optimisation. Bands 
corresponding to the expected sizes for the remaining primer pairs were produced when 
tested under optimum conditions. However, none was specific for amplification of the 
Brachyspira species for which they were designed. The type strains of B. hyodysenteriae and 
B. intermedia produced bands of the expected size (384 bp) in the semi-nested B. pilosicoli 
16S rRNA gene reaction. B. aalborgi nox gene B primers amplified B. innocens,  B. 
intermedia and B. pilosicoli strains. The B. aalborgi 16S rRNA gene primer pair amplified 
B. aalborgi only when tested as a single stage reaction. However, when a nested reaction 
was performed with the B. aalborgi 16S rRNA gene first round primers, strains of B. 
pilosicoli and B. hyodysenteriae were amplified. Attempts to increase the specificity of the 
reactions by increasing annealing temperature and MgCl2 concentration were not successful.  
 
4.3.2 Detection  of  B. pilosicoli in faecal specimens 
The DNA from stool samples (n=610) analysed by culture in Chapter 3 was 
extracted by the QIAmp method, and subjected to amplification using B. pilosicoli and B. Chapter 4 - Faecal PCR 
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aalborgi 16S rRNA gene PCRs. An additional 30 samples from control individuals were 
analysed also. Eight samples from Aboriginal Australians were not tested, as described 
below. In this section, the detection of B. pilosicoli is described. Comparisons between 
samples in which B. pilosicoli was detected by both culture and PCR (PCR positive - culture 
positive), or by PCR alone (PCR positive - culture negative) are made. The following 
section describes the detection of B. aalborgi, and both Brachyspira spp. together. Data from 
univariate analyses of epidemiological data are first presented, and are followed in each 
section by logistic regression models.  
Samples from a total of 571 patients were analysed by both B. pilosicoli PCR (this 
chapter) and culture (Chapter 3). Of samples from 38 culture positive individuals, which 
were extracted by the QIAmp method, all were positive by PCR for B. pilosicoli. An 
additional 17 samples that were culture negative were B. pilosicoli PCR positive, and 
comprised seven from Aboriginal Australians and 10 from migrants. Thus, the sensitivity of 
PCR for the detection of B. pilosicoli compared to culture of the organism was 100%, with a 
specificity of 96.8%, while the sensitivity of culture compared to PCR was only 69.1%, 
however the specificity of culture was 100%. 
 
4.3.2.1 Aboriginal  Australians 
One hundred and sixty seven samples from 145 Aboriginal Australians were 
amplified by PCR after QIAmp extraction. Of the eight other samples which were analysed 
by culture in Chapter 3, seven were extracted by the JetQuick method only, of which five 
were entirely negative by all methods, one was B. pilosicoli PCR positive but culture 
negative, and one was B. pilosicoli PCR and culture positive. The final sample was not 
available for extraction by either method. These eight samples were not included in the 
epidemiological analyses. 
Multiple samples (2 - 4) were obtained from 17 patients. Brachyspira spp. were not 
detected by PCR in any sample from 13 of these patients, while B. pilosicoli alone was 
cultured from and detected by PCR in one sample from the four remaining patients. In one 
of these four patients, a second sample collected on the same day was PCR positive but 
culture negative and, for another patient, a second sample collected 3 months after the first 
was both PCR and culture positive (strains WHP06 and WHP12). Collection of more than 
one sample did not increase the probability of detecting B. pilosicoli in these 17 patients (P = 
0.21), and the first sample only from these two individuals were included in the analysis. 
B. pilosicoli was detected in 14.5% (21/145) of Aboriginal patients after QIAmp 
extraction. Detection occurred in all 16 culture positive samples from the 15 patients 
described in Chapter 3, although DNA from one sample was extracted by the JetQuick 
method only. An additional eight samples from eight other patients were positive by PCR Chapter 4 - Faecal PCR 
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alone, and again one of these was extracted only by the JetQuick method. A second sample 
from a previously culture positive patient was PCR positive only.  
A comparison of sample characteristics and risk factors between the 14 QIAmp-
extracted PCR positive - culture positive samples, and the seven QIAmp-extracted PCR 
positive - culture negative samples is shown in Table 4.2. There was no significant 
difference in days elapsed between faecal sample collection and culture, in the proportion of 
B. aalborgi detected in B. pilosicoli culture negative samples, or in the presence of any other 
organism. All PCR positive - culture negative samples were collected in 1999 (P = 0.0068), 
and were from patients aged <2 years or ≥5 years old (P = 0.025). Spirochaetes were not 
detected by microscopy in any PCR positive - culture negative sample (P = 0.0010). A 
higher proportion of individuals with wet stools (57.1%) were PCR positive - culture 
negative, although this was not a significant difference (P = 0.064).  
The detection of additional B. pilosicoli by PCR did not alter the significance of 
many risk factors when compared with detection by culture. The only new risk factor for the 
detection of B. pilosicoli was the detection of B. aalborgi, which was significantly more 
common in individuals in whom B. pilosicoli was detected (P <0.001). The detection of G. 
intestinalis, H. nana or protozoa generally was no longer significantly associated with B. 
pilosicoli carriage. While the P values of the remaining risk factors, other organisms or 
reasons for investigation were altered, the significance of each remained unchanged. All 
these data are presented in Appendix A5.1.  
B. pilosicoli was detected by PCR in a further four patients who were hospitalised, 
in addition to the four hospitalised patients in whom the organism was cultured (Section 
3.3.1.1). The proportion of hospitalised patients in whom B. pilosicoli was detected was not 
significantly different from those without B. pilosicoli (P = 0.87). These additional patients 
included two children under 2 years, and a 7 year old, all with gastrointestinal symptoms, 
and an adult with chronic renal failure, eosinophilia and chest pain. A non-spirochaetal 
pathogen was detected only in the sample from the 7 year old.  
Two logistic regression models were created for these data, with factors remaining 
in the model at the P = 0.1 level. In the model of risk factors and organisms associated with 
B. pilosicoli detection (Table 4.3), the odds of being male was 0.38 (95% CI 0.1 – 1.9; P = 
0.096). The odds of B. pilosicoli detection was 11.7 times greater if B. aalborgi was also 
detected, and 10.0 times greater if B. hominis was detected. The logistic regression model 
created for reasons for investigation in this population is presented in Table 4.4; here the 
odds of B. pilosicoli colonisation was 10.9 times greater if “worms?” had been given as a 
reason for investigation, and 5.5 greater if any of chronic diarrhoea, FTT, or being 
underweight were the reasons for the inquiry.  
 Chapter 4 - Faecal PCR 
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4.3.2.2  Migrants to Western Australia 
B. pilosicoli was detected by PCR in 15.0% (34/227) of samples from migrants to 
Western Australia. B. pilosicoli was detected by PCR in all 24 samples where B. pilosicoli 
was cultured, and in samples from an additional 10 individuals where PCR was positive, but 
isolation by culture was not achieved. A comparison of sample characteristics and risk 
factors between PCR positive - culture positive samples and PCR positive - culture negative 
samples is shown in Table 4.5. There was no significant difference in days between sample 
collection and culture, month of isolation, sample consistency, age or gender of the 
individuals. Proportions of PCR positive - culture negative samples were significantly higher 
in Europeans than in non-Europeans (P = 0.031), and three of these five samples were 
obtained from European individuals in a single family. Proportions of B. aalborgi detected 
in B. pilosicoli PCR positive - culture negative samples (60%) were higher than in culture 
positive samples (25%), although this was not significant (P = 0.06). No other organism was 
found in a significantly higher proportion in either group. 
As with the Aboriginal population, the significance of few risk factors was altered 
by the PCR detection of additional B. pilosicoli in 10 migrants. The detection of B. pilosicoli 
was significantly higher for individuals in whom B. aalborgi had been detected (P <0.001), 
and was no longer significantly associated at P = 0.05 with detection of any parasite or 
protozoan. Again, while the specific P values of the remaining risk factors and other 
organisms were changed, the significances were unaltered, and these data are presented in 
Appendix A5.2.  
The same variables remained in the logistic regression model as when B. pilosicoli 
was isolated by culture in Section 3.3.2.2. The final logistic regression model is presented in 
Table 4.6. B. pilosicoli was 3.4 times more likely to be detected in individuals who were not 
of European origin. The odds of B. pilosicoli colonisation was 6.5 times higher when I. 
bütschlii was detected, and 21.0 times higher if B. aalborgi was detected.  
As with detection of B. pilosicoli by culture, some PCR positive migrant individuals 
came from the same family group. Ten families had one positive individual (three more than 
were positive by culture), while 13 individuals (six more than were positive by culture) came 
from five families with multiple positive individuals. B. pilosicoli was detected by PCR in 
two individuals each from three families where three, four and five members were tested, 
and in three and four individuals from two families where six members were tested. An 
individual identified as belonging within a family group was not significantly more likely to 
have another family member colonised (P = 0.25). Again, the mean family size for positive 
individuals (4.3 people) was not significantly different from the mean family size for 
families with negative individuals (3.9 people; P = 0.34). Neither the number of individuals Chapter 4 - Faecal PCR 
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who were tested within a family, nor the proportion of family members who were tested 
affected the number of family members in whom B. pilosicoli was isolated.  
 
4.3.3 Detection  of  B. aalborgi in faecal specimens 
4.3.3.1 Control  individuals 
Only B. aalborgi was detected in the control population. Five of the 60 samples that 
had been cultured were positive for B. aalborgi, and no sample from the additional 30 
volunteers was positive, giving an overall prevalence of 5.6%. The faecal sample from the 
culture positive individual was among the five from positive individuals. The five positive 
individuals were Caucasian and had not taken antibiotics in the previous month, and there 
was no significant difference in risk factors for the detection of B. aalborgi in samples from 
positive and negative individuals. As no P value was ≤0.25, the data were not modelled by 
logistic regression. Therefore, the P values for risk factors for B. aalborgi detection in 
control individuals are presented in Appendix A6.1. 
In addition to the 60 samples that had been cultured from 60 control individuals, 
repeat samples were collected from two positive individuals. Samples were acquired from 
volunteer C40 in March, April, May, August and September on the same date of each 
month.  B. aalborgi was detected in all five samples over the 6 month period but the 
organism was not isolated on any occasion. This individual reported abdominal pain in the 
month prior to the first sample, but denied symptoms in subsequent months. Included in the 
original 60 samples were samples collected from three siblings in the same family. Two 
were PCR positive for B. aalborgi but culture negative, and spirochaetes were identified in 
the third by microscopy only. A second sample from one of these children (C46) was 
collected 7 months after the initial sampling, and this too was PCR positive - culture 
negative. All three volunteers denied abdominal symptoms. 
 
4.3.3.2  Rural non-Aboriginal Australians 
In the rural non-Aboriginal patients, only B. aalborgi was detected, and this was at a 
prevalence of 5.6% (8/142 patients). The risk factors and reasons for investigation associated 
with detection of B. aalborgi which were significant at P ≤0.25 after univariate analysis are 
presented in Table 4.7, while factors with P values >0.25 can be found in Appendix A6.2. 
No stable logistic regression models could be produced for this population using the listed 
variables. 
The mean age of positive individuals was 47.6 years (SD ± 21.3 years), which was 
not significantly different from the mean age of negative individuals. All eight positive 
patients were aged ≥18 years (P = 0.039) and four of these patients were aged ≥60 years Chapter 4 - Faecal PCR 
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(Figure 4.3). Although positive patients were not significantly more likely to be ≥60 years 
than negative individuals (P = 0.069), they were significantly more likely to be aged 
between 60 - 69 years than <60 or ≥70 years (P = 0.0026).  
The predominance of males (75%) in the positive patients was not significant (P = 
0.055), neither was the predominance (75%) of stools of normal consistency compared with 
negative samples (P = 0.07). The proportion of patients from the South West region of 
Western Australia (see Figure 3.3) was significantly higher in the positive samples than 
those which were negative (P = 0.013). Another organism, G. intestinalis, was detected in 
only one sample, and no organism was significantly associated with detection of B. aalborgi 
in these samples. All eight patients were suffering from diarrhoea, and this finding was 
significantly more frequent in samples from which B. aalborgi was detected than in samples 
which were negative (P = 0.048). 
 
4.3.3.3 Aboriginal  Australians 
B. aalborgi was detected in 6.9% (10/145) of Aboriginal Australians, and both 
spirochaetes were detected in 4.1% (6/145) of individuals. An analysis of risk factors, other 
organisms and reasons for investigation associated with B. aalborgi detection (P ≤0.25) is 
presented in Table 4.8, and in Table 4.9 for both B. aalborgi and B. pilosicoli together. The 
remaining factors are presented in Appendices A6.3 and A6.4, respectively. The mean age of 
positive individuals was 28.0 years (SD = 33.2 years), which was not significantly different 
from the mean age of negative individuals (14.1 years, SD = 21.3 years; P = 0.20). The age 
distribution of PCR detection of Brachyspira spp. is presented in Figure 4.4. B. aalborgi was 
detected in significantly higher proportions of patients age ≥2 years old (P = 0.013), but 
there was no significant difference in carriage in patients ≥60 years compared to those <60 
years. Carriage of both spirochaetes was only significantly higher in the ≥60 year age group 
(P = 0.045). Colonisation of B. aalborgi or both spirochaetes together was not affected by 
patient gender, geographic location, rainfall distribution, or stool consistency. 
Detection of B. pilosicoli (P <0.001), H. nana (P = 0.0031), any non-spirochaetal 
organism (P = 0.02), any parasite (P = 0.004) or protozoa (P = 0.048) was significantly 
higher in individuals in whom B. aalborgi was detected. The detection of any non-
spirochaetal organism (P = 0.019), parasite (P = 0.0055), protozoan (P = 0.024) or uncertain 
pathogen (P = 0.036) was significantly higher where both spirochaetes were detected. 
Specifically, detection of T. trichuria (P = 0.041), B. hominis (P = 0.021), or E. nana (P = 
0.0041) was significantly higher in these patients.  
The presence of B. aalborgi or both spirochaetes was significantly less likely to 
occur if diarrhoea was a reason for investigation (P = 0.016 and P = 0.044, respectively). Chapter 4 - Faecal PCR 
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Conversely, the detection of B. aalborgi or both spirochaetes was significantly more likely 
when eosinophilia (P <0.001 and P = 0.0083), eosinophilia, being underweight or 
experiencing weight loss (P <0.001 and P <0.001) or eosinophilia, being underweight, 
having weight loss or possible worms (P <0.001 and P <0.001) were the reasons for 
investigation. In addition, B. aalborgi was more likely to be detected in individuals in whom 
worms alone were suspected (P = 0.038).  
Four patients in whom B. aalborgi was detected were hospitalised, and included two 
of the patients in whom B. pilosicoli was detected but not cultured; a child under 2 years 
with gastrointestinal symptoms and an adult with chronic renal failure, eosinophilia and 
chest pain. B. aalborgi only was detected in the other two hospitalised patients, a child of 5 
years with eosinophilia and possible worms in whom H. nana was detected, and an adult in 
whom giardia was suspected, but in whom no other organism was detected.  
As with analysis of B. pilosicoli, two logistic regression models were created for B. 
aalborgi carriage in this population, with risk factors and organisms associated with 
detection remaining in the model presented in Table 4.10, and remaining reasons for 
investigation in Table 4.11. The odds of B. aalborgi detection were 6.6 times greater if the 
patient was >2 years (P = 0075), and 5.4 times greater if a parasite was detected. A number 
of reasons for investigation remained within the model, including eosinophilia (OR = 10.2), 
suspected Giardia (OR = 8.8), chronic diarrhoea, FTT or being underweight (OR = 4.9), and 
eosinophilia, weight loss, being underweight and possible worms (OR = 19.1). A stable 
model could not be generated for the detection of both organisms in this population.  
 
4.3.3.4  Migrants to Western Australia 
B. aalborgi was detected in 7.9% (18/227) of samples from migrants to Western 
Australia, and both spirochaetes were detected in 5.3% (12/227) of samples from these 
individuals. The risk factors that were significant for the colonisation of these spirochaetes at 
P ≤0.25 after univariate analysis are presented in Table 4.12, while those with a P value 
>0.25 are to be found in Appendices A6.5 and A6.6.  
Unlike carriage of B. pilosicoli, carriage of B. aalborgi or both Brachyspira spp. was 
not associated with geographical origin. The mean age of colonised individuals (24.8 years; 
SD = 14.2 years) was not significantly different from those in whom no B. aalborgi was 
detected (P = 0.13). In no particular age group were significantly higher numbers of B. 
aalborgi or both organisms detected (Figure 4.5). The only organisms that were significantly 
associated with carriage of B. aalborgi were B. pilosicoli (P <0.001) and any protozoan (P = 
0.014), while no other organism was significantly associated with the detection of both 
Brachyspira spp. together. No logistic regression model could be generated for the detection 
of B. aalborgi or both organisms in this population.  Chapter 4 - Faecal PCR 
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B. aalborgi was detected in samples from individuals belonging to seven family 
groups. Five families had one positive individual, two positive individuals came from a 
family of four and five positive individuals came from a family of six. Furthermore, both 
Brachyspira spp. were detected in samples from individuals from the latter two families; in 
two from the family of four, and in four of the five individuals from the family of six. In 
addition, both species were detected in two of the five families containing single positive 
individuals. 
For detection of B. aalborgi, family size affected the number of positive individuals. 
The mean size of a positive family (6.3, SD = 2.1 people) was significantly greater than the 
mean family size for negative individuals (3.7, SD = 1.5 people; P <0.001). Moreover, the 
number of individuals tested within a family was significantly associated with detection of 
B. aalborgi (P <0.001), with the mean number of individuals tested from positive families 
being 5 (SD = 1.2) and of negative families being 3 (SD = 1.3). In addition, if a family 
member was positive, it was significantly more likely that other family members would be 
colonised (P = 0.008). Family size did not affect the number of positive individuals when 
both spirochaetes were detected (P = 0.271), and while the number of individuals tested 
within the family was significantly associated with detection (P = 0.009), another family 
member was not more likely to be colonised if a colonised individual was already present in 
a family (P = 0.08). The proportion of family members who were tested did not affect the 
number of family members in whom B. aalborgi or both spirochaetes was detected.  
 
4.3.4 Microscopy 
Phase contrast microscopy of faecal samples was carried out (Chapter 3, Section 
3.5), and samples from a total of 547 patients were analysed by both PCR and microscopy. 
One or other of the two Brachyspira spp. were detected by PCR in 75 patients, and 
spirochaetes were observed by microscopy in 40 patients, however only samples from 32 
patients were positive by both techniques. Spirochaetes were observed in a total of eight 
samples which could not be detected or identified by either culture or PCR. PCR products 
were obtained in seven of the 15 samples that were culture negative but contained 
spirochaetes microscopically. In five samples, B. aalborgi alone was detected, and in the 
other two samples both B. aalborgi and B. pilosicoli were detected.  
The sensitivity of microscopy compared to PCR for detection of either Brachyspira 
spp. was only 42.6%, and the specificity of the technique was 98.3%. The use of microscopy 
as a technique to detect any B. pilosicoli was good, with samples from 27 patients being 
positive by both techniques, giving a sensitivity of 50.9% and a specificity of 97.1%. In 
contrast, microscopy was much poorer as a method of detecting B. aalborgi alone than B. Chapter 4 - Faecal PCR 
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pilosicoli alone. Spirochaetes were observed in only 5 of 21 patients who were positive for 
B. aalborgi alone, giving a sensitivity of 23.8% and a specificity 93.1%. Spirochaetes were 
observed in samples from 21 of 28 (75%) patients positive for B. pilosicoli alone, and here 
sensitivity was 75% and specificity was 96.3%. Nevertheless, if either spirochaete, or any B. 
pilosicoli, or B. pilosicoli alone, or B. aalborgi alone was detected in a sample by PCR, it 
was significantly more likely to contained spirochaetes that were observable by microscopy 
(P <0.001, P <0.001, P <0.001, P = 0.017, respectively). 
 
4.3.5 Sequencing 
Sequencing of the B. pilosicoli and B. aalborgi 16S rRNA gene PCR products was 
performed to confirm the identity of the products. Only around one third of the total number 
of amplified products were sequenced, but samples from which both intestinal spirochaetes 
were detected were included, and all four population groups were represented. The 
sequences generated using forward primers from both 16S rRNA gene PCRs were of better 
quality than those generated with the reverse primers, and thus the former were analysed 
only.  
Sequences of 24 B. pilosicoli PCR products from migrants and Aboriginal 
Australians were compared to the sequences of the 16S rRNA genes of B. pilosicoli 
P43/6/78
T (Accession number U23032) and WesB (U23034) (Appendix A7.1). A region of 
254 bp was sequenced for all PCR products, and a region of 386 bp was generated for the 
majority of products. The main sequence pattern generated was 100% homologous to the 
sequence of B. pilosicoli P43/6/78
T in the region equivalent to 243 bp to 652 bp of E. coli. 
Departures from this sequence occurred in sequence A47, with the replacement of cytosine 
by thymine at base 248 equivalent, in sequences M61 and M62 at base 307 equivalent where 
cytosine was replaced by thymine, and in sequence A160, where a cytosine was inserted 
between bases 326 and 327 equivalent.  
B. aalborgi sequences from 12 B. aalborgi PCR products from migrants, 
Aboriginals and non-Aboriginal individuals were compared with those of B. aalborgi 513A
T 
(Accession Z22781) and W1 (AF200693). Additionally, all PCR products obtained from 
control group individuals were analysed (Appendix A7.2). A region of 344 bp was 
sequenced for all products, with a region of 423 bp assessed for most PCR products. The 
sequence obtained from the majority of PCR products was 100% homologous to B. aalborgi 
513A
T, and in the region equivalent to 215 bp to 629 bp of E. coli. Departures from this 
pattern existed in sequences NA96, M197 and C07, where guanine was replaced by thymine 
at base 416 equivalent, and in NA96 and C07 where thymine was replaced by cytosine at 
base 436. These same changes were noted in the isolates obtained from sample C07 in Chapter 4 - Faecal PCR 
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Chapter 3. Other changes to sequence NA96 occurred at bases 585 and 587 where thymine 
were replaced by guanine and cytosine, respectively, and a replacement of cytosine for 
thymine at base 214, a change also seen in sequence C03. An insertion of thymine occurred 
between 530 and 531 in sequence NA131. Sequences of PCR products obtained from 
volunteer C40 in March, April, May, August and September were all identical in this region, 
as were the two samples from control individual C46. 
The B. aalborgi sequences were compared to differentiating nucleotide positions 
identified in the phylogenetic analysis performed by Pettersson et al. (2000). The B. 
aalborgi type strain and the strains from this study with identical sequences corresponded to 
cluster 1 identified by these researchers. The changes to sequence NA96 at bases 416, 436, 
585 and 587 suggested it was a cluster 3 strain, while strains C07 and M197 also 
demonstrated changes in common with this cluster. Additionally, the cytosine replacement at 
base 214 in NA96 and C03 was consistent with them being cluster 2 and 3 strains (Dr 
Andrew Mikosza, Murdoch University, pers. comm.). 
 
4.4 DISCUSSION 
The purpose of the work described in this chapter was to determine the optimal 
method for detecting Brachyspira spp. DNA in faeces by PCR, and then use this technique 
to ascertain the faecal prevalence of Brachyspira  spp. in four Western Australian 
populations. It was considered that using a molecular method would give a more accurate 
estimate of prevalence than culture; the difficulties associated with cultivating B. aalborgi 
have already been discussed, and microscopy of samples indicated the presence of 
uncultivated spirochaetes in samples from 2.7% of patients. PCR could also be used to 
ascertain the accuracy of B. pilosicoli prevalence assessed by culture. A column method was 
utilised to extract DNA from the faecal samples, which was then amplified by two PCR 
methods using primers targeting the 16S rRNA genes. Successful amplification of both 
Brachyspira spp. was achieved from clinical human faecal specimens. The optimisation of 
the PCR methodologies is first discussed, followed by a comparison of culture, PCR and 
microscopy as methods for detection of the Brachyspira spp.. The prevalence and other 
epidemiological aspects of the two species in the human populations, and results from 
sequencing the PCR products are then discussed.  
 
4.4.1  Optimisation of molecular methods 
The 16S rRNA PCRs and primers utilised for the detection of B. pilosicoli and B. 
aalborgi in this study were developed previously for identification of these two organisms in 
colonic biopsy specimens (Mikosza et al., 1999; Mikosza et al., 2001). PCRs based on the Chapter 4 - Faecal PCR 
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nox gene also were designed at that time, however, this gene has been characterised for 
fewer Brachyspira spp. and other unrelated gastrointestinal organisms than the 16S rRNA 
gene. In view of this, and the large number of samples examined in this study, the 16SrRNA 
PCRs alone were judged sufficient for the purposes of detecting Brachyspira spp. in human 
faeces.  
The reaction parameters for the 16S rRNA PCRs had been optimised in our 
laboratory by Mikosza et al. (1999), and the primers screened for cross reactions with other 
Brachyspira spp., including the type strains of B. pilosicoli, B. aalborgi, B. intermedia, B. 
hyodysenteriae and B. innocens, as well as five other B. pilosicoli strains. To amplify frozen 
cells or cells resuspended in TE buffer in the current investigation, little further optimisation 
of reactions was required. The optimal MgCl2 concentration required by both sets of primers 
was confirmed as 1.5mM. In the PCR targeting B. aalborgi, a band of 472 bp was produced 
more consistently when an annealing temperature of 48°C rather than 46°C was used. 
Biphasic reactions using wax, and 3% DMSO were initially employed as reported (Mikosza 
et al., 1999). When higher quality primers were used, neither wax nor 3% DMSO improved 
the quality, brightness or consistency of band production, thus for simplicity, single phase 
reactions without DMSO were utilised.  
As the investigation required the analysis of large numbers of samples, storage of 
PCR mixes and faecal samples was necessary. Therefore, tests to determine the effect of 
storage conditions was carried out. The levels of detection of Brachyspira spp. cells in TE 
were the same, whether the PCR mixtures were freshly made or stored at -20°C for one 
month. In addition, storage of seeded faeces at -80°C for over 3 months did not affect the 
level of spirochaete detection.  
Previously, an extensive comparison between methods for B. hyodysenteriae DNA 
extraction from seeded pig faeces and field samples from infected animals was carried out 
by a colleague (Atyeo, 1998). The methods evaluated included a phenol chloroform 
extraction, a CTAB method, immunomagnetic separation, a boiling preparation utilising the 
Instagene matrix (Biorad Laboratories), a protocol using polyvinylpolypyrrolidone (PVPP) 
and glass milk purification, a diatomaceous earth (DEX) method, and a DEX method after 
selective culture of the faecal samples. Two kit methods, the QIAmp blood and tissue kit 
(Qiagen Pty Ltd, Australia), and the Nucleon DNA extraction kit (Scotlab Biosciences, 
USA) were also trialled, but did not have the lowest levels of detection. The most sensitive 
methods for DNA extraction were the PVPP and the DEX protocols, with a limit of 
detection of 1 x 10
6 B. hyodysenteriae/g seeded faeces, and the DEX method plus culture 
(CRDEX), at 1 x 10
3 - 1 x 10
4 organisms/g. The Nucleon kit (Elder et al., 1994) and a 
CTAB method (Leser et al., 1997) were also utilised by other researchers working on B. 
hyodysenteriae.  Chapter 4 - Faecal PCR 
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None of the best methods advocated by Atyeo (Atyeo, 1998) were attempted in the 
work described in this thesis, for the following reasons. As discussed in Chapter 3, B. 
aalborgi is difficult to cultivate, so an extraction method relying on the cultivation step in 
the CRDEX protocol was unlikely to give a good representation of the species in faeces. In 
addition, the limit of detection of the other methods was considered to be higher than ideal. 
At the time the selection of extraction methods was made, numerous spin column methods 
were being developed for DNA extraction from tissue, and later faeces. Column methods are 
rapid compared to other methods, often taking less than 3 h for the extraction of several 
samples without the need for complex manipulations, and do not require the use of toxic or 
hazardous reagents (Montiero et al., 1997). Protocols specifically for faecal samples offer 
the advantages of removing PCR inhibitors present in stools, including polysaccharides, bile 
salts and haemoglobin degradation products (McOrist et al., 2002). These benefits suggested 
that a column method could be successfully developed for extraction of Brachyspira spp. 
DNA.  
Initially, the Genomed JetQuick tissue spin column kit was evaluated against a 
Roche column kit, which is designed primarily for extraction of viral DNA from serum and 
plasma. By direct comparison, the limit of detection after the JetQuick extraction (1 x 10
6 
organisms/g) appeared consistently lower than the Roche kit (1 x 10
7 organisms/g), so for 
this and also reasons of lower cost, the JetQuick method was chosen for analysis of clinical 
samples.  
Nevertheless, when extraction of DNA from clinical faecal samples was performed 
using JetQuick columns, PCRs undertaken on three B. pilosicoli culture positive samples 
were negative (false negatives). It was supposed that the numbers of spirochaetes in the 
samples in question were lower than the limit of detection of this DNA extraction, so a 
nested PCR approach was attempted to increase sensitivity. Unfortunately, none of the 16S 
rRNA or nox gene primers created were species specific, due to the highly conserved nature 
of these genes in Brachyspira spp. (Stanton et al., 1996; Atyeo et al., 1999b). While some of 
the species tested were not human intestinal spirochaetes, the range of B. pilosicoli and B. 
aalborgi strains tested was too small to be certain that non-specific amplification might not 
occur with other human spirochaete species. 
Alternatively, the false negative samples may still have contained inhibitors which 
had not been removed by the JetQuick extraction procedure. Other concerns about the kit 
existed over the poor stability of reagents and the poor quality of columns, which had a 
capacity to collapse at high centrifugation speeds (Dr Andrew Mikosza, Murdoch 
University, pers. comm.). In addition, the columns did not have lids, which was perceived to 
be responsible for the 5.5% of false positives. As a result of these issues, and the failure to 
develop nested PCRs for the Brachyspira spp., the Qiagen QIAmp DNA Stool Mini Kit Chapter 4 - Faecal PCR 
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DNA extraction method was then tested for use in this investigation. Previously, in a 
comparison of five column methods for DNA extraction from faecal samples, the QIAmp 
stool kit was the only technique which was suitable for a single round PCR (McOrist et al., 
2002).  
The QIAmp stool kit was utilised for DNA extraction from the clinical and control 
samples. Levels of detection from seeded faeces were as low as 40 - 400 organisms per 
reaction tube, which was only 1.7 - 17 times that of the detection limit of cells alone in the 
PCR reactions. However, this level corresponded only to 1 x 10
5 - 1 x 10
6 organism/g faeces, 
due to dilution steps within the protocol. It may have been the dilution steps, and the use of 
the “Inhibitex” tablet from the kit, which were responsible for removing inhibitors and 
allowing the amplification of DNA from all B. pilosicoli culture positive samples. In 
addition, only one possible false negative was found when compared to the 73 samples also 
extracted by the JetQuick method.  
It is possible, however, that other undetected false negatives may have occurred, as 
these were not measured in the study. Faecal samples are notoriously difficult to extract 
DNA from, due to the dense microbial flora, and variable stool consistency and composition 
(McOrist et al., 2002). In particular, polysaccharides of dietary origin are believed to 
interfere with enzyme activity (Montiero et al., 1997; McOrist et al., 2002). Some 
researchers have included an internal control molecule, or mimic, to demonstrate when 
inhibition occurred (Englund et al., 1999). The creation of plasmid constructs, similar to 
those described by Englund et al., (1999), to be amplified by the B. aalborgi and B. 
pilosicoli 16S rRNA primers, was outside the scope of this investigation. Thus, it is possible 
that some faecal samples that were negative by PCR still contained B. pilosicoli or B. 
aalborgi. 
False positives after extraction with the QIAmp kit also were reduced compared to 
extraction with the JetQuick column, although this was not a significant difference. This 
again may have been due to presence of a lid on the QIAmp column reducing cross 
contamination. Only 0.9% of the 632 samples extracted with the QIAmp kit were regarded 
as explainable false positives, in that a positive tube occurred in one duplicate on one 
occasion, and this was adjacent to a tube from a true positive sample. Nonetheless, there 
were 10 other tubes which were positive once that were not adjacent to a positive tube. 
These samples may have represented true positives at the lower limit of the extraction and 
detection procedures, or false positives. All precautions to reduce false positives were made, 
by the preparation of PCR mixes, inoculation and electrophoresis in separate, designated 
rooms and the addition of duplicate tubes for each sample in each reaction set. The repetition 
of each entire reaction was unnecessary.  
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4.4.2  A comparison of methods for the detection of spirochaetes in 
faeces 
Culture, PCR and phase contrast microscopy were the three methods used to detect 
intestinal spirochaetes in human faeces. Of these, microscopy was the least specific method, 
since the identity of the organisms could not be conclusively determined by this technique, 
as has been observed throughout the spirochaete literature. B. pilosicoli was the main species 
observed by microscopy, with spirochaetes observed in 75% of samples in which B. 
pilosicoli alone was detected by PCR, compared to only 23.8% of samples which contained 
B. aalborgi alone. This may have been due to the greater width of B. pilosicoli, which is 
0.25 – 0.3µm (Trott et al., 1996c), compared to only 0.2 µm for B. aalborgi (Hovind-
Hougen et al., 1982), possibly making B. pilosicoli easier to observe among other faecal 
organisms. Alternatively, as fewer isolates of B. aalborgi were available for comparison, a 
greater familiarity with the microscopic appearance of B. pilosicoli may have led to this 
result. 
As a method of detecting Brachyspira spp., microscopy also had poor sensitivity. 
The limit of detection of both species from seeded faeces was inconsistent and high, with 
between 1 x 10
7 - 1 x 10
5 organisms/g of faeces visible in this way. For detection of B. 
pilosicoli, microscopy had a sensitivity of 68.4% compared to culture and 50.9% compared 
to PCR, while the sensitivity for both spirochaetes was 42.6%. Nevertheless, if spirochaetes 
were observed in a sample, detection of a Brachyspira spp. was significantly more likely to 
be confirmed by another method than if spirochaetes were not observed. The technique was 
the least time consuming approach, taking only minutes to determine the presence of 
spirochaetes, and thus was useful as an initial screen and a confirmatory diagnostic tool.  
As described in Chapter 3, culture was a very useful technique for assessing the 
prevalence of B. pilosicoli in the samples from patients, although it was less sensitive than 
PCR. When tested on seeded faeces, culture was the most sensitive method of detecting B. 
pilosicoli, with isolation possible from faeces containing 1 x 10
2 – 2 x 10
3 cfu/g. On the 
other hand, more individual infected people were identified when PCR was used. Isolation 
of  B. pilosicoli was more laborious and time consuming than microscopy, due to 
requirements for specialised media, a greater than 5 d incubation period, and the necessity of 
using an anaerobic atmosphere. One advantage of obtaining B. pilosicoli isolates was that 
characterisation studies could be subsequently performed.  
Furthermore, results from the work presented in this chapter indicated that culture 
was not useful to survey B. aalborgi prevalence, as this organism was detected at around 6% 
by PCR in all four populations, and yet only one isolate was obtained. The lowest 
concentration of B. aalborgi cells isolated from seeded faeces was 2 x 10
4 cfu/g, which was Chapter 4 - Faecal PCR 
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a poorer level of detection than for B. pilosicoli. Culture of B. aalborgi was considerably 
more laborious than culture of B. pilosicoli, as has been discussed in detail in the previous 
chapter.  
PCR gave a more rapid result, but was also more labour intensive than culture. 
While the lower limit of detection of spirochaetes by PCR was 1 x 10
6 organism/g seeded 
faeces for B. pilosicoli and 1 x 10
5 organism/g for B. aalborgi, PCR was the most successful 
method of detecting spirochaetes in faeces. For B. aalborgi, this was clearly for reasons 
relating to the difficulties with culture. Further evidence for the increased sensitivity of PCR 
came from analysis of the initial microscopy results, with B. aalborgi being detected in 
seven of the 15 microscopy positive samples where culture of a spirochaete was not 
achieved.  
On the other hand, a possible explanation for increased detection of B. pilosicoli 
positive samples by PCR was that the B. pilosicoli in the PCR positive - culture negative 
samples had died due to contact with oxygen or antibiotics, or were non-viable for some 
other reason, but the DNA was amplified by PCR. Again, this idea was supported by the 
greater proportion of spirochaetes which were detected by microscopy in culture positive 
samples. This was probably because it was easier to see spirochaetes by microscopy when 
organisms were motile and thus viable. This difference was significant in Aboriginals and 
close to significance in migrants (P = 0.06). However, the time between sample collection 
and culture was not critical in terms of successful isolation, as has previously been reported 
by Lee and Hampson (1992). Another explanation for greater B. pilosicoli detection by PCR 
may have been due to spirochaete distribution in samples. If spirochaetes were unevenly 
distributed, they may have been detected only in the sample prepared for PCR. 
Alternatively, all the seeding tests were performed on faecal samples from one individual, 
which may have influenced the results of the limit of detection assays. PCR detection in 
samples with hypothetically less inhibitors may have been more sensitive, and accounted for 
greater detection by PCR. No studies on inhibition, viability or distribution of spirochaetes 
throughout the faecal samples were performed, but these might be important for future 
studies. 
Spirochaetes were detected by microscopy in samples from eight individuals (three 
migrants, three Aboriginals and one control) that were not identified by either PCR or 
culture. These spirochaetes could represent another spirochaete species, a subset of B. 
aalborgi which were not amplified by the 16S rRNA primers, or an operator error in 
microscopy. It is possible that the spirochaetes in these samples were unevenly distributed, 
and that the portion chosen for PCR had an organism concentration below the limit of 
detection. Alternatively, the samples may have contained inhibitors which prevented proper 
functioning of the polymerase enzyme. One approach to identify these spirochaetes might be Chapter 4 - Faecal PCR 
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to identify whether inhibitors were present, then amplify the DNA with more general 
primers, and then sequence the products. Unfortunately, further investigation of these 
alternatives was outside the scope of this thesis. 
In the work described in this thesis, PCR and sequencing were used as methods of 
confirming the identity of Brachyspira spp. isolates, in place of the more traditional 
biochemical means. This technique was chosen for reasons of ease, and because of some 
limitations which currently exists with using biochemistry to identify Brachyspira spp.. 
Variation in some biochemical characteristics has been reported for human isolates of B. 
pilosicoli (Jones et al., 1986; Tompkins et al., 1986; Lee et al., 1993c; De Smet et al., 1998), 
and  B. aalborgi has been inadequately characterised, due to the scarcity of isolates. 
Sequencing was also used to confirm the specificity of the PCR reactions in around one third 
of positive samples, and will be discussed further in Section 4.4.4. 
None of the current techniques utilised in clinical medical microbiology laboratories 
specifically target detection of Brachyspira spp.. This is for reasons of cost effectiveness, 
but mainly due to the continued doubt over the clinical significance of these organisms. In 
addition, while culture, PCR and phase contrast microscopy are all techniques used in 
clinical microbiology, standard methodologies are inadequate for detecting the spirochaetes. 
If a patient was suffering from long-standing gastrointestinal symptoms without another 
apparent cause, any of the procedures described in this thesis, but particularly PCR, would 
be useful in ascertaining whether a Brachyspira spp. was present. A protocol which might 
improve B. aalborgi isolation in future investigations would be to use faecal PCR first to 
determine positive samples without B. pilosicoli, and then attempt isolation from these 
samples. 
 
4.4.3 Detection  of  Brachyspira spp. in faecal specimens 
4.4.3.1  B. aalborgi  
B. aalborgi was found in almost equal proportions in all four population groups 
examined in this investigation; in 7.9% of migrants, 6.9% of Aboriginal Australians, 5.6% of 
rural non-Aboriginal Australians, and 5.6% of healthy, mainly Caucasian control 
individuals. In addition, carriage in migrants was not affected by country of origin, with 
approximately equal proportions in African, Middle Eastern and European individuals. This 
is a new finding, since before this study, B. aalborgi had been specifically identified by PCR 
only in ill non-Aboriginal (Caucasian) individuals with HIS (Mikosza et al., 1999; Kraaz et 
al., 2000; Heine et al., 2001; Jensen et al., 2001; Mikosza et al., 2001), but in none of the 
other groups. B. aalborgi also has been detected in the faeces of native populations in Bali, 
Indonesia (22.2%) (Munshi et al., 2003a) and India (6%) (Munshi et al., 2003c), two groups Chapter 4 - Faecal PCR 
   110
which were not represented in the migrants tested in this study. These data suggest that B. 
aalborgi may be distributed at a similar prevalence in many human populations throughout 
the world.  
The distribution of B. aalborgi appeared to be quite different from that of B. 
pilosicoli, which was found only in Aboriginal and migrant individuals, even after PCR 
detection. Kraaz et al. (2000) suggested that national and geographical differences existed in 
the prevalence of the Brachyspira spp. involved in HIS. This observation was supported by 
the faecal carriage of Brachyspira spp. determined in this study.  
There was a lack of consistency between the populations in the risk factors which 
were associated with detection of B. aalborgi. For the age association of B. aalborgi 
carriage, all colonised non-Aboriginal individuals were over 18 years, and more likely to be 
between 60 and 70 years. However, two out of five children in the control population were 
colonised, and Aboriginal children over 2 years, as well as adults, were more likely to be 
colonised. In addition, migrants were not significantly more likely to be colonised at any 
particular age. This finding was also observed in the epidemiological study of B. aalborgi 
carriage in India (Munshi et al., 2003c).  
Amongst colonised individuals, the predominant gender was also different between 
different populations. The sexual orientation of most subjects was not known, so the 
proportion of homosexual males in each population could not be estimated. HIS has been 
detected in a high proportion of homosexual males (Law et al., 1994; Trivett-Moore et al., 
1998) and presumably some of the spirochaetes involved were B. aalborgi. The male gender 
bias in HIS reported by Lindboe et al. (1993; Lindboe, 2001) was observed in B. aalborgi 
carriage in the non-Aboriginal rural population, where six of eight individuals were male. 
This predominance was not significant, which could relate to the small number of positive 
individuals in this population. Some of these males colonised by B. aalborgi, and males in 
other populations, may have been homosexual. However, other positive individuals were 
women, known heterosexual males (in the control population) and children, so carriage of B. 
aalborgi was clearly not specifically related to being a homosexual male in this study. In 
fact, there was a female predominance in B. aalborgi carriage in the Aboriginal population, 
and although not significant at the P  = 0.05 level, this factor remained in the logistic 
regression model, with a P value of 0.096. The reason for this observation is unknown.  
The detection of other organisms in the samples containing B. aalborgi was likewise 
inconsistent between the population groups, which probably reflected different exposures to 
various microorganisms. B. aalborgi carriage in both Aboriginal and migrant groups was 
significantly associated with detection of B. pilosicoli. No other organism was associated 
with B. aalborgi detection in non-Aboriginals, again possibly due to the small sample size. 
In migrants, the presence of any protozoan but not any parasite was associated with Chapter 4 - Faecal PCR 
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detection of B. aalborgi. In Aboriginal Australians, parasites, pathogens, any organism, and 
in particular H. nana, were associated with B. aalborgi carriage, with parasites remaining 
within the logistic regression model. In the Aboriginals, however, these organism categories 
were also significantly associated with detection of B. pilosicoli, and with the detection of 
both organisms together. As a result, the impact of B. aalborgi alone on parasite detection 
was difficult to assess. Carriage of B. aalborgi in Aboriginals may relate to reasons for 
carriage of B. pilosicoli, postulated in Chapter 3, Section 3.4.2, such as the age related 
acquisition of intestinal parasites. Unfortunately, numbers of samples from Aboriginals 
where only B. aalborgi was detected were too few to analyse any difference in risk factors 
for those individuals.  
The reasons for similar prevalence rates, yet different risk factors for B. aalborgi 
carriage in each population group are currently unknown, but may relate to unmeasured 
factors which were common to each population, such as specific behaviours, hygienic 
practice or immune status. Studies on B. aalborgi have been so few that the results in this 
investigation represent preliminary data. The presence of B. pilosicoli, age, gender, and 
ownership of pets (assessed only in the control population) were risk factors for B. aalborgi 
carriage in common between this study and the one performed in India (Munshi et al., 
2003c). In that study, detection of B. aalborgi was associated with treatment of drinking 
water, detection of B. pilosicoli and the detection of B. aalborgi in another family member. 
In migrants in the current investigation, B. aalborgi carriage was also more likely if another 
family member was colonised. In addition, the chance of a family member being colonised 
was dependent on the size of the family group, with a larger family more likely to contain 
positive individuals. These data suggest that transmission of B. aalborgi can occur between 
family members. 
While numbers of control individuals were small, two children in whom B. aalborgi 
was detected came from the same family. In one of these children, strains of B. aalborgi 
were detected at two time points in 7 months. Another control individual was colonised by 
strains over a period of 6 months. It was uncertain whether the detection represented 
continuous colonisation over these times, or repeated transient infections. As both 
individuals were healthy, and B. aalborgi was present in all of the samples examined, 
continuous colonisation seemed more likely. A typing technique would be useful to confirm 
this idea. Sequencing of the 16S rRNA gene PCR products was carried out for three 
individuals from one migrant family, and for the control individuals at each time point. All 
these sequences were identical in this region, however, as will be discussed in section 4.4.4, 
the method may not have been sensitive enough to ascertain whether strains were different.  
The pathogenic significance of B. aalborgi could not be resolved in this 
investigation. Firstly, B. aalborgi was detected in similar proportions in samples from ill and Chapter 4 - Faecal PCR 
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healthy individuals. Detection was not associated with the presence of gastrointestinal 
symptoms in control individuals, nor with loose or wet stool consistency in any population 
group. In addition, detection of B. aalborgi was significantly associated with different 
reasons for investigation in the two ill population groups. Detection of B. aalborgi was 
associated with diarrhoea in non-Aboriginals (P = 0.048), but amongst Aboriginals was 
significantly associated with an absence of diarrhoea (P = 0.016). The organism was 
significantly associated with a number of other reasons for investigation in Aboriginals, 
including eosinophilia, weight loss, being underweight and suspected worms (OR = 19.1; P 
= 0.0019). Whether B. aalborgi was a cause of these symptoms, or was excreted as a result 
of the symptoms caused by some other source, was unknown.  
The role of B. aalborgi in the human gastrointestinal tract could be that of a 
commensal, as first suggested by Henrik-Nielsen and colleagues (1983). This idea is 
supported by its similar prevalence in all population groups. However, in rural Aboriginal 
and non-Aboriginals in this investigation, B. aalborgi was found in individuals with 
gastrointestinal symptoms without detection of other organisms. A similar situation has been 
reported in other investigations (Guccion et al., 1995; Mikosza et al., 1999; Heine et al., 
2001). B. aalborgi may have the capacity to cause disease under certain circumstances, such 
as in individuals with poor immune status, or in a conducive gut microenvironment. This 
might be reflected in the extent of the colonisation in different individuals, and in this study 
this possibility was not examined. The use of quantitative “Real time” PCR could be used to 
address this issue, but extent of intestinal colonisation may not be proportional to shedding 
into faeces. An alternative explanation is that the virulence of B. aalborgi may differ 
between strains, and disease may occur in some individuals and not others. Studies on the 
virulence of B. aalborgi after culture or sequencing of the organism would be useful to 
examine these possibilities further.  
 
4.4.3.2  B. pilosicoli  
Greater numbers of individuals colonised by B. pilosicoli were detected by PCR 
than by culture in both the migrant and Aboriginal Australian populations. As with the 
results of culture, the prevalence deduced by PCR in these two very different population 
groups was approximately equal, and the organism remained undetected in non-Aboriginal 
and control populations. Reasons for greater detection by PCR were investigated, and have 
been discussed in Section 4.42.  
Detection of B. pilosicoli by PCR did very little to change the identification of risk 
factors which were significant in either migrant or Aboriginal Australian populations. Aside 
from detection of B. aalborgi, no risk factor was newly significant after these analyses, 
which again indicated that culture was an appropriate method for investigation of B. Chapter 4 - Faecal PCR 
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pilosicoli epidemiology. The carriage of a few parasite species ceased to be significant for B. 
pilosicoli carriage, which may relate to changes in samples size. Four more patients were in 
hospital at the time of sampling, and B. pilosicoli may have been responsible for 
gastrointestinal symptoms in two infants in whom no other pathogen was detected. As the 
carriage of B. pilosicoli in both populations was examined extensively in Chapter 3, it will 
not be discussed here further.  
It was difficult to ascertain the significance of detecting both Brachyspira  spp. 
together in Aboriginals and migrant populations. Carriage of B. aalborgi and B. pilosicoli 
together has been significantly greater in all three studies examining faecal carriage of these 
organisms (Munshi et al., 2003a; Munshi et al., 2003c), however the biological significance 
of this occurrence remains uncertain. There did not seem to be any factors which 
significantly related to detection of both spirochaetes together, rather those factors which 
were significant appeared to be related to carriage of either B. aalborgi or B. pilosicoli. A 
wider range of other organisms was significant for detection of both Brachyspira spp. in 
Aboriginals, which probably related to the small sample size. If larger numbers of both 
species were found in this population, many of these significances may have disappeared, as 
was noted for PCR detection of B. pilosicoli compared with culture. In migrants, significant 
risk factors were few. Ideally, a larger study where a comparison of individuals with B. 
pilosicoli alone, B. aalborgi alone and both organisms together may have identified risk 
factors specific for carriage of both Brachyspira together. 
 
4.4.4  Sequence analysis of 16S rRNA PCR products  
Sequencing was carried out on the products of the B. aalborgi and B. pilosicoli 16S 
rRNA PCRs, in order to confirm that the correct spirochaete species were amplified by the 
primers used in these reactions. This technique has been used recently by researchers of HIS 
for a similar purpose (Mikosza et al., 1999; Kraaz et al., 2000). Representative PCR 
products were tested from each population group, and from samples in which one or both 
spirochaetes were detected. In all instances, the correct Brachyspira spp. was identified by 
the original PCR.  
A very limited typing comparison of strains was also possible using this data. 
Sequences within a given species were identical for the most part. For B. pilosicoli, only 
four PCR products differed at one nucleotide from the type strain sequence. Interestingly, 
one of these, A47, was from the Aboriginal child from whom two isolates were obtained 
three months apart. The other isolate from this child possessed the main sequence. Another 
different sequence was from an Aboriginal individual with two PCR positive samples which 
were collected at the same time. These results may indicate the presence of more than one B. Chapter 4 - Faecal PCR 
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pilosicoli strain in these patients. The two other PCR products that were dissimilar from the 
main sequence type were amplified from two migrants within the same family, with the third 
positive individual in this family having the main type. As B. pilosicoli isolates were 
obtained from most of these samples, the use of a more traditional typing method would 
allow a useful comparison of these strains.  
Similar amounts of variation were present among B. aalborgi sequences. All except 
five strains were of a type identical to the cultured strains 513A
T and W1, which 
corresponded to cluster 1 described by Pettersson et al. (2000). Analysis of further variation 
within this cluster was not possible. Based on the phylogeny identified by Pettersson and 
colleagues, one of the five strains had nucleotide changes which placed it in cluster 3, two 
other strains shared some similarities with cluster 3 strains, including the cultured isolate 
C07, while another strain had a nucleotide change which could have placed it in cluster 2 or 
3. Unfortunately, as the amount of sequence obtained was small, and in a region of high 
homology within a gene of high homology, the sequencing analysis of B. aalborgi was only 
of limited epidemiological value. In addition, it is uncertain whether the cultured B. aalborgi 
strain represents the first cluster 3 strain to be isolated. More complete sequencing of this 
gene, or the use of another sequence-based typing method, such as multi-locus sequence 
typing, would be useful to further investigate this possibility, and more generally to 
investigate the epidemiology of B. aalborgi carriage in human populations.  
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C CH HA AP PT TE ER R   5 5: :   E EV VA AL LU UA AT TI IO ON N   O OF F   B BL LO OO OD D   C CU UL LT TU UR RE E   S SY YS ST TE EM MS S   F FO OR R   
T TH HE E   G GR RO OW WT TH H   A AN ND D   D DE ET TE EC CT TI IO ON N   O OF F   B B. .   P PI IL LO OS SI IC CO OL LI I   
5.1 INTRODUCTION 
Recently, B. pilosicoli was isolated from the blood of seriously ill individuals in 
France (Fournié-Amazouz et al., 1995), the USA (Trott et al., 1997b) and Greece (Kanavaki 
et al., 2002). The isolation of a spirochaete, which was probably B. pilosicoli, was described 
in an earlier French report of a similarly ill man (Lambert & Goursot, 1982). 
Spirochaetaemia associated with B. pilosicoli has not been reported in Australia, despite the 
existence of groups of individuals known to have a high rate of carriage and who have other 
debilitating conditions which might predispose to bacterial translocation across the intestinal 
wall. These groups include Aboriginal Australians (Lee & Hampson, 1992; Chapter 3), 
migrants from developing countries (Chapter 3), homosexual male patients and patients with 
HIV infection (Trivett-Moore et al., 1998).  
In the French and US cases, primary isolation of the organisms was achieved in 
blood culture systems that are either not available or rarely used in Australia. Automated 
blood culture systems with pre-set endpoints are routinely utilised in most large hospital 
diagnostic laboratories in Australia, and it was hypothesised that these systems may fail to 
detect spirochaetaemia caused by B. pilosicoli. No study has examined whether these 
systems are capable of detecting B. pilosicoli, however, it is unlikely that currently used 
cultural conditions are favourable for isolation of the spirochaete, as B. pilosicoli are slow to 
grow, and isolation from faeces can take at least 5 d (Tompkins et al., 1981). Therefore, 
concerns existed that B. pilosicoli spirochaetaemias were currently going undiagnosed in 
Australia. The specific objectives of the work described in this chapter were to: 
1.  Identify which commercially available blood culture media allowed the growth of B. 
pilosicoli. 
2.  Determine which blood culture systems permitted detection of B. pilosicoli in blood.  
3.  Attempt the isolation of B. pilosicoli from clinical blood culture specimens from a 
cohort of at risk individuals.  
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5.2  MATERIALS AND METHODS 
5.2.1  Blood culture media 
Blood culture media were purchased from the proprietors or their local distributors. 
Media included the BACTEC
 Plus Anaerobic/F culture vials, FOS culture supplement 
and BBL Septi-Chek TSB, BHI (brain heart infusion) and thioglycollate broth vials 
(Becton Dickinson, North Ryde, NSW, Australia), BacT/Alert
 Anaerobic and FAN 
Anaerobic culture bottles (Organon Teknika Corporation, Durham, NC, USA) and Hémoline 
Performance Diphasique and Performance Anaerobic (bioMérieux Australia Pty. Ltd., 
Baulkham Hills, NSW, Australia). The components of each medium are presented in 
Appendix A8.1. 
 
5.2.2  Evaluation of blood culture systems 
5.2.2.1  Preparation of inocula 
Brachyspira pilosicoli strains from blood (382/91, PE90, 28/94, RA87 and H1), 
human faeces (H121, H171 and WesB) and the type strain P43/6/78
T were incubated in 
Kunkle’s medium until log phase was reached. Further details of these strains are available 
in Appendix A2.1. Cultures were diluted in PBS, adjusted to 1 x 10
5 organisms/ml and 
concentrations of 10
4, 10
3 and 10
2 organisms/ml were prepared by serial 10-fold dilution. 
One ml of each suspension was added to 9 ml of blood to give final concentrations of 1 x 
10
4, 1 x 10
3, 1 x 10
2 and 1 x 10
1 organisms/ml of blood. The tops of the bottles of proprietary 
media were disinfected with an alcohol wipe and these 10 ml volumes were then inoculated 
into the media.  
 
5.2.2.2 Blood 
Blood, consisting of human red blood cells that were immediately past expiry for 
human transfusions, was supplied by the Australian Red Cross (East Perth, WA, Australia). 
Blood was processed by the Red Cross, where plasma was removed and the cells 
reconstituted with 100ml Adsol (Baxter Healthcare Pty. Ltd., Old Toongabbie, NSW, 
Australia), a solution comprising dextrose, sodium chloride, adenine and mannitol.  
 
5.2.2.3  Blood culture systems and media 
A “blood culture system” was defined as the entire proprietary set-up for culture and 
detection of organisms in the blood. For manual systems, this involved media which were 
incubated in a conventional incubator, while for automated systems, media, automated 
instrumentation and computer components were included in this term. Blood culture Chapter 5 - Blood Culture 
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systems, media used, and strains examined in each system and media are presented in Table 
5.1.  B. pilosicoli strains 382/91, PE90 and H171 were tested in manual and automated 
systems. The other six strains, 28/94, RA87, H1, WesB, H121 and P43/6/78
T were tested 
simultaneously with the first three strains, but only in the BACTEC PLUS Anaerobic/F and 
BacT/Alert FAN Anaerobic culture vials. Additionally, H1 and PE90 were tested again in 
BACTEC PLUS Anaerobic/F, to examine the effects of subculture and transport on B. 
pilosicoli recovery.  
 
5.2.2.4  Incubation and detection of B. pilosicoli growth  
All bottles were incubated for a maximum of 28 d. For manual bottles, culture was 
carried out at 37°C, according to the manufacturers’ protocols. The Hémoline Diphasique 
medium was tilted to flood the agar at 4 h, 24 h and then every 48 h, while the Hémoline 
Anaerobic medium and SeptiChek media were not agitated, although sampling did require 
tipping of bottles. A 0.5 ml sample was taken from all manual media on 2, 5, 7, 10, 14, 18, 
21, 24 and 28 d, using a sterile needle and syringe. The sample was plated to BA and 
incubated anaerobically for up to 14 d. If microbial growth was suspected at these times, due 
to a colour change in the medium or build up of gas, a sample was also examined 
microscopically.  
For automated bottles, incubation, agitation and monitoring was performed by the 
machinery of each automated system. Samples of 0.5 ml were taken at 7, 14, 21 and 28 d 
from any bottle that had not yet signalled, and were incubated as above. Care was taken to 
minimally disturb any gas present in bottles when samples were removed. When a bottle was 
flagged as positive by automated machinery, bottles were removed, and a sample of broth 
was examined microscopically and plated onto BA. Spirochaete numbers were estimated 
using a Helber counting chamber, after centrifugation at 985 x g for 5 min to remove red 
blood cells. 
For automated bottles used to examine subculture effects, bottles were either 
incubated without being subcultured or were sampled as above. To determine transport 
effects, bottles were cultured for 5 d, and a 0.5 ml sample was taken. Bottles were then 
incubated at RT for one or three days and returned to the automated machinery for 21 d, 
after which time a terminal subculture was performed. 
 
5.2.2.5 Endpoint  determination 
The endpoint for manual bottles was defined as the day on which a sample was 
taken which subsequently yielded a growth of spirochaetes on BA. Actual times between 
inoculation and confirmation of a positive result were longer, because of the need for 
prolonged incubation of the plates. For automated bottles, time to positivity was measured Chapter 5 - Blood Culture 
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by automated machinery, and was defined as the time from the commencement of 
incubation to when an automatic signal was detected. In cases where bottles did not signal, 
the endpoint was again the sampling day from which a positive subculture was obtained.  
 
5.2.3 Isolation  of  B. pilosicoli from blood 
5.2.3.1  Selection of blood samples 
Blood samples (n=1063) submitted for routine culture to the PathCentre laboratories 
in Perth, Kalgoorlie, Derby and Port Hedland in Western Australia, and to the Royal Darwin 
Hospital in the Northern Territory between August 1998 and February 2000, were examined 
for B. pilosicoli. The samples were selected from patients with a range of clinical conditions 
which included malignancy (n=108), HIV infection (n=9) and other immune deficiencies 
(n=109) such as neutropoenia, chronic renal failure and patients on immunosuppressive 
medication or treatments. Those with stroke (n=17), alcohol intoxication (n=5), liver disease 
(n=29) and gastrointestinal pain or diarrhoea (n=205), including appendicitis, also were 
included. Patients with fever (n=456) or septic shock (n=125) were also chosen, and a 
proportion of those with one of the above conditions also had fever (256/482; 53.1%) or 
sepsis (44/482; 9.1%) recorded. Patients (n=801) were from urban (n=300) and rural 
Western Australia (n=323), and from near Darwin (n=178) in the Northern Territory of 
Australia. Patients were Aboriginal Australians (n=302; 37.7%), non-Aboriginal individuals 
(n=241; 30.8%), or of unknown ethnic background (n=352; 43.9%). 
 
5.2.3.2  Culture of blood samples 
Blood samples were cultured in the BACTEC 9240 automated blood culture system 
using Anaerobic/F medium. The incubation protocol for samples from urban individuals was 
extended to 14 d if no positive signal was achieved at 3 d. This was accomplished by 
manually overriding the settings on the BACTEC 9240 instrument. Samples were excluded 
if a positive signal was achieved before 5 d. Samples from rural individuals that signalled 
negative after 5 d incubation by the standard procedure were sent from the branch laboratory 
of origin overnight to the Perth laboratory where they were re-incubated in the BACTEC 
9240 for 21 d. Terminal subculture onto BA with 14 d anaerobic incubation was carried out 
after these times, and a wet mount was examined by phase contrast microscopy for the 
presence of spirochaetes. 
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5.3 RESULTS 
5.3.1 Growth  of  B. pilosicoli strains 382/91, PE90 and H171 in all blood 
culture systems  
The minimum time to detection of any concentration of B. pilosicoli strains 382/91, 
PE90 and H171, and the lowest inoculum detected in each blood culture system are 
summarised in Table 5.2. The manual media (Figures 5.1 and 5.2) supported growth of each 
strain, except for the manual BBL Septi-Chek system with Thioglycollate Broth, in which 
H171 was not detected. No strain was detected by signal or subculture in the BacT/Alert 
system with FAN Anaerobic medium (Figure 5.3). All three strains grew in the BacT/Alert 
Anaerobic medium (Figure 5.4), although 382/91 failed to signal and was detected only by 
subculture. The other systems and media supported growth of the spirochaete strains, but at 
various limits of detection and times to detection. 
Strain 382/91 tended to be detected earlier and at lower initial inoculum level than 
the other two strains. For a given strain, overall results were similar for different manual 
systems and media, with detection limits of between 1 x 10
1 and 1 x 10
4 spirochaetes/ml of 
blood in the original inoculum. The endpoint of individual manual bottles was determined 
by subculture, and the plates inoculated from bottles sampled between 2 and 10 d generally 
took another 5 - 8 d to be recorded as positive. In most cases, subculture was more sensitive 
than phase contrast microscopy as a detection method, as spirochaetes were observed earlier 
and at lower concentrations by subculture.  
 
5.3.2 Growth  of  six additional B. pilosicoli in automated systems  
Strains 28/94, RA87, H1, WesB, H121 and P43/6/78
T all grew and signalled in the 
BACTEC system using the PLUS Anaerobic/F medium (Table 5.3). Time to first detection 
by signal in this system for the six strains ranged from 5.7 to 14.9 d. Unexpectedly, strain H1 
took 16.6 d to signal at the highest inoculum, although bottles containing the highest 
inoculum of a given strain generally signalled first. Limits of detection for the six strains 
varied between 1 x 10
1 (strains WesB, H121 and P43/6/78
T) and 1 x 10
3 (strain H1) 
spirochaetes/ml of blood in the original inoculum. Spirochaetes could be seen in wet mount 
preparations at the time of signalling. Positive bottles contained between 4 x 10
7 and 5 x 10
8 
organisms/ml, confirming that the strains had proliferated. B. pilosicoli was subsequently 
detected by subculture from all bottles which signalled positive, in the sample taken 
immediately prior to signalling. Growth from subculture took 2 - 8 d.  
None of the bottles signalled positive in the BacT/Alert system using the FAN 
Anaerobic medium. However, four of the six strains were detected by subculture; P43/6/78
T 
at all concentrations, WesB from 1 x 10
4 and 1 x 10
3, and H121 and RA87 from the 1 x 10
4 Chapter 5 - Blood Culture 
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dilution only. The first detectable growth was observed on the 7 d subculture plate for strains 
WesB, H121 and P43/6/78
T, and 14 d for strain RA87 (Table 5.3). Again growth took 
between 5 and 8 d. Except for faecal strain H121 at the 1 x 10
4 dilution, viable organisms 
were observed by microscopy and recovered by subculture from the vials at successive 
sampling points. A considerable build up of gas was noticed in these vials at 21 and 28 d, 
and this had to be vented before the subculture was taken. The graphs of CO2 production 
over time produced by the BacT/Alert computer for these vials had a positive slope, 
indicating CO2 production in the vials. The bases of the bottles also became yellow (Figure 
5.3), but nevertheless they did not signal.  
 
5.3.3  The effect of subculture and incubation at room temperature on 
recovery of PE90 and H1. 
Weekly subculture and the removal of the culture bottle for 1 d had no effect on time 
to positivity for strain PE90 in the BACTEC machinery (Table 5.4). However, removal of 
the bottle for 3 d increased detection time by 2 d. Strain H1 was more affected by these 
manipulations; the organism was not recovered from bottles with RT incubation. Also the 
organism was detected by subculture only from the bottle which underwent weekly 
subculture.  
 
5.3.4 Isolation  of  B. pilosicoli from clinical blood culture specimens 
Intestinal spirochaetes were neither cultured nor observed by 14 d incubation for 
urban samples, or by 21 d for rural samples in the BACTEC 9240 automated blood culture 
system using Anaerobic/F medium with terminal subculture and microscopy. A signal was 
achieved in 52/1063 (4.9%) bottles, however, wet mount, Gram staining and colonial 
morphologies revealed that none of the organisms recovered were spirochaetes, and the 
identities of these organisms were not investigated further.  
 
5.4 DISCUSSION 
5.4.1  Evaluation of blood culture systems and media 
Culture of blood is the gold standard method for diagnosis of septicaemia 
(Weinstein, 1996). At present, the most time- and cost-effective method of detecting a 
bloodstream infection is to culture the blood in manufactured complex media, which are 
incubated and continuously monitored by automated machinery. The major automated blood 
culture systems in use worldwide are the BACTEC 9000 series (Becton Dickinson 
Diagnostic Instrument Systems, Sparks, Md), BacT/Alert (Organon Teknika Corporation, Chapter 5 - Blood Culture 
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Durham, N.C.), the ESP system (Difco, Detroit, Michigan) and the Vital system 
(bioMérieux, France). Each has been extensively tested for their capacity to detect clinically 
relevant organisms with the least financial cost and time to patient, hospital and laboratory 
(Zwadyk et al., 1994; Smith et al., 1995; Chapin & Lauderdale, 1996; Lelievre et al., 1997).  
The BACTEC and BacT/Alert are the two systems most widely used in Australian 
laboratories, consequently these systems and media were investigated. The ESP system, 
which was used to obtain the isolate from the patient in the USA (Trott et al., 1997b) is not 
available in Australia (Mr David Flood, Becton Dickinson, Australia, pers. comm.). Both 
BACTEC and BacT/Alert are fully automated; the machinery includes self-contained 
agitators, incubators and are non-radiometric, unlike previous systems (Thorpe et al., 1990; 
Nolte et al., 1993). Microbial growth is detected by a change in pH, based on the non-
invasive and continuous monitoring of CO2 (Smith et al., 1995). Differences between the 
systems exist in their proprietary media and analysis software, and in the manner that this 
CO2 is measured. For BacT/Alert, a dark green colourimetric sensor changes to yellow as the 
H
+ ion concentration in the sensor increases in response to increasing CO2. As the sensor 
changes to yellow, reflected red light increases and is transferred to a voltage signal (Thorpe 
et al., 1990). The BACTEC system uses a similar principle, only a fluorescence sensor is 
bonded to the base of the bottle, and the signal is an increase in fluorescence in response to 
increasing H
+ ions (Nolte et al., 1993). Both systems are similar in their capacity to recover 
clinical organisms (Smith et al., 1995; Ziegler et al., 1998).  
Manual systems are decreasing in popularity, as they are more time-consuming and 
labour-intensive than automated systems, and lack the advantage of interfacing with hospital 
computer systems (Weinstein, 1996). Currently available manual systems include the BBL 
Septi-Chek (Becton Dickinson Microbiology Systems, Cockeysville, Md), Hémoline 
(bioMérieux, Marcy l’Etoile, France) and Signal (Oxoid Limited Basingstoke, England). 
These are available in Australia, but are only used by small laboratories or in remote areas 
where automated methods are too expensive or otherwise impractical. Fewer studies have 
been performed for manual systems, due to their more limited use.  
Two manual systems were investigated for their ability to support the growth of B. 
pilosicoli. Hémoline blood culture bottles were evaluated as they had been used to isolate B. 
pilosicoli from some of the French patients. Septi-Chek bottles were tested as these are often 
used to culture blood from Australian Aboriginal patients in remote rural communities.  
Results from the assessment of blood culture systems in this chapter have 
demonstrated that those in common use in Australian diagnostic laboratories are sub-optimal 
for the detection of B. pilosicoli. Studies of both automated and manual systems in clinical 
settings have shown that the majority of organisms encountered in blood require a protocol 
of less than 7 d for detection. The use of a 5 d protocol is regarded as a working compromise Chapter 5 - Blood Culture 
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between maximum detection and cost effectiveness (Hardy et al., 1992; Nolte et al., 1993; 
Wilson et al., 1995; Doern et al., 1996). The 28 d protocol used in the evaluation study was 
chosen so that the slow growing B. pilosicoli would be detected if it grew at all in the media 
of each system. The initial inoculum of 10 ml was chosen at the recommendation of the 
manufacturers. Dilution of a clinical blood sample in media by 1:5 vol/vol is preferred over 
1:10 to enhance organisms recovery (Auckenthaler et al., 1982). It is believed that the 
number of microorganisms in the bloodstream in an adult with a bacteraemic episode is 
between <1-10 cfu/ml (Weinstein, 1996). Thus a low inoculum was used to assess the limit 
of detection, which was as little as 1 x 10
1 spirochaetes/ml of blood in some cases. 
The BACTEC system was superior to other systems tested for the growth and 
detection of seeded B. pilosicoli. However, the time required by the BACTEC for detection 
was not within the 5 d protocol normally adopted by clinical diagnostic laboratories. Time to 
first signal for all nine strains at any concentration varied between 5.6 and 14.9 d (mean 7.5 
d), and while spirochaetes were visible by wet mount microscopy, it was another 2 to 8 d 
before the subculture grew on BA. Anaerobic incubations of this duration are not routinely 
used in clinical diagnostic laboratories. Even in a pilot study where initial inoculum 
concentrations of 1 x 10
8 - 1 x 10
5 spirochaetes/ml of blood were used, detection was 
achieved within 5 d for only 5/40 bottles (Ms Rini Margawani, Murdoch University, pers. 
comm.). 
All strains tested grew in the BACTEC Anaerobic Plus/F medium and were detected 
by the BACTEC machinery, which compared favourably with other systems. Although 
strains 382/91, PE90 and H171 were not inoculated at 1 x 10
1 spirochaetes/ml of blood into 
the medium containing FOS, the limits of and times to detection were similar, regardless of 
this supplement. Besides enhancing the growth of fastidious organisms, FOS is purported to 
have a neutralising effect on SPS, a chemical known to effect growth of some microbes 
(Eng, 1975). SPS is present in media as an anticoagulant, and is also used to counteract the 
bactericidal activity of serum. FOS did not improve growth or detection time, suggesting 
that B. pilosicoli was not susceptible to SPS at the concentration in the media. Thus there 
appeared to be no advantage to supplementing the Anaerobic/F medium with FOS. 
The BacT/Alert system performed poorly for the detection and recovery of B. 
pilosicoli. It is likely that both media and algorithmic components of the system contributed 
to this poor performance. Strains 382/91, PE90 and H171 grew in the Anaerobic medium, 
but not in the FAN Anaerobic medium. The FAN Anaerobic medium contains Ecosorb, a 
proprietary material composed of activated carbon particles and Fuller’s earth (Wilson et al., 
1995). This material was considered likely to be responsible for the lack of growth, as an 
examination of the components of these two media (Appendix A8.1) revealed few other 
differences. The mechanism of action of Ecosorb is unknown, but it is thought to non-Chapter 5 - Blood Culture 
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specifically bind inhibitory factors other than antimicrobials (Wilson et al., 1995). Whilst 
designed to increase organism recovery, Ecosorb may have bound necessary growth 
requirements for B. pilosicoli, such as cholesterol, which is essential for growth of B. 
hyodysenteriae (Stanton & Cornell, 1987), and may also be required by B. pilosicoli.  
The BacT/Alert Anaerobic medium permitted growth of the three B. pilosicoli 
strains tested, although even with this medium, one strain did not signal, and time to 
detection was longer than with the BACTEC system. B. pilosicoli was only recovered from 
bottles inoculated with 1 x 10
3 or 1 x 10
4 spirochaetes/ml of blood, which again suggests that 
the medium was not optimal for B. pilosicoli growth. The other six strains were tested only 
in the FAN Anaerobic medium, where two did not grow, strain H121 grew only briefly on 
subculture, and only the type strain was detected in a bottle inoculated with 1 x 10
1 
spirochaetes/ml of blood. Presumably more of these strains may have grown and been more 
rapidly detected at lower concentrations if the Anaerobic medium had been tested. The most 
recent isolation from a male in Greece was achieved using the BacT/Alert system (Kanavaki 
et al., 2002). However, the media used was not recorded, so unfortunately a direct 
comparison between these results cannot be made. The isolate obtained by Kanavaki et al. 
(2002) signalled after 4.3 d. Based on the results in this investigation, it was likely that the 
concentration of the organism in the blood of the patient was high. 
Detection algorithms also contributed to the poor performance of the BacT/Alert 
system. The system failed to signal the presence of B. pilosicoli even when a build up of 
CO2 had been generated and the organism had been recovered by subculture (4 of 9 strains: 
8 of 36 bottles). It is unlikely that the detection algorithm could be changed to accommodate 
slow growing organisms such as B. pilosicoli without markedly affecting the overall 
performance for the majority of clinical organisms encountered. Even the detection 
algorithm in the BACTEC machinery was not ideally suited to the slow growth of B. 
pilosicoli. Graphs of CO2 production over time in this system indicated that signalling 
occurred after the maximum fluorescence for some strains, when CO2 was decreasing more 
rapidly. The fluorescence in these particular strains appeared to rise too slowly for the 
detection parameters, and resulted in an extended time to detection.  
Care was taken not to disturb gas levels present in automated bottles, which might 
have affected the detection system of the automated machinery. The weekly subculture did 
not affect the time to detection for PE90 in the BACTEC, but did affect H1, which appeared 
to grow more slowly than the other strains. However, H1 did signal from the 1 x 10
4 and 1 x 
10
3 bottles when the BACTEC Anaerobic Plus/F medium were subcultured in previous tests, 
albeit later than other strains, so it is uncertain why this organism failed to grow after 
subculture on this occasion. Nevertheless, the BacT/Alert system possibly was more Chapter 5 - Blood Culture 
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sensitive to such disturbances than the BACTEC system, and this may have influenced the 
lack of detection in the former system.  
The manual bottles were less efficient for detection of B. pilosicoli than the 
BACTEC system, due to the time and labour involved in monitoring the vials. A major 
disadvantage was the need for regular blind subculturing to detect the organism, since 
positive bottles did not appear obviously so. While minimum time to positivity by subculture 
varied from 2 to 10 d, which was earlier than for BACTEC media, it should be emphasised 
that organisms were often not at a high enough concentration to be visible by microscopy at 
these time points. Again, these plates had to be incubated for 5 - 8 d before growth was 
detected. Although they are not widely used in Australia, growth in the two Hémoline 
preparations confirmed the utility of the Hémoline media for isolation of B. pilosicoli from 
blood, as originally described by the French workers (Fournié-Amazouz et al., 1995). 
Therefore, either Hémoline or Septi-Chek could be used with some confidence to detect B. 
pilosicoli  spirochaetaemia in laboratories where automated systems are not available, 
provided the vials were incubated for long enough to accommodate the organism’s slow 
growth.  
This evaluation of blood culture systems indicated that the BACTEC system was 
best for the detection of B. pilosicoli in the seeded blood culture, and suggested a likely 
superiority for the detection of a B. pilosicoli spirochaetaemia in patients. An 18 d 
incubation using the BACTEC Plus Anaerobic/F Culture Vials should recover any clinical 
isolate without further modification to the protocol. BacT/Alert could not be recommended, 
although if unavoidable, the BacT/Alert Anaerobic Culture Bottles should be selected, and 
terminal subculturing carried out. As machine space is often an important consideration, the 
use of manual bottles may be more acceptable to laboratories, although detection would be 
laborious. An 18 d protocol with blind subculture every 3 d would allow detection of viable 
isolates in either of the manual systems tested. It is also recommended firstly that a sample 
from any positive bottle is examined by wet mount under a phase contrast microscope, as the 
organism is slender and very difficult to detect by gram staining, and secondly that 
subcultures on BA are incubated anaerobically for up to 10 d before being discarded.  
 
5.4.2 Lack  of  B. pilosicoli isolates from clinical blood culture 
specimens 
The isolation of B. pilosicoli from 1063 blood specimens from 801 patients was 
attempted, however B. pilosicoli was not obtained. This result is probably not surprising, 
given the rarity of reported isolations from the blood. Even the series reported from French Chapter 5 - Blood Culture 
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patients appears to been collected from between 1980 - 1994, based on the strain 
designations (Fournié-Amazouz et al., 1995).  
The six French patients with B. pilosicoli spirochaetaemia had a variety of serious 
illnesses, were immunocompromised (Fournié-Amazouz et al., 1995), and three had 
diarrhoea (Lambert & Goursot, 1982; Trott et al., 1997b). Other isolates from blood have 
been obtained by this group since their initial report, although clinical details are unknown 
(Prof. David Hampson, Murdoch University, pers. comm.). The French patient with the 
earlier probable case of B. pilosicoli spirochaetaemia was similarly ill and had bloody 
diarrhoea (Lambert & Goursot, 1982). An isolate was obtained from an AIDS patient on 
chemotherapy in the USA (Trott et al., 1997b), and the most recent report involved an 
elderly man in Greece who was on chemotherapy and had lymphoma, bloody diarrhoea and 
abdominal pain (Kanavaki et al., 2002). Thus B. pilosicoli appears to have been isolated 
only from the blood of seriously ill and immunocompromised individuals of probable 
European background. HIV positive individuals are among populations known to have a 
high rate of faecal carriage (Käsbohrer et al., 1990), as are Aboriginal Australians (Lee & 
Hampson, 1992; Chapter 3). The health of Aboriginal Australians is recognised as being 
much worse than that of other Australian populations (Gracey et al., 1992), and concern 
existed that more serious disease associated with B. pilosicoli was going unrecognised in this 
population. Thus individuals chosen for investigation included Aboriginal Australians with 
symptoms similar to those of previous cases (Fournié-Amazouz et al., 1995; Trott et al., 
1997b; Kanavaki et al., 2002), or with symptoms potentially indicating intestinal spirochaete 
carriage. These symptoms and underlying diseases included fever, stroke, alcoholism, 
cancers, other immunocompromise, and gastrointestinal symptoms such as abdominal pain 
and diarrhoea. In one French individual, severe arteriopathy was the underlying disease, 
however patients with cardiac symptoms were not included in this study. 
Certain limitations existed in the current investigation of clinical blood culture 
samples, which may have accounted for the negative results. The accuracy of selecting 
patients using request form details could have been problematic, as blood cultures are 
requested for a wide range of clinical pictures, often to exclude infection as a source of fever 
(Dr Ronan Murray, Division of Microbiology and Infectious Diseases, PathCentre, pers. 
comm.). Additionally, doctors often do not generally write informative patient histories on 
the laboratory request forms, so patients who were inappropriate for inclusion were 
undoubtedly selected. Conversely, other patients who may have been of interest, but for 
whom details were not recorded, were not included in the study. However, this method of 
patient selection was the least intrusive and time-consuming. 
Anaerobic bacteraemias are reported to be polymicrobial in between 18% and 49% 
of patients, depending on the population in question (Vazquez et al., 1987; Spanik et al., Chapter 5 - Blood Culture 
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1996). If any such episodes had occurred with B. pilosicoli, it is likely that the faster 
growing organism would have signalled, and the bottle become unavailable for study, as 
bottles were selected only after remaining negative for 5 d. Clinical laboratories do not 
routinely incubate anaerobic subcultures for long enough to isolate B. pilosicoli nor do they 
routinely perform wet mount microscopy on blood culture samples. Thus any B. pilosicoli 
involved in polymicrobial bacteraemia would have remained undetected.  
The numbers of patients sampled who were at risk for B. pilosicoli blood infection 
was possibly quite low. Only 302 patients were positively identified as Aboriginal 
Australian, and while no data were obtained on intestinal carriage of B. pilosicoli in any 
patient, the carriage of this spirochaete is rare in Caucasian individuals (Tompkins et al., 
1986; Lee & Hampson, 1992; Trott et al., 1997a). Based on the results presented in Chapter 
3, where a prevalence of faecal carriage of 9.9% was found in Aboriginals, only 30 
Aboriginal patients may have been potentially colonised with the organism. The highest 
carriage was in children under 18 y, and only 89/801 (11.0%) of bottles were obtained from 
children under 18 y, and only 33 of these were from Aboriginals. Bacteraemia in children 
under 10 y is usually investigated in specialised paediatric media, such as the BACTEC Peds 
Plus medium. PE90 and H1 neither signalled nor were reisolated from this medium (data not 
shown), as it is principally designed for aerobic organisms. 
Even if an individual was spirochaetaemic, this may have been missed by the 
sampling technique. Bacteraemia are often intermittent (Bryan, 1989), and it is usual that 
two or more samples are obtained for culture throughout a suspected bacteraemia (Reimer et 
al., 1997). However, while two or more additional samples were obtained from 122 (15.2%) 
patients in the study, this did not result in isolation of B. pilosicoli.  
Further organism and host characteristics may explain the lack of positive results. 
Whether  B. pilosicoli isolates which inhabit the gastrointestinal tract of Aboriginals are 
capable of causing an invasive disease is not known. Alternatively, as more serious infection 
with the organism has not been described in Aboriginals, possibly members of this 
population become immune at an early stage in life. A study of invasive mechanisms and 
characteristics which allow survival of B. pilosicoli in the human bloodstream is required 
using animal models. Further information regarding immunity might be gained by 
identification of specific immunogenic surface components of the spirochaete, followed by 
serological surveys of human populations.  
Lastly, it is possible that any potential B. pilosicoli in a sample from a rural setting 
would have been adversely affected by travel conditions. A small study examining the effect 
of bottle removal from the BACTEC machinery after 5 d indicated that travel time, which 
was on average 3 d between the rural and central laboratories, may have affected B. Chapter 5 - Blood Culture 
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pilosicoli recovery. H1 in particular was included as it was the slowest to signal in other 
studies described in this chapter, and did not signal on primary isolation (Trott et al., 1997b).  
Despite these problems, a considerable number of blood culture samples from 
populations considered to be at risk for bacteraemia with B. pilosicoli were tested, and 
conditions which were the most appropriate for B. pilosicoli detection and growth in blood 
culture media were utilised. Thus it can be concluded that spirochaetaemia caused by 
intestinal spirochaetes is not common in these Australian populations. However, B. pilosicoli 
should not be completely disregarded as a possible cause of bacteraemia in certain patient 
groups, particularly those who are ill or immunocompromised and have gastrointestinal 
symptoms, and possibly ill individuals who have a high risk of intestinal carriage of the 
organism. 
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6.1 INTRODUCTION 
Certain features of the human populations from which B. pilosicoli isolates were 
obtained were identified as being interesting from an epidemiological point of view. In the 
Aboriginal Australian population, two B. pilosicoli isolates were obtained from one 
Aboriginal child at an interval of 3 months. This child and a second child from whom a B. 
pilosicoli isolate was obtained originated from the same Kimberley community, and both 
children plus a third were hospitalised at the time of sampling. In the migrant population, 
three family groups contained more than one individual from whom an isolate of B. 
pilosicoli was cultivated. The use of a strain typing method was considered to be an 
appropriate way to examine the relationships between these isolates, and it was hypothesised 
that this would permit further understanding of the transmission and population biology of 
B. pilosicoli.  
A variety of methods has been used to type intestinal spirochaetes and characterise 
the relationships between strains. While multilocus enzyme electrophoresis (MLEE) and 
pulsed-field gel electrophoresis (PFGE) have both been successfully applied to the 
subspecific typing of B. pilosicoli and B. hyodysenteriae (Lee et al., 1993a; Lee & Hampson, 
1994; Atyeo et al., 1996; Rayment et al., 1997; Atyeo et al., 1999a; Fellström et al., 1999), 
the latter technique was more discriminatory for this purpose (Trott et al., 1998; Atyeo et al., 
1999a). Both MLEE and PFGE in turn are more discriminatory than serotyping for B. 
hyodysenteriae, and easier to interpret than restriction endonuclease analysis (Lee et al., 
1993a; Atyeo et al., 1999a). PFGE therefore was selected for use in the current work 
because of its high level of discrimination. Thus the specific aim of the work described in 
this chapter was to: 
Examine the relationships between B. pilosicoli isolates obtained from Aboriginal 
patients and migrants to WA, using PFGE. Chapter 6 - PFGE 
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6.2  MATERIALS AND METHODS 
PFGE was performed using the contour-clamped homogenous electric field system 
(CHEF DR III, Biorad Laboratories, Richmond, VA). The preparation of DNA plugs, 
digestion and electrophoresis was performed by the method of O'Brien et al. (1999), with 
minor modifications as described below.  
 
6.2.1 Bacterial  strains 
The B. pilosicoli strains analysed (n=56) included 39 of 40 isolates from Aboriginal 
Australians and migrants described in Chapter 3. Strain WHP15 was not analysed because it 
could not be recovered from -80°C storage. Fourteen strains from Aboriginal Australians, 
isolated in a study between 1989 – 1991 by J.I. Lee (Lee & Hampson, 1992; Lee, 1994), one 
strain each from an Australian homosexual male (Gap 401) and an Omani national (31B), 
and the porcine type strain P43/6/78
T were also included for comparative purposes. Further 
details of these isolates are provided in Appendix A2.1. All B. pilosicoli were revived from  
-80°C storage, subcultured once, and grown on BA for 5 d. Each strain was typed twice. 
 
6.2.2  Preparation of DNA from cells 
Cell suspensions equivalent to a 5.0 McFarland opacity standard (5 x 10
9 cells/ml) 
were made in TE buffer. Cells were centrifuged for 3 min and resuspended in 50 µl cold TE. 
Fifty µl lysostaphin and 100 µl of molten low melting point agarose were added and the 
mixture pipetted into sterile pre-chilled plug moulds. Plugs were set at 4°C for 20 min and 
placed in 500 µl lysis buffer with 12.5 µl lysozyme at 37°C for 18 h. The lysis solution was 
removed, replaced with 500 µl TES and 20 µl proteinase K, and plugs were incubated at 
50°C for 18 h. Plugs were washed in six changes of 1 ml TE buffer according to the 
following regimen: 1 x 5 min; 1x 30 min; 2 x 1 h with shaking; 2 x 1 h at 50° C; followed by 
1 x 30 min in 0.1x TE and 1 x 30 min in 0.5 ml of 1 x restriction enzyme (RE) buffer 
provided with the restriction enzymes. Assistance with plug preparation was obtained from 
Ms Adele Clair, Molecular Epidemiology Laboratory, the Division of Microbiology and 
Infectious Diseases, PathCentre. 
 
6.2.3 Restriction  enzyme digestion and PFGE 
Plugs were digested for 24 h at 37°C with 50 units MluI in 3 µl bovine serum 
albumin and 300 µl fresh RE buffer. Plugs digested with 50 units SmaI were treated 
similarly, but incubation was at 25°C. Plugs were then placed in TE buffer and routinely Chapter 6 - PFGE 
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stored at 4°C. For electrophoresis, half a plug was heated at 56°C for 8 min, then loaded into 
the wells of an agarose gel immediately after pre-electrophoresis of the gel at running 
conditions for 1.5 h. Lambda ladder DNA size standards were included for comparison, and 
wells were sealed with plug agarose. For MluI digested plugs, electrophoresis in 0.5 x TBE 
was at 200 V for  20 h at 14°C, with pulse time ramped from 1 - 40 sec, and for SmaI 
digested plugs this protocol was followed by 2 h at 180 V ramped at 45 - 60 sec. The gel was 
stained by emersion in ethidium bromide, examined over UV light and photographed. 
Images were scanned using a Biorad Gel Doc 2000+ and analysed using Biorad Molecular 
Analyst Software. The program created a dendrogram from the Dice matrix of band 
matching coefficients at 1.0% tolerance by the unweighted pair group method of arithmetic 
averages (UPGMA) clustering fusion strategy. 
The interpretation of band patterns and the relatedness of strains in this study was 
based on the recommendations set out by Tenover et al. (1995) for typing bacteria in 
outbreak situations. Strains were considered genetically indistinguishable if the restriction 
patterns created after digestion with MluI and SmaI appeared identical in band size and 
number. A strain was considered “closely related” to another if the band patterns created by 
MluI or SmaI differed only by one or two bands. Two strains were only “possibly related” if 
three to six bands differed in the patterns, and the strains were considered to be “unrelated” 
if the patterns differed by more than seven bands. The description “clonal group” was 
created to identify groups of Aboriginal strains which were either indistinguishable or 
designated as “closely related” to each other after digestion by MluI and SmaI. 
6.3 RESULTS 
6.3.1  PFGE typing following MluI restriction digestion 
Digestion of DNA with MluI gave 8 - 16 bands, and 40 distinct banding patterns 
were obtained for the 56 strains (Table 6.1). Strains from Aboriginal Australians and 
migrants to WA were widely distributed throughout the dendrogram produced from analysis 
of MluI patterns (Figure 6.1). Strains from Aboriginals isolated in this study and in 1989 - 
1991 were not separated in the analysis, likewise, migrant isolates from Middle Eastern, 
African and European individuals were distributed throughout the dendrogram. The 
reference strains from the homosexual male, the Omani child and the type strain were 
located in MluI types 8, 14 and 17, respectively, near other strains. 
The two strains WHP06 and WHP12, obtained from the same Aboriginal child, 
were located in separate MluI PFGE types; 36 and 32, respectively. The isolate from the 
second child from this community was located in type 15, as was the isolate from the other 
hospitalised child.  Chapter 6 - PFGE 
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MluI PFGE types 2, 15, 21, 32, 35 and 36 contained multiple strains. All other MluI 
derived patterns represented single strains, although patterns from some strains exhibited 
similarities. In particular, strains obtained from Aboriginals were closely related; strain H56-
2 (MluI PFGE type 1) and WHP14 (type 3) each had a one band difference to the strains in 
type 2 (Table 6.2). Strain WHP10 in type 22 had one band difference with strains in type 21, 
and Karlos and WesB in types 38 and 39 had band differences in two places. Other strains 
were possibly related; a four band difference was observed between the strain from the 
Omani child in type 7 and strain WHP37 from an Iranian individual, in type 8. A six band 
difference existed between strain WHP01 from an Aboriginal child and WHP40 from a 
Burmese migrant, located in types 9 and 10, respectively. The remaining strains had greater 
than six bands different with neighbouring isolates. 
 
6.3.2  Further typing using SmaI restriction digestion 
Brachyspira  pilosicoli  strains which were indistinguishable after MluI digestion 
were analysed further using SmaI. A summary of subtypes created and the similarities 
between strains is provided in Table 6.2. The differentiation of some strains in MluI PFGE 
types 15, 32, 35 and 36 are presented in Figure 6.2. The B. pilosicoli strains in MluI PFGE 
types 2, 21 and 36, and the three strains tested from type 32 could not be differentiated by 
SmaI digestion, and all four types comprised strains from Australian Aboriginals. Strains in 
type 21 were obtained in 1989 - 1991 only, while strains in type 2, 32 and 36 were obtained 
in both 1989 - 1991 and 1998 - 1999.  
The two B. pilosicoli strains in MluI PFGE type 35 originated from two migrant 
individuals from the same family. A fragment shift resulted in a two band difference in the 
SmaI patterns for the strains. Multiple isolates from the other two families were distinct, 
being located in MluI PFGE types 23, 24 and 33 for one family and types 5 and 37 for 
isolates from the other family group.  
Type 15 contained seven strains from six Aboriginal patients sampled in this study 
and one individual from 1989 - 1991. The six isolates obtained in this study were from 
patients from a variety of geographical areas and from different months of sampling. Four of 
these were obtained from Aboriginal samples in which no other pathogen was detected. 
After analysis by SmaI, WHP02, WHP08 and WHP09 demonstrated minor departures from 
the main pattern exhibited by the other four strains.  
Six potential clonal groups of Aboriginal strains were identified, based on strains 
being indistinguishable or closely related (patterns differing by 1 - 2 bands) after MluI and 
SmaI digestion. Clonal groups are labelled A - F in Figure 6.1 and detailed in Table 6.2. 
Each contained 2 - 7 strains and comprised between 1 and 4 related PFGE patterns. Only Chapter 6 - PFGE 
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three of the 29 (10.3%) strains from Aboriginal individuals were not clustered in these six 
groups. In contrast, the 24 isolates from migrants were grouped in 23 different MluI PFGE 
types. The migrant strains occurred in significantly more PFGE types than the Aboriginal 
strains (P <0.001). The strains in clonal groups were obtained over a period of ten years 
from mainly Aboriginal Australian children from a variety of geographical areas. All of the 
strains obtained from samples in which no other pathogen was detected were located in 
clonal groups B, C and D. However, there was no significant difference in any characteristic 
between the individuals from whom the clonally grouped strains were obtained, and the 
remaining individuals.  
 
6.4 DISCUSSION 
6.4.1 PFGE 
In the work described in this chapter, PFGE was used to examine the relationships 
between the B. pilosicoli strains obtained in the studies described in Chapter 3. Excellent 
agreement between PFGE and MLEE has been demonstrated in previous studies which 
utilised both methods for typing Brachyspira  isolates, however, PFGE was the more 
discriminatory method (Trott et al., 1998; Atyeo et al., 1999a; Fellström et al., 1999). As the 
aim of the work described in this chapter was to examine the relationships of individual 
isolates to each other, that is, aspects of micro-variation between isolates, it was essential to 
choose the technique with the better discriminatory power.  
An examination of 20 restriction enzymes for their potential in mapping the 
chromosome of B. pilosicoli P43/6/78
T by PFGE was carried out by Atyeo (1998). Among 
the most promising candidate enzymes was MluI, which produced 10 bands and a clean 
DNA digestion in this strain. Subsequently, successful PFGE typing of B. pilosicoli (Atyeo 
et al., 1996; Mikosza, 1996; Trott et al., 1998), B. hyodysenteriae (Trott et al., 1996a; Atyeo 
et al., 1999a; Fellström et al., 1999), B. intermedia (Suriyaarachchi et al., 2000) and B. 
innocens (Fossi et al., 2001) was achieved with MluI, and thus the enzyme was chosen for 
use in this investigation.  
Other enzymes used in PFGE of Brachyspira spp. have included BglI, SacII, SalI, 
and SmaI (Rayment et al., 1997; Trott et al., 1998; Atyeo et al., 1999a; Fossi et al., 2001), 
and, from these, SmaI was chosen for use in this study to further differentiate strains with 
indistinguishable profiles following MluI digestion. SmaI was preferred over SacII and SalI, 
as it has had a long history of use in PFGE (McClelland et al., 1987), a lower relative cost 
than SalI, and produced a sufficient number of bands. This final attribute did not always 
occur when SalI (Mikosza, 1996) or SacII (Rayment et al., 1997) were utilised. In this study, Chapter 6 - PFGE 
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digestion of B. pilosicoli yielded 9 - 16 bands with MluI, and 6 - 10 bands with SmaI, both 
enzymes producing highly discriminating, reproducible patterns.  
It was recognised that bands at the same position are able to represent completely 
different sequences, and analysis with other enzymes may have produced different strain 
groupings (Shi et al., 1997). However, all strains which were indistinguishable after MluI 
digestion were either indistinguishable or closely related after SmaI digestion, so the 
possibility of this error occurring was believed to be low. The use of other forms of 
subspecific typing, such as multilocus sequence typing (Spratt, 1999) were outside the scope 
of this investigation, although this technique would be worth developing in future studies.  
 
6.4.2  PFGE typing of strains from Aboriginal and migrant individuals 
Using PFGE, 40  different  MluI types were obtained for 56 strains, confirming 
previous observations of the considerable genetic heterogeneity of B. pilosicoli (Atyeo et al., 
1996; Rayment et al., 1997; Trott et al., 1998). Strains from migrant and Aboriginal 
individuals were located throughout the deep branching MluI dendrogram. Some strains 
from each source showed less than 35% similarity, corresponding to other studies in which 
isolates from humans were distantly related (Atyeo et al., 1996; Rayment et al., 1997). The 
porcine type strain P43/6/78
T was not grouped separately from the human strains, which was 
similar to the results of a study in which human strains were predominant (Rayment et al., 
1997), but not a study where most strains analysed were from pigs (Atyeo et al., 1996). 
Strains from Australian Aboriginals were distributed throughout the MluI 
dendrogram. Unexpectedly, the majority (89.7%) were clustered in one of six “clonal 
groups” after analysis with MluI and SmaI, although these clonal groups were distantly 
related to each other. The strains from the Aboriginal Australians were collected over a ten 
year period, mainly from children with diarrhoea. The majority were recovered from 
individuals living in the Kimberley region, an area of 421451 km
2 which occupies one sixth 
of the area of Western Australia (www.kimberley.wa.gov.au). The children from whom 
isolates were collected in 1989 - 1991 lived near Fitzroy Crossing in the Kimberley (Lee & 
Hampson, 1992), while some Kimberley patients sampled during this investigation may 
have lived more than 500 km away. In addition, one strain in MluI type 15 was obtained 
from a community east of Kalgoorlie, WA, over 1400 km directly south of Fitzroy Crossing.  
The Aboriginal Australian population of Central Australia is characterised by a high 
population mobility. In one Central Australian community, only 174/422 (41%) of 
individuals were present at all four sampling times in one year, with some individuals 
reported to be over 1000 km away from the remote community under study (Warchivker et 
al., 1999). The mobility of Aboriginal people in the Kimberley region is not as well studied, Chapter 6 - PFGE 
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however, it is possible to speculate that certain members of the remote Kimberley 
communities in this study may have had direct contact at some time. However, the young 
age of many individuals sampled in this investigation, plus the lack of temporal association 
between the isolates make it unlikely that the results indicated direct transmission of B. 
pilosicoli between the individuals sampled. Instead, it would appear that clonal groups of 
strains are present in the WA Aboriginal population, contributing further to evidence for the 
epidemic population structure of B. pilosicoli in Australian Aboriginals (Trott et al., 1998).  
Many bacterial species, such as members of the Enterobacteriaceae, have a clonal 
population structure. These bacterial populations are characterised by the existence of a 
strong linkage disequilibrium, or the non-random association of alleles analysed by MLEE, 
which are not disrupted by recombination events (Maynard Smith et al., 1993). Isolates from 
species with clonal population structures are classified into groups from hosts that are 
temporally and geographically unassociated. Conversely, bacterial species with panmictic 
population structures are highly recombinant, and lack linkage disequilibrium. These 
bacteria are characterised by high levels of genetic diversity and the presence of more than 
one strain in a single host (Maynard Smith et al., 1993). Representative species include 
Neisseria gonorrhoea (O'Rourke & Stevens, 1993; O'Rourke & Spratt, 1994) and 
Helicobacter pylori (Go et al., 1996). An intermediate situation exists in epidemic bacterial 
populations, such as N. meningitidis (Maynard Smith et al., 1993), where the overall 
structure is shaped by extensive genetic recombination, and the strong linkage 
disequilibrium of a clonal population is not present. However, particular strains with some 
virulence or selective advantage can explode in the population and spread widely, giving the 
population an appearance of clonality, since temporally and geographically unassociated 
isolates are grouped together (Maynard Smith et al., 1993; Trott et al., 1997c).  
Previous population analysis of Brachyspira  spp. by MLEE revealed that B. 
pilosicoli isolates from PNG were panmictic in structure, based on a lack of linkage 
disequilibrium (Trott et al., 1998). However, B. pilosicoli isolates from Aboriginals, 
including some of the 1989 - 1991 isolates examined in this study, appeared clonal (Trott et 
al., 1998), as did B. hyodysenteriae (Trott et al., 1997c). It would now appear from the 
PFGE results presented here that certain clones of B. pilosicoli can persist for long periods 
and over long distances in the Australian Aboriginal population. Despite the recombinant 
structure of the PNG strains, three PFGE types were found occasionally in individuals in 
three of five unconnected villages that were sampled, representing 21/145 (14.5%) of 
isolates (Mikosza, 1996; Trott et al., 1998). However, where multiple strains of B. pilosicoli 
of human or animal origin with the same PFGE type have been found, it is more usual for 
there to have been close geographic links, such as originating from the same village (Trott et 
al., 1998), Aboriginal community or herd of pigs (Atyeo et al., 1996). Therefore, the results Chapter 6 - PFGE 
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described in this chapter are believed to be the first example of widely disseminated strains 
or clusters of strains of B. pilosicoli approximating clonal groups.  
There was no clear explanation for the existence of clonal groups from this analysis. 
One possibility is that increased virulence may have contributed to spread of these B. 
pilosicoli clones in the WA Aboriginals. Strains WHP06 (MluI type 36) and WHP12 (type 
32) were obtained three months apart from an Aboriginal child, who was hospitalised on the 
second occasion. Both were isolated without the presence of other pathogens and hence may 
have been primary pathogens. The strains were unrelated although each was located in a 
clonal group; D and E. Strain WHP11, recovered from a hospitalised child in the same 
community as the above child, was unrelated to both WHP06 or WHP12. Nevertheless, 
WHP11 and WHP09, isolated from the third hospitalised child, were located together in 
clonal group B (MluI type 15). A further two strains in group B were not isolated with other 
pathogens, and the only other isolate recovered without the detection of another pathogen 
was located in clonal group C. Unfortunately, the presence of other pathogens was not 
determined for the 1989 - 1991 population. 
Previously, a number of Aboriginal children living in the same community have 
been shown to carry the same strains of B. pilosicoli (Lee & Hampson, 1992; Atyeo et al., 
1996), and different B. pilosicoli strains have been isolated from individuals on successive 
sampling in PNG (Trott et al., 1998). It was possible that the child from whom two strains 
were isolated had been re-infected with another strain by the time of second sampling, or 
was colonised by more than one strain on one or both occasions. However, why each was 
located in a clonal group is unknown.  
Trott et al. (1998) had difficulty resolving the presence of an epidemic population 
structure in Aboriginal but not PNG strains, and speculated that some pressure existed in the 
Aboriginal population to favour the selection and dissemination of certain strains. The 
results regarding the hospitalised children and the lack of other pathogens in individuals with 
symptoms may indicate that strains in clonal groups were more virulent than other strains. 
Such mechanisms could include an increased ability to colonise the lower intestine, or cause 
diarrhoea, thus allowing greater organism dissemination, or some other mechanism allowing 
greater numbers or longer periods of B. pilosicoli shedding.  
However, the majority of strains from Aboriginals were clustered in the clonal 
groups. None of the factors analysed were significantly associated with the carriage of a 
clonal strain rather than a non-clonal strain, so it was possible that the non-clonal strains 
were also part of clonal groups, which were not sampled due to chance. Additionally, 
isolates from Aboriginals without diarrhoea were not included in this study. A study of 
virulence factors, and population analysis of B. pilosicoli from healthy Aboriginal 
individuals, is required to address the possibility of clonal strains being more virulent. Chapter 6 - PFGE 
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Antibiotic usage also may have favoured spread of clonal strains in the Aboriginal 
population, but not amongst the PNG villagers. Some strains may have developed resistance 
to one or more antimicrobial, and become over-represented in the population by a process of 
selection. Investigation into the antimicrobial susceptibility of strains is required to examine 
this possibility.  
As with Aboriginal Australians, strains from migrants were distributed throughout 
the dendrogram created after analysis with MluI, but did not form clonal groups. However, 
strains were obtained from individuals originating in 10 different countries throughout 
Africa, Asia, Europe and the Middle East, and heterogeneity was thus expected. B. pilosicoli 
strains WHP30 and WHP31, from two individuals in the same family, were closely related, 
having an indistinguishable pattern by MluI and only two band differences by SmaI. This 
suggests that transmission of the organism from one individual to the other may have 
occurred, or that both individuals were infected from a common source, with recombination 
producing the observed fragment shift. A faecal sample from one other member of this 
family was analysed, but neither B. aalborgi nor B. pilosicoli was detected. 
No other isolates from migrants were related, even among members of other 
families. Strains WHP22 and WHP23, located in types 23 and 24, came from two children 
of another family. The strains were 72% similar, however as eight bands were different 
between the types, they were unlikely to be related. Thus transmission between family 
members did not appear to be common, and confirms data from Chapters 3 and 4, where the 
detection of B. pilosicoli within families was not significantly associated with another family 
member being positive.  
Various alternatives could explain these findings. Exposure to B. pilosicoli by 
individuals within families could occur at different times, and/or from a variety of sources. 
This may be facilitated by long term carriage of B. pilosicoli in some populations. The study 
in PNG demonstrated that B. pilosicoli carriage with a single strain can occur over a 6 week 
period, and could be up to 4 months (Trott et al., 1997a). Additionally, while transmission 
may have occurred once within a family, it was not common. Infection with intestinal 
spirochaetes probably occurs by the faecal-oral route (Trott et al., 1997a), yet some barrier 
to transmission or infection may have operated between family members. However, the 
small number of isolates obtained from family members prevents further conclusions being 
drawn from this data. Clearly, there is still much to understand regarding the biology and 
potential pathogenicity of B. pilosicoli. A much greater understanding of the duration, 
nature, and potential human health implications of spirochaete carriage is required, and 
could be ascertained by carrying out longitudinal studies on different population groups.  
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7.1 INTRODUCTION 
Treatments for IS and human infection with B. pilosicoli have varied, and have met 
with mixed success. Therapeutic decisions in these situations have been made without 
supporting in vitro antimicrobial susceptibility data. Some susceptibility data have been 
determined for agents in veterinary usage, due to the economic impact of swine dysentery 
and PIS on the pig industry (Trott et al., 1996d; Oxberry & Hampson, 1998; Duhamel et al., 
1998b). However, the majority of these antimicrobials are not used for or are unsuitable for 
treating human infection. Strains from humans have received little attention; only one study 
involving 19 strains has been carried out, and this was prior to the description of B. pilosicoli 
(Tompkins et al., 1987). Additionally, important testing parameters have varied from study 
to study. Currently, there are no approved standards for antimicrobial testing of Brachyspira 
species (NCCLS, 2000). Thus there was a clear need to determine resistance profiles of 
human strains of B. pilosicoli. The specific aims of the work described in this chapter were 
to: 
1.  Develop a method for evaluating the antimicrobial susceptibility of B. pilosicoli. 
2.  Determine the in vitro antimicrobial susceptibility of B. pilosicoli strains to agents in 
human medicine, with a view to aiding therapeutic decisions. 
3.  Compare susceptibilities of humans strains from a range of geographic locations to gain 
important epidemiological insights about these groups of strains.  Chapter 7 - Antimicrobial Susceptibility 
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7.2  MATERIALS AND METHODS 
7.2.1  Determination of cell numbers corresponding to a 0.5 McFarland 
standard 
Suspensions of B. pilosicoli strains P43/6/78
T and WesB, corresponding to a 0.5 
McFarland opacity standard (Appendix A1.2), were made in BrB, PBS or TE, either in air or 
in an anaerobic chamber. Cell numbers were estimated microscopically and viable cell 
numbers were enumerated by the spread plate technique (Section 2.3.4).  
 
7.2.2  Testing of susceptibility media 
Media which were evaluated included Wilkins-Chalgren agar (WCA), WCA plus 
horse serum (WCA+HS), Brucella blood agar for susceptibility testing (BrBAS), BrBAS 
plus haemin (BrBAS+H) and BA, the latter included as a growth control. Organism 
suspensions corresponding to a 0.5 McFarland opacity standard were added to the wells of a 
sterile multipoint inoculator tray, and agar was inoculated using a Denley multipoint 
inoculator (Mast Labs, Liverpool, UK). Media were immediately incubated in the anaerobic 
chamber. Media were inspected for growth after 3 d, and the visual characteristics of each 
medium were compared. Initially, cells from each medium also were examined 
microscopically. 
Preliminary tests were performed with strains P43/6/78
T and WesB, and the final 
assessment was made using 12 other B. pilosicoli strains (C Malo, Naomi, Gap 183, Gap 34, 
Gorzalek, Hrm1A, Hrm2A, 21B, V1 H45, V1 H59, 1648 and WandF). Further details 
regarding strains are available in Appendix A2.1. 
 
7.2.3  Bacterial strains for antimicrobial susceptibility testing 
Antimicrobial susceptibility testing was carried out using B. pilosicoli strains 
(n=139) originating from humans (n=123) and pigs (n=16). Human strains were from Papua 
New Guinean (PNG) villagers (n=29), Aborigines from Western Australian communities 
(n=32), migrants to Western Australia (n=24), homosexual males and HIV positive patients 
(n=14) and individuals from Oman (n=10) and Italy (n=7). Seven human isolates from blood 
were also tested. Porcine strains were from Australia (n=9), North America (n=6) and the 
type strain P43/6/78
T from the UK. Further details regarding these strains and their sources 
can be found in Appendix A2.1 Reference organisms for control purposes included the 
facultative anaerobes S. aureus ATCC 29213 and E. faecalis ATCC 29212, and the 
anaerobes B. fragilis ATCC 25285, B. thetaiotaomicron ATCC 29741 and C. perfringens 
ATCC 13124.  Chapter 7 - Antimicrobial Susceptibility 
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7.2.4  Agar dilution susceptibility testing 
Doubling dilutions of antibiotics were performed in the appropriate diluent 
(Appendix A1.5) according to the scheme in the Wadsworth Anaerobic Bacteriology 
Manual (Summanen et al., 1993), and added to Wilkins-Chalgren agar containing 5% horse 
serum (Section 2.1.5). The agents tested were amoxicillin, ceftriaxone, chloramphenicol, 
ciprofloxacin, clindamycin, erythromycin, gentamicin, meropenem, metronidazole, 
moxifloxacin and tetracycline. The β-lactamase inhibitor clavulanic acid was tested in 
combination with amoxicillin. Agar was made less than 24 h before inoculation and stored at 
4°C until required. Plates containing amoxicillin were made on the day of use. Facultative 
control organisms were inoculated onto Mueller Hinton (MH) agar without horse serum.  
The antimicrobial susceptibility of B. pilosicoli strains was determined using an agar 
dilution method based on National Committee for Clinical Laboratory Standards (NCCLS) 
guidelines for susceptibility testing of anaerobic bacteria (NCCLS, 1990). Briefly, 
spirochaete stocks were thawed, passaged once on BA and suspensions corresponding to a 
0.5 McFarland standard were made in BrB. Suspensions were added to the wells of a sterile 
multipoint inoculator tray and agar was inoculated with a multipoint inoculator. Cultures 
were incubated immediately post inoculation, with anaerobic cultures placed in an anaerobic 
chamber for 96 h, and facultative anaerobic controls incubated aerobically at 37°C. 
Additional control plates included growth controls containing no antibiotic and a 
contamination control which was incubated aerobically, and was used to ensure inocula were 
not contaminated with other organisms. 
Cultures were compared to the growth control plate. The MIC was defined as the 
lowest concentration of antimicrobial yielding no growth, a haze, one discrete colony or 
multiple tiny colonies. Tests for each organism were performed at least in triplicate, and the 
MIC was determined as the modal value. An organism was defined as resistant to a 
particular agent if the MIC obtained was above the published breakpoint for anaerobic 
bacteria (Summanen et al., 1993).  
As a control for antibacterial activity, and to detect variations in MIC due to 
medium-antibiotic interactions, MICs of agents for anaerobic reference organisms were also 
determined in triplicate on the same media under the same test conditions, in accordance 
with standard protocols (Summanen et al., 1993). Where an agent did not have published 
values for anaerobes, aerobic reference organisms inoculated on MH were included for 
comparison. 
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7.2.5  β-Lactamase production 
β-Lactamase production was assessed in all B. pilosicoli strains using BBL Cefinase 
nitrocefin discs. Each disc was moistened with sterile distilled water and a loopful of 
spirochaete growth was smeared onto the disc surface. The disc was protected from drying 
and examined for a colour change reaction (colourless to red) within 5 min and then at 30 
min. S. aureus ATCC 29213 and S. aureus ATCC 25923 were included as positive and 
negative controls, respectively.  
 
7.2.6  SHV and TEM β-lactamase PCRs 
Cells of 10 B. pilosicoli strains containing a β-lactamase were inoculated into tubes 
for PCR amplification to detect an SHV or TEM β-lactamase. The strains included four from 
Australian Aboriginals (H 21, WesB, WHP02 and WHP09), and two strains each from 
homosexual males (Gap 51-2 and Gap 418), migrants (WHP20 and WHP35) and pigs 
(COF10 and 3295). These preparations were also tested with the 16S rRNA B. pilosicoli 
PCR (Section 2.4.3.1). Template DNA was whole cells added to reaction tubes by frozen 
cell pick for B. pilosicoli strains, and was DNA extracted by the boiling method for E. coli 
controls. 
Reaction mixture and cycling conditions used to amplify fragments of TEM and 
SHV β-lactamase DNA are given below.  
  10x  Tth  Plus  buffer    2.5  µl 
  d N T P s       2 . 5   µl 
  M g C l 2  (25  mM)     2.5  µl 
  Tth  Plus  (5.5  U/µl)    0.4  µl 
  Primer  forward  (10  ρmol/µl)   2.5  µl 
   reverse  (10  ρmol/µl)   2.5  µl 
  T e m p l a t e   D N A      2 . 5   µl 
  S t e r i l e   U H P W      9 . 6   µl 
       2 5 . 0   µl 
The primer pair for amplification of TEM β-lactamase DNA was TEM A and TEM 
B (Mabilat et al., 1990) and the amplification protocol was as follows; 
Initial denaturation     96°C    5 min  
Denaturation    96°C   1  min 
Annealing    42°C   1  min 
Extension    72°C   1  min 
      3 5   c y c l e s  
Final  extension    72°C   10  min Chapter 7 - Antimicrobial Susceptibility 
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The primer pair for the SHV β-lactamase PCR was SHV OS5 and SHV OS6 (Arlet 
et al., 1997) and the amplification protocol was; 
Initial denaturation     96°C    5 min  
Denaturation    96°C   1  min 
 Annealing    60°C   1  min 
 Extension    72°C   1  min 
       3 5   c y c l e s  
Final  extension    72°C   10  min 
Positive controls for the TEM β-lactamase PCR were E. coli 1993E R-TEM/ TEM-1 
and 1725E RP1/ TEM-2. For the SHV β-lactamase PCR, positive control organisms were 
two  E. coli BM694 with plasmids encoding SHV-2 and SHV-5 and E. coli 2008E 
p453/SHV-1. Negative controls in both tests were DepC, and fragments were resolved by 
electrophoresis on a 1% agarose gel. 
 
7.3 RESULTS 
7.3.1  Determination of cell numbers corresponding to McFarland 
standards 
Comparisons between total cell numbers obtained with a Helber counting chamber, 
and viable cell numbers obtained by the spread plate method are made in Table 7.1. A 0.5 
McFarland opacity standard corresponded to between 3 x 10
8 - 1.5 x 10
9 total 
spirochaetes/ml, which in turn represented 9.8 x 10
7 - 3.7 x 10
8 cfu/ml for P43/6/78
T, and 
2.45 x 10
7 – 1.9 x 10
8 cfu/ml for WesB. A greater than 4 log10 reduction in the number of 
viable cells compared to total cell number was observed for P43/6/78
T suspended in TE. The 
remaining log reductions in cell number were less than 1.0 for P43/6/78
T, and less than 1.3 
for WesB. Preparing cell suspensions in either PBS or BrB did not affect total cell count or 
log10 reduction, neither were these values affected by the preparation of suspensions in the 
anaerobic chamber.  
 
7.3.2  Selection of an agar medium for susceptibility testing 
P43/6/78
T and WesB were inoculated onto WC, WC+HS, BrBAS and BrBAS+H. 
Growth on each medium was strain dependent. P43/6/78
T grew poorly on WC agar but 
WC+HS, BrBAS+H and BrBAS all were acceptable for growth of both strains (Figure 7.1). 
By microscopic examination, cells from points of inoculation where growth was present 
were short and active, and cells were long, tangled and barely moving from where growth Chapter 7 - Antimicrobial Susceptibility 
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was faint. It was more difficult to see growth on both blood containing media than on 
WC+HS.  
Twelve strains of B. pilosicoli were inoculated onto WC+HS and BrBAS+H, the 
best and second best media for B. pilosicoli growth, respectively. Growth of the 12 strains 
after 3 d incubation on the two media is recorded in Table 7.2. On each medium, spirochaete 
growth was present, however, spreading from the points of inoculation was more common 
on BrBAS+H. Again, growth was easier to observe on WC+HS agar (Figure 7.2).  
 
7.3.3  In vitro antimicrobial susceptibility testing 
The MIC range, MIC50 and MIC90 of B. pilosicoli obtained by agar dilution for 12 
antimicrobials against 139 strains are presented in Table 7.3. Published breakpoints for 
anaerobic bacteria are included where they exist. In general, B. pilosicoli strains were 
susceptible to the agents tested, with MIC90 values below the breakpoints. Exceptions to this 
were amoxicillin and clindamycin which had MIC90 values of 64 µg/ml and 8 µg/ml, 
respectively. Erythromycin (MIC90 >512 µg/ml) and ciprofloxacin (MIC90 4 µg/ml) were not 
active against these organisms. Moxifloxacin demonstrated better activity than 
ciprofloxacin, with an MIC90 of 2 µg/ml. Resistance to amoxicillin was alleviated with the 
addition of clavulanic acid to agar with amoxicillin, reducing the MIC90 to 4 µg/ml.  
Clindamycin and erythromycin showed some cross resistance: all strains (n=19) 
resistant to clindamycin had MICs of >512 µg/ml for erythromycin, however 10 other strains 
with MICs of >512 µg/ml for erythromycin were not resistant to clindamycin. 
The distribution of the MICs obtained for amoxicillin, clindamycin, erythromycin, 
gentamicin and tetracycline for all 139 strains is presented in Figure 7.3. A bimodal 
distribution of MICs was recorded for amoxicillin, erythromycin and tetracycline, but not for 
clindamycin or gentamicin. For amoxicillin, the trough in the distribution corresponded to 
the published breakpoint, however, for tetracycline the MIC of all strains was below the 
breakpoint.  
The MICs obtained for amoxicillin, clindamycin, erythromycin, gentamicin and 
tetracycline varied depending on the source of the strains (Table 7.4). All strains from PNG 
villagers were susceptible to these antibiotics, and in all cases this was significantly lower 
than for other groups (P values <0.01 except for gentamicin where P = 0.024). The 
proportion of strains from Australian Aboriginals which were resistant to amoxicillin was 
significantly higher than for other groups (P <0.001). However, significantly lower 
proportions of strains from this group had raised MICs for gentamicin (P = 0.015) and 
tetracycline (P = 0.021). The proportion of strains from migrants to WA which were 
resistant to amoxicillin was not significantly higher than for other groups. However, Chapter 7 - Antimicrobial Susceptibility 
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significantly more strains from Africans (8/10; P = 0.0069) were resistant to amoxicillin, and 
significantly less strains from individuals from the Middle East (1/9; P = 0.011) were 
resistant when compared to other migrant strains. Over 85% of strains from homosexual 
males had elevated MICs for tetracycline (P <0.001). High proportions of strains from pigs 
showed raised MICs for all five antibiotics; these were significantly higher for clindamycin 
(P = 0.046), erythromycin (P = 0.025), gentamicin (P <0.001) and tetracycline (P = 0.013). 
Porcine strains from overseas sources were significantly more likely to exhibit raised MICs 
to clindamycin (P = 0.0048) and tetracycline (P = 0.0056) than Australian porcine strains. 
All population groups excepting those from PNG and Oman contained strains with elevated 
MICs for ≥3 antibiotics, but proportions were only significantly higher in strains from 
homosexual males (P = 0.006) and pigs (P = 0.013), and significantly lower in strains from 
PNG (P = 0.0062). Again, overseas porcine strains were significantly more likely to contain 
strains with raised MICs for ≥3 antibiotics (P = 0.024) than were strains from Australia. 
 
7.3.4 Determination  of  β-lactamase presence by nitrocefin discs 
Over 50% of strains were nitrocefin positive, which closely correlated to proportions 
of amoxicillin resistant strains. Significantly more strains from Aboriginal Australians than 
strains from other sources (P <0.001) were nitrocefin positive, while no strain from PNG 
natives was positive (P <0.001). Again while strains from migrants to Australia were not 
significantly more likely to be positive for nitrocefin than other groups, significantly more 
strains from Africans (9/10; P  = 0.011) were positive when compared to other migrant 
strains. 
 
7.3.5  A comparison of MIC and PFGE data  
Some strains for which the antimicrobial susceptibility was determined were also 
typed by PFGE (described in Chapter 6). The opportunity was therefore taken to compare 
MIC data with PFGE data for isolates from Aboriginal patients, since many of these isolates 
were clustered in clonal groups. This then would determine whether the MIC results were 
from unique strains or from clones that were spread throughout the Aboriginal population. In 
addition, whether clonal groups of isolates identified in Chapter 6 could be differentiated 
further on the basis of these phenotypic data would also be determined.  
The MICs for amoxicillin, clindamycin, erythromycin and tetracycline are compared 
to Mlu1 and Sma1 PFGE types for 29 of the 32 Aboriginal strains, and two closely related 
strains from Kurdish individuals within the same family in Table 7.5. MICs that were within 
one dilution of another were regarded as being the same for the purposes of this analysis. 
Strains from Aboriginals that were placed in clonal groups A - F in Chapter 6 were not Chapter 7 - Antimicrobial Susceptibility 
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significantly more likely to be resistant to amoxicillin (P = 0.63) or have a raised MIC to 
erythromycin (P = 0.30) than strains that were not placed in clonal groups (strains with 
PFGE types 9, 12, 19 and 28). In addition, all strains from Aboriginal individuals that were 
analysed by PFGE produced a β-lactamase. 
Strains within clonal groups A, B, D and E, which were identical after MluI and 
SmaI typing, could be further differentiated into two groups, based on major differences in 
MICs for the four agents. Likewise, strains from the two Kurdish individuals had different 
MIC patterns. The two strains in Mlu1 group 21 remained indistinguishable by this analysis. 
In addition, similarities in MIC pattern existed between closely related isolates, such as those 
with PFGE types 21 and 22.  
No clonal group contained greater than three strains that were indistinguishable in 
terms of both PFGE and MIC data; however, there were five instances where 2 - 3 isolates 
within the same clonal group were impossible to differentiate by these criteria. Therefore, a 
presumption was made that the 29 strains from Aboriginals shown in Table 7.5 represented 
21 clones (“presumptive clones”). The 13 indistinguishable strains were contained in 
presumptive clones 6 (n=3), 10 (n=2), 13 (n=3), 14 (n=3) and 15 (n=2). The MIC50, MIC90 
and proportions of strains with raised MICs were recalculated for the entire collection of 
strains, on the basis of there being 21 presumptive clones among the Aboriginal strains. The 
MIC50 for gentamicin became 8 µg/ml rather than 4 µg/ml, but there was no other difference 
in MIC50 or MIC90 values. There were minor changes to P values, although significances 
were not reclassified as a result of the recalculations. 
 
7.3.6  A comparison of MIC data with other susceptibility analyses 
The antimicrobial susceptibility of 70 strains in this study had been examined 
previously by agar dilution (Trott et al., 1996d; Duhamel et al., 1998b; Hommez et al., 
1998b; Oxberry, 2002). A comparison between the MICs obtained in this and previous 
studies is presented in Table 7.6, with breakpoints for resistance taken as those defined in 
this study. For each antimicrobial assessed in other studies, the MIC of the majority of 
strains was within one dilution of the value obtained in the current study. Only nine strains 
were resistant in other studies but susceptible in this study, and two of these were strains that 
were amoxicillin susceptible but nitrocefin positive. Four strains were susceptible in other 
studies but resistant in this study. The susceptibility of three of these strains to gentamicin 
was determined by Duhamel et al. (1998b), and the fourth was a strain which was resistant 
to ampicillin in one study (Oxberry, 2002), but sensitive in another (Trott et al., 1996d). 
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7.3.7  SHV and TEM β-lactamase PCRs 
Ten β-lactamase producing B. pilosicoli strains were tested using SHV and TEM β-
lactamase PCRs, and none produced bands of 790 bp or 1076 bp, respectively. PCR 
amplification of the E. coli positive controls did produce bands of these sizes. Cell 
preparations of all 10 B. pilosicoli strains amplified in B. pilosicoli 16S rRNA PCR to 
produce bands of 439 bp. 
 
7.4 DISCUSSION 
A standardised, accurate method was required to evaluate the antimicrobial 
susceptibility of B. pilosicoli. An agar dilution method was favoured over broth methods, as 
the latter were considered more difficult to adapt for spirochaete growth. Accordingly, an 
agar dilution method, based on the NCCLS method but modified in various ways, was 
employed for antimicrobial susceptibility testing of B. pilosicoli. This method had two 
possible benefits. Firstly, the development of a standardised method would allow results to 
be compared with future studies. Previous studies testing susceptibility of intestinal 
spirochaetes have tended not to adhere to standardised methods. The majority of previous 
reports have used agar methods, utilising TSA with 5% sheep, horse or cow blood with or 
without defibrination (Kitai et al., 1979; Tompkins et al., 1987; Rønne & Szacer, 1990; Trott 
et al., 1996d; Hommez et al., 1998b; Trampel et al., 1999). Other parameters used have 
varied, such as inoculum concentration from 5 x 10
3 to 1 x 10
7 cfu/ml (Duhamel et al., 
1998b; Hommez et al., 1998b), the duration of incubation from 48 h to 5 d (Tompkins et al., 
1987; Oxberry & Hampson, 1998) at 37°C or 42°C (Kitai et al., 1979; Duhamel et al., 
1998b) and the antimicrobial concentration (Smith et al., 1991; Trott et al., 1996d; Oxberry 
& Hampson, 1998; Duhamel et al., 1998b; Trampel et al., 1999). Additionally, the endpoint 
has varied. Rather than state the MIC as the lowest concentration of antimicrobial yielding 
no growth, MIC has been stated as the lowest concentration to completely prevent 
haemolysis (Kitai et al., 1979; Oxberry & Hampson, 1998; Hommez et al., 1998b).  
Reproducible antimicrobial susceptibility testing of B. hyodysenteriae has been 
achieved also by broth macrodilution (Buller & Hampson, 1994), and a broth microdilution 
method using BHIB plus 10% FCS and specialised plates has been developed (Karlsson et 
al., 1999). However, these plates are manufactured in Sweden and have only recently 
become commercially available, so they could not be used in this study.  
A second advantage of using an NCCLS-based method was the generation of results 
which could then be applied to clinical situations. This would be particularly so for cases of 
bacteraemia with B. pilosicoli, as MIC relates to achievable serum levels of a particular 
antibiotic. However, concentrations in other tissues vary with factors such as the chemical Chapter 7 - Antimicrobial Susceptibility 
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structure of each drug, and the penetration into the site of interest (Harding, 1985). 
Nevertheless, recommendations about the possible effectiveness of therapy can be made 
based on the MIC data alone. Treatments for HIS and other infections with B. pilosicoli have 
varied in case reports, and reasons for therapy failure and reported relapses have not been 
investigated. Additionally, therapeutic decisions have been made without any supporting 
antimicrobial susceptibility data. It was anticipated that producing susceptibility data using 
the method described would overcome some of these issues. 
 
7.4.1  Validation of the agar dilution method for testing of B. pilosicoli 
Initial validation of the agar dilution method involved determining how many B. 
pilosicoli cells were contained in a solution with a turbidity equivalent to a 0.5 McFarland 
Standard (Table 7.1). Ensuring appropriate cell numbers in susceptibility testing is 
important, as inaccurate data can be gathered when cell numbers are too high, due to the 
inoculum effect. This phenomenon is generally observed with β-lactam antibiotics and is 
manifested as a significant increase in MIC when the number of organisms inoculated is 
increased (Brook, 1989). For example, some bacteria appear susceptible when a low 
inoculum such as <10
4 cfu/ml is used, but appear resistant when a higher inoculum such as 
>10
6 cfu/ml is used. The effect has been described in aerobic, facultative and anaerobic 
organisms (Brook, 1989), and has also been described for B. hyodysenteriae (Kitai et al., 
1987). In that study, MICs varied with inoculum size for ampicillin and lincomycin, 
although the MIC for ampicillin was only 3.13 µg/ml with the largest inoculum of 10
8 - 10
9 
cfu/ml.  
A 0.5 McFarland standard is said to correspond to 1.5 x 10
8 cfu/ml (Summanen et 
al., 1993). This number varies, however, depending on cell size and shape, and cell 
characteristics such as clumping ability. For B. pilosicoli, a 0.5 McFarland Standard varied 
from around 3 x 10
7 to 3 x 10
8 cfu/ml in BrB and PBS, which would deliver 3 x 10
4 to 3 x 
10
5 cfu on inoculation to agar with the multipoint replicator. Viable cell numbers were 
slightly lower for WesB than for P43/6/78
T, and this appeared to be a strain related 
difference in the proportion of viable cell numbers in a given suspension. Thus care was 
taken to make suspensions to test the antimicrobial susceptibility of B. pilosicoli neither less 
turbid than a 0.5 McFarland Standard, nor significantly more turbid, otherwise an inoculum 
effect could be experienced. 
Methods of suspension preparation were also compared, using the log reduction in 
viable cell number compared to total cell number. TE was not a suitable solution in which to 
prepare suspensions, as numbers of viable cells were reduced by over four log10 compared 
with total cells.  Both BrB and PBS appeared to support the viability of this anaerobic Chapter 7 - Antimicrobial Susceptibility 
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spirochaete over the short period of time taken for preparation and inoculation. It was 
observed that judging the turbidity of suspensions prepared in BrB was slightly more 
difficult; however, no difference in cell numbers between BrB and PBS was evident. 
Preparing suspensions in the anaerobic chamber did not appear to affect viability, but, as it 
was more cumbersome to estimate turbidity in this manner, suspensions subsequently were 
prepared in air. 
The method chosen to estimate a 0.5 McFarland Standard was a 'by eye' comparison 
between the standard and the suspension in question, prepared in identical tubes. This was 
the fastest method of inoculum preparation, an important consideration for an anaerobic 
organism. A clear broth such as BrB has been recommended for suspension preparation 
(Summanen et al., 1993), and as using this broth did not affect viability, it was eventually 
chosen for determining the antimicrobial susceptibility of B. pilosicoli. However it was not 
possible to blank a nephelometer using BrB, so the “by eye” method was used. The 
reproducibility of the method was also examined in this test, and, regardless of strain, both 
total and viable cell numbers were found to fall within one log10.  
Unless good growth of an organism is achieved, an accurate MIC cannot be 
determined (Jousimies-Somer et al., 2002). Thus, choice of an appropriate medium for 
antimicrobial susceptibility testing of B. pilosicoli was imperative. NCCLS currently 
recommends the use of BrBA supplemented with laked blood, hemin and Vitamin K1 for 
agar susceptibility testing of anaerobes (NCCLS, 2000). WC and WC supplemented with 
serum or blood was a previous recommendation (NCCLS, 1990), however their use is no 
longer advocated, as both are inferior for the growth of fastidious organisms (Jousimies-
Somer et al., 2002). Values for ATCC reference strains were reported to be statistically 
similar among the three media. Since this new information was not available at the time of 
testing, growth was assessed on WC and BrBAS with and without the earlier recommended 
supplements of 5% horse serum and hemin, respectively (Summanen et al., 1993).  
Growth of P43/6/78
T and WesB was supported on WC+HS, BrBAS+H and BrBAS, 
and microscopy confirmed the viability of spirochaetes where growth was easily visible, and 
poor viability where growth was faint. WC+HS was chosen over BrBAS+H for 
antimicrobial susceptibility testing because it was easier to assess the growth characteristics 
of strains and it would be easier to compare spirochaete growth to the control plate. 
Additionally, there was less swarming of B. pilosicoli on WC+HS.  
While growth of 11 of the B. pilosicoli strains was satisfactory on WC+HS after 3 d, 
growth of the twelfth strain was faint. Incubation was increased to 4 d to determine the 
antimicrobial susceptibility of B. pilosicoli in this study. While 48 h is the recommended 
incubation time for anaerobic susceptibility determination (Summanen et al., 1993), most Chapter 7 - Antimicrobial Susceptibility 
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previous susceptibility studies of intestinal spirochaetes have required incubation duration of 
3 or 4 d for these slowly growing organisms. 
 
7.4.2 Antimicrobial  susceptibility testing of B. pilosicoli  
The results obtained in this study indicate that antimicrobial susceptibility testing of 
B. pilosicoli is possible by an agar dilution method based on the NCCLS method with 
various modifications. To summarise, these included use of WC agar with 5% horse serum, 
and an increased incubation time to 4 d. These modifications permitted consistent growth of 
all strains tested while allowing reference anaerobes to remain within their target susceptible 
ranges. The method was highly reproducible and easily adapted for testing B. pilosicoli, and 
may be suitable for testing other fast growing Brachyspira spp. 
Over 45% of B. pilosicoli strains tested had MICs of amoxicillin above 4 µg/ml, the 
NCCLS breakpoint for the agent. Amoxicillin susceptibility was restored by clavulanic acid 
in all instances, suggesting β-lactamase involvement. Similar findings were reported by 
Tompkins et al. (1987), who examined 19 spirochaete isolates from Asians and homosexual 
males living in the UK. Activity against penicillin and ampicillin was demonstrated in four 
of the spirochaetes, which were almost certainly B. pilosicoli, and clavulanic acid lowered 
the MICs for these antibiotics. Furthermore, the β-lactamases were membrane bound and 
non-inducible.  
Nitrocefin disks were used as another measure of β-lactamase activity, and to ensure 
that amoxicillin MICs were a true indication of resistance, rather than due to the inoculum 
effect. β-Lactamase activity determined by nitrocefin disk was present in greater than 50% 
of the strains in this study. For all except eight strains, nitrocefin positivity corresponded to 
an amoxicillin MIC above the breakpoint. The remaining strains had MICs of 2 µg/ml and 4 
µg/ml, and were also considered to be resistant to amoxicillin.  
Similar mechanisms of action are shared by macrolide, lincosamide and type B 
streptogramin antibiotics, and a common resistance pattern is produced (Karlsson et al., 
1999). The cross-resistance between these antibiotics is due to a mutation or methylation at 
equivalent to base 2058 or 2059 of the E. coli 23S rRNA gene (Weisblum, 1995). This 
phenomenon has been described in B. hyodysenteriae (Karlsson et al., 1999), where cross- 
resistance was demonstrated for clindamycin with both erythromycin and tylosin. It is likely 
that similar mechanisms exist in B. pilosicoli, although the situation here appears more 
complex.  
High erythromycin MICs were demonstrated by Karlsson et al. (1999; 2001) in B. 
hyodysenteriae (>256 µg/ml), in a small study of B. pilosicoli isolates by Trott et al. 
(1996d), and more recently for B. intermedia, B. innocens and B. murdochii (Karlsson et al., Chapter 7 - Antimicrobial Susceptibility 
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2003). In the current study, the majority of strains had very high erythromycin MICs 
possibly a result of species differences, but more likely due to incubation in an atmosphere 
containing 10% rather than 6% CO2 (Karlsson et al., 1999). Increased CO2 is known to 
decrease the pH value of the medium, and hence the activity of erythromycin in an anaerobic 
atmosphere (Goldstein et al., 1981).  
It was not surprising that all strains resistant to clindamycin had erythromycin MICs 
of >512 µg/ml, due to this cross-resistance. However, it was unexpected that 10 strains with 
erythromycin MICs of >512 µg/ml were susceptible to clindamycin. While five of these 
strains had MICs of 4 µg/ml and were probably resistant to clindamycin, three strains had 
MICs of ≤1 µg/ml and thus appeared to be truly susceptible to clindamycin. It was likewise 
unexpected that the clindamycin distribution of MICs was unimodal, but the distribution for 
erythromycin was bimodal. The in vitro susceptibility of these antimicrobials may need 
repeating in an atmosphere with less CO2 before determining if some alternative mechanism 
of resistance was operating here.  
As discussed throughout the work described in this thesis, Brachyspira pilosicoli 
can be isolated from different human populations, and it was thought that in vitro 
antimicrobial susceptibilities of groups of strains could differ depending on source. 
Therefore, organisms from as many representative groups as possible were chosen for 
testing. As expected, variations in MIC were observed for the diverse groups. The 
susceptibility of strains from people in a single PNG village to all antibiotics except 
ciprofloxacin was of considerable interest. These villagers had very basic living conditions, 
and were originally chosen for study in 1996 because of their lack of exposure to antibiotics 
(Trott, 1997). These strains may represent a naive population of B. pilosicoli which has had 
little exposure to antibiotics. 
Strains from the other population groups demonstrated resistance to β-lactams and 
lincosamides, and raised MICs for other antibiotics. A significantly higher proportion of the 
B. pilosicoli isolates obtained from the Aboriginal Australian population than from other 
groups contained a β-lactamase. This finding probably reflects the exposure of the 
Australian Aboriginals to antibiotics. Respiratory disease and otitis media are significant 
health problems in the Aboriginal Australian population (Williams et al., 1997; Leach, 
1999). Pneumococci are the biggest cause of pneumonia and otitis media in this population, 
and recommended therapies are penicillin G and amoxicillin, respectively (Grimwood et al., 
1997; Williams et al., 1997). Prior exposure to these drugs may therefore explain why B. 
pilosicoli strains were highly resistant to amoxicillin in this population.  
Nothing was known about the history of antibiotic usage in the migrant population. 
Thus the significance of detecting amoxicillin resistance in over 45% of strains from this Chapter 7 - Antimicrobial Susceptibility 
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population is uncertain. Likewise, detecting significantly more strains containing β-
lactamase from Africans than from other migrant sources is of undetermined importance, 
although numbers were small. High rates of amoxicillin resistance and β-lactamase 
production were demonstrated also in the strains from Oman. These strains were thought to 
come from individuals without recent antibiotic treatment (Barrett, 1990), although lifetime 
antibiotic usage in these patients was not recorded.  
Although no strain was resistant to tetracycline based on NCCLS breakpoints, 
strains from pigs and homosexual males demonstrated significantly higher proportions of 
strains with raised MICs between 1 - 4 µg/ml for this antibiotic, a phenomenon also recorded 
by Tompkins and colleagues in isolates from three homosexual males (Tompkins et al., 
1987). This latter group may have been exposed to tetracycline to treat sexually transmitted 
diseases, which could explain the shift obtained in the MIC of tetracycline. The presence of 
multiply resistant strains in this group may be due to similar reasons. However, the 
significance of observing tetracycline MICs of 1 - 4 µg/ml rather than NCCLS defined 
resistance of >8 µg/ml is unknown, and these strains may warrant further investigation.  
As expected, many swine strains demonstrated resistance to β-lactam and 
lincosamide antibiotics. This group contained a significantly higher proportion of strains 
with raised MICs for ≥3 antibiotics than other groups, possibly due to the wide use of 
antibiotics in the veterinary setting as growth promoters and therapeutic agents. The 
prominent use in swine farming of tylosin, another macrolide, and lincomycin, another 
lincosamide, has led to reports of a high frequency of resistance of intestinal spirochaetes to 
these antibiotics (Karlsson et al., 1999). This could account for decreased susceptibilities to 
erythromycin and clindamycin in porcine strains. Penicillins are also used frequently as 
therapy for other swine infections, although assessment of susceptibility to β-lactam 
antibiotics has been previously published only for B. hyodysenteriae (Kitai et al., 1979), 
where resistance was not noted. Non-Australian porcine strains were generally more 
resistant to the antimicrobials tested than the Australian strains. However, as only small 
numbers of strains were analysed, no further conclusions could be drawn.  
Only strains from pigs demonstrated significantly higher proportions of raised MICs 
for gentamicin, and again this was probably a reflection of antibiotic usage in these animals. 
Gentamicin is poorly active in anaerobic or hypercapnic conditions, and MICs are raised 4 to 
20 times compared with MICs measured in aerobic environments (Reynolds et al., 1976; 
Verklin & Mandell, 1977). As organisms in aerobic conditions are considered susceptible to 
gentamicin at MICs of ≤4 µg/ml, all strains in this study would be considered susceptible to 
this agent. Interestingly, Duhamel et al. (1998b) also tested the antimicrobial susceptibility 
of the six North American porcine isolates to gentamicin by agar dilution, and observed Chapter 7 - Antimicrobial Susceptibility 
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MICs of 1 µg/ml for all six. This result contrasted with MICs of 8 to 32 µg/ml for the strains 
observed in this study. Possible differences in the generation of an anaerobic atmosphere or 
inoculum size could account for these disparate values. Duhamel et al., (1998b) 
recommended breakpoints for gentamicin with pig isolates of ≤1 µg/ml as susceptible, 5 
µg/ml as intermediate and ≥10 µg/ml as resistant, however the bimodal distribution they 
described was not seen in this study, possibly as a result of the differences outlined above.  
Of the 64 remaining strains examined in this and other agar dilution studies, only 10 
other strains differed with respect to their resistance. The MICs of most strains were within 
one dilution of the value obtained in this study, despite differences in method and MIC 
determination (Trott et al., 1996d; Hommez et al., 1998b; Oxberry, 2002). However, as two 
of the above studies (Trott et al., 1996d; Oxberry, 2002) did not use doubling dilution series, 
less concordant results may have been obtained had these studies involved more dilutions. 
The dissimilarity in susceptibility results are probably due to these differences in 
methodology. 
Comparisons of PFGE and MIC values were made because of potential concerns 
regarding the accuracy of the calculations of MICs and proportions of resistant strains from 
the Aboriginal Australians, as these strains clustered together in clonal groups. When MIC 
and PFGE results were combined (Table 7.5), further distinctions could be made between 
some strains in all clonal groups except group C. Thirteen strains could not be discriminated. 
However, even when the presumption was made that all 13 strains represented five 
presumptive clones and MIC data were recalculated, differences to MIC50, MIC90 and P 
values were very minor. As few strains were involved, the influence of this as a cause of 
distortion to the MCI data was not examined further.  
In Chapter 6, it was suggested that the presence of an epidemic population structure 
for Aboriginal strains might relate to the presence of virulence factors or antibiotic 
resistance. β-Lactamase enzymes were present in strains from Aboriginal individuals, and 
absent in PNG strains, where a panmictic population structure had been previously 
demonstrated (Trott et al., 1998). From this comparison, however, it remains uncertain 
whether the presence of β-lactamase in Aboriginal strains was the reason why clonal groups 
were identified, since all the strains tested by PFGE contained a β-lactamase. While non-
clonal isolates may have belonged to other clonal groups not examined in this study, due to 
chance alone, further investigation of the reasons for differences in population structure of 
isolates obtained from various human population groups is required. 
 Chapter 7 - Antimicrobial Susceptibility 
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7.4.3  β-Lactamase production in B. pilosicoli 
It was not determined in this study whether amoxicillin resistance in B. pilosicoli 
was the result of a mutation to the penicillin binding protein or as the result of genetic 
exchange with another species of bacteria. The results here represent one of these 
alternatives, rather than intrinsic resistance, as both resistant and susceptible strains were 
observed. It is plausible that mutation followed by selection may have occurred, as a high 
proportion of resistance was found in the Aboriginal population in which penicillin usage is 
high, and absent in the PNG population, where previous exposure was lacking. It is quite 
possible that the spread of resistance in the Aboriginal population was driven by this 
selective pressure. 
Further insight might be gained with an examination of the β-lactamase enzymes. 
While over 190 β–lactamase enzymes have already been described (Bush et al., 1995), the 
β–lactamases detected here could represent novel enzymes, as spirochaete genetics are 
unique among eubacteria (Zuerner, 1997). Full characterisation of novel β–lactamase 
enzymes involves determining substrate profiles, including maximal hydrolysis rates (Vmax) 
and binding affinities (Km), inhibition profiles and isoelectric focussing characteristics, 
followed by comparisons with known β–lactamases with similar behaviour (Bush, 1989a). 
Cloning, sequencing and molecular characterisation are also important, but evaluating the 
biological activity is the most pertinent procedure. A detailed investigation of this type was 
not within the scope of this thesis. Such an investigation might allow examination of how 
enzymes in different strains were related to each other and to enzymes in other organisms. 
Conclusions could then be drawn regarding the possible origin of resistance.  
There is also no data and thus deficient understanding about the mode of genetic 
exchange in intestinal spirochaetes. Tompkins and colleagues (1987) were unable to 
demonstrate the presence of plasmids or the transfer of β-lactamase activity in the four 
strains they examined. Adachi and colleagues (1994), reported 3 plasmids in B. 
hyodysenteriae-like spirochaetes, however no further reports regarding this finding have 
been published. Plasmids are yet to be reported in other intestinal spirochaetes (Zuerner, 
1997). Extra-chromosomal DNA elements detected in B. hyodysenteriae and B. innocens 
(Joens et al., 1986; Combs et al., 1992), originally considered to be plasmid DNA, are now 
believed to have originated from bacteriophages (Humphrey et al., 1995). 
A transducing bacteriophage, VSH-1, capable of frequent, random packaging of 
chromosomal DNA has been induced in B. hyodysenteriae (Humphrey et al., 1997). 
Exchange of a gene conferring coumermycin A resistance between B. hyodysenteriae cells 
in broth culture was achieved, and VHS-1 was considered to be the likely agent of gene 
transfer (Stanton et al., 2001). Phages with similar morphology to VHS-1 have been induced Chapter 7 - Antimicrobial Susceptibility 
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in  B. pilosicoli (Calderaro et al., 1998). Although transduction studies have yet to be 
attempted in B. pilosicoli, it is possible that a bacteriophage similar to VSH-1 could be 
responsible for transfer of β–lactamase resistance between strains of B. pilosicoli. 
Based on the resistance of strains to amoxicillin and inhibition by clavulanic acid, it 
was considered that the β–lactamases in B. pilosicoli belonged to the Group 2 β–lactamases. 
This family contain enzymes which are active against a variety of penicillins and/or 
cephalosporins and are all inhibited by clavulanic acid. An attempt to confirm the β–
lactamases in B. pilosicoli as a TEM or SHV enzyme using PCRs to amplify portions of the 
β–lactamase genes was unsuccessful. The TEM and SHV are families in Group 2b and 2b', 
and are among the most common and well characterised of the plasmid mediated extended 
spectrum  β–lactamases found in Gram negative gut flora (Bush, 1989b). However, as 
substrate information was limited and plasmids are not common in Brachyspira, it was no 
surprise that this attempt was unsuccessful. The sequences of a β-lactamase gene may be 
quite novel and consequently, a detailed study of the nature, source and potential 
transmissibility of β–lactamases in B. pilosicoli is required.  
 
7.4.4 Therapeutic  considerations 
Previous reports on the in vitro antimicrobial susceptibility of intestinal spirochaetes 
have focussed on B. hyodysenteriae and porcine strains of B. pilosicoli, due to their 
significance in veterinary medicine. The most commonly utilised and thus best evaluated 
agents have included carbadox, tiamulin, lincomycin, tylosin and dimetridazole. However, in 
Australia, antimicrobials used for animals and humans are different (Anonymous, 1999), so 
the work on these agents is not of direct relevance to human medicine. In addition, the 
numbers of studies on B. pilosicoli have been small because the economic impact of PIS on 
the pig industry has not been well characterised.  
Although B. pilosicoli apparently has the capacity to cause prolonged diarrhoea, 
abdominal pain and rectal bleeding in humans, and has been isolated from bacteraemic 
patients on rare occasions, clinical susceptibility data are lacking. It was considered that 
comprehensive standardised susceptibility data were required to aid therapeutic decisions in 
these situations. For this reason, the activity of 12 clinically relevant antibiotics from 
representative families of compounds was tested in this study.  
It is recognised that spirochaetes are susceptible to many agents (Murray et al., 
1995). Consistent with this, all strains of B. pilosicoli were susceptible to ceftriaxone, 
chloramphenicol, meropenem, metronidazole and tetracycline based on NCCLS breakpoints 
for anaerobes. Breakpoints are currently unavailable for ciprofloxacin, which was tested as it 
is often used to treat diarrhoeal illness (Spicer et al., 2000), however, using a breakpoint of Chapter 7 - Antimicrobial Susceptibility 
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≥4 µg/ml (Snydman et al., 2000) 60% of isolates were resistant, consistent with the finding 
that the early quinolones, including ciprofloxacin, are not very active against anaerobes 
(Applebaum, 1995). The activity of moxifloxacin was slightly improved, although MICs 
were slightly higher than for other susceptible anaerobes (Goldstein et al., 2000).  
Metronidazole would be the drug of choice for therapy of HIS, or to remove carriage 
with B. pilosicoli, based on this susceptibility data and the history of its use. Treatment of IS 
with metronidazole has been frequent, and mostly successful. Initial failure occurred when 
the drug was used in combination with neomycin (White et al., 1994), and some relapses 
were associated with use of a suppository for a short duration (Douglas & Crucioli, 1981; 
Rodgers et al., 1986). In these instances and with other relapses (Cotton et al., 1984; 
Kostman et al., 1995), further treatment with metronidazole removed spirochaetes and 
relieved symptoms. Additionally, metronidazole is well established as a drug for use in gut 
infections and infections with anaerobic organisms (Freeman et al., 1997). It is well 
absorbed and has activity against the intestinal parasites which frequently have been found 
in association with spirochaete infection (Law et al., 1994; Duhamel et al., 1996; Trott et al., 
1996b) (Chapter 3). Although no longer used in veterinary medicine in Europe (Hommez et 
al., 1998b), due to concern about the carcinogenic potential of long-term metronidazole use 
in animals, cancer in humans due to metronidazole treatment has not been observed (Falagas 
et al., 1998). So long as the agent remains acceptable for human use, it would be the best 
choice for treatment of intestinal infections with B. pilosicoli.  
Although there are early reports describing the use of neomycin for treatment of IS 
(Gad et al., 1977), it was not tested in this study as it is potentially ototoxic and nephrotoxic 
(Masur et al., 1976), and even topical use is now rare (Spicer et al., 2000). Treatment with 
this agent has reportedly removed spirochaetes, but not relieved symptoms (Henrik-Nielsen 
et al., 1983; White et al., 1994). High MICs in both B. pilosicoli (Trott et al., 1996d; 
Trampel et al., 1999; Oxberry, 2002) and B. hyodysenteriae (Kitai et al., 1979; Trott et al., 
1996d) could explain these observations. Tetracyclines (as doxycycline) occasionally have 
been used to treat IS (Gad et al., 1977; Tompkins et al., 1987; Kostman et al., 1995), again 
with mixed results. As tetracyclines are used infrequently in Australian medicine for 
gastrointestinal disorders, the raised MICs observed in this study are probably clinically 
unimportant. The remaining antimicrobials to which B. pilosicoli were susceptible are not 
used to treat gastrointestinal infections.  
The high rates of β-lactamase production demonstrated in some groups of strains 
could explain reports of treatment failure of penicillin antibiotics in some cases of IS (Gad et 
al., 1977; Ruane et al., 1989; Kostman et al., 1995). Another concern is the use of penicillin 
as empirical therapy in spirochaetaemia. In the nine reported cases of B. pilosicoli Chapter 7 - Antimicrobial Susceptibility 
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spirochaetaemia, penicillin was used in two. Both patients responded to therapy, but 
subsequently died from cardiac or multi-organ failure (Lambert & Goursot, 1982; Kanavaki 
et al., 2002). Unfortunately these strains were not available for study and therapy was not 
recorded for the remaining cases. Based on these findings, penicillins could not be 
recommended for treatment of infections with B. pilosicoli. Suitable alternatives for 
septicaemic cases would be intravenous ceftriaxone or Timentin (ticarcillin plus clavulanic 
acid) (Spicer et al., 2000).  Chapter 8 - General Discussion 
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C CH HA AP PT TE ER R   8 8: :   G GE EN NE ER RA AL L   D DI IS SC CU US SS SI IO ON N   
8.1 INTRODUCTION 
The purpose of this final chapter is to bring together the findings made during the 
course of the study, and to discuss these in relation to the initial aims of the project. Areas 
where further work is required are also highlighted. The work described in this thesis had the 
following five main aims, which were to: 
1.  Develop appropriate methods for the detection of the two intestinal spirochaete species 
B. aalborgi and B. pilosicoli in human faeces, including improved isolation media, and 
DNA extraction and PCR techniques directly on faeces. 
2.  Use these methods to investigate the epidemiology and disease associations of B. 
pilosicoli and B. aalborgi carriage in Western Australians.  
3.  Develop methods to detect B. pilosicoli from the human blood, and determine the 
prevalence of B. pilosicoli spirochaetaemia. 
4.  Examine the genotypic relationships between isolates obtained and pre-existing strains 
using pulsed-field gel electrophoresis. 
5.  Examine the antimicrobial susceptibilities of B. pilosicoli isolates obtained and compare 
these with those of existing B. pilosicoli strains. 
 
8.2  METHODS FOR SPIROCHAETE DETECTION  
8.2.1  Detection in faeces 
At the outset of this investigation, the methodologies which existed for examination 
of intestinal spirochaetes in faecal specimens included microscopy, culture and PCR, 
however limitations existed with all techniques. Identification of B. pilosicoli and B. 
aalborgi  was difficult using microscopy, as the two spirochaetes species are 
morphologically similar. Problems were met with cultivation, with the spirochaetes 
requiring lengthy anaerobic incubation on nutritious growth media. In particular, culture of 
B. aalborgi was difficult, with only one isolate having been obtained from an intestinal 
biopsy, although by the end of this investigation, further strains had been isolated from 
intestinal biopsies (Kraaz et al., 2000; Jensen et al., 2001) and, very recently, from faeces 
(Calderaro et al., 2003). Methods of DNA extraction from faeces for use in PCR had been 
examined, but lacked sensitivity (Atyeo, 1998). Following the development of PCR primers 
for both Brachyspira spp. by a colleague investigating spirochaete prevalence in intestinal 
biopsy samples (Mikosza et al., 1999; Mikosza et al., 2001), it became possible to adopt 
PCR protocols to examine the prevalence of both organisms in faeces.  Chapter 8 - General Discussion 
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Three column methods for extraction of DNA from faeces were trialled using faecal 
samples that were seeded with B. pilosicoli or B. aalborgi. The QIAmp DNA stool mini kit 
was the most sensitive, and had a lower false negative rate than the JETQuick tissue DNA 
spin kit. This kit was optimised for DNA extraction from clinical specimens. A single step 
PCR was performed, utilising the previously developed primers targeting the 16S rRNA 
gene, as species-specific nested primers could not be developed in the region.  
Culture, microscopy and PCR were compared for detection of these organisms in 
faeces. As predicted, microscopy was useful for determining the presence of spirochaetes in 
faecal samples, but identification of the species was not possible using this technique. 
Culture enabled isolation of B. pilosicoli for further characterisation, and had the lowest 
limit of techniques for detection of this organism, but B. aalborgi recovery was poor. An 
array of alternative media components was examined for selective enrichment of B. aalborgi 
from faecal samples, as well as various incubation and pH parameters. However, only one B. 
aalborgi isolate was obtained from five PCR-confirmed positive individuals. This isolation 
was achieved using the optimal medium of BHIA plus 10% bovine blood, spectinomycin 
and polymyxin B, with incubation in an anaerobic jar at 37°C for 21 d. This was the first 
strain of B. aalborgi isolated from faeces at the time the work was carried out, indicating 
that isolation of the spirochaete from a sample with high numbers of competing flora was 
possible, but was by no means easy or common.  
PCR was the best overall method for examining the prevalence of Brachyspira spp. 
in faecal samples. The highest prevalence of both spirochaetes was obtained by this method, 
as well as the successful detection of B. aalborgi in all four population groups. Detection of 
spirochaetes by PCR was limited to spirochaetes of known sequences, however, sequences 
from all three Brachyspira clusters identified by Pettersson et al. (2000) were amplified in 
this investigation. As sequencing becomes cheaper and more commonplace, it is possible 
that our understanding of intestinal spirochaete prevalence will continue to expand. The use 
of this technique after PCR amplification with general Brachyspira  primers may allow 
identification in humans of currently uncultivated and uncharacterised spirochaete species, 
such as the putative species “B. christiani” (Jensen et al., 2001).  
 
8.2.2  Detection in blood 
At the commencement of this investigation, the prevalence of B. pilosicoli in blood 
in Australia was unknown. Although B. pilosicoli spirochaetaemia had been described in 
Europe and the USA, it had not been described in Australia. In order to investigate this 
effectively, the methods for culture of this organism in blood required optimisation. Systems 
chosen were the automated BACTEC and BacT/Alert systems and the manual Septi-Chek Chapter 8 - General Discussion 
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used widely by clinical laboratories in Australia, as well as the Hémoline manual system 
which had been used to isolate the majority of previous strains. All but the BacT/Alert 
performed adequately but required an extended incubation protocol, due to the slower 
growth of the spirochaetes. Moreover, detection in the BACTEC system was less laborious 
and time consuming due to the automated monitoring process.  
Methods were not optimised for the detection of B. aalborgi in blood, as the 
prevalence of faecal carriage of around 6% in different populations was not known at the 
time this work was carried out. In addition, spirochaetaemia with this organism has not yet 
been described. As more is learned about the pathogenicity of B. aalborgi, detecting this 
spirochaete in the blood may become important.  
 
8.3  THE EPIDEMIOLOGY OF B. AALBORGI AND B. PILOSICOLI  
8.3.1 Faecal  carriage 
Prior to the commencement of this study, understanding of the presence and 
distribution of Brachyspira spp. in humans was far from complete. In Australia, B. pilosicoli 
had been isolated from Aboriginals, homosexual males and HIV positive individuals, at 
between 10 and 40%, and identified in other populations in the developing world at <1%. B. 
aalborgi had been isolated from one biopsy specimen. Simultaneously with this study, a 
colleague applied PCR to intestinal biopsies with evidence of HIS (Mikosza et al., 1999). 
This and subsequent prevalence studies (Kraaz et al., 2000; Jensen et al., 2001; Mikosza et 
al., 2001) demonstrated B. pilosicoli in only 0 - 14% of cases of HIS. By contrast, B. 
aalborgi accounted for around 57 - 85% of cases, despite being isolated from only six 
biopsies from individuals with HIS. All were Caucasian individuals in whom a biopsy was 
required. B. aalborgi was only recently identified at a prevalence of 6% and 22.2% in faeces, 
in two populations from developing countries.  
The current investigation of the prevalence of Brachyspira spp. was performed using 
PCR on faeces, to avoid the perceived biases of previous studies. Most of the investigations 
of spirochaete prevalence in HIS used colorectal biopsies collected from ill Caucasians from 
developed countries, moreover, B. aalborgi prevalence could not be estimated in studies 
relying on culture. The populations and methodology chosen here eliminated both these 
problems. As a result, a new understanding was gained of B. aalborgi in human populations. 
B. aalborgi was identified at a similar prevalence (6 - 8%) from ill rural Aboriginal and non-
Aboriginal Australians, healthy migrants to Western Australia, and healthy, mainly 
Caucasian control individuals. In addition, approximately equal proportions were obtained 
from migrant individuals from African, Middle Eastern and Eastern European countries.  Chapter 8 - General Discussion 
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By contrast, B. pilosicoli was identified only in the Aboriginal Australians and 
migrants, again at similar rates in each group (15%), but at a higher prevalence than B. 
aalborgi. Significantly higher carriage was detected in migrants from Asian, African and 
Middle Eastern countries than from Eastern European countries. These distributions were 
similar to the previous high prevalence determined in populations from developing countries 
(Tompkins et al., 1986; Barrett, 1990; Trott et al., 1997a; Margawani et al., 2003; Munshi et 
al., 2003c) and Aboriginal Australians (Lee & Hampson, 1992), and the low prevalence in 
Caucasian individuals (Tompkins et al., 1986; Lee & Hampson, 1992). Therefore, the 
predominance of B. aalborgi in studies of HIS seems to relate to this organism being the 
more prevalent spirochaete in the Caucasian populations which were tested.  
It seems likely that the differences in spirochaete prevalence in the four population 
groups are the result of differences in exposure to B. pilosicoli and B. aalborgi. From this 
study it is possible to extrapolate that B. aalborgi may be present at similar proportions 
throughout many human populations. However, the means by which B. aalborgi 
colonisation occurs are currently unknown. Experimental infection with B. pilosicoli, and 
the subsequent development of symptoms, was shown to be possible in a healthy Caucasian 
individual (Oxberry et al., 1998), so the differences in B. pilosicoli prevalence that have 
been recorded cannot be explained by ethnicity. In addition, rural living per se was not 
responsible for colonisation in Aboriginals, as rural non-Aboriginals were not colonised by 
B. pilosicoli. However, differences may have existed in living conditions and behaviours 
between the two rural populations. In Aboriginals, these may have resulted in an increased 
faecal-oral contact with B. pilosicoli as a consequence of poor hygiene, poor drinking water 
quality, crowded living conditions and possibly increased exposure to animals, although 
evidence for zoonotic transmission of B. pilosicoli to humans has not been strong. 
Additional factors such as poor nutrition and being immunocompromised, which have been 
linked to B. pilosicoli infection in humans and animal species, also may have been 
responsible for the high prevalence in Aboriginals and migrants.  
In the ill populations, carriage of Brachyspira spp. was also related to age. Carriage 
of each organism in Aboriginal Australians was predominant in patients aged 2 - 18 y, with 
carriage of B. aalborgi associated with those >2 y, and B. pilosicoli carriage increased in 
those >60 y. Carriage of B. aalborgi in non-Aboriginals was significantly higher in patients 
>18 y and those between 60 - 69 y. Previous studies have identified higher B. pilosicoli 
carriage in children over 2 years (Lee & Hampson, 1992; Trott et al., 1997a), with young 
post-weaning animals also being the most susceptible to B. pilosicoli infection. The 
association of B. pilosicoli carriage with the older age group is a new finding. Likewise, the 
association of B. aalborgi carriage with any age group is novel, as detection of B. aalborgi Chapter 8 - General Discussion 
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carriage (albeit in healthy populations) in recent studies was not related to age (Munshi et 
al., 2003a; Munshi et al., 2003c).  
The predominant carriage of B. pilosicoli by individuals in the younger age groups 
was considered to be possibly related to the commencement of weaning and exposure-
related behaviours such as mouthing objects, increased mobility and loss of protective 
maternal antibody. The presence of the spirochaetes in the older groups may be due to a 
waning immunity. As B. aalborgi carriage was low in children under 2 y, it may be that a 
factor related to the age of weaning also has a function in B. aalborgi infection.  
In Aboriginals and migrants, detection of B. aalborgi and B. pilosicoli related to 
carriage of the other spirochaete, and the presence of a number of intestinal parasites. Few 
recent studies have specifically examined the role of other organisms in relation to detection 
of intestinal spirochaetes. However, the association of parasites with intestinal spirochaetes 
was identified in the early (pre-1930s) studies of intestinal spirochaetes, and has been 
reported in animal species infected with B. pilosicoli. In addition, a variety of other 
organisms has been detected with spirochaetes in cases of HIS (Takeuchi et al., 1974; Burns 
& Hayes, 1985; Surawicz et al., 1987).  
The presence of parasites may be markers for decreased hygiene in these 
populations, relate to behavioural and other factors such as young age common to the 
acquisition of both spirochaetes and parasites, or be due to an as yet unknown interaction 
between the organisms. If an interaction existed between the parasites and the spirochaetes, 
the parasites and/or the spirochaetes could encourage heavier colonisation of either 
organism, due to a change in the gut microenvironment, and thus be responsible for 
symptoms seen in some individuals. It may be possible that one specific organism has the 
capacity to interact with intestinal spirochaetes, such as the flagellated bacteria seen by 
Takeuchi et al. (1974) which were recently identified as Helicobacter spp. (Duhamel et al., 
2002). However, there were a number of different organisms associated both with HIS and 
with spirochaete carriage in this study. This finding may indicate that a more general 
mechanism, such as an alteration to the mucosa, is operating. Whether an interaction exists 
between parasites and spirochaetes, and whether HIS is a polymicrobial infection requires 
further investigation.  
In the analysis of B. pilosicoli carriage, there was little evidence for direct person to 
person transmission among migrant individuals. While two strains from two migrants within 
one family were closely related after PFGE analysis, other strains from members of other 
families were not related. In addition, families with one positive individual were not 
significantly more likely to contain another positive individual. Thus the two strains in 
question could have been obtained from the same infective source, rather than being directly 
transmitted. Conversely, there did appear to be indirect evidence for transmission of B. Chapter 8 - General Discussion 
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aalborgi between migrant family members, as families with one positive individual were 
significantly more likely to contain another positive individual. This trend was supported 
also by the observation that in the control population, two colonised children were in the 
same family.  
It is likely that B. pilosicoli infection in humans is spread by the faecal-oral route, 
with contaminated water a primary vehicle, although no study has been expressly designed 
to investigate this idea. The mechanisms of B. aalborgi transmission are yet to be elucidated. 
The faecal-oral route again seems most plausible, particularly as detection of B. aalborgi in 
both Aboriginals and migrants was associated with B. pilosicoli carriage. However, the 
organism may have a different survival rate in the environment to B. pilosicoli, and thus a 
more direct infection method may be predominant. Nevertheless, until a greater ability to 
culture this organism is achieved, investigations into transmission and survival rates in water 
and other potentially infectious sources may be difficult.  
 
8.3.2 Blood  culture 
Initially, there were concerns that B. pilosicoli spirochaetaemia might be occurring 
in some Western Australian populations with a high rate of intestinal carriage of the 
organism, but was going undiagnosed. Despite optimisation of methods for the culture and 
detection of B. pilosicoli in the BACTEC automated system, and the testing of over 800 at-
risk patients over a period of 18 months, an isolate was not obtained from the blood. 
Additionally, in the period between February 2000 and the present (July 2003), no case has 
been reported in Australia. Thus the prevalence of spirochaetaemia due to B. pilosicoli is 
likely to be very low. 
 
8.3.3 Molecular  epidemiology 
Molecular techniques were used to expand understanding of the epidemiology of the 
Brachyspira spp. infecting humans. As well as being useful to examine the relationships 
between specific strains, the population genetics of B. pilosicoli strains were compared after 
PFGE analysis. Despite B. pilosicoli being genetically diverse, geographically and 
temporally removed strains from Aboriginals were clustered together in clonal groups. This 
was consistent with a previous finding that strains from this population had an epidemic 
structure, and opposed to the observation that strains from PNG had a panmictic structure 
(Trott et al., 1998). This finding correlated well with the presence of a β-lactamase activity 
in strains from the Aboriginal population, and the absence of this activity in strains from 
PNG. The β-lactamase activity could be one explanation for the presence of the clonal 
groups, in that Aboriginal children may be prescribed β-lactam antimicrobials, and this Chapter 8 - General Discussion 
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selective pressure may have allowed selection of strains with this enzyme. However, as 
Aboriginal strains placed in both clonal and non-clonal groups contained β-lactamase 
enzymes, this explanation is either incorrect, or the non-clonal groups were in fact members 
of other clonal groups not identified in this study. Therefore, further investigation into the 
reasons for differences in population structure for various population groups is required. 
B. aalborgi was not typed by PFGE in the study, although limited sequence typing 
of PCR products was performed. While the sequences analysed were only short, all three 
currently recognised clusters of B. aalborgi appeared to be represented. A more complete 
molecular typing analysis of B. aalborgi from all four population groups would further the 
understanding of the epidemiology of this spirochaete.  
 
8.4  PATHOGENIC POTENTIAL AND CLINICAL SIGNIFICANCE OF 
INTESTINAL SPIROCHAETES 
The roles that B. pilosicoli and B. aalborgi play in human disease have not been 
clearly defined. Evidence for the organisms having pathogenic significance includes both 
Brachyspira spp. being observed in people with mild or chronic diarrhoea, rectal bleeding, 
and abdominal pain or discomfort (Guccion et al., 1995; Trivett-Moore et al., 1998; Mikosza 
et al., 2001). B. aalborgi may also be associated with pseudoappendicitis. More serious 
infections associated with intestinal spirochaetes have included invasive colitis and hepatitis 
(Kostman et al., 1995; Padmanabhan et al., 1996), while B. pilosicoli has been isolated from 
the blood of nine ill and immunocompromised individuals, with death occurring in six cases 
(Lambert & Goursot, 1982; Fournié-Amazouz et al., 1995; Trott et al., 1997b; Kanavaki et 
al., 2002). Experimental infection with a human strain of B. pilosicoli has been achieved in 
an Australian adult male, leading to abdominal discomfort, flatulence and headaches, which 
resolved after treatment (Oxberry et al., 1998). Experimental infection of chickens and pigs 
with the same strain resulted in diarrhoea and the presence of end-on attachment of the 
spirochaetes to the caecal mucosa (Trott et al., 1995; Trott et al., 1996b). However, carriage 
of both organisms also has been detected in healthy individuals (Trott et al., 1997a; Munshi 
et al., 2003c), and in many situations where symptoms were observed, other causes of these 
symptoms could be found. 
Unfortunately, it remained unclear from this study whether either B. pilosicoli or B. 
aalborgi was the cause of gastrointestinal disease. For both spirochaetes, approximately 
equal proportions of each organism were found in sick and healthy individuals. The 
spirochaetes could have been innocuous in most individuals, with other organisms or causes 
responsible for the reported symptoms in ill populations. In this case, carriage in the healthy 
groups provides evidence of this lack of pathogenicity. Many researchers have presumed Chapter 8 - General Discussion 
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that spirochaetes are harmless commensals (Henrik-Nielsen et al., 1983), as the organisms 
were observed in patients with a lack of attributable symptoms and/or tissue pathology. The 
results obtained in this investigation certainly demonstrated that both spirochaete species 
may be obtained from individuals without symptoms.  
Nevertheless, it was not definite that the Brachyspira spp. were entirely harmless. 
Each spirochaete may have caused disease in Aboriginal children in whom no other 
pathogen was present, particularly in hospitalised individuals, or may have contributed to 
pathology with known or suspected pathogens. Colonisation with B. pilosicoli was 
significantly more frequent in Aboriginal individuals with chronic diarrhoea or FTT, and 
there was evidence of recurrent infection in one hospitalised child. Likewise, B. aalborgi 
may have been a cause of symptoms of eosinophilia, weight loss, worms or being under 
weight in this population, and of symptoms of diarrhoea in rural non-Aboriginals. 
Previous reports have supported the idea that the Brachyspira  spp. may cause 
disease under certain circumstances. The most serious infections have included the cases 
where B. pilosicoli has been recovered from the blood, and where unidentified spirochaetes 
were seen in three AIDS patients with necrosis and inflammation of the colon and bile 
canaliculi (Kostman et al., 1995). The majority of reports where intestinal spirochaetes were 
observed have involved reasonably mild symptoms, including those where the positive 
identification of B. aalborgi was made by PCR (Guccion et al., 1995; Mikosza et al., 1999; 
Kraaz et al., 2000; Heine et al., 2001; Mikosza et al., 2001).  
As there is evidence of Brachyspira spp. carriage by healthy individuals and by 
those with symptoms, it may be that both spirochaetes have the capacity to be opportunistic 
pathogens. Hence, proliferation and symptoms may result when favourable circumstances 
occur in the host, as has been suggested by other researchers (Takeuchi et al., 1974; Gad et 
al., 1977; Delladetsima et al., 1987; Surawicz et al., 1987). Such mechanisms could include 
lowered immune function, stress, advancing age, or poor nutrition, or be more specifically 
associated with changes in the gut, such as where there is co-infection with parasites, 
intestinal stasis, irritation, antibiotic use or any other change in the host-spirochaete 
relationship. In all reports of serious disease to date, some form of immunocompromise has 
been present.  
The existence of epidemic clones and a high degree of strain diversity in B. 
pilosicoli has been used to explain variation in the clinical syndromes observed in animals 
and humans. Alternatively, it may be that the virulence of strains differs, with some strains 
having an increased capacity to cause gastrointestinal disease, given the right conditions, and 
either a subset or others having an increased capacity to enter the bloodstream.  
Whether both B. aalborgi and B. pilosicoli should be considered as normal flora of 
the human intestine remains to be determined, although it seems likely that they are at least Chapter 8 - General Discussion 
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in some population groups. B. aalborgi is known to have a limited host range, only affecting 
humans, other primates and possibly opossums, so it is likely that strains detected in this and 
previous studies have been of human origin. Although B. pilosicoli has a broader range of 
hosts in animal species, evidence for zoonotic transmission is lacking. B. pilosicoli strains 
detected in the current study again probably originated from human rather than animal or 
environmental sources, although they are present only in certain human populations.  
Prolonged carriage of either Brachyspira spp. has not been specifically determined. 
In this investigation, B. aalborgi, whether one or many strains, was shown to have persisted 
in two control individuals for at least 6 and 7 months. No unequivocal evidence exists for 
prolonged carriage of B. pilosicoli, although the study in PNG identified nine pairs of 
identical strains in 19 individuals sampled six weeks apart (Trott et al., 1997a). The effects 
of long term carriage or chronic infection with the Brachyspira spp. in humans are currently 
unknown.  
An alternative model for the development of disease caused by intestinal 
spirochaetes has been proposed by Duhamel and colleagues (1995a). These investigators 
suggested that human infection with B. pilosicoli occurred subclinically in mature 
individuals, but caused a more widespread infection with diarrhoea as a result of a lost 
mucosal absorptive capacity in immature hosts, as well as in HIV infected or otherwise 
immunocompromised adults. This scenario for B. pilosicoli may be expanded to include 
ideas relating to the work described in this thesis. In the Aboriginal Australians, infection 
with the spirochaete may occur at a young age, as a result of weaning-related behaviours and 
opportunity for exposure. The infection may cause initial symptoms such as a mild bout of 
diarrhoea and abdominal pain, possibly continuing to cause episodes of symptoms through 
childhood, and possibly contributing to the syndrome of failure to thrive. The spirochaetes 
may then either be cleared from the gut, or remain in small numbers as a part of the human 
flora into adulthood. In adulthood, infection may be symptomless as evidenced by carriage 
in migrants and individuals from PNG.  
At any age, further proliferation, more extensive gut colonisation and resultant 
symptoms may be possible with events causing changes to the gut microenvironment, or 
being immunocompromised, and also being dependent on the virulence of particular strains. 
The organism may have the potential to cause a spirochaetaemia in cases where the patient is 
extremely immunocompromised, but this event appears to be very rare. It could be possible 
that colonisation is lifelong and only becomes detectable on some occasions, either due to 
proliferation of the organism in favourable circumstances, or due to increased shedding, 
such as when the individual has diarrhoea because of other causes.  
The disease picture with B. aalborgi may be quite similar to that hypothesised for B. 
pilosicoli, but, as far less is currently known about elements of infection with the organism, Chapter 8 - General Discussion 
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further postulation is not warranted. It will be important to develop an appropriate animal 
model for B. aalborgi infection in which to examine some of these details further. 
 
8.5 LABORATORY  DIAGNOSIS AND TREATMENT OF INTESTINAL 
SPIROCHAETE INFECTION  
As well as developing and optimising techniques for detection of Brachyspira spp. 
in the course of this study, a discussion of their application to clinical microbiology is now 
made. Treatment of spirochaete infection is also discussed in this section. Examination of 
current diagnostic techniques suggested that Brachyspira spp. carriage in faeces, and B. 
pilosicoli infection in blood is going unrecognised in Australian clinical microbiology 
laboratories. Current protocols do not specifically target their detection, and medical opinion 
remains ambivalent about the significance of these organisms, at least in the gastrointestinal 
tract. The PCR, solid culture, blood culture and microscopic methods developed and adopted 
in the work described in this thesis are not difficult to use, and could be readily implemented 
to examine specimens. If the cause of chronic or recurrent gastrointestinal disease of 
unknown aetiology was being investigated without success, either or both intestinal 
spirochaetes need to be considered as a cause of symptoms, depending on the ethnic origin 
of the patient. Other such occasions might include investigations of children who are failing 
to thrive, or in immunocompromised individuals with gastrointestinal symptoms. Similar 
symptoms in other groups, especially Aboriginal Australians, migrants from developing 
countries, homosexual males and HIV positive patients still need to be considered.  
Likewise, a spirochaetaemia with B. pilosicoli may be missed using routine 
protocols for blood culture. However, if the spirochaete was suspected, modifications to the 
protocols are simple and easily instituted. A situation where this might be the case could be 
septicaemia without a known infectious focus. As numbers of immunocompromised 
individuals increase, greater awareness of the intestinal spirochaetes as potential pathogens 
is required.  
Once the presence and identity of spirochaetes are ascertained in a clinical situation, 
treatment may be appropriate. Metronidazole would be the drug of choice for therapy of 
gastrointestinal disorders with B. pilosicoli, based on the MIC data generated in this 
investigation, a history of successful use in intestinal spirochaete infection, and a lack of 
reported resistance. Other previously-used antimicrobials, including neomycin and members 
of the penicillin family, are not recommended. Resistance to these antimicrobials was 
observed in this and other investigations, and failures to alleviate symptoms or remove 
spirochaetes with these agents have been reported.  Chapter 8 - General Discussion 
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The reported clinical success of metronidazole may also be due to its anti-parasitic 
action. Other anti-parasitic drugs, mebendazole and piperazine, also have achieved symptom 
resolution and removal of spirochaetes (Burns & Hayes, 1985; Ruane et al., 1989; Cunha 
Ferreira et al., 1993), possibly by removing a necessary parasite co-factor for spirochaete 
infection. Alternatively, spirochaetes also may be susceptible to these agents. In addition, a 
growing tendency in Aboriginal communities to use comprehensive anti-parasitic therapy 
may result in underestimated reporting of B. pilosicoli, and a possible trend towards 
reducing incidence of the spirochaete. Non-specific treatments, such as improved diet and 
use of specific dietary supplements also may be successful in resolving a gut microflora 
imbalance, or other situations where the gut microenvironment is conducive to spirochaete 
proliferation. 
Suitable antimicrobials for treatment of B. aalborgi infections have not yet been 
ascertained. It is likely that MICs will be similar to those of B. pilosicoli, as B. aalborgi was 
certainly present among organisms in reports of HIS treatment, despite an inability to 
speciate the spirochaetes at that time. Moreover, treatment of B. aalborgi infection in three 
children with metronidazole and amoxicillin was successful, but not in one child treated with 
metronidazole and penicillin V (Heine et al., 2001). Whether B. aalborgi is resistant to β-
lactam antibiotics is unknown, but if it were, it may have been responsible for persisting 
symptoms in this fourth child. As a result of this evidence, and since antimicrobial 
susceptibilities are generally similar between other Brachyspira spp., the above guidelines 
for B. pilosicoli therapy could be followed until further studies are conducted. Ideally, MIC 
data need to be generated for B. aalborgi, to be certain that therapy is appropriate. 
Unfortunately, these data are dependent on isolating more B. aalborgi strains, as well as the 
development of appropriate ways to measure the MIC, once the organisms are isolated.  
Whether or not to treat gastrointestinal carriage of intestinal spirochaetes may be a 
contentious issue, due to the uncertain clinical significance of the organisms. If spirochaetes, 
alone or with parasites, are present with gastrointestinal symptoms, treatment with 
metronidazole is likely to remove spirochaetes and relieve symptoms. As previously 
discussed, the carriage of Brachyspira spp. is not always accompanied by symptoms, and in 
this situation the course of action for a medical professional is more uncertain. An argument 
exists for not treating for intestinal spirochaetes if they cause no harm, as over-prescription 
of antimicrobials is discouraged to prevent development of resistance. In addition, disrupting 
the balance of the microflora in the gut would not be recommended if the organism are 
members of the normal flora. The ability of both organisms to cause symptoms and more 
invasive disease in immunocompromised individuals is another situation where treatment is 
to be recommended, particularly with the small risk that B. pilosicoli could be involved in 
spirochaetaemia. The implications of prolonged intestinal spirochaete carriage are not yet Chapter 8 - General Discussion 
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known. Previous suggestions have been made for a role for spirochaetes in chronic diseases 
of unknown aetiology, such as Alzheimer’s disease or multiple sclerosis (Miklossy, 1993; 
Trott, 1997), but further work has not been forthcoming. If long-term carriage of either 
organism was found to be a significant cause of disease, recommendations for treatment in 
symptomless individuals would necessarily change. It is to be hoped that future studies into 
intestinal spirochaete carriage in humans will resolve these uncertainties. 
 
8.6 FUTURE  DIRECTIONS 
As a result of the work described in this thesis, further investigations could be 
performed to improve our understanding of aspects of intestinal spirochaete infection in 
humans. Firstly, deficiencies exist in knowledge relating to B. aalborgi infection and 
biology. Study has been hampered until recently by a lack of accurate diagnosis, and 
absence of the spirochaete in farmed animal species, where most work on B. pilosicoli has 
been performed. Much could be achieved if culture of the organism was possible. 
Investigations to determine whether cells were viable in faecal samples, using vital dyes, 
might be useful. The use of faecal PCR to identify B. aalborgi in samples which did not 
contain the faster growing B. pilosicoli might improve attempts at subsequent B. aalborgi 
isolation. Utilisation of a selective liquid medium such as that reported by Calderaro and 
colleagues (2003), or growth of strains in the presence of a cell line to which they might 
attach, could improve the proportion of cultivable strains. Once a collection of B. aalborgi 
strains was amassed, characterisation studies involving biochemistry, MLEE, PFGE or 
AFLP and antimicrobial susceptibility testing would be useful to more completely 
understand this organism. If the proportion of cultivable strains remains low, molecular 
methods of characterisation such as multi-locus sequence typing would be useful to further 
investigate the population structure and epidemiology of B. aalborgi in human populations. 
There is still much to understand about the biology and potential pathogenicity of 
Brachyspira spp. in humans. A useful way to examine intestinal spirochaete carriage and the 
role of the organisms in human disease would be to instigate a longitudinal study on 
different population groups, periodically examining intestinal biopsies and faeces together 
for  Brachyspira spp., and assessing for the development of disease. The use of general 
Brachyspira spp. PCR primers, followed by sequencing of the PCR product would also 
allow the inclusion of potentially new Brachyspira spp.. The logistics involved in a study of 
this kind would be complex and expensive, but could allow the risk factors and duration of 
carriage, association with gastrointestinal symptoms, and the development of chronic disease 
to be examined. In addition, intestinal carriage and faecal shedding could be correlated.  Chapter 8 - General Discussion 
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If well-expressed species-specific antigens could be identified to differentiate B. 
pilosicoli and B. aalborgi, surveys using human serum might allow a greater understanding 
to be obtained of the prevalence of and immunity to Brachyspira spp. in human populations. 
However, whether gut colonisation with intestinal spirochaetes elicits a serum immune 
response or even a mucosal response is not yet known. An understanding of why only 6% of 
individuals were colonised with B. aalborgi in populations might be obtained in this way. A 
case-control study utilising these kinds of detection methods may be a more realistic 
approach to examining the role of intestinal spirochaetes in chronic infections, such as the 
relationships between spirochaetes and intestinal cancers or polyps.  
In addition, more specific questions were raised by the investigation described in 
this thesis. A further understanding of transmission of the Brachyspira spp. could be 
examined by following a number of infected families over several months, to look for the 
transmission of strains between individuals. The presence of multiple strains in individuals 
at one time or over time could also be assessed in this way. Studies on B. aalborgi survival 
in environmental sources also may be useful to understand transmission of this organism. 
Whether or not B. pilosicoli contributes to FTT in Aboriginal children could be investigated 
by specifically examining carriage in children with this syndrome. A greater awareness of 
the role of both spirochaetes together, and with parasites in polymicrobial infection is 
required, and could be investigated with case-control studies, and also by co-infection 
studies in animal models. Another use for animal models would be to study the invasive 
mechanisms and characteristics that allow survival of B. pilosicoli in the human 
bloodstream. Studies on the virulence of both Brachyspira spp., whether by traditional or 
molecular approaches, may be useful to identify why such diverse clinical symptoms can be 
experienced following infection with these organisms. In particular sequencing and 
microarray techniques could be used to gain more knowledge about virulence and immunity. 
This sort of analysis may also further explain the presence of clonal grouping of strains 
found in the Aboriginal Australians. Finally, due to the apparent widespread distribution of a 
β-lactamase enzyme or enzymes in human strains, a detailed study of the nature, source and 
potential transmissibility of β-lactamases in B. pilosicoli is required.  
 
8.7  SUMMARY OF THESIS FINDINGS 
The following key achievements were accomplished in the investigation described 
in this thesis.  
1.  A medium was developed for the isolation of B. aalborgi from human faecal samples. 
2.  A single isolate of B. aalborgi was obtained from the faecal sample of a control 
individual with self-diagnosed chronic diarrhoea, and represented the first isolation of Chapter 8 - General Discussion 
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the organism from this type of specimen. The colonial, phase contrast and electron 
microscopic morphologies of two cell types present in the sample were described, and 
partial 16S rRNA sequences obtained.  
3.  Cultural media were utilised to isolate 40 strains of B. pilosicoli from the faeces of 
Aboriginal and migrant individuals in WA.  
4.  Methods were optimised to extract Brachyspira spp. DNA from faecal samples using a 
column method, and amplify the DNA using a PCR targeting the 16S rRNA gene of 
each species. 
5.  A comparison of B. aalborgi and B. pilosicoli presence in faecal samples was made by 
selective culture, PCR of faecal samples and phase-contrast microscopy. The highest 
prevalence of each spirochaetes was found with PCR, while microscopy was only 
suitable for confirmation of spirochaete occurrence. Culture was useful for isolation of 
B. pilosicoli but poor for isolation of B. aalborgi.  
6.  The prevalence of Brachyspira spp. was determined in Aboriginals and non-Aboriginals 
with gastrointestinal symptoms, and in healthy migrants and mainly Caucasian controls. 
B. aalborgi was present at around 6% in all four groups, and B. pilosicoli at around 15% 
in only Aboriginals and migrants. Carriage was analysed in relation to a number of 
potential risk factors, and the presence of other organisms in the samples, as well as 
reasons for investigation in ill individuals.  
7.  The carriage of B. aalborgi was significantly associated with young children and elderly 
patients, parasites, eosinophilia and worms in Aboriginals, with age and diarrhoea being 
risk factors in non-Aboriginals, and protozoal carriage associated with carriage in 
migrants. The presence of B. aalborgi was more likely in multiple members of migrant 
family groups than in just one individual within a family. 
8.  The carriage of B. pilosicoli was significantly associated with young children and 
elderly patients, parasites and chronic diarrhoea, FTT and being underweight in 
Aboriginals; being of non-European origin and certain parasites in migrants; and with B. 
aalborgi detection in both populations. 
9.  A comparison of commercially available automated and manual blood culture media and 
was made for the growth and detection of B. pilosicoli and optimal methods identified.  
10. Spirochaetaemia with B. pilosicoli was shown to be rare in Australia, as no isolate was 
obtained from the blood of at-risk individuals tested. 
11. B. pilosicoli isolates obtained from Aboriginals and migrants were compared using 
PFGE, and were shown to be genetically heterogenous. Clonal groups of strains were 
observed in Aboriginals, which confirmed the epidemic population structure of strains in 
this group. The widespread distribution of these strains may have been due to high 
proportions of β-lactamase activity detected.  Chapter 8 - General Discussion 
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12. MICs of medically important antimicrobials for treatment of B. pilosicoli infections 
were ascertained using an agar dilution method. The organisms were variably resistant 
to  β-lactam and lincosamide drugs and susceptible to other agents including 
metronidazole. Chapter 8 - General Discussion 
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APPENDIX 1: MATERIALS  
A1.1 Chemicals, reagents and desiccated media.  
  
Chemical / Reagent / Medium  Supplier 
  
Agarose  Scientifix, Cheltenham, Vic, Australia 
Amoxicillin  CSL Ltd, Parkville, Vic, Australia 
Anaerobe basal agar  Oxoid, Basingstoke, Hampshire, UK 
Barium chloride  BDH Chemicals, Port Fairy, Vic, Australia 
Boric acid  ICN Biomedicals Inc., Aurora, OH, USA 
Bovine blood  Animal Biological Collection and Delivery 
Enterprises, Kelmscott, WA, Australia 
Bovine serum albumin  Promega, Madison, WI, USA 
Brain Heart Infusion Agar  Oxoid 
Brij 58 (polyoxyethylene 20 cetyl ether)  Sigma, St Louis, MO, USA 
Brucella agar base  Oxoid 
Buffer J  Promega 
Ceftriaxone sodium salt  Roche Products Pty Ltd, Dee Why, NSW 
Australia 
Cholesterol Sigma 
Ciprofloxacin hydrochloride  Bayer, Leverkusen, Germany 
Chill-out 14 liquid wax  MJ Research Inc., Watertown Mass., USA 
Chloramphenicol   Sigma 
Clavulanic acid (lithium clavulanate)  GlaxoSmithKline, Boronia, Vic, Australia 
Clindamycin hydrochloride  Pharmacia and Upjohn Co., Kalamazoo, MI, 
USA 
Columbia agar base  Oxoid 
Cysteine hydrochloride monohydrate  Calbiochem Company, La Jolla, CA, USA. 
Defibrinated bovine blood  Animal Biological Collection and Delivery 
Enterprises 
Diethyl pyrocarbonate  Sigma Aldrich Pty Ltd, Castle Hill, NSW, 
Australia 
Dimethyl sulfoxide  BDH Chemicals Ltd, Poole, UK 
Dinucleotide triphosphates  Biotech International Ltd., Bentley, WA, 
Australia 
Disodium hydrogen orthophosphate  Merck Pty Ltd, Kilsyth, Vic, Australia 
DNA size standards   
 
 
Lambda ladder 
123bp ladder 
DNA ladder VIII 
Bio-rad Laboratories, Hercules, CA, USA 
Life Technologies, Grand Island, NY, USA 
Roche Diagnostics Pty Ltd, Castle Hill, NSW  
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A1.1 Continued. 
  
Chemical / Reagent / Medium  Supplier 
  
Erythromycin lactobionate  Blaschim, Milano, Italy 
Ethylenediaminetetraacetic acid 
disodium salt (EDTA) 
Merck 
Ethanol Merck 
Ethidium bromide   Sigma 
Foetal bovine serum  Life Technologies 
Gentamicin injection (BP 80 mg in 2 ml)  Pharmacia and Upjohn 
Glucose Merck 
Glycerol  BDH Chemicals, Australia 
Hemin chloride  Sigma 
Horse serum  Excel Laboratory Products, Belmont, WA, 
Australia 
Human blood  Australia Red Cross, East Perth, WA, 
Australia 
Hydrochloric acid  BDH Chemicals, Australia 
Lysostaphin Sigma 
Lysozyme Sigma 
Magnesium chloride  Biotech 
Meropenem trihydrate  Zeneca Inc., Wilmington, DE, USA 
Metronidazole   Sigma 
Moxifloxacin Bayer 
Mlu1 Biotech   
Mlu1 reaction buffer (10x)  Biotech  
Mueller-Hinton agar  Oxoid 
New born calf serum  Cytosystems Pty Ltd, Castle Hill, NSW, 
Australia 
Ovine blood  Animal Biological Collection and Delivery 
Enterprises 
Oxbile Merck 
PCR reaction buffer (10x)  Biotech  
Polymyxin B sulfate  Sigma 
Potassium chloride  Merck 
Potassium dihydrogen orthophosphate  BDH Chemicals, UK  
Proteinase K  Sigma 
Pulsed field certified agarose (plug agarose)  Bio-rad Laboratories Appendix 1 - Materials  
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A1.1 Continued. 
  
Chemical / Reagent / Medium  Supplier 
  
Resazurin (7-hydroxy-3H-phenoxazin-3-
one-10-oxide) 
Sigma 
Sma1 Sigma 
Sodium bicarbonate  Merck 
Sodium chloride  Merck 
Sodium deoxycholate  BDH Chemicals, Australia 
Sodium n-lauroyl sarcosine  Sigma 
Sodium dihydrogen orthophosphate  BDH Chemicals, UK 
Sodium hydroxide  David Brown Scientific, Osborne Park WA, 
Australia 
Spectinomycin dihydrochloride  Sigma 
Sulfuric acid  BDH Chemicals, Australia 
Tetracycline hydrochloride  Sigma 
Tris(hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl) 
Sigma 
Tth plus DNA polymerase  Biotech  
Trypticase soy agar, modified  Becton Dickinson, Cockeysville, MD, USA 
Trypticase soy broth  Becton Dickinson 
Yeast extract  Oxoid 
Wilkins-Chalgren anaerobe agar  Oxoid 
Vancomycin hydrochloride  Sigma 
Vitamin K1 Sigma 
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A1.2 Buffers and solutions 
Agarose for polymerase chain reaction 
Agarose was dissolved in 1x TAE. Gels of 1.5% (w/v) were used routinely. 
 
Agarose for pulsed-field gel electrophoresis 
Agarose was dissolved in 0.5 x TBE. Agarose for gels was 1% (w/v) and low melting point 
agarose for plugs was 1.8% (w/v). 
 
Barium chloride 
A 1.175% solution of barium chloride was made by dissolving 0.235 g of BaCl2.2H2O in   
20 mL DIW. 
 
Bile discs 
A solution of ox bile was made by adding 0.3 g to 10 ml DIW, heating to 56°C for 15 min to 
dissolve and autoclaving. Sterile dry filter paper discs were laid out in a sterile petri dish in a 
laminar flow hood, and volumes of 16.66 µl, 25 µl and 50 µl were pipetted to make 5 mg,  
10 mg and 15 mg discs. Discs were allowed to dry, dessicated at 56°C overnight and stored 
at 4°C until required.  
 
Diethylpyrocarbonate treated water (DepC) 
Diethyl  pyrocarbonate      400  µl 
HPW      400  ml 
The solution was shaken, incubated at 37°C for 12 h and autoclaved to sterilise.  
 
dNTPs 
A 5 mM concentration working mix of dNTPs was made from a 100 mM stock 
concentration of each in sterile UHPW.  
 
EDTA stock solutions 
A 0.5 M pH 8.0 stock solution was made by dissolving 46.5 g EDTA disodium salt in 250 
ml sterile HPW. A 0.4 M pH 7.5 stock solution was made by dissolving 37.22 g EDTA 
disodium salt in 250 ml. 
 
Ethidium Bromide 
Stock ethidium bromide of 10 mg/ml was stored in the dark at 4°C. This stock solution was 
diluted 1:2000 to stain agarose gels.  Appendix 1 - Materials  
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Haemin solution 
Haemin chloride (bovine)    0.5 g 
NaOH  (1  N)     10  ml 
D I W       9 0   m l  
The haemin was dissolved in the sodium hydroxide, the DIW added and the solution 
autoclaved to sterilise and stored at 4°C. 
 
Loading Buffer (6x) 
Bromophenol  blue    2.5  g 
Sucrose      400  g 
Stored at 4°C 
 
Lysis buffer 
Solution 1 
Brij  58      0.5  g 
  sodium  deoxycholate    0.2  g 
  sodium  lauroyl  sarcosine  0.5  g 
Solution 2 
  Tris  stock  solution    300  µl 
  NaCl      5.84  g 
    EDTA pH7.5 stock solution    25 ml 
 
Solution 1 was prepared in 30 ml HPW and heated to 60°C in a water bath to dissolve the 
components. This was added to Solution 2 and the combined volume made up to 100 ml and 
sterilised by autoclaving. 
 
Lysostaphin 
Powdered lysostaphin was made to a concentration of 400 µg/ml in UHPW, filter sterilised, 
aliquoted, and stored at -20°C. 
 
Lysozyme and Proteinase K 
Powdered lysozyme and proteinase K were each made to a concentration of 20 mg/ml in 
UHPW, filter sterilised, aliquoted, and stored at -20°C. 
 
McFarland nephelometer standards 
A 0.5 McFarland nephelometer standard was made according to the method of Summanen et 
al. (1993) by adding 9.95 ml of a 1% solution of sulfuric acid to 0.05 ml of a 1.175% Appendix 1 - Materials  
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solution of barium chloride. A 5.0 McFarland nephelometer standard was made by adding 
9.5 ml of sulfuric acid to 0.5 ml of barium chloride. After mixing, 5 ml volumes were added 
to glass vials and sealed with parafilm. The standards were agitated before use.  
 
Phosphate buffers (PB) 
Stock A (0.2 M) was made by dissolving 13.8 g NaH2PO4 in 500 ml DIW and Stock B (0.2 
M) by dissolving 14.2g Na2HPO4 in DIW. After autoclaving, 200 ml of 0.1M PB pH 6 was 
made by combining 87.7 ml Stock A, 12.3 ml Stock B and 100 ml SDW.  
 
Phosphate-buffered saline (PBS) 
NaCl      8.0  g 
KCl      0.2  g 
Na2HPO4     1.44  g 
KH2PO4    0.24  g 
pH 7.2 
 
Phosphotungstic acid 
Phosphotungstic  acid      3  ml 
Tris stock solution (2 M)    1 ml 
DIW        196  ml 
pH 7.3 
The phosphotungstic acid was added to the diluted Tris solution. 
 
Pig Faeces Extract 
The extract was prepared after the method of Kunkle et al. (1986) by emulsifying normal 
adult pig faeces in four parts sterile PBS, stirring for 24 h at 4°C, then centrifuging for 1 h at 
4°C at 9950 x g in a Beckman J2-21 centrifuge (Beckman Instruments, Palo Alto, CA, 
USA). The supernatant was stored at -20°C until required and added to media before 
autoclaving or as a filtered solution after autoclaving.  
 
Potassium chloride 
A 10 mM potassium chloride solution was prepared by dissolving 3.73 g KCl in 200 ml of 
DIW. 
 
Sodium hydroxide 
A 1 N solution was made by dissolving 4.0 g NaOH in 100 ml DIW. 
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Sulfuric acid 
A 1% solution of sulfuric acid was prepared by adding 1 ml of concentrated sulfuric acid    
(36 M) to 99 mL DIW. 
 
Tris acetic EDTA (TAE) buffer (50x) 
  Tris  Base     242  g 
  Glacial  acetic  acid    47.2  ml 
  0.5  M  EDTA  pH  8.0    50  ml 
The pH was adjusted to 8.0 with glacial acetic acid. TAE was diluted 1:50 with HPW as 
required. 
 
Tris - borate EDTA buffer (TBE) (10x) 
  Boric  acid     55  g 
  Tris  base     108  g 
    EDTA pH 8.0 stock solution    40 ml 
A working solution of 0.5x was made with HPW. 
 
Tris EDTA buffer (TE) 
  Tris  stock  solution    5  ml 
    EDTA pH 8.0 stock solution    200 µl 
pH 7.6 
Tris EDTA sarcosine buffer (TES)  
  Tris  stock  solution    2.5  ml 
    EDTA pH 8.0 stock solution    10 ml 
  lauroyl  sarcosine    1  g 
  HPW      100  ml   
 
Tris stock solution (2 M) 
A 250 ml stock solution was made in HPW.  
  T r i s   B a s e      6 0 . 5 5   g    
  concentrated  HCl    18.8  ml 
       p H   7 . 4  
 
10x Tth Plus buffer 
Tth Plus DNA Polymerase buffer (10x) consisted of 670 mM Tris-HCl (pH 8.8), 166 mM 
(NH4)2SO4, 4.5% Triton X-100 and 2 mg/ml gelatin (Biotech).  
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Vitamin K1 solution (1mg/ml) 
A 1 mg/ml solution of Vitamin K1 was prepared by adding 0.1 g to 100 ml absolute ethanol. 
This solution was protected from the light in a tightly sealed container and stored at 4°C. 
 
 
A1.3 Kits and other consumables. 
  
Consumable Supplier 
  
Acrodisc 0.45µm syringe filters  Pall Corporation, Ann Arbor, MI, USA 
Alcowipes skin cleansing swab  Promedica Australia Pty Ltd, Collingwood, Vic, 
Australia 
Antibiotic assay discs  Whatman Ltd, Maidstone, Kent, UK 
BBL Gaspaks  Becton Dickinson 
Filter Paper #3  Whatman 
High pure viral RNA kit  Roche Diagnostics, Mannheim, Germany 
Inoculation loops (10 µl)  Sarstedt Aktiengesellschaft and Co., Nümbrecht, 
Germany 
Jetquick tissue DNA spin kit  Genomed, Bad Oeynhausen, Germany 
Microring AC  Medical Wire and Equipment Group, Wiltshire, UK 
Microring AN  Medical Wire and Equipment Group 
Needles (0.9 x 25 mm)  Terumo Medical Corporation 
Nesco parafilm  Bando Chemical Industries Ltd, Kobe, Japan 
Nitrocephin discs BBL Cefinase  Becton Dickinson 
Polapan 667 B&W Instant Film  Polaroid Corporation, Hertfordshire, UK 
QIAmp DNA stool mini kit  Qiagen Pty Ltd, Clifton Hill, Vic, Australia 
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A1.4 Bacterial culture media. 
Brucella blood agar base (BrBAB) 
Brucella  Agar     43  g 
Haemin solution (5 mg/ml)    1 ml 
Vitamin K1 solution (1 mg/ml)    1 ml 
DIW      1  litre 
Defibrinated sheep blood in the original formulation (Summanen et al., 1993) was replaced 
with blood from other animal species in the present study. 
 
Brucella blood agar for susceptibility testing (BrBAS) 
Brucella  Agar     43  g 
Vitamin K1 solution (1 mg/ml)    1 ml 
DIW      1  litre 
Laked sheep blood      50 ml 
BrBAS plus haemin (BrBAS+H) was made with 1ml of a 5 mg/ml haemin solution added to 
the above formulation (Summanen et al., 1993). 
 
Brucella broth 
Brucella broth (BrB) was prepared by mixing Brucella agar with distilled water and then 
passing through a Whatman filter paper #3 before sterilising. 
 
Kunkle’s broth (modified) 
Trypticase soy broth      30 g 
Yeast  extract     10  g 
Glucose    5  g 
Sodium  carbonate    3  g 
Foetal calf serum      20 ml 
Newborn calf serum      5 ml 
Cholesterol     0.02  g 
Cysteine HCl.H2O    1  g 
Resazurin     1  ml 
The original formulation appears in Kunkle et al. (1986). The first four components were 
weighed into a flask containing the DIW and 1.1 ml concentrated HCl was added to adjust 
the pH to 6.85. The sera followed by the remaining components were added, and the broth 
was boiled. Upon cooling, the broth was transferred into Hungate tubes and a N2:CO2 gas 
mixture was bubbled through the liquid. The tubes were stoppered tightly, autoclaved in a 
press, and the stoppers were wrapped with parafilm and stored at RT until use. Appendix 1 - Materials  
201 
 
Kunkle’s agar base 
Trypticase soy broth      30 g 
Yeast  extract     10  g 
Glucose    5  g 
Sodium  carbonate    3  g 
The supplements in the original broth formulation (Kunkle et al., 1986) were included in 
some tests. 
 
WCA with 5% horse serum (WCA+HS) 
This medium was prepared by adding 20 ml of horse serum to cooled WCA. 
 
WCA+HS for susceptibility testing 
WCA was prepared and 17 ml aliquots were added to 25 ml McCartney bottles at 56°C. To 
each, 1 ml of horse serum and 2 ml of antibiotic solution at 10x the desired concentration 
were added, the agar swirled to mix and poured immediately.  
 
 
A1.5 Antibiotic solvents and diluents other than SDW. 
   
Antibiotic Solvent  Diluent 
   
Amoxicillin  0.1 M PB, pH 6  0.1 M PB, pH 6 
Chloramphenicol 95%  ethanol  SDW 
Clavulanic acid  0.1 M PB, pH 6  0.1 M PB, pH 6 
Erythromycin 95%  ethanol  SDW 
Metronidazole DMSO  SDW 
Rifampicin DMSO  SDW 
Vancomycin  0.05 N HCl  SDW 
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APPENDIX 2: BRACHYSPIRA STRAINS 
Appendix A2.1 Brachyspira reference and other strains used in this thesis.  
      
Species and strain name  Source  Reference  Chapters used 
      
Brachyspira aalborgi  
513A
T NCTC 11492 ATCC 43994 
Rectal biopsy, Denmark   (Hovind-Hougen et al., 1982)  Chapters 3 & 4 
W1  GI biopsy, Sweden  (Kraaz et al., 2000)  Chapters 3 & 4 
Brachyspira hyodysenteriae B78
T ATCC 27164  Pig, USA  (Harris et al., 1972a)  Chapter 4 
Brachyspira innocens B256
T ATCC 29796  Pig, USA  (Kinyon & Harris, 1979)  Chapter 4 
Brachyspira intermedia PWS/A
T ATCC 51140  Pig, UK  (Stanton et al., 1997)  Chapter 4 
Brachyspira pilosicoli  
P43/6/78
T ATCC 51139 
Pig, Scotland  (Taylor et al., 1980; Trott et al., 
1996c)  
Chapters 3 - 7 
WesB  Aboriginal child, Kimberley, WA  (Lee & Hampson, 1992)  Chapters 3 - 7 
WHP01 - WHP10, WHP 12 - WHP16  Aboriginal patients, WA  This study  Chapters 6 & 7 
WHP11  Aboriginal patients, WA  This study  Chapters 3, 6 & 7 
H 21, Rosie 2299  Aboriginal children, Kimberley, WA  (Lee & Hampson, 1992)  Chapters 3, 6 & 7 
167, H 7-2, , H 43, H 44, H 56-2, H 60-2, Cuthea 
Malo, Karlos, Margaret, Naomi, Quentin F1  
Aboriginal children, Kimberley, WA  (Lee & Hampson, 1992)  Chapters 6 & 7 
Shannon, Sonny Cyodor F1, Tristan  Aboriginal children, Kimberley, WA  (Lee & Hampson, 1992)  Chapter 7 
382/91  Blood, France,   (Fournié-Amazouz et al., 1995)  Chapters 3, 5 & 7 
28/94, PE90, RA87  Blood, France  (Fournié-Amazouz et al., 1995)  Chapters 5 & 7  
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A2.1 Continued.  
      
Species and strain name  Source  Reference  Chapters used 
      
BR81/80, HJ/28/90  Blood, France  (Fournié-Amazouz et al., 1995)  Chapter 7 
H1  Blood, AIDS patient, USA  (Trott et al., 1996c)  Chapters 3, 5 & 7 
Gap 34, 51-2, 417,  Homosexual male, Sydney, NSW  (Trivett-Moore et al., 1998)  Chapters 3 & 7 
Gap 401  Homosexual male, Sydney, NSW  (Trivett-Moore et al., 1998)  Chapters 6 & 7 
Gap 53, 183, 418, 58916, DB  Homosexual male, Sydney, NSW  (Trivett-Moore et al., 1998)  Chapter 7 
FT6   Homosexual males & AIDS patients, UK  (Rayment et al., 1997)  Chapters 3 & 7 
Gorzalek, M33432, 32B  Homosexual males & AIDS patients, UK  (Rayment et al., 1997)  Chapter 7 
“S. joneseii” ATCC 49776  Homosexual male, USA  (Jones et al., 1986)  Chapters 4 & 7 
HIV 3AB1  HIV patient, WA  -  Chapter 7 
H 121  Indonesian individual  -  Chapter 5 
H 171  Indonesian individual  -  Chapters 3 & 5 
HRM 1A, 2A, 4B  Italian patients  (Dettori et al., 1987)  Chapter 7 
HRM 2B  Italian patients  (Dettori et al., 1987)  Chapters 6 & 7 
HRM 5C, 8B, 14A  Italian patients  (Dettori et al., 1987)  Chapters 3 & 7 
WHP17-WHP19  Migrant individuals to WA  This study  Chapters 3, 6 & 7 
WHP20 -WHP40  Migrant individuals to WA  This study  Chapters 6 & 7  
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A2.1 Continued. 
      
Species and strain name  Source  Reference  Chapters used 
      
Oman 26  Omani child  (Barrett, 1990)  Chapters 4 & 7 
31B  Omani child  (Barrett, 1990)  Chapters 6 & 7 
Oman 11A, 13A   Omani individuals  (Barrett, 1990)  Chapters 3 & 7 
Oman 3, 14B, 17, 21B, 28  Omani individuals  (Barrett, 1990)  Chapter 7 
V1: H11, H14, H17, H22, H45, H51, H54, H56, H57, 
H58, H59, H73, H76, H86, H91, H95, H98, H103, 
H117, H126, H128, H132, H141, H146 
PNG villagers  (Trott et al., 1997a)   Chapter 7 
V1: H7, H39, H82  PNG villagers  (Trott et al., 1997a)   Chapters 3 & 7 
95/0438, COF10a, MW1, WandF, WandI, Zoey19  Pigs, Australia  (Trott et al., 1996d; Oxberry, 
2002) 
Chapter 7 
1648, 3295, 95/1000  Pigs, Australia  (Trott et al., 1996d; Oxberry, 
2002) 
Chapters 3 & 7 
89-2005B, 89-1069, 89-223A  Pigs, Canada  (Duhamel et al., 1998b)  Chapter 7 
B1555a, UNL-5, D9201243A,  Pigs, USA  (Duhamel et al., 1998b)  Chapter 7 Appendix 3 – Control group questionnaire 
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APPENDIX 3: QUESTIONNAIRE GIVEN TO CONTROL INDIVIDUALS 
A3.1 Questionaire: Carriage of intestinal spirochaetes by humans 
 
Date:  ……/……/……        Code  ………….. 
 
Please fill out or tick the appropriate boxes: 
 
1. What is your gender?                          Male                    Female 
 
2. What is your age?                  ___________Years 
 
3. In what country were you born?                          _______________________________ 
 
4. How long have you lived in Australia?               ______________Years 
 
5a. Have you been overseas in the last 6 months?                      Yes                  No 
 
  5b. If yes, which countries have you visited? 
 
 
6. What is your usual occupation?             _____________________________ 
 
7. How long have you been in this occupation?           __________________years 
 
8. Have you had diarrhoea or loose stools in the last month?                  Yes          No 
 
9. Have you had any abdominal pains or cramps in the last month?        Yes           No 
 
10. Have you taken antibiotics in the last month?                                     Yes           No 
 
11a. Do you have any animals in your household?                                    Yes          No 
 
  11b. If yes, what species of animals? 
 
Thank you for your cooperation with this study 
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APPENDIX 4: RISK FACTORS ASSOCIATED WITH CULTURE OF B. 
PILOSICOLI, WHERE P > 0.25.  
Appendix A4.1 Risk factors and frequency of other organisms in Aboriginals (n=151). 
    
 with  B. pilosicoli 
(n=15) 
without B. pilosicoli 
(n=136) 
P value 
 No  %  No  %   
         
Female gender  10  66.7  77  56.6  0.45 
Kimberley location  13  86.7  92  67.6  0.26 
Rainfall  400 - 800 mm  2  13.3  38  27.9   
  800 - 1600 mm  8  53.3  59  43.4  0.47 
  1600 - 3600 mm  5  33.3  39  28.7   
Bacteria: pathogenic  3 20.0 21  15.4 0.44 
Campylobacter coli  0 0.0  2  1.5 0.81 
Campylobacter jejuni  0 0.0  3  2.2 0.72 
Clostridium difficile  0 0.0  1  7.4 0.90 
Salmonella spp.  2  13.3  11  8.1  0.38 
Shigella spp. 0  0.0  1  7.4  0.90 
Cryptosporidium parvum  0 0.0  4  2.9 0.66 
Hookworm 0  0.0  3  2.2  0.72 
Strongyloides stercoralis  1 6.7  5  3.7 0.47 
Chilomastix mesnili  0 0.0  2  1.4 0.81 
Entamoeba coli  1 6.7  3  2.2 0.34 
Other Entamoeba spp.  0  0.0  3  2.2  0.72 
 
Appendix A4.2 Risk factors and frequency of other organisms in migrants (n=227). 
        
  with B. pilosicoli 
(n=24) 
without B. pilosicoli 
(n=203) 
P value 
 No  %  No  %   
          
Age <2  y  1  4.2  5  2.5   
  2 - 4 y  1  4.2  16  7.9  0.49 
  ≥5 y  22 91.7 182  89.7   
Age <2  y  1  4.2  5  2.5   
  2 - 17 y  10  41.7  74  36.5  0.75 
  ≥18 y  13 54.2 124  61.1   
Bacteria: pathogenic  0 0.0 10  4.9  0.32 
Aeromonas spp.  0 0.0  1  0.5  0.89 
Campylobacter jejuni  0 0.0  4  2.0  0.64 Appendix 4 – Risk factors associated with culture 
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Appendix A4.2 Continued. 
        
  with B. pilosicoli 
(n=24) 
without B. pilosicoli 
(n=203) 
P value 
 No  %  No  %   
          
Salmonella spp.  0  0.0  4  2.0  0.64 
Yersinia enterocolitica  0 0.0  2  1.0  0.80 
Parasites: pathogenic  2 8.3 15  7.4  0.56 
Ascaris lumbricoides  0 0.0  4  2.0  0.64 
Giardia intestinalis  2 8.3  8  3.9  0.29 
Strongyloides stercoralis  0 0.0  1  0.5  0.89 
Endolimax nana  0 0.0  4  3.9  0.64 
Any pathogen  2 8.3 14  6.9  0.52 
 
Appendix A4.3 Correlation of B. pilosicoli culture with reasons for investigation in 
Aboriginal patients (n=151). 
        
 with  B. pilosicoli 
(n=15) 
without B. pilosicoli 
(n=136) 
P value 
 No  %  No  %   
         
Abdominal pain  0  0.0  5  3.7  0.58 
Anaemia 0  0.0  7  5.1  0.47 
Blood/bleeding 0  0.0  5  3.7  0.58 
Diarrhoea & vomiting  2  13.3  18  13.2  0.62 
 &  fever  0  0.0  4  2.9  0.65 
Eosinophilia 1  6.7  3  2.2  0.34 
Fever/sepsis 1  6.7  9  6.6  0.66 
Failure to thrive (FTT)  2  13.3  10  7.4  0.34 
Gastroenteritis 0  0.0  10  7.4  0.34 
HIV 0  0.0  2  1.5  0.81 
Loose/offensive stool  1  6.7  5  3.7  0.47 
Nausea 0  0.0  1  0.7  0.90 
Pyelonephritis 0  0.0  1  0.7  0.90 
Weight loss  0  0.0  6  4.4  0.53 
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APPENDIX 5: RISK FACTORS ASSOCIATED WITH PCR DETECTION OF 
B. PILOSICOLI.  
Appendix A5.1 Risk factors for B. pilosicoli detection, the frequency of other organisms 
being present and reasons for investigation in Aboriginals (n=145).  
    
 with  B. pilosicoli (n=21) without  B. pilosicoli 
(n=124) 
P value 
 No  %  No  %   
          
Age    mean 19.1y  SD 29.0 y  mean 14.4y  SD 21.2y  0.37 
Age <2  y  6  28.6  63  50.8   
  2 - 4 y  7  33.3  17  13.7  0.048* 
  ≥5 y  8 38.1 44  35.5   
Age <2  y  6  28.6  63  50.8   
  2 - 17 y  9  42.9  23  18.5  0.035* 
  ≥18 y  6 28.6 38  30.6   
Age  ≥60 y  4 19.0 5  4.0  0.026* 
Female gender  15  71.4  66  53.2  0.19 
Hospitalised 8  38.1  53  42.7  0.87 
Kimberley location  16  76.2  83  66.9  0.56 
Rainfall  400 - 800 mm  3  14.3  37  29.8   
  800 - 1600 mm  12  57.1  53  42.7  0.30 
  1600 - 3600 mm  6  28.6  34  27.4   
Loose or wet stool   13  61.9  97  78.2  0.18 
Community dweller  18  85.7  80  64.5  0.095 
Detection of B. aalborgi  6 28.6 4  3.2  <0.001 
Bacteria: pathogenic  2 9.5 21 16.9  0.31 
Aeromonas spp.  1 4.8 0  0.0  0.14 
Salmonella spp.  1  4.8  11  8.9  0.46 
Parasites: pathogenic  7 33.3 32  25.8  0.65 
Hookworm 1  4.8  1  0.8  0.27 
Giardia intestinalis  4 19.0 12  9.7  0.18
† 
Hymenolepis nana  4 19.0 7  5.6  0.055
† 
Strongyloides stercoralis  1 4.8 5  4.0  0.62 
Trichuris trichuria  1 4.8 0  0.0  0.14 
Potential pathogen: 
(Blastocystis hominis) 
4 19.0 2  1.6  0.0041* Appendix 5 – Risk factors associated with B. pilosicoli  
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Appendix A5.1 Continued. 
    
 with  B. pilosicoli 
(n=21) 
without  B. pilosicoli 
(n=124) 
P value 
 No  %  No  %   
         
Uncertain pathogen:  2 9.5  6  4.8 0.33 
Endolimax nana  1 4.8  0  0.0 0.14 
Entamoeba coli  1 4.8  2  1.6 0.38 
Other Entamoeba spp.  1  4.8  2  1.6  0.38 
Trichomonas hominis  1 4.8  1  0.8 0.27 
Any parasite  11 52.4  28  22.6  0.0098* 
Any protozoan  8 38.1  25  20.2  0.067
† 
Any pathogen  8 38.1  39  31.5 0.73 
Any organism  12 57.1  38  30.6  0.034* 
Diarrhoea 10  47.6  75  60.5  0.39 
 &  vomiting  3  14.3  16  12.9  0.54 
 long  term/recurrent  4  19.0  7  5.6  0.055 
Eosinophilia 2  9.5  2  1.6  0.10 
Fever/sepsis 1  4.8  9  7.3  0.56 
Failure to thrive (FTT)  2  9.5  9  7.3  0.49 
Gastroenteritis 1  4.8  9  7.3  0.56 
Giardia? 2  9.5  4  3.2  0.21 
Loose/offensive stool  1  4.8  5  4.0  0.62 
Underweight 1  4.8  1  0.8  0.27 
Worms? 2  9.5  3  2.4  0.15 
Chronic diarrhoea, FTT or 
underweight 
7 33.3  17  13.7  0.034* 
 
* These characteristics were also significant when analysis was carried out by culture.  
† These characteristics were significant only when samples were analysed by culture.  Appendix 5 – Risk factors associated with B. pilosicoli  
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Appendix A5.2 Risk factors for B. pilosicoli detection, and the presence of other organisms 
for migrant individuals (n=227). 
        
  with B. pilosicoli (n=34) without  (n=193) P value 
 No  %  No  %   
         
Age    mean 21.4 y SD 13.4 y  mean 24.9 y SD 16.0 y  0.24 
Age    <18  y  14 41.2 69 35.8  0.68 
Female  gender  15 44.0 99 51.0  0.56 
European  origin  8  23.5 86 44.6  0.035* 
Formed or semi-formed 
stool 
27  79.0 165 85.0  0.52 
Detection of B. aalborgi 12  35.3  6  3.1  <0.001 
Bacteria: pathogenic  1 2.9 9 4.7  0.54 
Salmonella spp.  1 2.9 3 1.6  0.48 
Parasites: pathogenic  2  5.9 15 7.8  0.52 
Giardia intestinalis  2 5.9 8 4.0  0.46 
Potential pathogen: 
(Blastocystis hominis) 
11 32.4 43 22.3  0.29 
Uncertain pathogen:  10 29.4 33 17.1  0.15 
Chilomastix mesnili  1 2.9 0 0.0  0.15 
Entamoeba coli  6 17.6  13 6.7  0.046* 
Other Entamoeba  spp. 3 8.8 6 3.1  0.14 
Iodamoeba bütchlii  5 14.7 3  1.6  0.0023* 
Any parasite  15 44.1 61 31.6  0.22
† 
Any protozoan  15 44.1 57 29.5  0.14
† 
Any pathogen  3  8.8 13 6.7  0.44 
Any organism  16 47.1 68 35.2  0.26 
 
* These characteristics were also significant when analysis was carried out by culture 
(Chapter 3). 
† These characteristics were significant only when samples were analysed by culture. 
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APPENDIX 6: RISK FACTORS ASSOCIATED WITH PCR DETECTION OF 
B. AALBORGI, WHERE P > 0.25.  
Appendix A6.1 Risk factors for B. aalborgi detection in non-Aboriginal urban control 
individuals (n=90). 
    
 with  B. aalborgi 
(n=5) 
without B. aalborgi 
(n=85) 
P value 
 No  %  No  %   
         
Age <18  y  2  40.0  31/83  37.3  0.62 
Female gender  2  40.0  44  51.8  0.48 
Born in Australia   4  80.0  45/55  81.8  0.65 
Overseas travel past 6 months  1  20.0  9/55  16.4  0.61 
Formed or semi formed stool   5  100.0  66  77.6  0.30 
Pets 3  60.0  22/55  40.0  0.34 
Diarrhoea 1  20.0  21/54  38.9  0.38 
Abdominal pain  1  20.0  13/50  26.0  0.62 
 
Appendix A6.2 Risk factors for B. aalborgi detection in samples from rural non-Aboriginal 
patients (n=142), the presence of other organisms in samples and reasons for investigation.  
    
 with  B. aalborgi (n=8) without  B. aalborgi 
(n=134) 
P value 
 No  %  No  %   
          
Hospitalised 1  12.5  30  22.4  0.45 
Bacteria:   0 0.0 14  10.4  0.43 
Campylobacter coli  0 0.0 5  3.7 0.75 
Campylobacter jejuni  0 0.0 7  5.2 0.66 
Salmonella spp.  0  0.0  1  0.7  0.94 
Shigella spp. 0  0.0  2  1.5  0.89 
Parasites:  1 12.5 22  16.4 0.62 
Blastocystis hominis  0 0.0 7  5.2 0.66 
Cryptosporidium parvum  0 0.0 2  1.5 0.89 
Entamoeba coli  0 0.0 6  4.5 0.70 
Giardia intestinalis  1 12.5 9  6.7 0.45 
Strongyloides stercoralis  0 0.0 1  0.7 0.94 
Any pathogen  1 12.5 26  19.4 0.53 
Any organism  1 12.5 36  26.9 0.33 Appendix 6 – Risk factors associated with B. aalborgi  
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Appendix A6.2 Continued. 
    
 with  B. aalborgi (n=8) without  B. aalborgi 
(n=134) 
P value 
 No  %  No  %   
          
Abdominal pain  1  12.5  25  18.7  0.55 
Anaemia 0  0.0  2  1.5  0.89 
Blood/bleeding 0  0.0  10  7.5  0.54 
Diarrhoea & vomiting  0  0.0  7  5.2  0.54 
    & fever  0  0.0  4  3.0  0.71 
Crohn's disease?  0  0.0  1  0.7  0.94 
C. difficile? 0  0.0  1  0.7  0.94 
Diverticulitis 0  0.0  1  0.7  0.94 
Eosinophilia 0  0.0  2  1.5  0.89 
Fever/sepsis 0  0.0  6  4.5  0.70 
Failure to thrive (FTT)  0  0.0  1  0.7  0.94 
Gastroenteritis 0  0.0  1  0.7  0.94 
Giardia? 0  0.0  9  6.7  0.58 
Loose/offensive stool  0  0.0  8  6.0  0.62 
Nausea 0  0.0  3  2.2  0.84 
Wind 0  0.0  1  0.7  0.94 
Chronic diarrhoea, 
FTT or underweight 
0 0.0 10  7.5 0.54 
 
Appendix A6.3 Risk factors for B. aalborgi detection, the presence of other organisms and 
reasons for investigation for Aboriginal patients (n=145).  
        
  with B. aalborgi 
(n=10) 
without (n=135)  P value 
  No % No %   
        
Female  gender  5  50.0 76 56.3  0.47 
Hospitalised  4  40.0 57 42.2  0.58 
Kimberley  location  6  60.0 93 68.9  0.40 
Community  dweller  7  70.0 91 67.4  0.58 
Bacteria: pathogenic  1  10.0 23 17.0  0.48 
Salmonella  spp  1 10.0  11 8.1  0.59 
Abdominal  pain  1 10.0 4  3.0  0.30 Appendix 6 – Risk factors associated with B. aalborgi  
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Appendix A6.3 Continued.  
        
  with B. aalborgi 
(n=10) 
without (n=135)  P value 
  No % No %   
        
Anaemia  1 10.0 5  3.7  0.35 
Long term/ recurrent 
diarrhoea 
1 10.0  10 7.4  0.56 
Failure to thrive (FTT)  1  10.0  10  7.4  0.56 
Giardia?  1 10.0 5  3.7  0.35 
Weight  loss  1 10.0 4  3.0  0.30 
 
Appendix A6.4 Risk factors for detection of both B. aalborgi and B. pilosicoli, the 
frequency of other organisms and reasons for investigation in Aboriginals (n=145). 
         
  with both spirochaetes (n=6)  without (n=139)  P value 
 No  %  No  %   
          
Age <2  y  1  16.7 68  48.9   
  2 - 4 y  2  33.3  22  15.8  0.26 
  ≥5 y  3 50.0  49  35.3   
Age <2  y  1  16.7 68  48.9   
  2 - 17 y  2  33.3  30  21.6  0.30 
  ≥18 y  3 50.0  41  29.5   
Female gender  3  50.0  78  56.1  0.54 
Hospitalised 2  33.3  59  42.4  0.50 
Kimberley location  4  66.7  95  68.3  0.62 
Community dweller  5  83.3  93  66.9  0.37 
Bacteria: pathogenic  1 16.7  23  16.5  0.70 
Salmonella spp  1  16.7  11  7.9  0.41 
Giardia intestinalis  1 16.7  11  7.9  0.41 
Abdominal pain  0  0.0  5  3.6  0.81 
Anaemia 0  0.0  6  4.3  0.77 
Long term/ recurrent 
diarrhoea 
1 16.7  10  71.9  0.38 
Failure to thrive (FTT)  1  16.7  10  7.2  0.38 
Giardia? 0  0.0  6  4.3  0.77 
Weight loss  0  0.0  5  3.6  0.81 
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Appendix A6.5 Analysis of risk factors for B. aalborgi detection, and the presence of other 
organisms in migrant individuals (n = 227).  
        
  with B. aalborgi 
(n=18) 
without (n=209)  P value 
 No  %  No  %   
         
Age <18 y  7  38.9  76  36.4  0.97 
Female gender  8  44.4  105  50.0  0.82 
European origin  8  44.4  86  41.1  0.98 
Bacteria: pathogenic  0 0.0  10  4.8  0.43 
Parasites: pathogenic  2 11.1  15  7.2  0.40 
Potential pathogen: 
(Blastocystis hominis) 
4 22.2  50  23.9  0.57 
Any parasite  7 38.9  69  33.0  0.81 
Any pathogen  2 11.1  14  6.7  0.37 
Any organism  7 38.9  77  36.8  0.93 
 
Appendix A6.6 Analysis of risk factors for detection of both B. aalborgi and B. pilosicoli, 
and the presence of other organisms in migrant individuals (n = 227).  
        
  with both spirochaetes (n=12)  without (n=215)  P value 
 No  %  No  %   
         
Age <18 y  4  33.3  79  36.7  0.54 
Female gender  6  50.0  107  49.8  0.78 
European origin  6  50.0  88  40.9  0.37 
Formed or semi-formed 
stool 
11 92.0  181  84.0  0.42 
Bacteria: pathogenic  0 0.0  10  4.7  0.57 
Parasites: pathogenic  0 0.0  17  7.9  0.38 
Giardia intestinalis  0 0.0  10  4.7  0.57 
Potential pathogen: 
(Blastocystis hominis) 
2 16.7  52  24.2  0.42 
Entamoeba coli  3 25.0  46  21.4  0.50 
Any parasite  4 33.3  72  33.5  0.63 
Any pathogen  0 0.0  16  7.4  0.41 
Any organism  4 33.3  80  37.2  0.53 
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APPENDIX 7: SEQUENCE DATA 
Appendix A7.1 Sequences of B. pilosicoli 16S rRNA gene PCR products from Aboriginal 
Australian patients and migrant individuals. 
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Appendix A7.1 Continued. 
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Appendix A7.1 Continued. 
 
 
A - adenine, C- cytosine, G- guanine, T- thymine, Y - cytosine or thymine, W - adenine or 
thymine, N - nucleotide; AA - Aboriginal Australian, M - migrant. 
 
 
Appendix A7.2 Sequences of B. aalborgi 16S rRNA gene PCR products from Aboriginal 
and non-Aboriginal Australian patients, migrants and control individuals. 
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A7.2 Continued. 
 Appendix 7 – Sequence data 
219 
A7.2 Continued. 
 
 
A - adenine, C- cytosine, G- guanine, T- thymine, K - guanine or thymine, S - guanine or 
cytosine, N - nucleotide; AA - Aboriginal Australian, NA - non-Aboriginal Australian, M - 
migrant, C - control individual 
 
  
Appendix 8 – Composition of blood culture media              220 
APPENDIX 8: COMPOSITION OF BLOOD CULTURE MEDIA 
Appendix A8.1 Composition of blood culture media in g/L as listed on the pack inserts. 
                 
Component Hémoline  Septi-Chek    BACTEC BacT/Alert 
 Diphasique   
liquid, solid phase 
Anaerobic TSB  BHI Thioglyc   Anaerobic  Anaerobic  FAN 
Anaerobic 
                 
Trypticase  10,  10  10             
Casein peptone      17    15     
27.5 
19.5  
Soy peptone      3        together  3   
Gelatin  10,  10  10    20         
Digest of gelatin        3.5           
Brain heart infusion        17.5          15 
Animal tissue digest              0.5     
Meat  peptone        2         
Yeast extract  5, 5  5  2.5  4  5    4     
                 
Dextrose 3,  1  3  2.5  2  5    2.5     
Fructose             2.5     
                 
Sodium chloride  5, 5  5  5  5  2         
Sodium pyruvate  1, 1  1                
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A8.1 Continued. 
                  
Component Hémoline  Septi-Chek    BACTEC BacT/Alert 
 Diphasique   
liquid, solid phase 
Anaerobic TSB  BHI Thioglyc   Anaerobic  Anaerobic  FAN 
Anaerobic 
                 
Sodium bicarbonate  0.2, -  0.2               
Sodium citrate              0.2     
Magnesium  sulfate          0.2       
Dipotassium phosphate      2.5  2.5      2.4     
Tris  buffer  1.7,  0.7  1.6             
                 
L-Arginine 1,  1  1          2.5     
Haemin  0.005,  0.005 0.005  0.005       0.005 0.005 0.005 
Vit  K3  0.0005,  0.0005  0.0005          0.0005 0.0005 0.0005 
Vit B6  0.001, -  0.001    0.1          0.01 
NAD  0.001,  -               
“complex amino acids and 
carbohydrate substrates” 
             NS  NS 
SPS  0.25,  -  0.25  0.5  0.25  0.5    0.5 0.35 0.5 
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A8.1 Continued. 
                  
Component Hémoline  Septi-Chek   BACTEC  BacT/Alert 
 Diphasique   
liquid, solid phase 
Anaerobic TSB  BHI Thioglyc   Anaerobic  Anaerobic  FAN 
Anaerobic 
                 
Cysteine  hydrochloride    0.5             
L-cystine         0.5     NS  
Sodium  thioglycollate          0.5       
“Thiols”             1.6     
“reducing  agents”              NS  
                 
Agar heteropolysaccharide  -, 19                 
Nonionic adsorbing resin              160     
Cationic exchange resin              10     
Ecosorb                 75 
pH  7.3 7.3             
Final Volume  NS,  NS  80  70  70  70    25 40 40 
 
TSB - trypticase soy broth; BHI - brain heart infusion (modified); Thiogly - thioglycollate broth; FOS - fastidious organism supplement;  
NAD - nicotinamide adenine dinucleotide; SPS - sodium polyanetholsulfonate, NS - not statedAppendix 8 – Composition of blood culture media 
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Table 1.1 Key biochemical reactions to differentiate between members of the genus Brachyspira. 
               
Enzyme Activity*  Species Haemolysis  Indole 
production 
Hippurate 
hydrolysis 
Flagella 
per cell  α-Galactosidase  α-Glucosidase  β-Glucosidase 
MLEE 
group 
               
B. hyodysenteriae  S +
† -  22-28  -  +/-  +  I 
B. innocens  W -  -  20-26  -  +/-  +  III 
B. pilosicoli  W          - (v)  +  8-12  +/-  +/-  -  VI 
B. intermedia  W +  -  24-28  -  +  +  II 
B. murdochii  W -  -  22-26  -  -  +  V 
B. alvinipulli  W - +  22-30  -  -  +  IV 
B. aalborgi  W - W 8  -  -  -  VII 
 
Table based on that of Stanton et al. (1998), with information from Kraaz et al. (2000) and Trott et al. (1996c). 
Key: S – strong, W – weak, v – variable, + – positive, - – negative, +/- – strains can be positive or negative. 
* measured by API-ZYM 
† indole negative strains have been described (Hommez et al., 1998a; Fellström et al., 1999). 
 
    
Table 1.2 A comparison of growth substrates for Brachyspira species. 
            
Substrate  B. 
hyodysenteriae
B. 
innocens
B. 
intermedia
B. 
murdochii
B. 
pilosicoli 
B. 
alvinipulli
            
D-Glucose + +  +  +  +  + 
D-Fructose  +  +  +  +        +(v)  + 
Sucrose +  +  +  +  +  - 
D-Trehalose +  +  + +  +  - 
D-Galactose  +  +  +  -        -(v)  - 
D-Mannose  +  +  -  +        +(v)  + 
Maltose  +  + +  + v + 
N-acetyl-D-
glucosamine 
+ +  +  +  +  + 
            
D-Glucosamine            +  +  -  -  +  + 
Pyruvate +  +  +  +  +  - 
L-Fucose -  +  +  +  +  - 
D-Cellobiose -  + -  + +  ND 
D-Ribose -  -  -  -  +  - 
D-Xylose  -  - -  - v - 
Lactose +  +  -  +  ND  - 
Pyruvate +  +  +  +  +  - 
 
Table based on information in Kinyon & Harris (1979), Stanton & Lebo (1988), Swayne et 
al, (1995), Trott et al. (1996c), Stanton et al. (1997) and Stanton et al. (1998). Substrates 
which did not support the growth of any isolate include L-arabinose, D-fucose, D-raffinose, 
D-melibiose, L-rhamnose, D-xylose, galactosamine, N-acetyl-galactosamine, cellulose, 
esculin, soluble starch, pectin, mucin, glycogen, polygalacturonic acid, glutathione, glycerol, 
mannitol, acetate, lactate, succinate, and 50x MEM amino acids. 
Key: v – variable, + – positive, - – negative, ND – not determined.     
Table 1.3 Biochemical characteristics of B. pilosicoli and B. aalborgi. 
    
Substrate  B. pilosicoli  B. aalborgi 
    
Alkaline phosphatase  1-2  0-1 
Esterase C4  3-5  0-1 
Esterase lipase C8  2-4  1 
Acid phosphatase  0-1  2 
α-Galactosidase  0-5 0 
β-Galactosidase  4-5 5 
α-Glucosidase  0-3 0 
Phosphoamidase 0.5-1  1 
Aesculin hydrolysis  +  - 
Hippurate hydrolysis  +  W 
Indole -(v)  - 
H2S moderate  ND 
Fermentation of:     
Glucose   +  ND 
Fructose +  ND 
Maltose +  ND 
Sucrose +  ND 
Lactose +  ND 
Trehalose +(v)  ND 
Mannitol v  ND 
Xylose v  ND 
Mannose +  ND 
Arabinose +(v)  ND 
Cellobiose +  ND 
Galactose +  ND 
 
Table based on information from Hovind-Hougen et al. (1982), Sanna et al. (1984), 
Tompkins et al. (1986), Trott et al. (1996c) and Kraaz et al, (2000). Enzymes to which no 
reaction occurred include lipase, leucine arylamidase, valine arylamidase, cysteine 
arylamidase, trypsin, chymotrypsin, β-glucosidase β-glucuronidase, N-acetyl-β-glucosidase, 
α-mannosidase, α-fucosidase, catalase, oxidase, gelatinase.  
Key: + – positive, - – negative, v – variable, ND – not determined, W – weak, 0 - 5 – levels 
of reaction where 0 = negative, 1 = weak positive, 5 = strong positive    
Table 1.4 A summary of early prevalence surveys of intestinal spirochaetes in humans. 
      
Year  Prevalence Subjects  Reference 
      
1916  3.3%  1291 hospitalised British soldiers   (Fantham & Cantab, 
1916b) 
1917 56.5% 
41% 
554 hospitalised British soldiers with dysentery 
100 hospitalised British soldiers with non-
diarrhoeal illness 
(Carter, 1917)* 
1917 60% 
44% 
82 civilians without GI complaints 
23 healthy men in Liverpool 
(MacFie & Carter, 1917) 
1917  100%  20 native and European patients in West Africa  (MacFie, 1917) 
1918  71%  46 hospitalised patients in the Philippines with 
diarrhoeal and non-diarrhoeal illnesses 
(Crowell & Haughwort, 
1918)* 
1920  61%  100 hospitalised children in the Philippines 
with diarrhoeal and non-diarrhoeal illnesses 
(Haughwort & 
Horrilleno, 1920)* 
1921 1.2%  83 native Puerto Rican patients with no history 
of diarrhoea 
(Hegner, 1921)* 
1922 0%  105  patients  hospitalised at Johns Hopkins, 
Baltimore 
(Hogue, 1922) 
1923  28%  178 healthy infants and adults in Chicago 
130 hospitalised patients in Chicago, some 
with diarrhoea  
(Parr, 1923) 
 
Table based on Table 1 of Ruane et al. (1989). 
* cited in Ruane et al. (1989). 
    
Table 1.5 A summary of recent prevalence surveys of HIS in humans. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Cells/ Pathological 
findings 
Diagnosis Other 
organisms/ 
spirochaetes 
Significance Reference 
                 
1971 144  rectal 
biopsy 
6.9%  neoplasm, UC, Crohn’s 
disease,  
HIS on non-neoplastic  
epi cells 
LM, TEM ND 
             
 790 
appendix, 
Scotland 
7.8% total; 4/107 
51/523 
7/160 
per occasionem 
pseudoappendicitis 
acute appendicitis 
HIS; no symptoms which 
distinguished appendices 
with or without HIS 
  
HIS unlikely to 
have serious 
pathological 
importance or be 
responsible for 
appendicitis sympt
(Lee et al., 1971) see 
also Harland & Lee 
(1967) in Table 1.6  
                
1974 349  colonic 
biopsy  
525 appendix
USA 
1.9% 
 
2% 
2 polyps, 1 acute 
appendicitis rest normal; 
symptoms attributable to 
other diagnoses  
HIS on normal cells; 
microvilli loss; 
inflammation in acute 
appendicitis only; epi cell, 
lp, mφ invasion  
LM, TEM flagellates, 
gonorrhoea  
in 1 case 
mucosal invasion 
potential to cause 
structural alteration 
and sympt 
(Takeuchi et al., 
1974) 
                 
1981 100  HM 
rectal biopsy, 
Scotland 
36%  various diagnoses after 
anal intercourse but 
sympt with HIS NS  
HIS; 32% no pathogen but 
plasma &/or neutrophil 
cells in lp 
LM gonorrhoea, 
syphilis, or no 
pathogen 
HIS uncertain cause 
of mucosal 
anomaly, suggest 
sexual transmission
(McMillan & Lee, 
1981) 
                 
1983 300 
colorectal 
biopsy 
Denmark 
5.0% constipation,  diarrhoea, 
diverticulitis, Ca, 
malabsorption, gastric 
ulcer, dyspepsia 
HIS on normal cells; no 
inflammation 
LM, TEM ND  harmless 
commensal; normal 
mucosa, treatment 
didn’t relieve sympt 
(Henrik-Nielsen et 
al., 1983) 
                 
1985  8 HM AIDS, 
colorectal 
biopsy, USA
12.5% ARLS,  diarrhoea, 
weight loss, 
lymphadenopathy  
HIS; mast, plasma & mφ 
cells, no invasion 
LM, TEM NP  probably of no 
pathological 
consequence 
(Dobbins & 
Weinstein, 1985) 
                    
Table 1.5 Continued. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Cells/ Pathological 
findings 
Diagnosis Other 
organisms/ 
spirochaetes 
Significance Reference 
                 
1985 681  appendix
Denmark 
2.6% total; 2/107 
13/105 
3/414 
0/44 
per occasionem 
pseudoappendicitis 
acute appendicitis 
other conditions 
HIS on normal cells; no 
inflammation, shorter 
microvilli 
LM, TEM ND  massive HIS could 
account for 
symptoms in 
pseudoappendicitis
(Henrik-Nielsen et 
al., 1985) 
                  
1985 14  rectal 
biopsy India 
64.2%  healthy; no diarrhoea 2 
months prior to biopsy 
HIS; stunted microvilli, 
electron dense bodies,  
LM, TEM ND  HIS part of altered 
microflora of colon 
in tropical setting 
(Mathan & Mathan, 
1985) 
                  
1987 145  colonic 
biopsy 
Greece  
16.5%  
(12F, 12M) 
carcinoma, polyps, UC 
diverticulitis, diarrhoea, 
abdo pain 
HIS, absent on neoplasia, 
no inflammation 
LM, TEM ND  pathogenicity not 
yet clear 
(Delladetsima et al., 
1987) 
                  
1987 100  colonic 
biopsy 
7%  abdo pain, diarrhoea 
constipation, bleeding, 
mucus, low Hb 
HIS; mucosa 
macroscopically normal  
LM  ND  HIS may be cause 
of unexplicable LI 
sympt, marker for 
STDs in HM 
(Prior et al., 1987) 
                  
1987  122 HM USA 30%  anal discharge & 
discomfort, diarrhoea, 
proctitis,  
3 asymptomatic 
HIS; abnormal 
sigmoidoscopy and 
inflammation in 36%, no 
unique features with HIS 
LM multiple 
pathogens, HIS 
assoc with N. 
gonorrhoeae 
difficult due to 
other infections, no 
assoc with sympt or 
abnormal histology 
(Surawicz et al., 
1987) 
                 
1990 27  HIV
+ HM, 
colorectal 
biopsy, faeces 
Germany 
44%  diarrhoea, weight loss, 
fever, abdo pain or 
bloating, constipation 
HIS LM, 
TEM, C
S
growth 
characteristics 
of B. pilosicoli 
metronidazole 
improved 
symptoms 
(Käsbohrer et al., 
1990) 
                    
Table 1.5 Continued. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Cells/ Pathological 
findings 
Diagnosis Other 
organisms/ 
spirochaetes 
Significance Reference 
                 
1993 270  children,
colonic 
biopsy, UK 
1.1% 
(1F 2M) 
rectal bleeding, abdo 
pain 
HIS in crypts, inflamm, 
inflammatory cells, 
eosinophils 
LM, 
TEM, 
SEM 
Enterobius 
vermicularis, 
Ascaris 
lumbricoides 
consider HIS with 
long term diarrhoea 
in children 
(Cunha Ferreira et al., 
1993) see also Table 
1.6 
                 
1993 1205 
colorectal 
biopsy 
Norway 
1.9% 
(9F, 21M) 
bloody stools, diarrhoea, 
constipation, abdo pain 
with Ca, Crohn’s 
disease, polyps 
HIS; stunted microvilli; no 
inflammation 
LM, TEM ND  HIS may explain 
symptoms where no 
other histological 
cause was found 
(Lindboe et al., 1993) 
                 
1994 130  rectal 
biopsy HM 
Australia 
39.0% 
(44% 
HIV
+) 
25% loose stool abdo 
bloat, nausea, flatulence
HIS; patchy, moderate or 
heavy, not assoc with 
sympt, proctitis 
LM, TEM HIS assoc with 
Entamoeba 
histolytica,  
 & 3 - 5 NPP 
HIS possible 
manifestation of 
altered bowel 
immunity 
(Law et al., 1994) 
                 
1996 282  colonic 
biopsy Brazil
1.4% 
(2M, 2F) 
(1 child) 
diarrhoea, abdo pain, 
constipation, rectal 
bleeding long term 
HIS in crypts, vascular 
redness, mild inflammation, 
Ca rectum, megacolon 
LM, 
TEM, 
SEM 
ND  diarrhoea in one 
patient may have 
been caused by HIS
(De Brito et al., 1996a; 
De Brito et al., 1996b)  
see also Table 1.6 
                 
1997 109  appendix 
USA 
3.7% 
(2F, 2M) 
(1HIV
+) 
1 acute appendicitis,  
1 pseudoappendicitis,  
2 other conditions 
HIS on normal epi cells into 
crypts, no inflammation 
except 1 acute case  
LM, TEM ND  remains obscure  (Yang & Lapham, 
1997) 
                 
1998 40  HM, 
rectal biopsy 
Australia 
(~50% HIV
+)
55% minor  non-specific 
gastrointestinal sympt 
HIS on normal mucosa; no 
inflammation or invasion; 
LM, 
TEM, C
S, 
PCR 
32.5% B. 
pilosicoli by 
culture 
B. aalborgi 
significance 
overestimated in 
previous studies 
(Trivett-Moore et al., 
1998) 
                    
Table 1.5 Continued. 
                  
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Cells/ Pathological 
findings 
Diagnosis Other 
organisms/ 
spirochaetes 
Significance Reference 
                  
1999 16  colorectal 
biopsy USA, 
Norway, 
Australia 
assessing 
Brachyspira 
prevalence in 
proven HIS 
(5F, 11M) 
HIS; Ca, diverticulitis, 
polyps, abdo pain, rectal 
bleeding, also sympt in 
Guccion et al. (1995) 
Table 1.6 
HIS; no inflammation in 
Norway, Australian 
samples, USA samples as 
per Guccion et al. (1995) 
Table 1.6 
LM, PCR, 
S 
prevalence of 
62.5% B. 
aalborgi, 0% 
B. pilosicoli by 
PCR 
B. aalborgi 
confirmed as an 
aetiological agent 
of HIS  
(Mikosza et al., 1999); 
2 patients from 
Guccion et al. (1995) 
see Table 1.6 
                  
2001 45  colorectal 
biopsy, 
Denmark, 
Norway 
assessing 
Brachyspira 
prevalence in 
proven HIS 
(17F, 28M) 
HIS; diarrhoea, abdo 
pain, rectal bleeding, 
IBD, bloody, mucousy 
stools, proctitis, purulent 
discharge, polyp, Ca 
HIS on normal cells; no 
inflammation or invasion, 
rare mononuclear infiltrate 
into lp 
FISH, 
PCR, S, 
C
S 
57.9% B. 
aalborgi, 0% 
B. pilosicoli, 
44.4% new 
Brachyspira  
B. aalborgi & an 
uncharacterised 
Brachyspira spp. a 
common cause of 
HIS  
(Jensen et al., 2001) 
                  
2001 35  colorectal 
biopsy, 
Sweden 
assessing 
Brachyspira 
prevalence in 
proven HIS  
HIS; ND  ND  PCR, S  65.7% B. 
aalborgi, 5.7% 
B. pilosicoli, 
17.1% new 
Brachyspira  
B. aalborgi may be 
a more common & 
significant cause of 
HIS than previously 
thought 
(Kraaz et al., 2001) 
 
                  
2001 402 colorectal 
biopsy 
Norway  
3.0% (3F, 
9M) 
resections performed 
due to neoplasm, IBD, 
diverticulitis 
ND LM  ND  NA  (Lindboe,  2001) 
                  
2001 28  colonic, 
rectal biopsy, 
appendix, 
Australia 
(1HM 2HIV
+)
assessing 
Brachyspira 
prevalence in 
proven HIS 
(12F, 16M) 
HIS; diarrhoea, ulcers 
polyps, abdo pain, 
anaemia, rectal bleeding, 
proctitis, appendicitis, 
IBD 
HIS; inflammation, 
lymphocyte aggregates, 
polyps, increase 
eosinophils,  
LM, PCR, 
S 
prevalence of 
85.7%  
B. aalborgi, 
14.3%  
B. pilosicoli  
B. aalborgi a more 
common cause of 
HIS than B. 
pilosicoli  
in Australians  
(Mikosza et al., 2001) 
                     
Key: abdo – abdominal; AIDS – acquired immunodeficiency syndrome; ARLS – AIDS-related lymphadenopathy syndrome; assoc – associated; Ca – cancer 
or carcinoma; C
A – culture attempted; C
S – culture successful; epi – epithelial (cell); F – female; FISH – fluorescent in situ hybridisation; HIV
+ – human 
immunodeficiency virus positive; HM – homosexual male; IBD – irritable bowel disease; HIS – human intestinal spirochaetosis; LM – light microscopy; lp – 
lamina propria; mφ - macrophage; M – male; NA – not applicable; ND – not determined; NP – not present; NPP – non-pathogenic protozoa; PCR - 
polymerase chain reaction; S – sequencing; SEM – scanning electron microscopy; STDs – sexually transmitted diseases; sympt – symptoms; TEM – 
transmission electron microscopy; UC – ulcerative colitis; UK – United Kingdom; USA – United States of America 
    
Table 1.6 A summary of case and case-control studies of intestinal spirochaetes in humans. 
               
Year Subjects  Symptoms/ 
disease assoc 
Cells/ Pathological findings  Diagnosis Other 
organisms 
Treatment Reference 
               
1967 2F,  8M 
Scotland 
long term diarrhoea, 
abdo pain, constipation, 
rectal bleeding; with Ca, 
appendicitis, polyps 
HIS; epi cell vacuoles and 
lysosome, no inflammation 
LM, TEM ND  ND  (Harland & Lee, 
1967) 
              
1968 1  unkn, 
USA 
SLE, no gastrointestinal 
sympt 
HIS; normal proctoscopy  LM, TEM ND  ND  (Gear & Dobbins, 
1968) 
              
1973  2M, Italy  healthy volunteers 
without symptoms, 
normal sigmoidoscopy 
HIS; absent microvilli; more 
lymphocyte, eosinophil, mast, 
mφ cells; lysosome, epi cell, lp, 
invasion; swollen mitochondria
LM, TEM E. coli  NA (Minio et al., 1973) 
              
1977 3F,  1M 
Sweden 
diarrhoea, mucous, 
constipation, abdo pain, 
distension, appendicitis, 
HIS, mucosa otherwise normal LM, TEM, 
SEM 
ND  pen no change, doxy partial 
HIS removal, neo removed 
HIS and sympt 
(Gad et al., 1977) 
              
1977 1M 
Sweden 
long term bloody 
diarrhoea, abdo pain, 
UC, polyps 
HIS into goblet cells; changes 
of low grade UC 
LM, TEM ND  polyp removal resolved sympt (Willén et al., 1977) 
              
1981 5F,  7M 
Edinburgh
long term diarrhoea, 
abdo pain, constipation, 
bleeding, proctocolitis 
HIS; vacuoles, R bodies, 
lysosome activity, irregular 
mitochondria 
LM, TEM, 
SEM 
NP  met removed HIS and/or sympt 
or spontaneous sympt 
resolution 
(Crucioli & Busuttil, 
1981) 
              
1981 2M 
Edinburgh
diarrhoea, mucous, 
rectal bleeding 
normal or chronic inflammation 
with non-specific proctitis 
LM, TEM  ND  met removed sympt & HIS  
(1 relapse) 
(Douglas & Crucioli, 
1981) 
               
    
Table 1.6 Continued 
               
Year Subjects  Symptoms/ 
Associated diseases 
Cells/ Pathological findings  Diagnosis  Other 
organisms 
Treatment Reference 
               
1982  1M UK  Crohn’s disease, 
diarrhoea, weight loss, 
abdo pain 
HIS into crypts; cell damage, 
epi, mφ, & Schwann cell 
invasion, obscured microvilli 
LM, TEM, 
SEM 
NP  IV met and amp removed HIS (Antonakopoulos et 
al., 1982) 
              
1982  1F, UK  long term diarrhoea, 
abdo discomfort & 
distension 
HIS, proctitis  LM, TEM, 
C
S 
spirochaetes 
different from 
B. pilosicoli 
spontaneous resolution 
diarrhoea, other symptoms not 
relieved by met 
(Tompkins et al., 
1982) 
              
1984  4M UK  
(1HM) 
diarrhoea, mucous, 
weight loss, CLL,  
abdo pain 
ND  LM, TEM  ND  IV pen, non-specific removed 
sympt, or met removed sympt 
& HIS (1 relapse) 
(Cotton et al., 1984) 
              
1985 1HM   
S Africa 
diarrhoea, abdo pain, 
nausea, malaise 
HIS; mild lp oedema, vascular 
loss, occasional histiocyte 
LM  threadworm  met & mebendazole removed 
sympt & HIS 
(Burns & Hayes, 
1985) 
              
1986  1F, UK  long term diarrhoea, 
abdo pain 
HIS; microvilli blunting, epi 
cell invasion, vascularity loss 
LM, TEM, 
C
A 
NP  met removed sympt & HIS  
(1 relapse) 
(Rodgers et al., 
1986) 
              
1986  5HM UK  diarrhoea, purulent 
rectal discharge, pain on 
defecation  
HIS; microvilli loss; no 
invasion 
LM, TEM, 
C
S 
spirochaetes 
different from 
B. aalborgi 
ND (Cooper et al., 1986) 
              
1987 2F,  UK, 
Switzerland 
diarrhoea, nausea, 
constipation, rectal 
bleeding, weight loss 
HIS; epi cell vacuoles, depleted 
microvilli, lysosome activity, R 
bodies; epi cell & mφ invasion; 
mast & IgE cells increased 
LM,  
TEM, 
SEM, IHC 
ND  met removed sympt & HIS or 
spontaneous sympt resolution 
(Gebbers et al., 
1987) 
                  
Table 1.6 Continued. 
               
Year Subjects  Symptoms/ 
Associated diseases 
Cells/ Pathological findings  Diagnosis  Other 
organisms 
Treatment Reference 
               
1988  5F, 9M (3 
children), 
Ireland 
long term diarrhoea, 
abdo pain, rectal 
bleeding, constipation, 
with Ca, polyp, IBS, 
pseudoappendicitis,  
HIS; no inflammation, normal 
mucosa by TEM in 1 case 
LM, TEM 
1 case 
ND ND  (Mooney et al., 
1988) 
              
1989 1F,  2M 
Switzerland
diarrhoea, abdo pain   HIS; epi cell & mφ invasion; 
mast & IgE cells increased 
LM, TEM, 
C
S 
ND ND  (Gebbers  &  Marder, 
1989) 
              
1993 3  children 
(1F 2M) 
England 
rectal bleeding, abdo 
pain 
HIS into crypts; inflammation, 
inflammatory cells, eosinophils
LM, TEM, 
SEM 
Enterobius 
vermicularis, 
Ascaris 
lumbricoides
piperazine or mebendazole 
resolved sympt 
(Cunha Ferreira et 
al., 1993) 
              
1994 3F,  5M 
Norway 
(cases) 
case-control study of 
HIS & adenocarcinoma 
vs adenocarcinoma 
alone 
cases had HIS; no 
inflammation; lower Ig cells, 
IgD, IgE & higher IgA than 
controls 
LM   ND  ND  (Lindboe et al., 
1994) 
              
1994 1F,  1M 
Scotland 
long term diarrhoea, 
mucous, rectal bleeding 
abdo pain,  
heavy or extensive HIS, mild 
oedema, no inflammation 
TEM, 
SEM, C
A 
ND  met removed sympt & HIS or 
spontaneous sympt resolution 
(Lo et al., 1994) 
              
1994 2  children 
(1F, 1M) 
NZ 
abdo pain, weight loss, 
vomiting, bloody stool, 
fever, appendicitis  
HIS; vacuoles; epi cell, mφ, lp 
invasion, normal appendix, 
mesenteric adenitis 
LM, TEM  ND  met and neo removed HIS but 
not sympt or spontaneous 
recovery 
(White et al., 1994) 
              
1995 2M, 
England 
polyps, diverticulitis, 
faecal incontinence 
HIS on non-neoplastic 
epithelium; blunted microvilli 
LM, TEM  ND  polyp removal, but 
consequences ND 
(Coyne et al., 1995) 
                  
Table 1.6 Continued. 
               
Year Subjects  Symptoms/ 
Associated diseases 
Cells/ Pathological findings  Diagnosis  Other 
organisms 
Treatment Reference 
               
1995 2HM  AIDS 
patients, 
USA 
long term diarrhoea, 
constipation, weight loss 
polyps, fever, anorexia 
mucosal ulceration 
HIS into crypts; mφ, plasma, 
lymphoid eosinophil, cells in 
lp; invasion in mφ, lysosomes; 
inflam, stunted microvilli 
LM, TEM  Shigella spp.,
B. aalborgi 
identified 
by PCR* 
polyp removal resolved sympt, 
tri/sulf no change, met 
removed sympt & HIS 
(Guccion et al., 
1995) 
 
              
1995 1F,  2M, 
HIV
+ 
patients 
USA 
abdo pain, diarrhoea, 
fever, blood & mucous 
in stools, fever, chills, 
weight loss, fatigue  
HIS; HIS of bile canaliculi; 
ulceration, polymorph 
neutrophil infiltration of colon 
or liver,  
LM, TEM  NP  limited improvement amox/ 
clav, met removed sympt & 
HIS (1 relapse) 
(Kostman et al., 
1995) 
              
1996 2M  2F 
(1 child) 
Brazil 
diarrhoea, abdo pain, 
constipation, rectal 
bleeding long term 
HIS into crypts; mild 
inflammation, vascular redness, 
Ca rectum, megacolon 
LM, TEM, 
SEM 
ND  met removed sympt & HIS  (De Brito et al., 
1996b; De Brito et 
al., 1996a) 
              
1996 1F,  2M 
Australia 
rectal bleeding, 
proctitis, nausea, weight 
loss, abdo pain 
diarrhoea, flatulence 
HIS; stunted microvilli; mφ, 
epi, goblet & Schwann cell 
invasion  
LM, TEM  Blastocystis 
hominis 
sympt improve by 
hydrocortisone foam or high 
fibre diet  
(Padmanabhan et al., 
1996) 
              
1996 1F  child 
France 
UC, long term bloody 
diarrhoea, nausea, abdo 
pain, vomiting, oedema, 
malnourished, other 
infections, death from 
septic shock 
HIS LM    B. hominis, 
Giardia cysts 
other 
organisms 
causing 
septicaemia 
met, prednisone, sulfasalazine, 
ceftriaxone, amikacin, 
ketoconazole to treat episodes 
septicaemia, oral candidiasis, 
bronchial pneumonia without 
success 
(Zerpa et al., 1996) 
              
1998  1M, Japan weight, loss polyps, 
diabetes  
HIS on normal cells; no 
invasion 
LM, TEM, 
SEM 
ND ND  (Nakamura et al., 
1998) 
                 
Table 1.6 Continued. 
               
Year Subjects  Symptoms/ 
Associated diseases 
Cells/ Pathological findings  Diagnosis  Other 
organisms 
Treatment Reference 
               
2000  1M, USA  long term abdo bloating, 
pain, diarrhoea 
HIS; mild chronic 
inflammation, epi, goblet cell 
invasion 
LM, TEM  NP  met removed sympt  (Peghini et al., 2000) 
              
2000 1M 
Sweden 
long term bloody, 
mucousy stool 
HIS on normal cells; no 
invasion, microvillus 
effacement 
LM, TEM, 
C
S, S, IHC 
B. aalborgi by 
sequencing 
ND (Kraaz et al., 2000) 
              
2001 4  children 
(2F 2M) 
Australia 
diarrhoea, vomiting, 
weight loss, abdo pain, 
rectal bleeding 
HIS; no inflammation  LM, PCR, 
C
A 
B. aalborgi 
identified 
by PCR 
met & amox or pen removed 
sympt or sympt & HIS (1 
relapse) 
(Heine et al., 2001) 
            
2002 8  children 
(5F, 3M) 
Sweden 
abdo pain, long term 
diarrhoea, rectal 
bleeding,  
HIS, stunted microvilli; 
lymphocytes, eosinophilia, 
lesions, polyps, chronic 
inflammation 
LM, TEM   H. pylori, 
enterobiasis, 
spirochaetes 
unidentified 
eryth, doxy, clarith, met, sympt 
improve but relapse; pen no 
effect 
(Marthinsen et al., 
2002) 
              
2003 1F 
Italy 
abdo pain, long term 
mucousy diarrhoea, 
rectal bleeding 
HIS, stunted microvilli; 
mucosal erosion, colitis 
LM, TEM, 
PCR, C
S, 
B, S, RFLP 
B. aalborgi 
identified by 
RFLP-PCR, S
met resolved HIS and  
removed sympt 
(Calderaro et al., 
2003) 
              
 
* – performed by Mikosza et al. (1999). 
 
    
Key: abdo – abdominal; AIDS – acquired immunodeficiency syndrome; amox/clav – amoxicillin/clavulanic acid; Ca – cancer or carcinoma; CLL – chronic 
lymphoblastic leukaemia; clarith - clarithromycin; C
A – culture attempted; C
S – culture successful; doxy – doxycycline; epi – epithelial (cell); eryth - 
erythromycin; F – female; HIV
+ - human immunodeficiency virus positive; HM – homosexual male; IHC – immunohistochemistry; HIS - intestinal 
spirochaetosis; IV – intravenous; LM – light microscopy; lp – lamina propria; mφ – macrophage; M – male; met – metronidazole; NA – not applicable; ND – 
not determined; NP – not present; neo – neomycin; pen – penicillin; PCR – polymerase chain reaction; RFLP – restriction length polymorphism analysis; 
SEM – scanning electron microscopy; S – sequencing; SLE – systemic lupus erythema; sympt – symptoms; TEM – transmission electron microscopy; tri/sulf 
– trimethoprim/sulfamethoxazole; UC – ulcerative colitis; UK – United Kingdom; unkn – unknown; USA – United States of America.     
Table 1.7 HIS studies where organisms have been cultured or substantially described.  
         
Year  Cellular 
morphology 
Culture Comments  Organism 
identity 
Reference 
          
1974  3 -6 µm x 0.2-0.4 µm 
2-6 spirals, 4 or 6 
flagella per cell end 
N  first ultrastructural characterisation 
of intestinal spirochaetes, from 
humans and monkeys 
either or both 
Brachyspira 
spp. 
(Takeuchi et al., 1974) 
          
1983  1.7-6 µm x 0.2 µm 
pointed ends, 4 
flagella per cell end 
S original  description  of  B. aalborgi 
and accompanying prevalence study 
B. aalborgi  (Hovind-Hougen et al., 
1982; Henrik-Nielsen et al., 
1983) 
          
1985  2-4.8 µm x 0.2 µm 
λ2 µm 
4 flagella each end 
N  morphologically identical to B. 
aalborgi from Henrik-Nielsen et al. 
(1983) 
probably 
B. aalborgi  
(Henrik-Nielsen et al., 
1985) 
          
1986  4-6 µm x 0.18-0.2 
µm λ2 µm &  
<4 µm x 0.3-0.4 µm 
U  shared properties with other 
spirochaetes including B. aalborgi 
probably 
B. aalborgi  
(Rodgers et al., 1986) 
          
1986  4-5 flagella per cell 
end 
S  size not measured, but less fastidious, 
growth faster and at 37°C and 42°C 
probably 
B. pilosicoli  
(Cooper et al., 1986) 
          
1989  1.9-7.1 µm x 0.18-
0.2 µm & <4 µm x 
0.2-0.41 µm, 4-8 
flagella per cell end 
S  enzyme and morphology of cultured 
organism similar to B. aalborgi, but 
no details or speciation 
either or both 
spp. 
(Gebbers & Marder, 1989) 
          
1990  4-18 µm x  
0.21-0.35 µm  
S  growth characteristics of B. pilosicoli probably 
B. pilosicoli 
(Käsbohrer et al., 1990) 
          
1993  4-6 µm x 0.2 µm 
S shaped 
N  morphological features described for 
B. aalborgi 
either or both 
spp. 
(Lindboe et al., 1993) 
             
Table 1.7 Continued.  
         
Year  Cell morphology  Culture  Comments  Organism 
identity 
Reference 
          
1994  ND  U  culture unsuccessful after 14d 
incubation 
possibly B. 
aalborgi  
(Lo et al., 1994) 
          
1995  6-9 µm x 0.12 µm  N  consistent with other intestinal 
spirochaetes 
possibly B. 
pilosicoli  
(Kostman et al., 1995) 
          
1998  8 µm x 0.2 µm 
8 flagella (4 per end) 
N  morphological features similar to B. 
aalborgi although slightly longer 
either or both 
spp. 
(Nakamura et al., 1998) 
          
1998  B. pilosicoli were 6-
10 µm length; 4-6 
flagella per cell end 
S  B. pilosicoli isolated in only 50% 
histologically identified HIS  
B. pilosicoli, 
possibly B. 
aalborgi 
(Trivett-Moore et al., 1998) 
          
2000  ND  S  second isolation of B. aalborgi from 
biopsy  
B. aalborgi by 
sequencing 
(Kraaz et al., 2000) 
          
2000  4-5 µm length 
4 flagella per cell end 
N  unable to speciate based on 
morphological criteria 
either spp.  (Peghini et al., 2000) 
          
2001  ND  U  isolation unsuccessful on a medium 
containing vancomycin 
B. aalborgi by 
PCR 
(Heine et al., 2001) 
          
2001 ND  S  B. aalborgi isolated and 
characterised from 2 patients 
B. aalborgi by 
sequencing 
(Jensen et al., 2001) 
          
2003  4 flagella per cell end  S  B. aalborgi isolated and 
characterised from 1 patient1 
B. aalborgi by 
sequencing 
(Calderaro et al., 2003) 
          
 
Key: ND – not determined, N– not attempted, S – successful, U – unsuccessful λ – wavelength.    
Table 1.8 A summary of surveys investigating intestinal spirochaete carriage in humans. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Diagnosis Spirochaetes  Other 
organisms 
Treatment/ 
Notes 
Reference 
                 
1981  3 HM, rectal 
swabs, faeces, 
UK 
ND  2 healthy, 1 urethral 
gonorrhoea, no GI 
symptoms 
LM, TEM, 
C 
10 - 20 µm x 0.3 - 0.5 
µm, 4-5 flagella per 
cell end; B. pilosicoli?
2 NP, 1 N. 
gonorrhoea 
urethra 
none of probenecid, 
oxytet, amp cured 
spirochaetes 
(Tompkins et al., 
1981) 
               
1982 1M,  blood, 
faeces, France
ND  bloody diarrhoea, hepatitis, 
cardiomyopathy, death from 
cardiac & renal failure  
LM, BC,  
C@42°C 
probable B. pilosicoli ND pen,  symptomatic; 
gave transient 
improvement 
(Lambert & 
Goursot, 1982) 
               
1983 faeces:  1679 
Belgium 
1.2%  diarrhoea, GI problems 
without diarrhoea 
LM, 
C@42°C 
they said B. 
hyodysenteriae 
8 had enteric 
pathogens 
ND 
  129 Rwanda  14.0%  diarrhoea, associated GI 
disorders 0 - 11 mo children
     
  93 Rwanda  22.6%  asymptomatic controls         
(Goossens et al., 
1983) & cited in 
Tompkins et al. 
(1986) 
               
1984  5F, 16M, Italy   diarrhoea, abdo pain, 
constipation, weight loss, 
rectal bleeding, fever, 
diverticulitis, liver Ca, 
hepatitis, 3 AIDS 
TEM, DM, 
C 
7 µm x 0.32 µm, 5 
flagella per cell end; B. 
pilosicoli biochem & 
MLEE (Lee & 
Hampson, 1994) 
ND ND  (Sanna et al., 1982; 
Sanna et al., 1984; 
Coene et al., 1989) 
               
1986 1527  faeces 
rectal swabs, 
UK 
1.5% total  
including:  
7/34
16/330
HM no GI sympt 
healthy Asians  
(1 child diarrhoea)  
C, B  growth and B 
characteristics of  
B. pilosicoli  
7 had enteric 
pathogens 
spontaneous 
recovery in child 
(Tompkins et al., 
1986) 
               
1986 11HM,  faeces, 
USA 
ND  diarrhoea  DM, C, B  7 - 10 µm x 0.2 µm; B. 
pilosicoli by B, MLEE 
(Lee & Hampson, 1994)
ND ND  (Jones et al., 1986) 
                    
Table 1.8 Continued. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Diagnosis Spirochaetes  Other 
organisms 
Treatment Reference 
                 
1989 18HM,  6M,  9 
unknown, 
faeces, USA 
ND  diarrhoea, 2 no diarrhoea, 
10 ARC, 2 AIDS, 5 chronic 
liver disease, Crohn’s, 
colitis, irritable bowel 
disease  
DM, C  ND  Entamoeba, 
Giardia, 
Strongaloides, 
Aeromonas, 
Isospora, NPP 
mebendazole, met, 
ery; removed 
spirochaetes & 
symptoms, pen did 
not, spontaneous 3
(Ruane et al., 
1989); may include 
patients in Jones et 
al. (1986) 
               
1990 faeces,  Oman
1000 hospital 
patients 
11.4%  abdo pain, diarrhoea, 
vomiting not assoc with 
carriage  
C, B  NS  ND  (Barrett, 1990) 
 292  healthy 
Omanis 
26.7% healthy   
7.9 µm x 0.4 µm 
distinct from B. 
aalborgi; B. pilosicoli 
by MLEE (Lee & 
Hampson, 1994) 
ND 
 
  
               
1992 181,  faeces, 
Australian 
Aboriginal 
community 
32.6%  healthy but watery or 
abnormal stool more likely 
to contain spirochaetes 
C, B  size consistent with 
other Serpulina; B. 
pilosicoli by MLEE  
(Lee & Hampson, 1994)
ND  ND  (Lee & Hampson, 
1992) 
 695  mainly 
non-Aboriginal
1.2%  various GI sympt      268 Giardia, 
others ND 
ND  
               
1992 97HM,  biopsy 
faeces, 
Australia 
13.4% diarrhoea  C,  TEM, 
SEM, B 
6 - 18 µm x 0.17 - 0.25 
µm resemble  
Anguillina coli 
ND ND  (Trivett et al., 
1992) 
               
1995 1F,  5M, 
blood, France
ND  fever 4, diarrhoea 2, various 
underlying disease; death 4
DM, BC, B, 
PCR 
B. pilosicoli by 
biochem, PCR 
ND “chemotherapy” 
one survivor 
(Fournié-Amazouz 
et al., 1995; Trott et 
al., 1997b) 
                  
Table 1.8 Continued. 
                 
Year No  Patients/ 
Sample/ 
Source 
Prevalence Symptoms/ 
Associated diseases 
Diagnosis Spirochaetes  Other 
organisms 
Treatment Reference 
                 
1997 496,  rectal 
swabs, Papua 
New Guinea 
22.8%  diarrhoea, abdo pain, 
respiratory, musculoskeletal 
sympt not assoc carriage  
C, PCR  B. pilosicoli by PCR  ND  tinidazole removed 
spirochaetes in 
16/18 individuals 
(Trott et al., 1997a) 
               
1997 1M  AIDS 
patient, USA
ND thrombophlebitis  after 
chemotherapy for Kaposi’s 
sarcoma 
BC, C, B, 
PCR 
B. pilosicoli  
by B, PCR 
ND ND  (Trott et al., 1997b) 
               
2002 316,  faeces, 
India 
6% B. aalborgi 
25.3% B. pilosicoli 
3.2% both spp. 
diarrhoea, abdo pain, 
weight loss; not assoc 
with either spp. 
PCR, S  B. aalborgi and B. 
pilosicoli identified by 
PCR and sequencing 
pathogens but 
carriage with B. 
pilosicoli NS 
ND (Traub et al., 2002; 
Munshi et al., 
2003b) 
               
2002 1M,  blood, 
Greece 
ND  bloody diarrhoea, abdo pain 
fever, chills, NHL, jaundice 
death by multi organ failure
BC, LM, C, 
PCR 
B. pilosicoli by PCR  NP  IV pen removed B. 
pilosicoli & fever 
but death 2 d later 
(Kanavaki et al., 
2002) 
               
2003 500,  faeces 
Indonesia 
11.8% B. 
pilosicoli 
higher prevalence 
with diarrhoea  
C, PCR   B. pilosicoli by PCR  ND  ND 
2003 469,  faeces 
Indonesia 
22.2%, B. 
aalborgi 6% both 
spp. 
not associated with 
clinical signs 
PCR  B. aalborgi by PCR  ND  ND 
(Margawani et al., 
2003; Munshi et al., 
2003a) both studies 
on same population 
               
2003 3M,  1F  biopsy, 
blood, faeces, 
Sweden 
ND  bloody diarrhoea, abdo pain 
IBD, anaemia, PCS 
C, B, LM  B. aalborgi  
by B  
ND  UC drug 5-ASA, 
met, no 
improvement 
(Råsbäck et al, 
2003) 
               
     
Key: abdo – abdominal; AIDS – acquired immunodeficiency syndrome; ARC - AIDS related complex; amp – ampicillin; B – biochemistry; BC – blood 
culture; C – culture; Ca – cancer; DM – dark field microscopy; ery - erythromycin; F – female; GI – gastrointestinal; HM – homosexual male; IBD, 
inflammatory bowel disease; IV – intravenous; LM – light microscopy; M – male; met – metronidazole; mo - month; MLEE - multilocus enzyme 
electrophoresis; ND – not determined; NP – not present; NHL – non-Hodgkin's lymphoma; oxytet – oxytetracycline; PCR – polymerase chain reaction; pen – 
penicillin; PSC - primary sclerosing cholangitis; S – sequencing; SEM – scanning electron microscopy; sympt - symptoms; TEM – transmission electron 
microscopy; UC - ulcerative colitis UK – United Kingdom; USA – United States of America.    
Table 1.9 Growth conditions used for attempted isolation of intestinal spirochaetes from humans.  
              
Reference Organism  Base  Blood  Antibiotics  Temp  (°C) Atmosphere  (%) Time 
              
(Tompkins et al., 1981; 
Tompkins et al., 1982; 
Tompkins et al., 1986;  
Lo et al., 1994) 
B. pilosicoli  
possibly B. aalborgi
B. pilosicoli  
ND 
BA#2 5%  Hu  S  37  90H2 10CO2  5 - 14 d 
              
(Barrett, 1990)  B. pilosicoli   BA#2  10% Cow  S  37  jar  3 - 4 wk 
              
(Gebbers et al., 1987)  ND  caso agar  10% Sh  SP  38.5  95H2 5CO2  
              
(Goossens et al., 1983)  “T. hyodysenteriae”  Columbia  10% Hu  SV 10 AmpB 2  42  5H2 10CO2 85N2  
              
(Cooper et al., 1986)  B. pilosicoli  NS  NS  SP, filters  36  humidity  5 d 
              
(Trivett-Moore et al., 1998; 
Heine et al., 2001) 
B. pilosicoli  
B. aalborgi 
TSA  5% defib Ho  S  37  10H2 5CO2 85N2 daily  14  d 
              
(Käsbohrer et al., 1990)  B. pilosicoli   TSA  5% Sh  S AmpB 2  37  10CO2 90N2 14  d 
              
(Jones et al., 1986)  B. pilosicoli   TSA  5% Hu, defib Ho SP  37  GasPak  5 - 7 d 
              
(Ruane et al., 1989)  ND  TSA  5% Ho, Hu  SP  37  GasPak  5 - 7 d 
              
(Lee & Hampson, 1992)  B. pilosicoli   TSA  5% defib Cow  SVC  37  94H2 6CO2  5 - 21 d 
              
(Margawani et al., 2003)  B. pilosicoli   TSA  5% defib Cow  SVC  37  94H2 6CO2  6 - 15 d 
              
(Trott et al., 1997a)  B. pilosicoli   TSA  5% Cow  SVC also SVCPN 25 39  94H2 6CO2  5 - 15 d 
              
(Hovind-Hougen et al., 
1982) 
B. aalborgi  TSA prered  10% Calf  SP  38.5  95H2 5CO2  at least 14 d 
              
(Kraaz et al., 2000)  B. aalborgi  TSA prered  10% Calf  SP  37  90-95H2 5-10CO2 5 - 28 d 
              
(Jensen et al., 2001)  B. aalborgi  TSA prered  10% Cow  SP  37  10H2 10CO2 80N2   3 - 4 wk 
              
(Sanna et al., 1982)  B. pilosicoli   TSA  7% Ho  SR  37  GasPak  5 d 
                 
Table 1.9 Continued.  
              
Reference Organism  Base  Blood  Antibiotics  Temp  (°C) Atmosphere  (%) Time 
              
(Calderaro et al., 2003)  B. aalborgi   TSA 
BAM 
BHIB 
TSB 
5% Sh 
7% Ho 
10% FCS 
10% FCS 
SR, SP in each 
medium 
 
37 10H2 10CO2 80N2   48 h - 8 wk, 
depending on 
specimen and 
medium 
              
 
Key: AmpB 2 – amphotericin B 2 µg/ml; BA#2 – blood agar base #2; BAM – blood agar modified; BHIB – brain heart infusion broth; C – colistin; defib – 
defibrinated; Ho – horse; Hu – human; N 25 – nalidixic acid 25 µg/ml; ND – not determined; NS – not stated; P – polymyxin; prered – pre-reduced; R – 
rifampicin; S – spectinomycin; Sh – sheep; TSA – trypticase soy agar; TSB – trypticase soy broth; V – vancomycin; wk – week.    
Table 2.1 Oligonucleotide primers used in this study.  
        
Reaction Name  Primer Name  Sequence (5'-3')  Size of Amplicon (bp)  Reference 
        
B. pilosicoli 16S rRNA  Acoli 1  AGA GGA AAG TTT TTT CGC TTC    (Park et al., 1995) 
  Serp 16S R583  CCC CTA CAA TAT CCA AGA CT 
 
439
 (Mikosza et al., 2001a) 
          
B. aalborgi 16S rRNA  Brach F161  TAC CGC ATA TAC TCT TGA C 
  Brach R596c  CCT ACA ATA TCC AAG AAC C 
 
472
 
 
 
(Mikosza et al., 1999) 
        
TEM β-lactamase  TEM A  ATA AAA TTC TTG AAG AC   
  TEM B  TTA CCA ATG CTT AAT CA 
 
1076
 
 
(Mabilat et al., 1990) 
        
SHV β-lactamase  SHV OS5  TTA TCT CCC TGT TAG CCA CC   
  SHV OS6  GAT TTG CTG ATT TCG CTC GG 
 
790
 
 
(Arlet et al., 1997) 
 
    
Table 3.1 Compounds and their concentrations tested in the development of selective media 
for Brachyspira aalborgi.  
  
Compound Concentration 
  
Spectinomycin  400 µg/ml 
Vancomycin  25 µg/ml 
Colistin  25 µg/ml 
Rifampicin  12.5 µg/ml 
Polymyxin B  5 µg/ml 
Colisitin
b  10 µg 
Erythromycin
b  60 µg 
Kanamycin
b  1000 µg 
Metronidazole
a  5 µg 
Novobiocin
a  5 µg 
Ox bile  5 mg, 10 mg, 15 mg 
Penicillin G
b 2  i.u. 
Rifampicin
b  15 µg 
Sodium polyanetholsulfonate (SPS)
a 1  mg 
Vancomycin
b  5 µg 
 
aMicroring AC 
bMicroring AN 
 
 
Table 3.2 In vitro susceptibilities (µg/ml) of B. pilosicoli (n=21) to polymyxin B, 
spectinomycin and vancomycin. 
      
Antimicrobial  Range  MIC50  MIC90 
      
Polymyxin B  128 - 512  256  512 
Spectinomycin >512  >512  >512 
Vancomycin   128 - 512  512  512 
    
Table 3.3 Risk factors associated with B. pilosicoli colonisation in Aboriginals (n=151) with 
a P value ≤0.25 by univariate analysis.  
    
 with  B. pilosicoli 
(n=15) 
without B. pilosicoli 
(n=136) 
P value 
 No  %  No  %   
         
Age  <2 y  3 20.0 69  50.7   
  2 - 4 y  7  46.7  18  13.2  0.0027 
  ≥5 y  5 33.3 49  36.0   
Age <2  y  3  20.0  69  50.7   
  2 - 17 y  8  53.3  25  18.4  0.0058 
  ≥18 y  4 26.6 42  30.9   
Age   >60 y  3  20.0  6  4.4  0.047 
Hospitalised 3  20.0  59  43.4  0.081 
Loose or wet stool   9  60.0  107  78.7  0.10 
Community dweller  11  73.3  93  68.4  0.15 
Bacteria: pathogenic          
Aeromonas spp. 1  6.7  0  0.0  0.10 
Parasites: pathogenic  7 46.7 35  25.7  0.082 
Giardia intestinalis  5 33.3 14  10.3  0.025 
Hymenolepis nana  4 26.7  7  5.1  0.014 
Trichuris trichuria  1 6.7  0  0.0  0.10 
Potential pathogen: 
(Blastocystis hominis) 
3 20.0  4  2.9  0.022 
Uncertain pathogen:  2 13.3  7  5.1 0.22 
Endolimax nana  1 6.7  0  0.0  0.10 
Trichomonas hominis  1 6.7  1  0.7  0.19 
Any parasite  10 66.7  33  24.3  0.0013 
Any protozoan  9 60.0 28  20.6  0.0022 
Any pathogen  8 53.3 42  30.9  0.074 
Any organism  11 73.3  43  31.6  0.0036 
    
Table 3.4 Risk factors associated with colonisation with B. pilosicoli in migrant individuals 
(n=227) with a P value ≤0.25 by univariate analysis.  
        
  with B. pilosicoli 
(n=24) 
without B. pilosicoli 
(n=203) 
P value 
 No  %  No  %   
         
Female gender  9  37.5  104  51.2  0.20 
European origin  3  12.5  91  44.8  0.005 
Formed or semi-formed stool  18  75.0  174  85.7  0.17 
Potential pathogen: 
(Blastocystis hominis) 
10 41.7  44  21.7 0.055 
Uncertain pathogen:  8 33.3 35  17.2  0.058 
Chilomastix mesnili  1 4.2  0  0.0 0.11 
Entamoeba coli  5 20.8 14  6.9 0.036 
Other Entamoeba spp.  2  8.3  7  3.4  0.24 
Iodamoeba bütchlii  4 16.7  4  3.9 0.005 
Any parasite  13 54.2  63  31.0 0.041 
Any protozoan  13 54.2  59  29.1 0.023 
Any organism  13 54.2  71  35.0 0.11 
 
 
Table 3.5 Correlation of B. pilosicoli culture with reasons for investigation for Aboriginal 
patients.  
        
 with  B. pilosicoli 
(n=15) 
without B. pilosicoli 
(n=136) 
P value 
  No % No %   
       
Diarrhoea  6  40.0 83 61.0 0.20 
  long  term/recurrent  3 20.0 8  5.9  0.081 
Giardia?  2 13.3 4  2.9 0.11 
Underweight  1 6.7 1 0.7  0.19 
Worms?  2 13.3 3  2.2  0.086 
Chronic diarrhoea, FTT or 
underweight 
6  40.0 18 13.2  0.016 
 
FFT - Failure to thrive    
Table 3.6 Factors associated with the culture of B. pilosicoli in Australian Aboriginals 
(n=145) that remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -3.23  0.49  -     
Age <60 y  1.83  0.84  6.2  1.2 - 32.3  0.030 
Any parasite  1.85  0.60  6.3  2.0- 20.4  0.0020 
 
 
Table 3.7 Factors associated with the culture of B. pilosicoli in migrants (n=227) that 
remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -3.89  0.65  -       
Detection of B. aalborgi  1.80  0.62  6.0  1.8 - 20.3  0.0036 
European ethnicity  1.86  0.67  6.4  1.7 - 23.9  0.0054 
Iodamoeba bütchlii   1.79  0.76  6.0  1.4 - 26.3  0.018 
 
 
Table 3.8 Reasons for investigation associated with the culture of B. pilosicoli in Australian 
Aboriginals (n=145) that remained in the logistic regression model. 
        
Reason for investigation  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -1.40  0.32  -       
Diarrhoea  -1.20  0.56  0.3  0.1 – 0.9  0.033 
Long term or recurrent 
diarrhoea 
2.05 0.78  7.8  1.7-  35.8  0.0085 
    
Table 4.1 Oligonucleotide primers constructed for nested and semi-nested reactions. 
             
Reaction Name  Primer Name  Sequence (5'-3')  Amplicon Size (bp) Annealing 
temperature 
[MgCl2] 
(µM) 
5% DMSO/ 
5% glycerol 
              
B. pilosicoli 16S rRNA*  A coli 1  AGA GGA AAG TTT TTT CGC TTC   
  B pilo 16S 3R509  GAC TTA TAA ATC CGC CTA CTC AC 
 
384 
 
 
55°C 
 
2.5 
 
- 
              
B. pilosicoli nox  B pilo nox F327  CCT ATT GAG GGC TTA AAA CAA G   
  B pilo nox 3R569  TTT CAG CCT CAT CAG TAA TCT CT 
 
242 
 
 
48°C 
 
2.5 
 
- 
              
B. aalborgi 16S rRNA  B aalb 16S F144  ACC GCA TAT ACT CTT GAC GCT AA   
  B aalb 16S R519  GTT CCG CCT ACT CAC CCT TTA 
 
375 
 
 
58°C 
 
3 
 
- 
              
B. aalborgi nox  A  B aalb nox 3aF129  TAG TAA AAG ACC CGA AAG GAT TA   
  B aalb nox 1cR313  GAG GAG TTA CTG GCC AAG AA 
 
184 
 
 
50°C 
 
2 
 
+ 
              
  B  B aalb nox 7F177  AAT CAG AAG GCA TAG ATG TTC AT   
  B aalb nox 1cR313  GAG GAG TTA CTG GCC AAG AA 
 
136 
 
 
52°C 
 
1.5 
 
- 
 
* reaction was semi-nested, using A coli primer designed by Park et al. (1995).    
Table 4.2 A comparison of characteristics and risk factors in B. pilosicoli PCR positive - 
culture positive, and PCR positive - culture negative samples from Aboriginal patients.  
        
  Culture positive (n=14)  Culture negative (n=7)  P value 
 No  %  No  %   
         
0-3 d to culture of sample*  10  71.4  3  42.9  0.21 
Wet stool  2  14.3  4  57.1  0.064 
Age <2  y  2  14.3  4  57.1   
  2 - 4 y  7  50.0  0  13.7  0.025 
  ≥5 y  2 14.3 3  42.9   
Sample collected 1998  9  64.3  0  0.0  0.0068 
Presence of B. aalborgi 4  28.6  2  28.6  0.70 
Presence of any other organism  10  71.4  2  28.6  0.08 
Spirochaetes observed by 
microscopy 
11 78.6 0  0.0  0.0010 
 
* time elapsed between collection of sample and cultivation for Brachyspira spp. 
 
 
Table 4.3 Factors associated with the PCR detection of B. pilosicoli in Australian 
Aboriginals (n=145) that remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -1.88  0.33  -       
Male gender  -0.98  0.59  0.4  0.1 – 1.2  0.096 
Detection of B. aalborgi  2.46 0.77 11.8  2.6  -  53.3  0.0014 
Presence of B. hominis  2.31 0.99 10.0  1.4  -  69.6  0.020 
 
Table 4.4 Reasons for investigation associated with the PCR detection of B. pilosicoli in 
Australian Aboriginals (n=145) that remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -2.80  0.39  -     
Worms?  2.40 0.99 10.9  1.6  –  76.5  0.016 
Chronic diarrhoea, FTT, 
underweight 
1.70  0.61  5.5  1.7 – 18.1  0.005    
Table 4.5 A comparison of characteristics and risk factors in B. pilosicoli PCR positive - 
culture positive, and PCR positive - culture negative samples from migrant individuals.  
        
  Culture positive (n=24)  Culture negative (n=10)  P value 
 No  %  No  %   
          
European patient origin  3  12.5  5  50.0  0.031 
0 - 1 d to culture of sample*  19  79.2  7  70.0  0.67 
Formed or semi-formed stool  18  75.0  9  90.0  0.31 
Sample collected 1998  12  50.0  5  50.0  0.71 
Presence of B. aalborgi 6  25.0  6  60.0  0.062 
Presence of any parasite  13  54.2  2  20.0  0.072 
Spirochaetes observed by 
microscopy 
15 62.5 2 20.0  0.060 
 
* time elapsed between collection of sample and cultivation for Brachyspira spp. 
 
 
Table 4.6 Factors associated with the PCR detection of B. pilosicoli in migrants (n=227) that 
remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -3.13  0.47  -     
Detection of B. aalborgi  3.05 0.60 21.0  6.5  -  68.6  <0.001 
European ethnicity  1.23  0.51  3.4  1.2 - 9.4  0.016 
Iodamoeba bütchlii   1.88  0.77  6.5  1.4 - 29.7  0.015 
    
Table 4.7 Risk factors and reasons for investigation relating to PCR detection of B. aalborgi 
from rural non-Aboriginal patients (n=142) by univariate analysis (P ≤0.25).  
    
 with  B. aalborgi 
(n=8) 
without B. aalborgi 
(n=134) 
P value 
 No  %  No  %   
          
Age  ≥18 y  8 100.0  88  65.7 0.039 
Age <60  y  4  50.0  107  79.6   
  60 - 69 y  4  50.0  13  9.7  0.0026 
  ≥70 y  0 0.0  14  104   
Male gender  6  75.0  53  39.6  0.055 
South West location  5  62.5  26  19.4  0.013 
Formed or semi formed stool   6  75.0  57  42.5  0.077 
Diarrhoea 8  100.0  90  67.2  0.047 
Long term/recurrent diarrhoea  2  25.0  7  5.2  0.16 
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Figure 4.3 The distribution by age of B. aalborgi in rural non-Aboriginal patients (n=142). 
    
Table 4.8 Risk factors and reasons for investigation associated with PCR detection of B. 
aalborgi in Aboriginals (n=145) with a P value ≤0.25 by univariate analysis.  
        
  with B. aalborgi (n=10) without  B. aalborgi 
(n=135) 
P value 
 No  %  No  %   
          
Age <2  y  1  10.0  68  50.4   
  2 - 4 y  3  30.0  21  15.6  0.047 
  ≥5 y  6 60.0  46  34.1   
Age <2  y  1  10.0  68  50.4   
  2 - 17 y  5  50.0  27  20.0  0.026 
  ≥18 y  4 40.0  40  29.6   
Age <2  y  1  10.0  68  50.4 
  ≥2 y  9 90.0  67  49.6 
 
0.013 
Age <60  y  8  80.0  128  94.8 
  ≥60 y  2 20.0  7  5.2 
 
0.12 
Loose or wet stool   5  50.0  105  77.8  0.061 
Parasites: pathogenic  5 50.0  34  25.2  0.094 
Giardia intestinalis  2 20.0  10  7.4  0.19 
Hymenolepis nana  4 40.0  7  5.2  0.0031 
Strongyloides stercoralis  2 20.0  4  3.0  0.056 
Trichuris trichuria  1 10.0  0  0.0  0.069 
Potential pathogen: 
(Blastocystis hominis) 
2 20.0  4  3.0  0.056 
Uncertain pathogen:  2 20.0  6  4.4  0.096 
Endolimax nana  1 10.0  0  0.0  0.069 
Entamoeba coli  1 10.0  2  1.5  0.19 
Other Entamoeba spp.  1  10.0  2  1.5  0.19 
Any parasite  7 70.0  32  23.7  0.004 
Any protozoan  5 50.0  28  20.7  0.048 
Any pathogen  5 50.0  42  31.1  0.19 
Any organism  7 70.0  43  31.9  0.02 
Diarrhoea 1  10.0  84  62.2  0.016 
Eosinophilia 3  30.0  1  0.7  <0.001 
Underweight 1  10.0  1  0.7  0.13 
Worms? 2  20.0  3  2.2  0.038 
Chronic diarrhoea, FTT or  
being underweight 
3 30.0  21  15.6  0.22 
Eosinophilia, underweight or 
weight loss 
5 50.0  6  4.4  <0.001 
Eosinophilia, underweight, 
weight loss or worms? 
6 60.0  8  5.9  <0.001    
Table 4.9 Risk factors and reasons for investigation associated with PCR detection of both 
B. aalborgi and B. pilosicoli in Aboriginal patients (n=145) with a P value ≤0.25. 
          
  with both spirochaetes 
(n=6) 
without (n=139)  P value 
 No  %  No  %   
         
Age <2  y  1  16.7  68 48.9  0.13 
  ≥60 y  2 33.3  7  5.0  0.045 
Loose or wet stool   3  50.0  107  77.0  0.15 
Parasites: pathogenic  3 50.0  36  25.9  0.20 
Hymenolepis nana  2 33.3  9  6.5  0.067 
Strongyloides stercoralis  1 16.7  5  3.6  0.23 
Trichuris trichuria  1 16.7  0  0.0  0.041 
Potential pathogen: 
(Blastocystis hominis) 
2 33.3  4  2.9  0.021 
Uncertain pathogen:  2 33.3  6  4.3  0.036 
Endolimax nana  1 16.7  0  0.0  0.041 
Entamoeba coli  1 16.7  2  1.4  0.12 
Other Entamoeba spp.  1  16.7  2  1.4  0.12 
Any parasite  5 83.3  34  24.5  0.0055 
Any protozoan  4 66.7  29  20.9  0.024 
Any pathogen  3 50.0  44  31.7  0.20 
Any organism  5 83.3  45  32.4  0.019 
Diarrhoea 1  16.7  84  60.4  0.044 
Eosinophilia 2  33.3  2  1.4  0.0083 
Underweight 1  16.7  1  0.7  0.08 
Worms? 1  16.7  4  2.9  0.19 
Chronic diarrhoea, FTT or 
being underweight 
3 50.0  21  15.1  0.057 
Eosinophilia, underweight  
or weight loss 
3 50.0  8  5.8  <0.001 
Eosinophilia, underweight, 
weight loss or worms? 
4 66.7  10  7.2  <0.001 
    
Table 4.10 Factors associated with the PCR detection of B. aalborgi in Australian 
Aboriginals (n=145) that remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
       
Constant -4.78  1.05  -     
Age >2 years  1.88  1.06  6.6  0.8 - 52.3  0.075 
Any parasite  1.69  0.73  5.4  1.3 - 22.7  0.0205 
 
 
Table 4.11 Reasons for investigation associated with the PCR detection of B. aalborgi in 
Australian Aboriginals (n=145) that remained in the logistic regression model. 
        
Factor  β  SE (β)  Association with 
detection 
P value 
     OR  95%CI   
         
Constant -4.18  0.71  -       
Eosinophilia  2.32  1.38  10.2  0.7 – 154.0  0.093 
Giardia?  2.18  1.29  8.8  0.7 – 110.5  0.091 
Chronic diarrhoea, FTT, 
underweight 
1.60  0.89  4.9  0.9 – 28.6  0.074 
Eosinophilia, weight loss, 
underweight, worms? 
2.95  0.95  19.1  3.0 - 123.1  0.0019 
 
 
    
Table 4.12 Analysis of risk factors including the presence of other organisms in migrant individuals (n=227), in relation to detection of B. aalborgi or both B. 
aalborgi and B. pilosicoli by PCR.  
                
  with B. aalborgi 
(n=18) 
without (n=209)  P value  with both spirochaetes 
(n=12) 
without (n=215)  P value 
  No % No %    No  %  No  %   
                
Formed or semi-formed stool  17  94.0  175  84.0  0.20           
Giardia intestinalis  2 11.1 8  3.8  0.18           
Uncertain pathogen:  5 27.8  38  18.2  0.24  4  33.3  39 18.1 0.17 
Entamoeba coli  3 16.7  16 7.7  0.18           
Other Entamoeba spp.  2  11.1  7  3.3  0.15  2  16.7  7  3.3  0.075 
Iodamoeba bütchlii  2 11.1 6  2.9  0.13  2  16.7  6  2.8 0.060 
Any protozoan  7 38.9  30  14.4  0.014  4 33.3  33  15.3  0.11 
    
Table 5.1 Blood culture systems and media tested.  
    
Blood Culture System  Media  No isolates tested 
    
Hémoline   Diphasique  3
* 
 Anaerobic  3 
BBL Septi-Chek  TSB  3 
 BHI  3 
 Thioglycollate  Broth  3 
BACTEC 9240  PLUS Anaerobic/F with FOS  3 
  PLUS Anaerobic/F  3 + 6
† 
BacT/Alert Anaerobic  3 
  FAN Anaerobic   3 + 6 
 
Key: TSB - trypticase soy broth; BHI - brain heart infusion (modified); FOS - fastidious 
organism supplement 
*The three B. pilosicoli strains tested together were 382/91, PE90 and H171. 
†The other six B. pilosicoli strains were 28/94, RA87, H1, WesB, H121 and P43/6/78
T.    
Table 5.2 Limit of detection and minimum time to detection at any inoculum concentration 
for B. pilosicoli strains 382/91, PE90 and H171 in manual and automated blood culture 
systems. 
      
  Lowest inoculum detected 
(minimum time to detection (d)) 
System and media  382/91* PE90  H171 
      
Manual:      
Hémoline Diphasique  10
1 (2) 10
3 (5)  10
4 (7) 
Hémoline Anaerobic  10
2 (2) 10
2 (2) 10
4 (10) 
     
BBL Septi-Chek TSB   10
1 (2) 10
2 (2)  10
1 (7) 
BBL Septi-Chek BHI   10
1 (2) 10
2 (5)  10
2 (7) 
BBL Septi-Chek Thioglycollate Broth  10
1 (2) 10
1 (5) -
† 
     
Automated:      
BACTEC Plus Anaerobic/F  10
1 (5.6)
‡ 10
2 (10.7)
‡ 10
3 (7.3)
‡ 
BACTEC Plus Anaerobic/F FOS
§  10
2 (6.7)
‡ 10
2 (9.1)
‡  10
2 (7.3)
‡ 
     
BacT/Alert FAN Anaerobic  - - - 
BacT/Alert Anaerobic
§  10
4 (7) 10
3 (14.1)
‡  10
3 (9.5)
‡ 
 
* B. pilosicoli strains 382/91 and PE90 were isolated from human blood, H171 was isolated 
from human faeces. 
† No growth detected. 
‡ Detected by automated signal: all other bottles in all systems detected by subculture only. 
Subcultures required a further 5 - 8 d before detection was achieved. 
§ No bottle was inoculated at 1 x 10
1 spirochaetes/ml blood. 
    
Table 5.3 Limits of detection and time to detection for B. pilosicoli strains 28/94, RA87, H1, 
WesB, H121 and P43/6/78
T tested in automated systems.  
   
  Lowest inoculum detected 
(minimum time to detection (d)) 
   
Isolate BACTEC 
PLUS Anaerobic/F
* 
BacT/Alert 
FAN Anaerobic
† 
   
28/94 10
2 (7.4)  -
‡ 
RA87 10
2 (8.3)  10
4 (14) 
H1   10
3 (14.9)  - 
WesB 10
1 (5.7)  10
3 (7) 
H121 10
1 (8.5)  10
4 (7) 
P43/6/78
T 10
1 (6.9)  10
1 (7) 
 
* Detection by automated signal. 
† Detection by subculture, not signal. Subcultures were only taken on days 7, 14, 21 and 28 
and required a further 5 - 8 d incubation before detection was achieved. 
‡ No growth detected. 
 
 
Table 5.4 Effect of subculture and room temperature incubation on recovery of B. pilosicoli 
strains PE90 and H1 in the BACTEC blood culture system with Plus Anaerobic/F media. 
     
  Lowest inoculum detected 
(minimum time to detection (d)) 
Incubation conditions  PE90  H1 
     
No weekly subculture  10
3 (11.6)  10
4 (15.1) 
Weekly subculture  10
3 (11.2) 10
4 (14)* 
Room temperature incubation 1 d
†  10
4 (11.5)  -
§ 
Room temperature incubation 3 d
†  10
4 (13.3)  - 
 
* Detection by subculture, not signal. Subcultures required a further 5 - 8 d incubation before 
detection was achieved. 
† No bottle inoculated at 1 x 10
3 or 1 x 10
1 spirochaetes/ml blood. 
§ No growth detected.    
Table 6.1  Mlu1 PFGE types 1 - 40 for B. pilosicoli strains isolated from Aboriginal 
Australians and migrants, and reference strains.  
         
Mlu1 
type 
Isolate Gender/ 
age (y) 
Source Year  of 
isolation 
Reference^ 
         
1  H 56-2  Child  Aboriginal, Kimberley  1989-1991  (Lee & Hampson, 
1992) 
2 WHP03 
H 60-2 
F/1 
Child 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
1998 
1989-1991 
 
(Lee & Hampson, 
1992) 
3  WHP14  F/12  Aboriginal, Kimberley   1999   
4 WHP35 F/19  Eritrean  1999   
5 WHP25
‡ M/1  Somali  1998   
6 WHP34 M/56 Serbian/Croatian  1999   
7  31B  Child  Omani, reference strain    (Barrett, 1990) 
8 WHP37 M/10 Iranian  1999   
9 WHP01 F/3  Aboriginal,  Pilbara  1998   
10 WHP40 M/33 Burmese  1999   
11 WHP17 M/23 Iraqi  1998   
12 WHP04 F/3  Aboriginal,  Gascoyne  1998   
13 WHP39 F/16  Burmese  1999   
14 P43/6/78
T Pig  Porcine  type  strain  1972   
15  WHP02 
WHP07 
WHP08 
WHP09
H 
WHP11
*H 
WHP13 
Rosie 2299 
F/20 
F/9mo 
M/2 
M/4 
M/2 
F/1 
F/child 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, South Eastern 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
1998 
1998 
1998 
1998 
1999 
1999 
1989-1991 
 
 
 
 
 
 
(Lee & Hampson, 
1992) 
16 WHP20 F/12  Eritrean  1998   
17 WHP32 M/22 Somali  1999   
18 WHP19 M/3  Ethiopian  1998      
Table 6.1 Continued. 
         
Mlu1 
type 
Isolate Gender/ 
age (y) 
Source Year  of 
isolation 
Reference^ 
         
19  Margaret  F/child  Aboriginal, Kimberley  1989-1991  (Lee & Hampson, 
1992) 
20 WHP27 F/20  Afghani  1998   
21 H  44 
Quentin F1 
M/child Aboriginal,  Kimberley 
Aboriginal, Kimberley 
1989-1991 
1989-1991 
(Lee & Hampson, 
1992) 
22  WHP10 F/68  Aboriginal,  Kimberley 1998   
23 WHP22
† F/5  Afghani  1998   
24 WHP23
† F/6  Afghani  1998   
25 WHP18 M/37 Serbian  1998   
26 WHP29 M/7  Ethiopian  1999   
27 Gap401 M/adult  Homosexual  male, 
Sydney, reference strain 
 (Trivett-Moore et 
al., 1998) 
28  C Malo  Child  Aboriginal, Kimberley  1989-1991  (Lee & Hampson, 
1992) 
29 WHP33 F/20  Ethiopian  1999   
30 WHP26 M/36 Serbian  1998   
31 WHP36 M/15 Eritrean  1999   
32  WHP12
#*H 
WHP16 
167 
Naomi 
F/2 
M/77 
Child 
F/child 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
1999 
1999 
1989-1991 
1989-1991 
 
 
(Lee & Hampson, 
1992)  
33 WHP21
† F/41  Afghani  1998   
34 WHP28 M/9  Ethiopian  1998   
35 WHP30
§ 
WHP31
§ 
M/5 
M/43 
Kurd 
Kurd 
1999 
1999 
    
Table 6.1 Continued. 
         
Mlu1 
type 
Isolate Gender/ 
age (y) 
Source Year  of 
isolation 
Reference^ 
         
36 WHP05 
WHP06
#* 
H 21 
H 43 
H 7-2 
M/83 
F/2 
Child 
Child 
Child 
Aboriginal, Kimberley 
Aboriginal, Kimberley  
Aboriginal, Kimberley 
Aboriginal, Kimberley 
Aboriginal, Kimberley 
1998 
1998 
1989-1991 
1989-1991 
1989-1991 
 
 
(Lee & Hampson, 
1992) 
(Lee & Hampson, 
1992)  
37 WHP24
‡ F/21  Somali  1998   
38  Karlos  M/child  Aboriginal, Kimberley  1989-1991  (Lee & Hampson, 
1992) 
39  WesB  M/child  Aboriginal, Kimberley  1989-1991  (Lee & Hampson, 
1992) 
40 WHP38 M/38 Afghani  1999   
 
^ the remaining isolates were obtained in the work described in Chapter 3. 
†, ‡, §- these isolates were obtained from migrant individuals within three families 
#- these isolates were obtained from the same individual 
*- these isolates came from two Aboriginal patients from the same community 
H - these isolates came from three hospitalised Aboriginal patients  
highlight indicates B. pilosicoli strains which were isolated from Aboriginals in the absence 
of other pathogens 
Key: F - female, M- male.    
Table 6.2 Sma1 subtyping of B. pilosicoli which were identical by Mlu1 PFGE typing, and related isolates.  
          
Clonal 
group 
Mlu1 type  Sma1 
subtype 
Isolate  Source, gender/ age (y)  Year of 
isolation 
Comments 
          
A  1  nd  H 56-2  Aboriginal child, Kimberley  1989-1991  Additional band at 147 kb compared to MluI type 2  
  2  a  WHP03  Aboriginal, F/1, Kimberley  1998 
  2  a  H 60-2  Aboriginal child, Kimberley  1989-1991 
Two isolates identical by MluI and SmaI typing 
  3  nd  WHP14  Aboriginal, F/12, Kimberley   1999  Additional band at 355 kb compared to MluI type 2 
          
B  15  c  Rosie 2299  Aboriginal F/child, Kimberley  1989-1991  Four isolates identical by MluI and SmaI typing 
  15  c  WHP07  Aboriginal, F/9 mo, Kimberley 1998 
 15  c  WHP11* Aboriginal,  M/2,  Kimberley  1999 
 
 15  c  WHP13  Aboriginal, F/1, Kimberley  1999   
 15  d  WHP08  Aboriginal,  M/2,  Kimberley  1999  Additional band at 237 kb compared to subtype c 
 15  e  WHP09  Aboriginal, M/4, South Eastern 1998  Fragment shift from 139 kb to 150 kb compared to subtype c 
 15 f  WHP02  Aboriginal, F/20, Kimberley  1998  Loss of bands at 328 kb and 139 kb compared to subtype c 
          
C  21  g  H 44  Aboriginal child, Kimberley  1989-1991 
  21  g  Quentin F1  Aboriginal M/child, Kimberley 1989-1991 
Isolates identical by MluI and SmaI typing 
 22  nd  WHP10  Aboriginal, F/68, Kimberley  1998  Additional band at 102 kb compared to MluI type 21    
Table 6.2 Continued. 
          
Clonal 
group 
Mlu1 type  Sma1 
subtype 
Isolate  Source, gender/ age (y)  Year of 
isolation 
Comments 
          
D 32 h  WHP16  Aboriginal, M/77, Kimberley  1999  Three isolates identical by MluI and SmaI typing 
  32  h  167  Aboriginal child, Kimberley  1989-1991   
  32  h  Naomi  Aboriginal F/child, Kimberley  1989-1991   
 32  nd  WHP12
#*H  Aboriginal, F/2, Kimberley  1999  SmaI subtype not determined 
          
  35  i  WHP30  Kurd, M/5  1999  Two band differences by SmaI typing -  
  35  j  WHP31  Kurd, M/43  1999  472 kb fragment shift to 446 kb compared to subtype i 
          
E  36  k  WHP05  Aboriginal, M/83, Kimberley  1998  Five isolates identical by MluI and SmaI typing 
  36  k  WHP06  Aboriginal, F/2, Kimberley  1998   
  36  k  H 21  Aboriginal child, Kimberley  1989-1991   
  36  k  H 43  Aboriginal child, Kimberley  1989-1991   
  36  k  H 7-2  Aboriginal child, Kimberley  1989-1991   
          
F  38  nd  Karlos  Aboriginal M/child, Kimberley 1989-1991  Additional band at 362 kb and loss of a band at 148 kb 
compared to type 39 
  39  nd  WesB  Aboriginal M/child, Kimberley 1989-1991   
 
Key: nd - not determined, F - female, M - male, mo - month.  
    
Table 7.1 Cell numbers corresponding to a 0.5 McFarland Standard. 
        
Isolate Diluent/ 
conditions* 
Cell count by 
microscopy 
(spirochaetes/ml) 
Viable count by 
spread plate 
(cfu/ml) 
Log10 
reduction in 
cell number 
        
P43/6/78
T BrB  8.92  x  10
8  2.3 x 10
8 0.59 
 BrB 6.08  x  10
8 1.43  x  10
8 0.63 
 BrB 7.38  x  10
8 1.315  x  10
8 0.75 
 BrB 7.75  x  10
8  9.8 x 10
7 0.90 
  BrB/Chamber  1 x 10
9 1.04  x  10
8 0.98 
  PBS  1.5 x 10
9 3.68  x  10
8 0.61 
  PSB/Chamber  7.5 x 10
8 1.95  x  10
8 0.59 
  TE  3 x 10
8 2.65  x  10
4 4.05 
        
WesB  BrB  1.1 x 10
9 1.91  x  10
8 0.76 
  BrB  7.2 x 10
8  9.5 x 10
7 0.88 
 BrB 7.54  x  10
8  7 x 10
7 1.03 
 BrB 6.71  x  10
8 3.45  x  10
7 1.29 
 BrB/Chamber 3.96  x  10
8 2.45  x  10
7 1.21 
 PBS 3.08  x  10
8  5.4 x 10
7 1.26 
 PBS/Chamber 6.38  x  10
8 1.11  x  10
8 0.76 
 
* preparation was in air unless stated 
 
Table 7.2 Growth of 12 isolates of B. pilosicoli on media for susceptibility testing. 
      
Isolate Source  WC  BBA+H 
      
C Malo  Aboriginal  +  + spreading 
Naomi Aboriginal  +  + 
Gap 183  HS Male  +  + 
Gap 34  HS Male  light but sufficient growth  + 
Gorzalek HS  Male  +  + 
Hrm1a Italian  +  + 
Hrm2a Italian  +  light  growth 
21B  Oman  + spreading  + spreading 
V1 H45  PNG  +  + spreading 
V1 H59  PNG  +  + spreading 
1648 Pig  +  + 
Wand F  Pig  +  + 
 
HS – homosexual, + - growth present   
Table 7.3 In vitro susceptibilities (µg/ml) of 139 human and porcine B. pilosicoli strains to 
twelve antimicrobial agents. 
          
Antimicrobial  Range  MIC50  MIC90  % Sus  Breakpoint* 
          
Amoxicillin 0.25  -  128  4  64  54.7  ≥8 
Amoxicillin/ 
Clavulanic acid 
0.25/0.125 - 4/2  1/0.5  4/2  100  ≥16/8 
Ceftriaxone  0.125 - 4  0.25  1  100  ≥64 
Chloramphenicol  0.5 - 2  1  2  100  ≥32 
Ciprofloxacin  1 - 4  4  4  39.6  ≥4 
Clindamycin  <0.0325 - 64  0.5  8  86.3  ≥8 
Erythromycin  1 - >512  256  >512  na   
Gentamicin  0.5 - 32  4  16  na   
Meropenem  0.125 - 0.5  0.25  0.25  100  ≥16 
Metronidazole  0.125 - 0.5  0.25  0.25  100  ≥32 
Moxifloxacin  1 - 4  2  2  na   
Tetracycline  0.125 - 4  0.25  2  100  ≥16 
 
* - Breakpoints obtained from NCCLS et al. (1990), except for that of ciprofloxacin 
(Snydman et al., 2000). 
na - not applicable 
    
Table 7.4 Percentage of B. pilosicoli strains exhibiting a β-lactamase, resistance to amoxicillin and clindamycin, and raised MICs to erythromycin, 
gentamicin, tetracycline and ≥3 of these 5 antimicrobials. 
                  
Source 
 
No 
 
Nitrocefin 
Positive 
(%) 
Amoxicillin 
% MIC  
≥8 µg/ml 
Clindamycin 
% MIC  
≥8 µg/ml 
Erythromycin 
% MIC  
>512 µg/ml 
Gentamicin 
% MIC  
≥16 µg/ml 
Tetracycline 
% MIC  
≥1 µg/ml 
% Isolates 
raised MIC to 
≥3 antibiotics 
                  
Aboriginal Australians  32  93.8*  81.3*  12.5  28.1  0.0
† 3.1
† 12.5 
Migrants  to  WA 24  58.3  45.8  12.5 20.8 4.2  4.2
† 4.2 
Homosexual males  14  50.0  50.0  28.6  35.7  21.4  85.7*  42.9* 
Omani nationals  10  60.0  60.0  0.0  0.0  10.0  0.0  0.0 
Blood isolates  7  28.6  14.3  42.9  42.9  28.6  42.9  28.6 
Italian patients  7  28.6  28.6  0.0  0.0  14.3  28.6  14.3 
PNG villagers  29  0.0
† 0.0
† 0.0
† 0.0
† 0.0
† 0.0
† 0.0
† 
Swine 16  62.5  62.5  31.3*  43.8*  43.8*  43.8*  37.5* 
Total 139  51.1  45.3  13.7  20.9  10.8  18.7  15.1 
 
* denotes percentage values which are significantly higher than the percentage obtained for all strains 
† denotes percentage values which are significantly lower than the percentage obtained for all strains 
 
    
Table 7.5 Comparison of PFGE and MIC data for Aboriginal and two migrant strains.  
             
Clonal 
Group 
Strain*  MluI 
type 
SmaI 
subtype
AMX
† CLI
† ERY
† TET
†  Pres 
clone** 
             
A H  56-2 1  nd 16 0.5  128  0.125  1 
 H  60-2  2  a 2
‡  0.25 256  2  2 
 WHP03  2  a  2
‡ 2  >512  0.25  3 
 WHP14  3  nd  128 0.5 256 0.25  4 
             
B WHP02  15  f  4
‡ 0.25  128  0.125 5 
 WHP13  15  c  16  0.25 256 0.25  6 
 WHP07  15  c  32  0.25 256 0.25  6 
 WHP11  15  c  32 0.5  256  0.25 6 
 Rosie  2299  15  c  32 4  >512  0.125  7 
 WHP08  15  d 32 8  >512  0.125  8 
 WHP09  15  e  64 0.5  256  0.125  9 
             
C Quentin  F1  21  g  16 0.06  256  0.125  10 
 H  44  21  g  16 0.125  128  0.125 10 
 WHP10  22 nd 16 0.016  128 0.25  11 
             
D Naomi  32  h  4
‡ 4  >512  0.25  12 
 167  32  h  8 1  256  0.125  13 
 WHP16  32  h 32 0.125  128  0.125 13 
 WHP12  32 nd 64  0.5 128  0.25 13 
             
na* WHP30 35  i  1  16  >512  0.125 na 
 WHP31  35  j 0.5  0.5  128  0.125  na 
             
E H  21  36 k 16 0.25  128  0.125  14 
 WHP06  36  k 32 0.5  256  0.125  14 
 H  43  36  k  64 0.25  256  0.125  14 
 WHP05  36  k 32  16  >512  0.125  15 
 H  7-2  36 k  32  16  >512  0.125 15 
             
F Karlos  38 nd 32 0.5 32  0.125  16 
 WesB  39  nd  32 1  128  0.125  17 
             
na
# WHP01  9  nd  8 8  >512  0.125  18 
 WHP04  12 nd 8 0.125  >512  0.25  19 
 Margaret  19  nd 32 2  256  0.25  20 
 C  Malo  28 nd 32 2  256  0.125  21 
 
Key: pres - presumptive, nd - not determined, na - not applicable, * - strains from two 
migrants in the same family; **- shading indicates resistance or raised MIC, as defined in 
Table 7.4; 
† - bold indicates presumed clones which were used in recalculation of MICs; 
‡ - 
strains were positive for β-lactamase production; 
# - remaining four strains were not grouped 
in clonal groups.  
    
Table 7.6 Comparison of MIC data for strains in the current study and in other studies. 
              
Agent  n Same  MIC 
(%) 
1 Dilution 
difference (%) 
≥2 Dilutions 
difference (%) 
Sensitive in 
this study (%) 
Resistant in 
this study (%) 
Reference 
              
AMX/AMP 67  37.3  44.8  13.4  3.0  1.5  (Trott et al., 1996d; Oxberry, 2002) 
              
MZT 67  43.3  56.7    0.0  0.0  0.0  (Trott et al., 1996d; Oxberry, 2002) 
              
TET 67  49.3  40.3  0.0  10.4  0.0  (Trott et al., 1996d; Oxberry, 2002) 
              
CHL 5  40.0  60.0  0.0  0.0  0.0  (Trott et al., 1996d) 
              
ERY 5  20.0  80.0  0.0  0.0  0.0  (Trott et al., 1996d) 
              
GEN 6  16.7  33.3  0.0  0.0  50.0  (Duhamel et al., 1998b; Hommez et al., 1998b) 
              
 
Key: AMX/AMP - amoxicillin/ampicillin, MZT - metronidazole, TET - tetracycline, CHL -chloramphenicol, ERY -erythromycin, GEN - gentamicin.  
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Figure 1.1 16S rRNA dendrogram of the spirochaetes, demonstrating phylogenetic
relationships between representatives of each genera. The scale bar represents a 5% 
difference in nucleotide sequence determined by taking the sum of all the horizontal 
lines connecting two species. Adapted from Paster et al. (1991) and Paster &
Dewhirst (2000).
5%Figure 1.2 Electron micrograph of B. pilosicoli strain HRM 12, demonstrating a narrow cell with pointed ends. Bar = 1.5 µm. Negatively 
stained with 2% phosphotungstic acid. From Sellwood & Bland (1997). Figure 1.3 Scanning electron micrograph of porcine intestinal spirochaetosis
on colonic mucosa, showing end-on attachment to the luminal surface of the 
mucosal cells. Bar = 2 µm. From Sellwood and Bland (1997).
Figure 1.4 Photomicrograph of a paraffin-embedded rectal biopsy from a 60 y 
old Norwegian male with human intestinal spirochaetosis, showing a false 
brush border of B. aalborgi. Bar = 10 µm. Stained with haematoxylin and 
eosin. From Mikosza et al., (1999).Figure 3.1 The distribution by age of B. pilosicoli in migrant individuals (n=227).
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Figure 3.2 The distribution by age of B. pilosicoli in Aboriginal patients (n=151).
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Figure 3.3 Map of Western Australia with geographical areas used in the 
statistical analysis.KIMBERLEY
Fitzroy Crossing
Figure 3.3 Map of Western Australia with geographical areas used in the 
statistical analysis.Figure 3.4 Sequences of 16S rRNA gene PCR products from B. aalborgi isolates 
obtained from control individual C07. Sequences were aligned with those of the B. 
aalborgi type strain 513AT and strain W1, with numbering equivalent to E. coli
positions (Brosius et al., 1978). Colony types A and B were identical when 
sequenced in forward (F) and reverse (R) directions, as were products from mixed 
growth on primary isolation plates. Figure 3.5 Electron micrograph showing the 
two spirochaete cell types isolated from the 
faeces of a human volunteer. Bar represents 
1 µm. The plump spirochaete cell is 4.5 µm 
long and 0.25 µm wide, while the thinner 
cell type is 3.2 µm long and 0.10 - 0.13 µm 
wide.Figure 3.6 Electron micrograph showing the insertion of four periplasmic flagella into the end of the plump spirochaete isolated from 
the faeces of a human volunteer. Insertion sites are marked (    ). Bar represents 250 nm. Figure 3.7 Electron micrograph showing the insertion of four periplasmic flagella into the end of the thin spirochaete
isolated from the faeces of a human volunteer. Insertion sites are marked (    ). Bar represents 250 nm. 1 81 52 22 9
R1
R2
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R1
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1 9 17 26
492 bp
369 bpFigure 4.2 PCR products obtained from B. pilosicoli 16S rRNA gene PCR, 
comparing the QIAmp DNA extraction method with the direct cell 
inoculation of B. pilosicoli P43/6/78T. Lanes 1 – 16, Rows 1 and 2; extraction 
by QIAmp method. Lanes 1 – 7 and Lanes 9 - 15; B. pilosicoli P43/6/78T at 1 
x 108 to 1 x 102 organisms/ml in faeces, Lanes 8 and 16; faeces seeded with 
TE.
Lanes 15 – 28, Rows 1 and 2; direct inoculation of B. pilosicoli P43/6/78T. 
Lanes 17 – 24; P43/6/78T in TE at 1 x 108 to 1 x 101 organisms/ml. Lane 25, 
Row 1; positive control B. pilosicoli P43/6/78T inoculated by frozen cell pick, 
Lane 25, Row 2; PCR negative control DepC. Lane 26, Rows 1 and 2; DNA 
size standard 123bp ladder. 
Figure 4.1 PCR products obtained from B. pilosicoli 16S rRNA gene PCR, 
comparing the JetQuick and Roche DNA extraction methods. Lanes 1 – 14, 
Rows 1 and 2; extraction by Jetquick method. Lanes 1 – 6; B. pilosicoli
WesB at 1 x 108 to 1 x 103 organisms/ml of DepC in faeces, Lane 7; faeces 
seeded with DepC alone. Lanes 8 – 13 faeces seeded with WesB at 1 x 108 to 
1 x 103 organisms/ml of PBS, Lane 14; faeces seeded with PBS.
Lanes 15 – 28, Rows 1 and 2; extraction by Roche method. Lanes 15 – 20; 
faeces seeded with WesB at 1 x 108 to 1 x 103 organisms/ml of DepC, Lane 
21; faeces seeded with DepC. Lanes 22 – 27; faeces seeded with WesB at 1 x 
108 to 1 x 103 organisms/ml of PBS, Lane 28; faeces seeded with PBS. 
Lane 29, Rows 1 and 2; positive control B. pilosicoli WesB in DepC, Lane 
30, Row 1; PCR negative control DepC. Lane 30, Row 2; DNA size standard 
DNA ladder VIII.
The limit of B. pilosicoli detection after extraction by the JetQuick method 
was 1 x 105 organisms/ml of DepC or PBS and for the Roche method was 1 x 
106 organisms/ml of DepC or PBS.Figure 4.4 The distribution by age of Brachyspira spp. in Aboriginal patients (n=145).
Figure 4.5 The distribution by age of Brachyspira spp. in migrant individuals (n=227).
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sFigure 5.1 (above) The BBL SeptiChek TSB (green), 
Thioglycollate (orange) and  BHI (yellow) blood culture 
bottles. Note that light does not penetrate media well.
Figure 5.2 (below) The Hémoline
Anaerobic (red) and Diphasique (green) 
blood culture bottles. Note the agar slope on 
the side of the Diphasique bottle.Figure 5.3 (above) A BacT/Alert Anaerobic (purple) and an 
uninoculated FAN Anaerobic (orange) culture bottle. Note the 
colourimetric indicator on the bottle base, which turns yellow 
when positive and is dark green when negative.
Figure 5.4 (below) An uninoculated BACTEC Plus 
Anaerobic bottle with BACTEC FOS components.100 90 80 70 60 50 40 30
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FFigure 6.1 Dendrogram showing percentage similarity between 56 strains of 
B. pilosicoli digested with MluI enzyme. PFGE types with more than one 
strain are coloured red, and strains with similar PFGE types that were 
classified in clonal groups are highlighted yellow and designated A – F. 
Strains from Australian Aboriginals are shown in blue and migrant strains in 
black. The reference strains from Oman and Sydney and the porcine type 
strain are located in MluI types 7, 27 and 14, respectively, and are shown in 
green. Symbols †, ‡, and § represent samples obtained from migrant 
individuals of the same family. Strains WHP06 and WHP12, obtained from 
the same Aboriginal child, are located with other strains in types 36 and 32, 
respectively (#). Strain WHP09, from another Aboriginal child in the same 
community (*) is located in type 15, as is WHP11, an isolate from another 
hospitalised child (H). * * *
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Figure 6.2 PFGE banding patterns obtained from Sma1 digestion of 
strains in MluI types 35, 15, 32 and 36. Lambda DNA size standards (kb) 
are in lanes 1 and 14. Strains WHP30, WHP31, WHP02, WHP07, 
WHP08, WHP09, WHP11, WHP13, 167, WHP16, H21 and WHP06 are 
shown in lanes 2 - 13. Strains WHP30 and WHP31 differ by one band at 
approximately 440 kb (marked by the arrow). Strains WHP07, WHP11 
and WHP13 (lanes 5, 8 and 9) are identical (marked by asterisks), while 
WHP02, WHP08 and WHP09 differ from this pattern. The pairs of isolates 
167 and WHP16 (lanes 10 and 11) and H21 and WHP06 (lanes 12 and 13) 
are identical to each other.Figure 7.1 Growth of B. pilosicoli strains P43/6/78T and WesB on four media  
for susceptibility testing. Top (L - R) - blood agar, Wilkins-Chalgren agar plus 
horse serum; Bottom (L - R)  - Brucella blood agar for susceptibility testing 
plus horse serum, Brucella blood agar for susceptibility testing .Figure 7.2 (L - R) - Brucella blood agar for susceptibility testing plus horse serum (BBAS+H) and Wilkins-Chalgren agar 
plus horse serum (WC+HS) inoculated with 12 B. pilosicoli strains. Note the ease with which points of inoculation are 
observed on WC+HS, and the difficulty seeing growth on BBAS+H.0.25 0.5 1 2 4 8 16 32 64 128
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Figure 7.3 Distribution of MICs for five antimicrobial 
agents against 139 strains of B. pilosicoli.